0000081362-22-000007.txt : 20220506 0000081362-22-000007.hdr.sgml : 20220506 20220505170343 ACCESSION NUMBER: 0000081362-22-000007 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 93 CONFORMED PERIOD OF REPORT: 20220331 FILED AS OF DATE: 20220505 DATE AS OF CHANGE: 20220505 FILER: COMPANY DATA: COMPANY CONFORMED NAME: QUAKER CHEMICAL CORP CENTRAL INDEX KEY: 0000081362 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS PRODUCTS OF PETROLEUM & COAL [2990] IRS NUMBER: 230993790 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-12019 FILM NUMBER: 22897522 BUSINESS ADDRESS: STREET 1: ONE QUAKER PARK STREET 2: 901 HECTOR STREET CITY: CONSHOHOCKEN STATE: PA ZIP: 19428 BUSINESS PHONE: 6108324000 MAIL ADDRESS: STREET 1: ONE QUAKER PARK STREET 2: 901 HECTOR ST CITY: CONSHOHOCKEN STATE: PA ZIP: 19428 10-Q 1 kwr-20220331.htm QUAKER CHEMICAL CORPORATION kwr-20220331
False 2022 --12-31 30000000 Q1 0000081362 PA 1 30000000 17911583 17897033 8/1/2024 ☒ 0000081362 2022-01-01 2022-03-31 0000081362 us-gaap:RestrictedStockMember 2022-03-31 0000081362 us-gaap:RestrictedStockUnitsRSUMember 2022-03-31 0000081362 us-gaap:RestrictedStockMember 2022-01-01 2022-03-31 0000081362 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-03-31 0000081362 2021-01-01 2021-03-31 0000081362 kwr:StockOptionsCompensationExpenseMember 2022-01-01 2022-03-31 0000081362 kwr:StockOptionsCompensationExpenseMember 2021-01-01 2021-03-31 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2022-01-01 2022-03-31 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2021-01-01 2021-03-31 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2022-01-01 2022-03-31 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2021-01-01 2021-03-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-03-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-01-01 2021-03-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2022-01-01 2022-03-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2022-01-01 2022-03-31 0000081362 2022-03-31 0000081362 2021-12-31 0000081362 us-gaap:EmployeeStockOptionMember 2022-03-31 0000081362 us-gaap:CommonStockMember 2020-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000081362 us-gaap:RetainedEarningsMember 2020-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000081362 us-gaap:NoncontrollingInterestMember 2020-12-31 0000081362 us-gaap:OtherIntangibleAssetsMember 2021-12-31 0000081362 2021-03-31 0000081362 us-gaap:EMEAMember us-gaap:IntersegmentEliminationMember 2021-01-01 2021-03-31 0000081362 us-gaap:IntersegmentEliminationMember srt:AsiaPacificMember 2021-01-01 2021-03-31 0000081362 us-gaap:EMEAMember us-gaap:IntersegmentEliminationMember 2022-01-01 2022-03-31 0000081362 us-gaap:IntersegmentEliminationMember srt:AsiaPacificMember 2022-01-01 2022-03-31 0000081362 us-gaap:InterestRateSwapMember 2019-11-30 0000081362 us-gaap:InterestExpenseMember 2021-01-01 2021-03-31 0000081362 us-gaap:InterestExpenseMember 2022-01-01 2022-03-31 0000081362 srt:AmericasMember 2022-01-01 2022-03-31 0000081362 us-gaap:EMEAMember 2022-01-01 2022-03-31 0000081362 srt:AsiaPacificMember 2022-01-01 2022-03-31 0000081362 srt:AmericasMember 2021-01-01 2021-03-31 0000081362 us-gaap:EMEAMember 2021-01-01 2021-03-31 0000081362 srt:AsiaPacificMember 2021-01-01 2021-03-31 0000081362 srt:AmericasMember us-gaap:IntersegmentEliminationMember 2021-01-01 2021-03-31 0000081362 srt:AmericasMember us-gaap:IntersegmentEliminationMember 2022-01-01 2022-03-31 0000081362 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-03-31 0000081362 2022-04-30 0000081362 2020-12-31 0000081362 us-gaap:OtherIntangibleAssetsMember 2022-03-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2022-03-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2022-03-31 0000081362 kwr:MatchingStockContribution401KPlanCompensationExpenseMember 2021-01-01 2021-03-31 0000081362 kwr:MatchingStockContribution401KPlanCompensationExpenseMember 2022-01-01 2022-03-31 0000081362 2021-01-01 2021-12-31 0000081362 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateSwapMember 2021-12-31 0000081362 us-gaap:InterestRateSwapMember 2021-12-31 0000081362 us-gaap:FairValueInputsLevel1Member 2022-03-31 0000081362 us-gaap:FairValueInputsLevel2Member 2022-03-31 0000081362 us-gaap:FairValueInputsLevel3Member 2022-03-31 0000081362 us-gaap:FairValueInputsLevel1Member 2021-12-31 0000081362 us-gaap:FairValueInputsLevel2Member 2021-12-31 0000081362 us-gaap:FairValueInputsLevel3Member 2021-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2022-03-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-03-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-03-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2021-12-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2022-01-01 2022-03-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-01-01 2022-03-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-01-01 2022-03-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2021-03-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-03-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-03-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-03-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-01-01 2021-03-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-01-01 2021-03-31 0000081362 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0000081362 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0000081362 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0000081362 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-03-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0000081362 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0000081362 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-03-31 0000081362 us-gaap:RevolvingCreditFacilityMember 2022-03-31 0000081362 us-gaap:DomesticLineOfCreditMember 2022-03-31 0000081362 us-gaap:ForeignLineOfCreditMember 2022-03-31 0000081362 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember 2022-01-01 2022-03-31 0000081362 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember 2022-01-01 2022-03-31 0000081362 us-gaap:DomesticLineOfCreditMember 2021-12-31 0000081362 kwr:BankLinesOfCreditAndOtherDebtObligationsMember 2021-12-31 0000081362 kwr:BankLinesOfCreditAndOtherDebtObligationsMember 2022-03-31 0000081362 us-gaap:CorporateBondSecuritiesMember 2022-01-01 2022-03-31 0000081362 us-gaap:ForeignCountryMember country:IT 2022-01-01 2022-03-31 0000081362 us-gaap:ForeignCountryMember country:BR 2022-01-01 2022-03-31 0000081362 us-gaap:ForeignCountryMember country:NL 2022-01-01 2022-03-31 0000081362 us-gaap:ForeignCountryMember country:CN 2022-01-01 2022-03-31 0000081362 us-gaap:ForeignCountryMember country:ES 2022-01-01 2022-03-31 0000081362 us-gaap:StateAndLocalJurisdictionMember 2022-01-01 2022-03-31 0000081362 us-gaap:ForeignCountryMember country:IN 2022-01-01 2022-03-31 0000081362 srt:MinimumMember kwr:AcpMember 2022-03-31 0000081362 srt:MaximumMember kwr:AcpMember 2022-03-31 0000081362 kwr:SbDeckingMember 2022-03-31 0000081362 srt:MinimumMember kwr:HoughtonEnvironmentalMattersMember 2022-03-31 0000081362 srt:MaximumMember kwr:HoughtonEnvironmentalMattersMember 2022-03-31 0000081362 kwr:HoughtonEnvironmentalMattersMember 2022-03-31 0000081362 kwr:HoughtonEnvironmentalMattersMember 2021-12-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2022-01-01 2022-03-31 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2022-01-01 2022-03-31 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2022-01-01 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2022-01-01 2022-03-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember kwr:MetalsMember 2022-01-01 2022-03-31 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember kwr:MetalsMember 2022-01-01 2022-03-31 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember kwr:MetalsMember 2022-01-01 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember 2022-01-01 2022-03-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember us-gaap:ProductMember 2022-01-01 2022-03-31 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember us-gaap:ProductMember 2022-01-01 2022-03-31 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember us-gaap:ProductMember 2022-01-01 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:ProductMember 2022-01-01 2022-03-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2022-01-01 2022-03-31 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2022-01-01 2022-03-31 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2022-01-01 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2022-01-01 2022-03-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember 2022-01-01 2022-03-31 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember 2022-01-01 2022-03-31 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember 2022-01-01 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember 2022-01-01 2022-03-31 0000081362 us-gaap:TransferredAtPointInTimeMember srt:AmericasMember us-gaap:OperatingSegmentsMember 2022-01-01 2022-03-31 0000081362 us-gaap:EMEAMember us-gaap:TransferredAtPointInTimeMember us-gaap:OperatingSegmentsMember 2022-01-01 2022-03-31 0000081362 srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember us-gaap:OperatingSegmentsMember 2022-01-01 2022-03-31 0000081362 srt:AmericasMember us-gaap:TransferredOverTimeMember us-gaap:OperatingSegmentsMember 2022-01-01 2022-03-31 0000081362 us-gaap:EMEAMember us-gaap:TransferredOverTimeMember us-gaap:OperatingSegmentsMember 2022-01-01 2022-03-31 0000081362 srt:AsiaPacificMember us-gaap:TransferredOverTimeMember us-gaap:OperatingSegmentsMember 2022-01-01 2022-03-31 0000081362 us-gaap:TransferredAtPointInTimeMember us-gaap:OperatingSegmentsMember 2022-01-01 2022-03-31 0000081362 us-gaap:TransferredOverTimeMember us-gaap:OperatingSegmentsMember 2022-01-01 2022-03-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember kwr:MetalsMember 2021-01-01 2021-03-31 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember kwr:MetalsMember 2021-01-01 2021-03-31 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember kwr:MetalsMember 2021-01-01 2021-03-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2021-01-01 2021-03-31 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2021-01-01 2021-03-31 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2021-01-01 2021-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember 2021-01-01 2021-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2021-01-01 2021-03-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember us-gaap:ProductMember 2021-01-01 2021-03-31 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember us-gaap:ProductMember 2021-01-01 2021-03-31 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember us-gaap:ProductMember 2021-01-01 2021-03-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:ProductMember 2021-01-01 2021-03-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-03-31 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-03-31 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-03-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-03-31 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-03-31 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-03-31 0000081362 us-gaap:OperatingSegmentsMember 2021-01-01 2021-03-31 0000081362 us-gaap:TransferredAtPointInTimeMember srt:AmericasMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-03-31 0000081362 us-gaap:EMEAMember us-gaap:TransferredAtPointInTimeMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-03-31 0000081362 srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-03-31 0000081362 srt:AmericasMember us-gaap:TransferredOverTimeMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-03-31 0000081362 us-gaap:EMEAMember us-gaap:TransferredOverTimeMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-03-31 0000081362 srt:AsiaPacificMember us-gaap:TransferredOverTimeMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-03-31 0000081362 us-gaap:TransferredAtPointInTimeMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-03-31 0000081362 us-gaap:TransferredOverTimeMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-03-31 0000081362 us-gaap:IntersegmentEliminationMember kwr:GlobalSpecialtyBusinessesMember 2022-01-01 2022-03-31 0000081362 us-gaap:IntersegmentEliminationMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-03-31 0000081362 us-gaap:PerformanceSharesMember 2022-01-01 2022-03-31 0000081362 us-gaap:PerformanceSharesMember 2021-01-01 2021-03-31 0000081362 kwr:CombinationAndOtherAcquisitionRelatedMember 2022-01-01 2022-03-31 0000081362 kwr:CombinationAndOtherAcquisitionRelatedMember 2021-01-01 2021-03-31 0000081362 srt:SubsidiariesMember country:AR 2022-01-01 2022-03-31 0000081362 us-gaap:CorporateBondSecuritiesMember 2022-03-31 0000081362 us-gaap:CorporateBondSecuritiesMember 2021-12-31 0000081362 us-gaap:LineOfCreditMember 2019-11-30 0000081362 us-gaap:LineOfCreditMember 2022-03-31 0000081362 us-gaap:LineOfCreditMember 2022-01-01 2022-03-31 0000081362 srt:MaximumMember us-gaap:LineOfCreditMember 2021-03-31 0000081362 us-gaap:LineOfCreditMember 2021-12-31 0000081362 us-gaap:ForeignLineOfCreditMember 2021-12-31 0000081362 kwr:IndustrialDevelopmentBondsMember 2022-03-31 0000081362 kwr:IndustrialDevelopmentBondsMember 2021-12-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember 2021-12-31 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember 2021-12-31 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember 2021-12-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember 2022-03-31 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember 2022-03-31 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember 2021-12-31 0000081362 us-gaap:OperatingSegmentsMember 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2021-12-31 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2022-03-31 0000081362 us-gaap:InterestRateSwapMember 2022-01-01 2022-03-31 0000081362 us-gaap:InterestRateSwapMember 2021-01-01 2021-12-31 0000081362 us-gaap:ForeignCountryMember country:DE kwr:HoughtonMember 2022-03-31 0000081362 country:IT us-gaap:ForeignCountryMember 2022-03-31 0000081362 kwr:TrademarksFormulationsandproducttechnologymemberMember 2022-03-31 0000081362 kwr:TrademarksFormulationsandproducttechnologymemberMember 2021-12-31 0000081362 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember kwr:TopFiveMember 2022-01-01 2022-03-31 0000081362 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember kwr:LargestCustomerMember 2022-01-01 2022-03-31 0000081362 us-gaap:CommonStockMember 2021-03-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0000081362 us-gaap:RetainedEarningsMember 2021-03-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0000081362 us-gaap:NoncontrollingInterestMember 2021-03-31 0000081362 us-gaap:CommonStockMember 2021-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000081362 us-gaap:RetainedEarningsMember 2021-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000081362 us-gaap:NoncontrollingInterestMember 2021-12-31 0000081362 us-gaap:CommonStockMember 2022-03-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0000081362 us-gaap:RetainedEarningsMember 2022-03-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0000081362 us-gaap:NoncontrollingInterestMember 2022-03-31 0000081362 srt:SubsidiariesMember country:AR 2021-01-01 2021-03-31 0000081362 kwr:AssetsRelatedToSealingAndImpregnationOfMetalCastingsMember 2022-01-01 2022-01-31 0000081362 kwr:AssetsRelatedToPicklingInhibitorTechnologiesMember 2022-01-01 2022-01-31 0000081362 us-gaap:PatentedTechnologyMember kwr:AssetsRelatedToPicklingInhibitorTechnologiesMember 2022-01-31 0000081362 us-gaap:CustomerRelationshipsMember kwr:AssetsRelatedToPicklingInhibitorTechnologiesMember 2022-01-01 2022-01-31 0000081362 us-gaap:PatentedTechnologyMember kwr:AssetsRelatedToPicklingInhibitorTechnologiesMember 2022-01-01 2022-01-31 0000081362 kwr:BaronIndustriesMember 2021-11-01 2021-11-30 0000081362 kwr:BaronIndustriesMember 2021-11-30 0000081362 us-gaap:CustomerRelationshipsMember kwr:BaronIndustriesMember 2021-11-30 0000081362 us-gaap:PatentedTechnologyMember kwr:BaronIndustriesMember 2021-11-30 0000081362 us-gaap:CustomerRelationshipsMember kwr:BaronIndustriesMember 2021-11-01 2021-11-30 0000081362 us-gaap:PatentedTechnologyMember kwr:BaronIndustriesMember 2021-11-01 2021-11-30 0000081362 kwr:AssetsRelatedToHydraulicFluidsCoolantsCleanersAndRustPreventativeOilsMember 2021-11-01 2021-11-30 0000081362 kwr:GrindaixGmbhMember 2021-09-01 2021-09-30 0000081362 kwr:GrindaixGmbhMember 2021-09-30 0000081362 kwr:AssetsForChemicalMaskantsMember 2021-06-01 2021-06-30 0000081362 kwr:TinplatingsolutionsMember 2021-02-01 2021-02-28 0000081362 kwr:TinplatingsolutionsMember 2021-02-28 0000081362 us-gaap:CustomerRelationshipsMember kwr:TinplatingsolutionsMember 2021-02-28 0000081362 us-gaap:PatentedTechnologyMember kwr:TinplatingsolutionsMember 2021-02-28 0000081362 us-gaap:TrademarksMember kwr:TinplatingsolutionsMember 2021-02-28 0000081362 us-gaap:CustomerRelationshipsMember kwr:TinplatingsolutionsMember 2021-02-01 2021-02-28 0000081362 us-gaap:TrademarksMember kwr:TinplatingsolutionsMember 2021-02-01 2021-02-28 0000081362 us-gaap:PatentedTechnologyMember kwr:TinplatingsolutionsMember 2021-02-01 2021-02-28 0000081362 srt:MaximumMember kwr:FacilitiesVehiclesAndMachineryAndEquipmentMember 2022-03-31 0000081362 srt:MaximumMember us-gaap:LandMember 2022-03-31 0000081362 us-gaap:PerformanceSharesMember 2022-03-31 0000081362 kwr:DefinedContributionPlanMember 2022-01-01 2022-03-31 0000081362 kwr:DefinedContributionPlanMember 2021-01-01 2021-03-31 0000081362 us-gaap:ForeignCountryMember 2021-12-31 0000081362 us-gaap:ForeignCountryMember 2022-03-31 0000081362 kwr:SbDeckingMember 2022-01-01 2022-03-31 0000081362 kwr:HoughtonEnvironmentalMattersMember 2022-01-01 2022-03-31 0000081362 us-gaap:InsuranceClaimsMember 2022-03-31 0000081362 us-gaap:InsuranceClaimsMember 2022-01-01 2022-03-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-12-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2022-01-01 2022-03-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2022-03-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-12-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-01-01 2021-03-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-03-31 0000081362 us-gaap:ForeignCountryMember country:DE 2022-01-01 2022-03-31 0000081362 us-gaap:ForeignCountryMember country:MX 2022-01-01 2022-03-31 0000081362 us-gaap:ForeignCountryMember country:CA 2022-01-01 2022-03-31 0000081362 us-gaap:InternalRevenueServiceIRSMember 2022-01-01 2022-03-31 0000081362 us-gaap:ForeignCountryMember country:GB 2022-01-01 2022-03-31 0000081362 srt:MaximumMember country:IT us-gaap:ForeignCountryMember kwr:HoughtonMember 2022-01-01 2022-03-31 0000081362 srt:MinimumMember country:IT us-gaap:ForeignCountryMember kwr:HoughtonMember 2022-01-01 2022-03-31 0000081362 srt:MaximumMember country:IT us-gaap:ForeignCountryMember kwr:HoughtonMember 2021-10-01 2021-12-31 0000081362 srt:MinimumMember country:IT us-gaap:ForeignCountryMember kwr:HoughtonMember 2021-10-01 2021-12-31 0000081362 country:IT us-gaap:ForeignCountryMember kwr:HoughtonMember 2022-03-31 0000081362 country:IT us-gaap:ForeignCountryMember kwr:HoughtonMember 2022-01-01 2022-03-31 0000081362 kwr:GrindaixGmbhMember 2021-02-01 2021-02-28 0000081362 srt:MinimumMember kwr:TaxAttributesOfTheAcquisitionMember kwr:CoralChemicalCompanyMember 2022-03-31 0000081362 srt:MaximumMember kwr:TaxAttributesOfTheAcquisitionMember kwr:CoralChemicalCompanyMember 2022-03-31 0000081362 kwr:HoughtonCombinationMember 2022-03-31 0000081362 kwr:HoughtonCombinationMember 2021-12-31 0000081362 us-gaap:ForeignCountryMember kwr:NetherlandsAndSpainMember 2022-03-31 0000081362 srt:MaximumMember us-gaap:ForeignCountryMember country:DE kwr:HoughtonMember 2022-01-01 2022-03-31 0000081362 srt:MinimumMember us-gaap:ForeignCountryMember country:DE kwr:HoughtonMember 2022-01-01 2022-03-31 0000081362 us-gaap:CustomerListsMember 2022-03-31 0000081362 us-gaap:CustomerListsMember 2021-12-31 0000081362 srt:SubsidiariesMember country:AR us-gaap:AssetsTotalMember us-gaap:GeographicConcentrationRiskMember 2022-01-01 2022-03-31 0000081362 srt:SubsidiariesMember country:AR us-gaap:GeographicConcentrationRiskMember us-gaap:SalesRevenueNetMember 2022-01-01 2022-03-31 0000081362 srt:ScenarioForecastMember 2022-12-31 0000081362 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateSwapMember 2022-03-31 0000081362 us-gaap:InterestRateSwapMember 2022-03-31 0000081362 kwr:LongTermIncentivePlanLtipMember 2022-01-01 2022-03-31 0000081362 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2022-01-31 0000081362 us-gaap:CustomerRelationshipsMember us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2022-01-31 iso4217:EUR iso4217:USD xbrli:pure xbrli:shares iso4217:USD xbrli:shares dummy:People
 
 
 
 
 
 
 
 
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
 
FORM
10-Q
 
 
☒
QUARTERLY
 
REPORT PURSUANT TO SECTION 13
 
OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended
March 31, 2022
OR
 
☐
TRANSITION REPORT PURSUANT TO
 
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
 
OF 1934
For the transition period from
 
to
Commission file number
001-12019
QUAKER CHEMICAL CORPORATION
(Exact name of Registrant as specified in its charter)
 
 
Pennsylvania
 
23-0993790
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
 
901 E. Hector Street
,
Conshohocken
,
Pennsylvania
 
19428 – 2380
(Address of principal executive offices)
 
(Zip Code)
Registrant’s telephone number, including area code:
610
-
832-4000
Not Applicable
Former name, former address and former fiscal year,
 
if changed since last report.
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $1 par value
KWR
New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports
 
required to be filed by Section 13 or 15(d) of the Securities
 
Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant
 
was required to file such reports), and (2) has been subject
 
to such filing requirements for the past 90
days.
 
Yes
 
☒
 
No
 
☐
 
Indicate by check mark whether the registrant has submitted
 
electronically every Interactive Data File required to be submitted
 
pursuant to Rule 405 of Regulation
 
S-T
(§232.405 of this chapter) during the preceding 12 months (or for such
 
shorter period that the registrant was required to submit
 
such files).
 
Yes
 
☒
 
No
 
☐
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated
 
filer, a non-accelerated filer, a smaller reporting company, or an emerging
growth company. See the definitions of “large accelerated filer,” “accelerated filer,”
 
“smaller reporting company,”
 
and “emerging growth company” in Rule 12b-2 of
the Exchange Act.
Large accelerated filer
 
☒
Accelerated filer
 
☐
Non-accelerated filer
 
☐
Smaller reporting company
☐
Emerging growth company
 
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use
 
the extended transition period for complying with any new
 
or revised
financial accounting standards provided pursuant to Section 13(a)
 
of the Exchange Act.
 
☐
Indicate by check mark whether the registrant is a shell company (as
 
defined in Rule 12b-2 of the Exchange Act).
 
Yes
 
☐
 
No
 
☒
Indicate the number of shares outstanding of each of the
 
issuer’s classes of common stock, as of the latest practicable date.
Number of Shares of Common Stock
Outstanding on April 30, 2022
 
17,912,086
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2
PART
 
I
FINANCIAL INFORMATION
Item 1.
 
Financial Statements (Unaudited).
Quaker Chemical Corporation
Condensed Consolidated Statements of Income
(Dollars in thousands, except per share data)
Unaudited
Three Months Ended March 31,
2022
2021
Net sales
$
474,171
$
429,783
Cost of goods sold (excluding amortization expense - See Note 13)
 
328,100
 
273,589
 
Gross profit
 
146,071
 
156,194
Selling, general and administrative expenses
 
111,795
 
104,310
Restructuring and related charges
820
1,175
Combination, integration and other acquisition-related expenses
4,053
5,815
 
Operating income
 
29,403
 
44,894
Other (expense) income, net
 
(2,206)
 
4,687
Interest expense, net
 
(5,345)
 
(5,470)
 
Income before taxes and equity in net income of associated companies
 
21,852
 
44,111
Taxes on income before
 
equity in net income of associated companies
 
2,866
 
10,689
 
Income before equity in net income of associated companies
 
18,986
 
33,422
Equity in net income of associated companies
 
835
 
5,210
 
Net income
19,821
38,632
Less: Net income attributable to noncontrolling interest
5
17
 
Net income attributable to Quaker Chemical Corporation
$
19,816
$
38,615
Per share data:
 
 
Net income attributable to Quaker Chemical Corporation common
shareholders – basic
$
1.11
$
2.16
Net income attributable to Quaker Chemical Corporation common
 
shareholders – diluted
$
1.11
$
2.15
Dividends declared
$
0.415
$
0.395
The accompanying notes are an integral part
 
of these unaudited condensed consolidated financial statements.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3
Quaker Chemical Corporation
Condensed Consolidated Statements of Comprehensive
 
Income
(Dollars in thousands)
Unaudited
Three Months Ended March 31,
 
2022
2021
Net income
$
19,821
$
38,632
Other comprehensive (loss) income, net of tax
Currency translation adjustments
(6,866)
(25,461)
Defined benefit retirement plans
496
1,292
Current period change in fair value of derivatives
1,100
562
Unrealized loss on available-for-sale securities
(1,000)
(3,025)
Other comprehensive loss
(6,270)
(26,632)
 
Comprehensive income
13,551
12,000
Less: Comprehensive income attributable to noncontrolling
 
interest
(6)
(15)
Comprehensive income attributable to Quaker Chemical Corporation
$
13,545
$
11,985
The accompanying notes are an integral part
 
of these unaudited condensed consolidated financial statements.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4
Quaker Chemical Corporation
Condensed Consolidated Balance Sheets
(Dollars in thousands, except par value)
Unaudited
March 31,
 
December 31,
2022
2021
ASSETS
 
 
 
 
Current assets
 
 
 
 
Cash and cash equivalents
$
161,552
$
165,176
Accounts receivable, net
 
458,459
 
430,676
Inventories
Raw materials and supplies
146,289
129,382
Work-in-process
 
and finished goods
153,506
135,149
Prepaid expenses and other current assets
 
67,853
 
59,871
Total current
 
assets
 
987,659
 
920,254
Property, plant and equipment,
 
at cost
439,318
434,344
Less accumulated depreciation
(242,203)
(236,824)
Property, plant and equipment,
 
net
197,115
197,520
Right of use lease assets
38,245
36,635
Goodwill
 
630,938
 
631,194
Other intangible assets, net
 
1,012,068
 
1,027,782
Investments in associated companies
 
90,003
 
95,278
Deferred tax assets
 
11,496
 
16,138
Other non-current assets
 
29,198
 
30,959
Total assets
$
2,996,722
$
2,955,760
LIABILITIES AND EQUITY
 
 
Current liabilities
 
 
Short-term borrowings and current portion of long-term debt
$
61,385
$
56,935
Accounts payable
 
253,906
 
226,656
Dividends payable
7,433
7,427
Accrued compensation
 
26,396
 
38,197
Accrued restructuring
4,435
4,087
Accrued pension and postretirement benefits
1,549
1,548
Other accrued liabilities
 
97,445
 
95,617
Total current
 
liabilities
 
452,549
 
430,467
Long-term debt
 
858,287
 
836,412
Long-term lease liabilities
27,433
26,335
Deferred tax liabilities
 
170,622
 
179,025
Non-current accrued pension and postretirement benefits
44,667
45,984
Other non-current liabilities
 
47,464
 
49,615
Total liabilities
 
1,601,022
 
1,567,838
Commitments and contingencies (Note 18)
Equity
 
 
Common stock, $
1
 
par value; authorized
 
 
 
outstanding 2022 –
17,911,583
 
shares; 2021 –
17,897,033 shares
17,912
17,897
Capital in excess of par value
 
918,699
 
917,053
Retained earnings
 
528,716
 
516,334
Accumulated other comprehensive loss
 
(70,261)
 
(63,990)
Total Quaker
 
shareholders’ equity
 
1,395,066
 
1,387,294
Noncontrolling interest
 
634
628
Total equity
1,395,700
1,387,922
Total liabilities and equity
$
2,996,722
$
2,955,760
The accompanying notes are an integral part
 
of these unaudited condensed consolidated financial statements.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5
Quaker Chemical Corporation
Condensed Consolidated Statements of Cash Flows
(Dollars in thousands)
Unaudited
Three Months Ended March 31,
 
2022
2021
Cash flows from operating activities
 
 
 
 
 
Net income
$
19,821
$
38,632
Adjustments to reconcile net income to net cash used in operating activities:
 
 
Amortization of debt issuance costs
1,187
1,187
Depreciation and amortization
 
20,447
 
22,145
Equity in undistributed earnings of associated companies, net of dividends
 
2,135
 
(5,105)
Acquisition-related fair value adjustments related to inventory
—
801
Deferred compensation, deferred taxes and other,
 
net
(3,778)
(9,888)
Share-based compensation
 
2,462
 
3,779
Gain on disposal of property, plant,
 
equipment and other assets
 
(23)
 
(5,410)
Combination and other acquisition-related expenses, net of payments
(4,246)
(2,884)
Restructuring and related charges
820
1,175
Pension and other postretirement benefits
 
(1,316)
 
(1,034)
(Decrease) increase in cash from changes in current assets and current
 
 
liabilities, net of acquisitions:
Accounts receivable
 
(26,270)
 
(46,270)
Inventories
 
(33,873)
 
(24,994)
Prepaid expenses and other current assets
 
(6,506)
 
(8,315)
Change in restructuring liabilities
(408)
(3,034)
Accounts payable and accrued liabilities
 
23,249
 
26,597
 
Net cash used in operating activities
 
(6,299)
 
(12,618)
Cash flows from investing activities
 
 
Investments in property,
 
plant and equipment
 
(8,847)
 
(3,934)
Payments related to acquisitions, net of cash acquired
 
(9,383)
 
(26,655)
Proceeds from disposition of assets
—
14,744
 
Net cash used in investing activities
 
(18,230)
 
(15,845)
Cash flows from financing activities
 
 
Payments of long-term debt
 
(14,112)
 
(9,551)
Borrowings on revolving credit facilities, net
43,000
30,000
Repayments on other debt, net
(102)
(188)
Dividends paid
 
(7,428)
 
(7,052)
Stock options exercised, other
 
(801)
 
(178)
 
Net cash provided by financing activities
 
20,557
 
13,031
 
Effect of foreign exchange rate changes on cash
 
348
 
(3,008)
Net decrease in cash and cash equivalents
 
(3,624)
 
(18,440)
Cash and cash equivalents at the beginning of the period
 
165,176
 
181,895
Cash and cash equivalents at the end of the period
$
161,552
$
163,455
The accompanying notes are an integral part
 
of these unaudited condensed consolidated financial statements.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6
Quaker Chemical Corporation
Condensed Consolidated Statements of Changes in Equity
 
(Dollars in thousands, except per share amounts)
(Unaudited)
Accumulated
Capital in
Other
Common
Excess of
Retained
Comprehensive
Noncontrolling
Stock
Par Value
Earnings
Loss
Interest
Total
Balance at December 31, 2020
$
17,851
$
905,171
$
423,940
$
(26,598)
$
550
$
1,320,914
Net income
—
—
38,615
—
17
38,632
Amounts reported in other
comprehensive loss
—
—
—
(26,630)
(2)
(26,632)
Dividends ($
0.395
 
per share)
—
—
(7,062)
—
—
(7,062)
Share issuance and equity-based
compensation plans
24
3,577
—
—
—
3,601
Balance at March 31, 2021
$
17,875
$
908,748
$
455,493
$
(53,228)
$
565
$
1,329,453
Balance at December 31, 2021
$
17,897
$
917,053
$
516,334
$
(63,990)
$
628
$
1,387,922
Net income
—
—
19,816
—
5
19,821
Amounts reported in other
comprehensive loss
—
—
—
(6,271)
1
(6,270)
Dividends ($
0.415
 
per share)
—
—
(7,434)
—
—
(7,434)
Share issuance and equity-based
compensation plans
15
1,646
—
—
—
1,661
Balance at March 31, 2022
$
17,912
$
918,699
$
528,716
$
(70,261)
$
634
$
1,395,700
The accompanying notes are an integral part
 
of these unaudited condensed consolidated financial statements.
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
7
Note 1 – Basis of Presentation and Description of Business
 
Basis of Presentation
As used in these Notes to Condensed Consolidated Financial Statements, the
 
terms “Quaker,” “Quaker Houghton,” the
“Company,” “we,” and “our” refer to Quaker Chemical Corporation
 
(doing business as Quaker Houghton), its subsidiaries, and
associated companies, unless the context otherwise requires.
 
As used in these Notes to Condensed Consolidated Financial Statements,
the term Legacy Quaker refers to the Company prior to the closing of its combination
 
with Houghton International, Inc. (“Houghton”)
(herein referred to as the “Combination”).
 
The condensed consolidated financial statements included herein are unaudited and
 
have
been prepared in accordance with generally accepted accounting principles
 
in the United States (“U.S. GAAP”) for interim financial
reporting and the United States Securities and Exchange Commission (“SEC”)
 
regulations.
 
Certain information and footnote
disclosures normally included in financial statements prepared in accordance
 
with U.S. GAAP have been condensed or omitted
pursuant to such rules and regulations.
 
In the opinion of management, the financial statements reflect all adjustments
 
consisting only
of normal recurring adjustments, which are necessary for a fair statement of
 
the financial position, results of operations and cash flows
for the interim periods.
 
The results for the three months ended March 31, 2022 are not necessarily indicative
 
of the results to be
expected for the full year.
 
These financial statements should be read in conjunction with the Company’s
 
Annual Report filed on Form
10-K for the year ended December 31, 2021 (the “2021 Form 10-K”).
 
Description of Business
The Company was organized in 1918, incorporated as a Pennsylvania
 
business corporation in 1930, and in August 2019
completed the Combination with Houghton to form Quaker Houghton.
 
Quaker Houghton is the global leader in industrial process
fluids.
 
With a presence around the world, including
 
operations in over
25
 
countries, the Company’s customers
 
include thousands of
the world’s most advanced and specialized
 
steel, aluminum, automotive, aerospace, offshore, can,
 
mining, and metalworking
companies.
 
Quaker Houghton develops, produces, and markets a broad range of formulated chemical
 
specialty products and offers
chemical management services (which the Company refers to as “Fluidcare
TM
”) for various heavy industrial and manufacturing
applications throughout its
four
 
segments: Americas; Europe, Middle East and Africa (“EMEA”); Asia/Pacific; and
 
Global Specialty
Businesses.
Hyper-inflationary economies
Based on various indices or index compilations being used to monitor inflation
 
in Argentina as well as economic instability,
effective July 1, 2018, Argentina’s
 
economy was considered hyper-inflationary under U.S. GAAP.
 
As of, and for the three months
ended March 31, 2022, the Company's Argentine subsidiaries represented
 
less than
1
% of the Company’s consolidated
 
total assets and
net sales, respectively.
 
During each of the three months ended March 31, 2022 and 2021, the Company
 
recorded $
0.2
 
million of
remeasurement losses associated with the applicable currency conversions
 
related to Argentina.
 
These losses were recorded within
foreign exchange losses, net, which is a component of other (expense) income, net,
 
in the Company’s Condensed Consolidated
Statements of Income.
Note 2 – Business Acquisitions
2022 Acquisitions
 
In January 2022, the Company acquired a business that provides pickling
 
inhibitor technologies for the steel industry,
 
drawing
lubricants and stamping oil for metalworking, and various other lubrication,
 
rust preventative, and cleaner applications, for its
Americas reportable segment for approximately $
8.0
 
million.
 
This business broadens the Company’s
 
product offerings within its
existing metals and metalworking business in the Americas region.
 
The Company allocated $
5.6
 
million of the purchase price to
intangible assets, comprised of $
5.1
 
million of customer relationships to be amortized over
14
 
years; and $
0.5
 
million of existing
product technologies to be amortized over
14
 
years.
 
In addition, the Company recorded $
1.8
 
million of goodwill related to expected
value not allocated to other acquired assets, all of which is expected to be tax deductible
 
in various jurisdictions
 
in which the
Company operates.
 
In January 2022, the Company acquired a business related to the sealing and impregnation
 
of metal castings for the automotive
sector, as well as impregnation resin and
 
impregnation systems for metal parts, for its Global Specialty Business reportable segment
for approximately
1.2
 
million EUR or approximately $
1.4
 
million.
 
This business expands the Company's geographic presence in
Germany as well as broadens its product offerings and
 
service capabilities within its existing impregnation business acquired
 
as part of
the Norman Hay acquisition in 2019.
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
8
The results of operations of the 2022 acquired assets and businesses subsequent
 
to the respective acquisition dates are included in
the unaudited Condensed Consolidated Statements of Income for the quarter ended
 
March 31, 2022.
 
Applicable transaction expenses
associated with these acquisitions are included in Combination,
 
integration and other acquisition-related expenses in the Company’s
unaudited Condensed Consolidated Statements of Income.
 
Certain pro forma and other information is not presented, as the operations
of the acquired assets and businesses are not considered material to the overall operations
 
of the Company for the periods presented.
Previous Acquisitions
 
In November 2021, the Company acquired Baron Industries (“Baron”),
 
a privately held Company that provides vacuum
impregnation services of castings, powder metals and electrical components
 
for its Global Specialty Businesses reportable segment for
$
11.0
 
million, including an initial cash payment of $
7.1
 
million, subject to post-closing adjustments as well as certain earn-out
provisions initially estimated at $
3.9
 
million that are payable at different times from 2022 through
 
2025.
 
The earn-out provisions
could total a maximum of $
4.5
 
million.
 
The Company allocated $
8.0
 
million of the purchase price to intangible assets, $
1.1
 
million of
property, plant and
 
equipment and $
1.5
 
million of other assets acquired net of liabilities assumed, which includes $
0.3
 
million of cash
acquired.
 
In addition, the Company recorded $
0.4
 
million of goodwill, all of which is expected to be tax deductible.
 
Intangible assets
comprised $
7.2
 
million of customer relationships to be amortized over
15 years
; and $
0.8
 
million of existing product technology to be
amortized over
13 years
.
 
 
In November 2021, the Company acquired a business that provides
 
hydraulic fluids, coolants, cleaners, and rust preventative oils
in Turkey for its EMEA reportable segment for
3.2
 
million EUR or approximately $
3.7
 
million.
 
In September 2021, the Company acquired the remaining interest in Grindaix
 
-GmbH (“Grindaix”), a Germany-based, high-tech
provider of coolant control and delivery systems for its Global Specialty Businesses reportable
 
segment for
2.4
 
million EUR or
approximately $
2.9
 
million, which is gross of approximately $
0.3
 
million of cash acquired.
 
Previously, in February
 
2021, the
Company acquired a
38
% ownership interest in Grindaix for
1.4
 
million EUR or approximately $
1.7
 
million.
 
The Company recorded
its initial investment as an equity method investment within the Consolidated Financial
 
Statements and accounted for the purchase of
the remaining interest as a step acquisition whereby the Company remeasured
 
the previously held equity method investment to its fair
value.
 
In June 2021, the Company acquired certain assets for its chemical milling maskants
 
product line in the Global Specialty
Businesses reportable segment for
2.3
 
million EUR or approximately $
2.8
 
million.
 
In February 2021, the Company acquired a tin-plating solutions business for
 
the steel end market for $
25.0
 
million.
 
This
acquisition is part of each of the Company’s
 
geographic reportable segments.
 
The Company allocated $
19.6
 
million of the purchase
price to intangible assets, comprised of $
18.3
 
million of customer relationships, to be amortized over
19 years
; $
0.9
 
million of existing
product technology to be amortized over
14 years
; and $
0.4
 
million of a licensed trademark to be amortized over
3 years
.
 
In addition,
the Company recorded $
5.0
 
million of goodwill, all of which is expected to be tax deductible in various jurisdictions in which
 
we
operate.
 
Factors contributing to the purchase price that resulted in goodwill included the
 
acquisition of business processes and
personnel that will allow Quaker Houghton to better serve its customers.
 
As of March 31, 2022, the allocation of the purchase price of these acquisitions have
 
not been finalized and the one-year
measurement period has not ended, with the exception of the tin-plating
 
solutions business acquired in February 2021, the
measurement period for which ended in February 2022.
 
Further adjustments may be necessary as a result of the Company’s
 
on-going
assessment of additional information related to the fair value of assets acquired
 
and liabilities assumed.
 
In December 2020, the Company acquired Coral Chemical Corporation (“Coral”),
 
a privately held U.S.-based provider of metal
finishing fluid solutions.
 
Subsequent to the acquisition, the Company and the sellers of Coral (the “Sellers”) have
 
worked to finalize
certain post-closing adjustments.
 
In April 2022, after failing to reach resolution, the Sellers filed suit asserting certain
 
amounts owed
related to tax attributes of the acquisition.
 
Based on the facts and circumstances of the claim asserted by the Sellers, the Company
believes the potential range of exposure for this claim is $
0
 
to $
1.5
 
million.
 
Note 3 – Recently Issued Accounting Standards
Recently Issued Accounting Standards
 
Adopted
The FASB issued ASU 2020
 
-04
, Reference Rate Reform (Topic
 
848): Facilitation of the Effects of Reference Rate Reform
 
on
Financial Reporting
 
in March 2020.
 
The FASB subsequently
 
issued ASU 2021-01
, Reference Rate Reform (Topic
 
848): Scope
 
in
January 2021 which clarified the guidance but did not materially change
 
the guidance or its applicability to the Company.
 
The
amendments provide temporary optional expedients and exceptions
 
for applying U.S. GAAP to contract modifications, hedging
relationships and other transactions to ease the potential accounting
 
and financial reporting burden associated with transitioning away
from reference rates that are expected to be discontinued, including
 
the London Interbank Offered Rate (“LIBOR”).
 
ASU 2020-04 is
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
9
effective for the Company as of March 12, 2020 and generally can
 
be applied through December 31, 2022.
 
On December 10, 2021,
the Company entered into a Second Amendment to Credit Agreement (“Second
 
Amendment”) with Bank of America N.A., an update
to provide for the use of a non-USD currency LIBOR successor rate.
 
The Company elected to apply the expedients provided in ASU
2020-04 with respect to the Second Amendment.
 
The Company will continue to monitor for potential impacts related to its USD-
based LIBOR rates.
 
See Note 14 of Notes to Condensed Consolidated Financial Statements.
Note 4 – Business Segments
The Company’s operating
 
segments, which are consistent with its reportable segments, reflect the structure of the
 
Company’s
internal organization, the method by which the Company’s
 
resources are allocated and the manner by which the chief operating
decision maker assesses the Company’s
 
performance.
 
The Company has
four
 
reportable segments: (i) Americas; (ii) EMEA; (iii)
Asia/Pacific; and (iv) Global Specialty Businesses.
 
The three geographic segments are composed of the net sales and operations in
each respective region, excluding net sales and operations managed globally
 
by the Global Specialty Businesses segment, which
includes the Company’s container,
 
metal finishing,
 
mining, offshore, specialty coatings, specialty grease and Norman
 
Hay businesses.
Segment operating earnings for each of the Company’s
 
reportable segments are comprised of the segment’s
 
net sales less directly
related cost of goods sold (“COGS”) and selling, general and administrative
 
expenses (“SG&A”).
 
Operating expenses not directly
attributable to the net sales of each respective segment,
 
such as certain corporate and administrative costs, Combination, integration
and other acquisition-related expenses, and Restructuring and related
 
charges,
 
are not included in segment operating earnings.
 
Other
items not specifically identified with the Company’s
 
reportable segments include interest expense, net and other (expense) income,
net.
The following table presents information about the performance of the Company’s
 
reportable operating segments for the three
months ended March 31, 2022 and 2021:
Three Months Ended
March 31,
 
2022
2021
Net sales
 
 
 
 
 
 
Americas
$
154,144
$
134,871
EMEA
 
125,687
 
119,814
Asia/Pacific
 
104,234
 
96,706
Global Specialty Businesses
 
90,106
 
78,392
Total
 
net sales
$
474,171
$
429,783
Segment operating earnings
Americas
$
29,220
$
32,234
EMEA
16,766
25,244
Asia/Pacific
21,907
27,478
Global Specialty Businesses
 
25,035
 
24,169
Total
 
segment operating earnings
 
92,928
 
109,125
Combination, integration and other acquisition-related expenses
(4,053)
(5,815)
Restructuring and related charges
(820)
(1,175)
Fair value step up of acquired inventory sold
—
(801)
Non-operating and administrative expenses
 
(43,463)
 
(40,992)
Depreciation of corporate assets and amortization
 
(15,189)
 
(15,448)
Operating income
29,403
44,894
Other (expense) income, net
(2,206)
4,687
Interest expense, net
 
(5,345)
 
(5,470)
Income before taxes and equity in net income of associated companies
$
21,852
$
44,111
Inter-segment revenues for the three months ended March 31,
 
2022 and 2021 were $
2.9
 
million and $
3.3
 
million for Americas,
$
8.9
 
million and $
8.8
 
million for EMEA, $
0.3
 
million and $
0.1
 
million for Asia/Pacific and $
1.7
 
million and $
2.0
 
million for Global
Specialty Businesses, respectively.
 
However, all inter-segment transactions
 
have been eliminated from each reportable operating
segment’s net sales and earnings for
 
all periods presented in the above tables.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
10
Note 5 – Net Sales and Revenue Recognition
Arrangements Resulting in Net Reporting
As part of the Company’s Fluidcare
TM
 
business, certain third-party product sales to customers are managed by the Company.
 
The
Company transferred third-party products under arrangements recognized
 
on a net reporting basis of $
19.8
 
million and $
17.8
 
million
for the three months ended March 31, 2022 and 2021, respectively.
 
Customer Concentration
A significant portion of the Company’s
 
revenues are realized from the sale of process fluids and services to manufacturers of
steel, aluminum, automobiles, aircraft, industrial equipment, and durable
 
goods.
 
As previously disclosed in the 2021 Form 10-K,
during the year ended December 31, 2021, the Company’s
 
five largest customers (each composed of multiple subsidiaries or
 
divisions
with semiautonomous purchasing authority) accounted for approximately
10
% of consolidated net sales, with its largest customer
accounting for approximately
3
% of consolidated net sales.
Contract Assets and Liabilities
The Company had no material contract assets recorded on its Condensed
 
Consolidated Balance Sheets as of March 31, 2022 or
December 31, 2021.
The Company had approximately $
6.9
 
million and $
7.0
 
million of deferred revenue as of March 31, 2022 and December 31,
2021, respectively.
 
For three months ended March 31, 2022, the Company satisfied all of the associated performance
 
obligations and
recognized into revenue the advance payments received and recorded
 
as of December 31, 2021.
Disaggregated Revenue
The Company sells its various industrial process fluids, its specialty chemicals
 
and its technical expertise as a global product
portfolio.
 
The Company generally manages and evaluates its performance by segment
 
first, and then by customer industry,
 
rather than
by individual product lines.
 
Also, net sales of each of the Company’s major product
 
lines are generally spread throughout all three of
the Company’s geographic
 
regions, and in most cases, approximately proportionate to the level of total sales in each
 
region.
The following tables disaggregate the Company’s
 
net sales by segment, geographic region, customer industry,
 
and timing of
revenue recognized for the three months ended March 31, 2022 and 2021.
Three Months Ended March 31, 2022
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
56,160
$
36,839
$
55,287
 
$
148,286
Metalworking and other
97,984
88,848
48,947
235,779
154,144
125,687
104,234
384,065
Global Specialty Businesses
57,264
20,021
12,821
90,106
$
211,408
$
145,708
$
117,055
$
474,171
Timing of Revenue Recognized
Product sales at a point in time
$
201,284
$
137,203
$
114,625
 
$
453,112
Services transferred over time
10,124
8,505
2,430
21,059
$
211,408
$
145,708
$
117,055
$
474,171
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
11
Three Months Ended March 31, 2021
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
46,793
$
34,274
$
49,743
 
$
130,810
Metalworking and other
88,078
85,540
46,963
220,581
134,871
119,814
96,706
351,391
Global Specialty Businesses
45,256
20,272
12,864
78,392
$
180,127
$
140,086
$
109,570
$
429,783
Timing of Revenue Recognized
Product sales at a point in time
$
171,594
$
131,162
$
106,399
 
$
409,155
Services transferred over time
8,533
8,924
3,171
20,628
$
180,127
$
140,086
$
109,570
$
429,783
Note 6 - Leases
The Company has operating leases for certain facilities, vehicles and machinery
 
and equipment with remaining lease terms up to
10 years
.
 
Operating lease expense is recognized on a straight-line basis over the lease term. In addition,
 
the Company has certain land
use leases with remaining lease terms up to
93 years
.
The Company has
no
 
material variable lease costs or sublease income for three months ended March
 
31, 2022 and 2021. The
following table sets forth the components of the Company’s
 
lease cost for three months ended March 31, 2022 and 2021:
Three Months Ended
March 31,
2022
2021
Operating lease expense
$
3,409
$
3,612
Short-term lease expense
219
251
Supplemental cash flow information related to the Company’s
 
leases is as follows
:
Three Months Ended
March 31,
2022
2021
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases
$
3,365
$
3,579
Non-cash lease liabilities activity:
Leased assets obtained in exchange for new operating lease liabilities
4,689
3,050
Supplemental balance sheet information related to the Company’s
 
leases is as follows:
March 31,
December 31,
2022
2021
Right of use lease assets
$
38,245
$
36,635
Other current liabilities
10,540
9,976
Long-term lease liabilities
27,433
26,335
Total operating lease liabilities
$
37,973
$
36,311
Weighted average
 
remaining lease term (years)
5.9
5.6
Weighted average
 
discount rate
4.14%
4.22%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
12
Maturities of operating lease liabilities as of March 31, 2022 were as follows:
March 31,
2022
For the remainder of 2022
$
8,990
For the year ended December 31, 2023
9,513
For the year ended December 31, 2024
7,292
For the year ended December 31, 2025
5,375
For the year ended December 31, 2026
4,338
For the year ended December 31, 2027 and beyond
7,046
Total lease payments
42,554
Less: imputed interest
(4,581)
Present value of lease liabilities
$
37,973
Note 7 – Restructuring and Related Activities
The Company’s management approved a global restructuring plan (the “QH Program”) as part of its plan to realize certain cost
synergies associated with the Combination in the third quarter of 2019. The QH Program includes restructuring and associated
severance costs to reduce total headcount by approximately 400 people globally, as well as plans for the closure of certain
manufacturing and non-manufacturing facilities.
 
The exact timing and total costs associated with the QH Program will depend on
 
a
number of factors and are subject to change; however,
 
the Company currently expects reductions in headcount and site closures to
continue to occur throughout 2022 under the QH Program.
 
Employee separation benefits will vary depending on local regulations
within certain foreign countries and will include severance and other benefits.
 
All costs incurred to date relate to severance costs to reduce headcount,
 
including customary and routine adjustments to initial
estimates for employee separation costs, as well as costs to close certain
 
facilities and are recorded in Restructuring and related
charges in the Company’s
 
Condensed Consolidated Statements of Income.
 
As described in Note 4 of Notes to Condensed
Consolidated Financial Statements, restructuring and related charges
 
are not included in the Company’s
 
calculation of reportable
segments’ measure of operating earnings and therefore these costs are not
 
reviewed by or recorded to reportable segments.
Activity in the Company’s accrual
 
for restructuring under the QH Program for the three months ended March 31, 2022
 
is as
follows:
QH Program
Accrued restructuring as of December 31, 2021
$
4,087
Restructuring and related charges
820
Cash payments
(408)
Currency translation adjustments
(64)
Accrued restructuring as of March 31, 2022
$
4,435
Note 8 – Share-Based Compensation
The Company recognized the following share-based compensation expense
 
in its Condensed Consolidated Statements of Income
for the three months ended March 31, 2022 and 2021:
Three Months Ended
March 31,
 
2022
2021
Stock options
$
267
$
308
Non-vested stock awards and restricted stock units
1,548
1,396
Non-elective and elective 401(k) matching contribution in stock
—
1,553
Director stock ownership plan
24
203
Performance stock units
623
319
Total share-based
 
compensation expense
$
2,462
$
3,779
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
13
Share-based compensation expense is recorded in SG&A, except for less than $
0.1
 
million and $
0.3
 
million during the three
months ended March 31, 2022 and 2021, respectively,
 
recorded within Combination, integration and other acquisition-related
expenses.
Stock Options
During the first quarter of 2022, the Company granted stock options under
 
its long-term incentive plan (“LTIP
 
”) that are subject
only to time vesting over a
three year
 
period.
 
For the purposes of determining the fair value of stock option awards, the Company
used a Black-Scholes option pricing model and the assumptions set forth
 
in the table below:
March 2022
Grant
Number of options granted
27,077
Dividend yield
0.80
%
Expected volatility
38.60
%
Risk-free interest rate
2.07
%
Expected term (years)
4.0
The fair value of these options is amortized on a straight-line basis over the vesting period.
 
As of March 31, 2022, unrecognized
compensation expense related to all stock options granted
 
was $
2.9
 
million, to be recognized over a weighted average remaining
period of
1.9
 
years.
Restricted Stock Awards
 
and Restricted Stock Units
During the three months ended March 31, 2022, the Company granted
17,425
 
non-vested restricted shares and
4,490
 
non-vested
restricted stock units under its LTIP,
 
subject to time-based vesting, generally over a
three year
 
period.
 
The fair value of these grants is
based on the trading price of the Company’s
 
common stock on the date of grant.
 
The Company adjusts the grant date fair value of
these awards for expected forfeitures based on historical experience.
 
As of March 31, 2022, unrecognized compensation expense
related to the nonvested restricted shares was $
6.4
 
million, to be recognized over a weighted average remaining period of
2.1
 
years,
and unrecognized compensation expense related to nonvested restricted
 
stock units was $
1.3
 
million, to be recognized over a weighted
average remaining period of
2.3
 
years.
Performance Stock Units
The Company grants performance-dependent stock awards (“PSUs”) as a component
 
of its LTIP,
 
which will be settled in a
certain number of shares subject to market-based and time-based vesting conditions.
 
The number of fully vested shares that may
ultimately be issued as settlement for each award may range from
0
% up to
200
% of the target award, subject to the achievement of
the Company’s total shareholder
 
return (“TSR”) relative to the performance of the Company’s
 
peer group, the S&P Midcap 400
Materials group.
 
The service period required for the PSUs is three years and the TSR measurement
 
period for the PSUs is generally
from January 1 of the year of grant through December 31 of the year prior
 
to issuances of the shares upon settlement.
 
Compensation expense for PSUs
 
is measured based on their grant date fair value and is recognized on
 
a straight-line basis over
the three year vesting period.
 
The grant-date fair value of the PSUs was estimated using a Monte Carlo
 
simulation on the grant date
and using the following assumptions set forth in the table below:
March 2022
Grant
Number of PSUs granted
16,820
Risk-free interest rate
2.11
%
Dividend yield
0.93
%
Expected term (years)
3.0
As of March 31, 2022, the Company estimates that it will issue 0 fully vested shares
 
as of the applicable settlement date of all
outstanding PSUs awards based on the conditions of the PSUs and performance
 
to date for each award.
 
As of March 31, 2022,
 
there
was approximately $
6.4
 
million of total unrecognized compensation cost related to PSUs which the Company
 
expects to recognize
over a weighted-average period of
2.3
 
years.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
14
Defined Contribution Plan
The Company has a 401(k) plan with an employer match covering
 
a majority of its U.S. employees.
 
The Company matches
50
%
of the first
6
% of compensation that is contributed to the plan, with a maximum matching contribution of 3% of
 
compensation.
 
Additionally, the plan
 
provides for non-elective nondiscretionary contributions on behalf of participants
 
who have completed one year
of service equal to
3
% of the eligible participants’ compensation.
 
Beginning in April 2020 and continuing through March 2021, the
Company matched both non-elective and elective 401(k) contributions
 
in fully vested shares
 
of the Company’s common stock
 
rather
than cash.
 
There were
no
 
matching contributions in stock for the three months ended March 31, 2022. For
 
the three months ended
March 31, 2021, total contributions were $
1.5
 
million.
Note 9 – Pension and Other Postretirement
 
Benefits
The components of net periodic benefit (income) cost for the three months
 
ended March 31, 2022 and 2021 are as follows:
Three Months Ended March 31,
 
Other
Pension Benefits
Postretirement Benefits
2022
2021
2022
2021
Service cost
$
180
$
316
$
(8)
$
1
Interest cost
1,360
1,090
9
11
Expected return on plan assets
(2,084)
(2,082)
—
—
Actuarial loss (gain) amortization
257
855
(24)
—
Prior service cost (income) amortization
2
2
1
—
Total net periodic benefit
 
(income) cost
$
(285)
$
181
$
(22)
$
12
Employer Contributions
As of March 31, 2022, $
1.0
 
million and $
0.1
 
million of contributions have been made to the Company’s
 
U.S. and foreign pension
plans and its other postretirement benefit plans, respectively.
 
Taking into consideration
 
current minimum cash contribution
requirements, the Company currently expects to make full year cash contributions
 
of approximately $
6.6
 
million to its U.S. and
foreign pension plans and approximately $
0.2
 
million to its other postretirement benefit plans in 2022.
Note 10 – Other (Expense) Income, Net
The components of other (expense) income, net for the three months ended
 
March 31, 2022 and 2021 are as follows:
Three Months Ended
 
March 31,
2022
2021
Income from third party license fees
$
404
$
339
Foreign exchange losses, net
(1,905)
(1,478)
Gain on disposals of property,
 
plant, equipment and other assets, net
23
5,410
Non-income tax refunds and other related (expense) credits
(1,322)
97
Pension and postretirement benefit income, non-service components
479
124
Other non-operating income, net
115
195
Total other (expense)
 
income, net
$
(2,206)
$
4,687
Non-income tax refunds and other related (expense) credits during the
 
three months ended March 31, 2022 includes other expense
related to an indemnification asset associated with the settlement of certain
 
income tax audits at one of the Company’s
 
Italian affiliates
for tax periods prior to August 1, 2019.
 
See Note 11 of Notes to Condensed Consolidated
 
Financial Statements.
 
Gain on disposals of
property, plant, equipment
 
and other assets, net, during the three months ended March 31, 2021, includes a gain on the
 
sale of certain
held-for-sale real property assets related to the Combination.
 
Foreign exchange losses, net, during each of the three months ended
March 31, 2022 and 2021 include foreign currency transaction losses of approximately
 
$
0.2
 
million related to hyper-inflationary
accounting for the Company’s Argentine
 
subsidiaries.
 
See Note 1 of Notes to Condensed Consolidated Financial Statements.
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
15
Note 11 – Income Taxes
 
and Uncertain Income Tax
 
Positions
The Company’s effective
 
tax rates for the three months ended March 31, 2022 and 2021 were
13.1
% and
24.2
%, respectively.
 
The Company’s effective
 
tax rate for the three months ended March 31, 2022 was largely driven by changes in
 
the valuation
allowance for foreign tax credits due to recently issued legislative guidance
 
and audit settlements reached with Italian tax authorities.
 
In addition, the Company incurred higher tax expense during the three months
 
ended March 31, 2022 related to the Company
recording earnings in one of its subsidiaries at a statutory tax rate of
25
% while it awaits recertification of a concessionary
15
% tax
rate, which was available to the Company during all of 2021.
 
Comparatively,
 
the prior year first quarter effective tax rate was
impacted by the sale of a subsidiary which included certain held-for-sale
 
real property assets related to the Combination.
 
As of December 31, 2021, the Company had a deferred tax liability of $
8.4
 
million on certain undistributed foreign earnings,
which primarily represents the Company’s
 
estimate of non-U.S. income taxes the Company will incur to ultimately remit certain
earnings to the U.S.
 
The balance as of March 31, 2022 was $
8.0
 
million.
As of March 31, 2022, the Company’s
 
cumulative liability for gross unrecognized tax benefits was $
20.1
 
million, a decrease of
approximately $
2.4
 
million from the cumulative liability accrued as of December 31, 2021.
 
The Company continues to recognize interest and penalties associated with uncertain
 
tax positions as a component of taxes on
income before equity in net income of associated companies in its Condensed
 
Consolidated Statements
 
of Income.
 
The Company
recognized a benefit of $
0.3
 
million for interest and a benefit of $
1.6
 
million for penalties in its Condensed Consolidated Statements of
Income for the three months ended March 31, 2022, and recognized
 
an expense of less than $
0.1
 
million for interest and a benefit of
$
0.1
 
million for penalties in its Condensed Consolidated Statements of Income for the
 
three months ended March 31, 2021.
 
As of
March 31, 2022, the Company had accrued $
2.7
 
million for cumulative interest and $
1.6
 
million for cumulative penalties in its
Condensed Consolidated Balance Sheets, compared to $
3.1
 
million for cumulative interest and $
3.1
 
million for cumulative penalties
accrued at December 31, 2021.
During the three months ended March 31, 2022 and 2021, the Company
 
recognized decreases of $
2.8
 
million and $
0.3
 
million,
respectively, in its cumulative
 
liability for gross unrecognized tax benefits due to the settlement of income
 
tax audits with the Italian
tax authorities, as well as the expiration of the applicable statutes of
 
limitations for certain tax years.
The Company estimates that during the year ending December 31, 202
 
2
 
it will reduce its cumulative liability for gross
unrecognized tax benefits by approximately $
4.2
 
million due to the settlement of income tax audits and the expiration of the statute of
limitations with regard to certain tax positions.
 
This estimated reduction in the cumulative liability for unrecognized
 
tax benefits does
not consider any increase in liability for unrecognized tax benefits with regard
 
to existing tax positions or any increase in cumulative
liability for unrecognized tax benefits with regard to new tax positions for
 
the year ending December
 
31, 2022.
The Company
 
and its subsidiaries are subject to U.S. Federal income tax, as well as the income tax of various
 
state and foreign
tax jurisdictions.
 
Tax years that remain subject
 
to examination by major tax jurisdictions include Italy from
2007
, Brazil from
2011
,
Germany from
2015
, the Netherlands, Mexico and China from
2016
, Canada, Spain, and the U.S. from
2017
, the United Kingdom
from
2018
, India from fiscal year beginning April 1, 2017 and ending March 31,
2018
, and various U.S. state tax jurisdictions from
2011
.
 
As previously reported, the Italian tax authorities have assessed additional tax due from the Company’s subsidiary, Quaker Italia
S.r.l., relating to the tax years 2007 through 2015. The Company has filed for competent authority relief from these assessments under
the Mutual Agreement Procedures (“MAP”) of the Organization for Economic Co-Operation and Development for all years except
2007. In 2020, the respective tax authorities in Italy, Spain and the Netherlands reached agreement with respect to the MAP
proceedings which the Company has accepted.
 
As of March 31, 2022, the Company has received $
1.6
 
million in refunds from the
Netherlands and Spain.
 
In February 2022, the Company received a settlement notice from the Italian taxing
 
authorities confirming the
amount due of $
2.6
 
million, having granted the Company’s request
 
to utilize its remaining net operating losses to partially offset
 
the
liability.
 
As a result of the settlement the Company recognized tax expense of $
0.8
 
million for the quarter ended March 31, 2022.
Houghton Italia, S.r.l is also involved
 
in a corporate income tax audit with the Italian tax authorities covering tax years
2014
through
2018
.
 
During the fourth quarter of 2021, the Company settled a portion of the Houghton Italia,
 
S.r.l. corporate income tax
audit with the Italian tax authorities for the tax years
2014
 
and
2015
.
 
During the three months ended March 31, 2022 the Company
settled tax years 2016 through 2018 for a total of $
2.1
 
million.
 
In total, the Company has now settled all years 2014 through 2018 for
$
3.7
 
million.
 
Accordingly, the Company has
 
released all reserves relating to this audit for the settled tax years.
 
As a result of the
settlement and reserve release the Company recognized a net benefit
 
to the tax provision of $
2.1
 
million during the first quarter of
2022.
 
The Company has established an indemnification receivable of $
3.8
 
million in connection with its claim against the former
owners of Houghton for any pre-Combination tax liabilities arising from
 
this matter.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
16
Houghton Deutschland GmbH is also under audit by the German tax authorities for
 
the tax years
2015
 
through
2017
.
 
Based on
preliminary audit findings, primarily related to transfer pricing,
 
the Company has recorded reserves for $
0.3
 
million as of March 31,
2022.
 
Of this amount, $
0.3
 
million relates to tax periods prior to the Combination and therefore the Company
 
has submitted an
indemnification claim with Houghton’s
 
former owners for any tax liabilities arising pre-Combination.
 
As a result, a corresponding
indemnification receivable has also been established.
Note 12 – Earnings Per Share
The following table summarizes earnings per share calculations for
 
the three months ended March 31, 2022 and 2021:
Three Months Ended
March 31,
 
2022
2021
Basic earnings per common share
 
Net income attributable to Quaker Chemical Corporation
$
19,816
$
38,615
Less: income allocated to participating securities
 
(78)
 
(154)
Net income available to common shareholders
$
19,738
$
38,461
Basic weighted average common shares outstanding
17,826,061
17,785,370
Basic earnings per common share
$
1.11
$
2.16
Diluted earnings per common share
Net income attributable to Quaker Chemical Corporation
$
19,816
$
38,615
Less: income allocated to participating securities
(78)
(154)
Net income available to common shareholders
$
19,738
$
38,461
Basic weighted average common shares outstanding
17,826,061
17,785,370
Effect of dilutive securities
25,798
70,607
Diluted weighted average common shares outstanding
17,851,859
17,855,977
Diluted earnings per common
 
share
$
1.11
$
2.15
Certain stock options,
 
restricted stock units and PSUs are not included in the diluted earnings per share calculation
 
when the
effect would have been anti-dilutive.
 
The calculated amount of anti-diluted shares not included were
12,260
 
and
2,083
 
for the three
months ended March 31, 2022 and 2021, respectively.
 
Note 13 – Goodwill and Other Intangible Assets
 
Changes in the carrying amount of goodwill for the three months ended
 
March 31, 2022 were as follows:
Global
Specialty
Americas
EMEA
Asia/Pacific
Businesses
Total
Balance as of December 31, 2021
$
214,023
$
135,520
$
162,458
$
119,193
 
$
631,194
Goodwill additions
1,752
—
—
32
1,784
Currency translation adjustments
 
1,376
(2,569)
(328)
(519)
 
(2,040)
Balance as of March 31, 2022
$
217,151
$
132,951
$
162,130
$
118,706
 
$
630,938
Gross carrying amounts and accumulated amortization for definite-lived
 
intangible assets as of March 31, 2022 and December 31,
2021 were as follows:
Gross Carrying
Accumulated
Amount
Amortization
2022
2021
2022
2021
Customer lists and rights to sell
$
855,309
 
$
853,122
 
$
159,576
 
$
147,858
Trademarks, formulations and product
 
technology
 
162,408
 
 
163,974
 
 
40,565
 
 
38,747
Other
 
6,361
 
 
6,309
 
 
5,989
 
 
5,900
Total definite-lived
 
intangible assets
$
1,024,078
 
$
1,023,405
 
$
206,130
 
$
192,505
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
17
The Company amortizes definite-lived intangible assets on a straight-line basis over
 
their useful lives.
 
The Company recorded
$
14.6
 
million and $
14.8
 
million of amortization expense for the three months ended March
 
31, 2022 and 2021, respectively.
 
Estimated annual aggregate amortization expense for the current year
 
and subsequent five years is as follows:
For the year ended December 31, 2022
$
59,465
For the year ended December 31, 2023
59,293
For the year ended December 31, 2024
58,701
For the year ended December 31, 2025
57,924
For the year ended December 31, 2026
57,678
For the year ended December 31, 2027 and beyond
532,124
The Company has four indefinite-lived intangible assets totaling $
194.1
 
million as of March 31, 2022, including $
193.0
 
million of
indefinite-lived intangible assets for trademarks and tradename associated
 
with the Combination.
 
Comparatively, the Company had
four indefinitely-lived intangible assets for trademarks and tradename
 
totaling $
196.9
 
million as of December 31, 2021.
 
Note 14 – Debt
Debt as of March 31, 2022 and December 31, 2021 includes the following:
As of March 31, 2022
As of December 31, 2021
Interest
Outstanding
 
Interest
Outstanding
 
Rate
Balance
Rate
Balance
Credit Facilities:
Revolver
1.68%
$
254,453
1.62%
$
211,955
U.S. Term Loan
1.71%
528,750
1.65%
540,000
EURO Term Loan
1.50%
132,037
1.50%
137,616
Industrial development bonds
5.26%
10,000
5.26%
10,000
Bank lines of credit and other debt obligations
Various
1,659
Various
1,777
Total debt
$
926,899
$
901,348
Less: debt issuance costs
(7,227)
(8,001)
Less: short-term and current portion of long-term debts
(61,385)
(56,935)
Total long-term debt
$
858,287
$
836,412
Credit facilities
The Company’s primary credit facility
 
(as amended, the “Credit Facility”) is comprised of a $
400.0
 
million multicurrency
revolver (the “Revolver”), a $
600.0
 
million term loan (the “U.S. Term
 
Loan”), each with the Company as borrower,
 
and a $
150.0
million (as of August 1, 2019) Euro equivalent term loan (the “EURO Term
 
Loan” and together with the “U.S. Term
 
Loan”, the
“Term Loans”)
 
with Quaker Chemical B.V.,
 
a Dutch subsidiary of the Company as borrower, each
 
with a five year term maturing in
August 2024
.
 
Subject to the consent of the administrative agent and certain other conditions, the Company
 
may designate additional
borrowers.
 
The maximum amount available under the Credit Facility can be increased by up
 
to $
300.0
 
million at the Company’s
request if there are lenders who agree to accept additional commitments and
 
the Company has satisfied certain other conditions.
 
Borrowings under the Credit Facility bear interest at a base rate or LIBOR plus an
 
applicable margin based upon the Company’s
consolidated net leverage ratio.
 
On December 10, 2021, the Company entered into the Second Amendment with Bank of America
N.A., to include among other things, an update to provide for use of a non-USD
 
currency LIBOR successor rate.
 
The variable interest
rate incurred on the outstanding borrowings under the Credit Facility during
 
the three months ended March 31, 2022 was
approximately
1.6
%.
 
As of March 31, 2022, the interest rate of the outstanding borrowings under the Credit
 
Facility was
approximately
1.7
%.
 
In addition to paying interest on outstanding principal under the Credit Facility,
 
the Company is required to pay
a commitment fee ranging from
0.2
% to
0.3
% depending on the Company’s consolidated
 
net leverage ratio to the lenders under the
Revolver in respect of the unutilized commitments thereunder.
 
The Company has unused capacity under the Revolver of
approximately $
142
 
million, net of bank letters of credit of approximately $
4
 
million, as of March 31, 2022.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
18
The Credit Facility is subject to certain financial and other covenants.
 
The Company’s initial consolidated net debt to
consolidated adjusted EBITDA ratio could not exceed 4.25 to 1, with step downs in the permitted ratio over the term of the Credit
Facility. As of March 31, 2021, the consolidated net debt to adjusted EBITDA may not exceed 3.75 to 1. The Company’s
consolidated adjusted EBITDA to interest expense ratio cannot be less than 3.0 to 1 over the term of the agreement. The Credit
Facility also prohibits the payment of cash dividends if the Company is in default or if the amount of the dividend paid annually
exceeds the greater of $50.0 million and 20% of consolidated adjusted EBITDA unless the ratio of consolidated net debt to
consolidated adjusted EBITDA is less than 2.0 to 1, in which case there is no such limitation on amount.
 
As of March 31, 2022 and
December 31, 2021, the Company was in compliance with all of the Credit Facility covenants
.
 
The Term Loans
 
have quarterly
principal amortization during their
five year
 
terms, with
5.0
% amortization of the principal balance due in years 1 and 2,
7.5
% in year
3, and
10.0
% in years 4 and 5, with the remaining principal amount due at maturity.
 
During the three months ended March 31, 2022,
the Company made quarterly amortization payments related to
 
the Term Loans totaling
 
$
14.1
 
million.
 
The Credit Facility is
guaranteed by certain of the Company’s
 
domestic subsidiaries and is secured by first priority liens on substantially all of the assets of
the Company and the domestic subsidiary guarantors, subject to certain
 
customary exclusions.
 
The obligations of the Dutch borrower
are guaranteed only by certain foreign subsidiaries on an unsecured basis.
The Credit Facility required the Company to fix its variable interest rates on at least
20
% of its total Term Loans.
 
In order to
satisfy this requirement as well as to manage the Company’s
 
exposure to variable interest rate risk associated with the Credit Facility,
in November 2019, the Company entered into $
170.0
 
million notional amounts of three year interest rate swaps at a base rate of
1.64
%
plus an applicable margin as provided in the Credit Facility,
 
based on the Company’s consolidated
 
net leverage ratio.
 
At the time the
Company entered into the swaps, and as of March 31, 2022, the aggregate
 
interest rate on the swaps, including the fixed base rate plus
an applicable margin, was
3.1
%.
 
See Note 17 of Notes to Condensed Consolidated Financial Statements.
The Company capitalized $
23.7
 
million of certain third-party debt issuance costs in connection with executing
 
the Credit Facility.
 
Approximately $
15.5
 
million of the capitalized costs were attributed to the Term
 
Loans and recorded as a direct reduction of long-
term debt on the Company’s Consolidated
 
Balance Sheet.
 
Approximately $
8.3
 
million of the capitalized costs were attributed to the
Revolver and recorded within other assets on the Company’s
 
Consolidated Balance Sheet.
 
These capitalized costs are being
amortized into interest expense over the
five year
 
term of the Credit Facility.
 
As of March 31, 2022 and December 31, 2021, the
Company had $
7.2
 
million and $
8.0
 
million, respectively,
 
of debt issuance costs recorded as a reduction of long-term debt.
 
As of
March 31, 2022 and December 31, 2021, the Company had $
3.9
 
million and $
4.3
 
million, respectively,
 
of debt issuance costs recorded
within other assets.
 
Industrial development bonds
As of March 31, 2022 and December 31, 2021, the Company had fixed rate,
 
industrial development authority bonds totaling
$
10.0
 
million in principal amount due in
2028
.
 
These bonds have similar covenants to the Credit Facility noted above.
Bank lines of credit and other debt obligations
The Company has certain unsecured bank lines of credit and discounting
 
facilities in certain foreign subsidiaries, which are not
collateralized.
 
The Company’s other debt obligations
 
primarily consist of certain domestic and foreign low interest rate or interest-
free municipality-related loans, local credit facilities of certain foreign subsidiaries
 
and capital lease obligations.
 
Total unused
capacity under these arrangements as of March 31, 2022 was approximately
 
$
30
 
million.
In addition to the bank letters of credit described in the “Credit facilities” subsection
 
above, the Company’s only other
 
off-balance
sheet arrangements include certain financial and other guarantees.
 
The Company’s total bank letters of
 
credit and guarantees
outstanding as of March 31, 2022 were approximately $
6
 
million.
The Company incurred the following debt related expenses included
 
within Interest expense, net, in the Condensed Consolidated
Statements of Income:
Three Months Ended
March 31,
 
2022
2021
Interest expense
$
4,746
$
4,650
Amortization of debt issuance costs
1,187
1,187
Total
$
5,933
$
5,837
Based on the variable interest rates associated with the Credit Facility,
 
as of March 31, 2022 and December 31, 2021, the amounts
at which the Company’s total debt
 
were recorded are not materially different from their fair market value.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
19
Note 15 – Accumulated Other Comprehensive Income
The following tables show the reclassifications from and resulting balances
 
of accumulated other comprehensive income
(“AOCI”) for the three months ended March 31, 2022 and 2021:
Defined
Unrealized
Currency
Benefit
Gain (Loss) in
 
Translation
Retirement
Available-for-
Derivative
Adjustments
Plans
Sale Securities
Instruments
Total
Balance at December 31, 2021
$
(49,843)
$
(13,172)
$
397
$
(1,372)
$
(63,990)
Other comprehensive (loss) income before
reclassifications
(6,867)
432
(1,277)
1,429
(6,283)
Amounts reclassified from AOCI
—
229
11
—
240
Related tax amounts
—
(165)
266
(329)
(228)
Balance at March 31, 2022
$
(56,710)
$
(12,676)
$
(603)
$
(272)
$
(70,261)
Balance at December 31, 2020
$
(2,875)
$
(23,467)
$
3,342
$
(3,598)
$
(26,598)
Other comprehensive (loss) income before
 
reclassifications
(25,459)
781
(745)
730
(24,693)
Amounts reclassified from AOCI
—
862
(3,085)
—
(2,223)
Related tax amounts
—
(351)
805
(168)
286
Balance at March 31, 2021
$
(28,334)
$
(22,175)
$
317
$
(3,036)
$
(53,228)
All reclassifications related to unrealized gain (loss) in available-for-sale securities
 
relate to the Company’s equity
 
interest in a
captive insurance company and are recorded in equity in net income
 
of associated companies.
 
The amounts reported in other
comprehensive income for non-controlling interest are related to
 
currency translation adjustments.
Note 16 – Fair Value
 
Measurements
The Company has valued its company-owned life insurance policies at fair value.
 
These assets are subject to fair value
measurement as follows:
Fair Value
 
Measurements at March 31, 2022
Total
Using Fair Value
 
Hierarchy
Assets
Fair Value
Level 1
Level 2
Level 3
Company-owned life insurance
$
2,395
$
—
$
2,395
$
—
Total
$
2,395
$
—
$
2,395
$
—
Fair Value
 
Measurements at December 31, 2021
Total
Using Fair Value
 
Hierarchy
Assets
Fair Value
Level 1
Level 2
Level 3
Company-owned life insurance
 
$
2,533
$
—
$
2,533
$
—
Total
$
2,533
$
—
$
2,533
$
—
The fair values of Company-owned life insurance assets are based on quotes
 
for like instruments with similar credit ratings and
terms.
 
The Company did not hold any Level 3 investments as of March 31,
 
2022 or December 31, 2021, respectively,
 
so related
disclosures have not been included.
Note 17 – Hedging Activities
In order to satisfy certain requirements of the Credit Facility as well as to manage
 
the Company’s exposure to variable
 
interest
rate risk associated with the Credit Facility,
 
in November 2019, the Company entered into $
170.0
 
million notional amounts of three
year interest rate swaps.
 
See Note 14 of Notes to Condensed Consolidated Financial Statements.
 
These interest rate swaps are
designated as cash flow hedges and, as such, the contracts are marked-to-market
 
at each reporting date and any unrealized gains or
losses are included in AOCI to the extent effective and reclassified to interest
 
expense in the period during which the transaction
effects earnings or it becomes probable that the forecasted
 
transaction will not occur.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
20
The balance sheet classification and fair values of the Company’s
 
derivative instruments, which are Level 2 measurements, are as
follows:
Fair Value
Consolidated
March 31,
 
December 31,
Balance Sheet Location
2022
2021
Derivatives designated as cash flow hedges:
Interest rate swaps
Other accrued liabilities
$
353
$
1,782
$
353
$
1,782
The following table presents the net unrealized loss deferred to AOCI:
March 31,
 
December 31,
2022
2021
Derivatives designated as cash flow hedges:
Interest rate swaps
AOCI
$
272
$
1,372
$
272
$
1,372
The following table presents the net gain reclassified from AOCI to earnings:
Three Months Ended
March 31,
 
2022
2021
Amount and location of expense reclassified
 
 
from AOCI into expense (Effective Portion)
Interest expense, net
$
(637)
$
(643)
Interest rate swaps are entered into with a limited number of counterparties,
 
each of which allows for net settlement of all
contracts through a single payment in a single currency in the event of a default on
 
or termination of any one contract.
 
As such, in
accordance with the Company’s accounting
 
policy, these derivative instruments
 
are recorded on a net basis within the Condensed
Consolidated Balance Sheets.
Note 18 – Commitments and Contingencies
The Company previously disclosed in its 2021 Form 10-K that AC Products, Inc.
 
(“ACP”), a wholly owned subsidiary,
 
has been
operating a groundwater treatment system to hydraulically contain groundwater
 
contamination emanating from ACP’s site,
 
the
principal contaminant of which is perchloroethylene.
 
As of March 31, 2022, ACP believes it is close to meeting the conditions for
closure of the groundwater treatment system, but continues to operate
 
this system while in discussions with the relevant authorities.
 
 
As of March 31, 2022, the Company believes that the range of potential-known
 
liabilities associated with the balance of the ACP
water remediation program is approximately $
0.1
 
million to $
1.0
 
million.
 
The low and high ends of the range are based on the length
of operation of the treatment system as determined by groundwater modeling.
 
Costs of operation include the operation and
maintenance of the extraction well, groundwater monitoring and
 
program management.
The Company previously disclosed in its 2021 Form 10-K that an inactive
 
subsidiary of the Company that was acquired in 1978
sold certain products containing asbestos, primarily on an installed basis, and
 
is among the defendants in numerous lawsuits alleging
injury due to exposure to asbestos.
 
During the three months ended March 31, 2022, there have been no significant
 
changes to the facts
or circumstances of this previously disclosed matter,
 
aside from on-going claims and routine payments associated with this litigation.
 
Based on a continued analysis of the existing and anticipated future claims against
 
this subsidiary, it is currently
 
projected that the
subsidiary’s total liability over
 
the next
50 years
 
for these claims is approximately $
0.3
 
million (excluding costs of defense).
The Company previously disclosed in its 2021 Form 10-K that it is party to certain environmental
 
matters related to certain
domestic and foreign properties.
 
These environmental matters primarily require the Company
 
to perform long-term monitoring as
well as operating and maintenance at each of the applicable sites.
 
During the three months ended March 31, 2022, there have been
 
no
significant changes to the facts or circumstances of these previously disclosed
 
matters, aside from on-going monitoring and
maintenance activities and routine payments associated with each of
 
the sites.
 
The Company continually evaluates its obligations
related to such matters, and based on historical costs incurred and
 
projected costs to be incurred over the next
27 years
, has estimated
the range of costs for all of these environmental matters, on a discounted
 
basis, to be between approximately $
5
 
million and $
6
 
million
as of March 31, 2022, for which $
5.9
 
million was accrued within other accrued liabilities and other non-current
 
liabilities on the
Company’s
 
Condensed Consolidated Balance Sheet as of March 31, 2022.
 
Comparatively, as of December
 
31, 2021, the Company
had $
5.6
 
million accrued for with respect to these matters.
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
21
The Company believes, although there can be no assurance regarding the
 
outcome of other unrelated environmental matters, that
it has made adequate accruals for costs associated with other environmental
 
problems of which it is aware.
 
Approximately $
0.4
million were accrued as of both March 31, 2022 and December 31, 2021,
 
respectively, to provide
 
for such anticipated future
environmental assessments and remediation costs.
 
In connection with obtaining regulatory approvals for the Combination,
 
certain steel and aluminum related product lines of
Houghton were divested in August 2019.
 
The Company previously disclosed in its 2021 Form 10-K that in July 2021, the entity
 
that
acquired these divested product lines submitted an indemnification claim
 
for certain alleged breaches of representation made by
Houghton in the agreement pursuant to which such assets had been divested.
 
The Company responded to the subject matters of the
indemnification claim and during the first quarter of 2022 the matter was resolved
 
consistent with the Company’s expectations
 
and
position that there were no amounts owed by the Company.
The Company previously disclosed in its 2021 Form 10-K that two of the Company’s
 
locations suffered property damages as a
result of flooding and fire, respectively.
 
The Company maintains property insurance for all of its facilities globally.
 
During the three
months ended March 31, 2022, there have been no significant changes to
 
the facts or circumstances of these previously disclosed
matters, aside from the on-going restoration of both sites.
 
The Company, its insurance
 
adjuster and insurance carrier are actively
managing the remediation and restoration activities associated with these
 
events and at this time the Company has concluded, based on
all available information and discussions with its insurance adjuster
 
and insurance carrier, that the losses were covered
 
under the
Company’s property insurance
 
coverage, net of an aggregate deductible of $
2.0
 
million.
 
The Company has received payments from
its insurers of $
2.1
 
million and has recorded an insurance receivable associated with these events (and
 
a gain on insurance recoveries
for losses incurred) of $
0.5
 
million as of March 31, 2022.
The Company is party to other litigation which management currently
 
believes will not have a material adverse effect on the
Company’s results of operations,
 
cash flows or financial condition.
 
In addition, the Company has an immaterial amount of contractual
purchase obligations.
Quaker Chemical Corporation
Management’s Discussion and Analysis
22
 
Item 2.
 
Management’s Discussion and
 
Analysis of Financial Condition and Results of Operations
.
As used in this Report, the terms “Quaker Houghton,” the “Company
 
,” “we,” and “our” refer to Quaker Chemical Corporation
(doing business as Quaker Houghton), its subsidiaries, and associated companies,
 
unless the context otherwise requires.
 
The term
Legacy Quaker refers to the Company prior to the closing of its combination
 
with Houghton International, Inc. in 2019 (“Houghton”)
(herein referred to as the “Combination”).
Executive Summary
Quaker Houghton is the global leader in industrial process fluids.
 
With a presence around the world, including operations
 
in over
25 countries, our customers include thousands of the world’s
 
most advanced and specialized steel, aluminum, automotive, aerospace,
offshore, can, mining, and metalworking companies.
 
Our high-performing, innovative and sustainable solutions are backed by best-
in-class technology,
 
deep process knowledge, and customized services.
 
Quaker Houghton is headquartered in Conshohocken,
Pennsylvania, located near Philadelphia in the U.S.
Overall, the Company’s first quarter
 
of 2022 performance reflected continued progress navigating through
 
a very challenging
economic environment, including significant raw material cost escalation, supply
 
chain and logistics disruptions and the direct,
indirect and global impacts of the war in Ukraine and other global events
 
that presented headwinds to the Company in the first quarter
of 2022.
 
Net sales in the first quarter of 2022 were $474.2 million, an increase of 10% compared
 
to $429.8 million in the first quarter
of 2021, primarily driven by an increase in selling price and product mix
 
of approximately 17% and additional net sales from
acquisitions of 2%, partially offset by a decline in organic
 
sales volume of 6% and the unfavorable impact from foreign currency
translation of 3%.
 
The increase in selling price and product mix is primarily the result of
 
continued and strategic price increases
implemented to help offset the unprecedented increase in
 
raw material costs as well as global supply chain and logistics and labor cost
pressures that began during 2021 and continued through the first quarter
 
of 2022.
 
The decline in organic sales volumes was primarily
attributable to the comparison to a very strong first quarter of 2021, where
 
customers replenished their supply chains due to the
continued economic recovery from COVID-19, the impact of lower
 
volumes related to the tolling agreement for previously divested
products associated with the Combination and lower sales volumes attributable
 
to the war in Ukraine.
 
The Company’s organic
 
sales
volumes increased approximately 3% sequentially compared to the
 
fourth quarter of 2021, as continued new business wins were
partially offset by the Company’s
 
actions to strategically reduce volumes in accordance with its ongoing value
 
-based pricing
initiatives.
The Company generated net income in the first quarter of 2022 of $19.8 million,
 
or $1.11 per diluted share, compared to a first
quarter of 2021 net income of $38.6 million, or $2.15 per diluted
 
share.
 
Excluding non-recurring and non-core items in each period,
the Company’s first quarter of 2022
 
non-GAAP earnings per diluted share were $1.42 compared to $2.11
 
in the prior year first quarter
and the Company’s current quarter
 
adjusted EBITDA of $60.4 million decreased 22% compared to $77.1
 
million in the first quarter of
2021.
 
These results were primarily driven by lower gross margins in
 
the current quarter due to significantly higher raw material and
other input costs as well as the direct and indirect impacts of global supply chain disruptions,
 
and to a lesser extent, by higher selling,
general and administrative expenses (“SG&A”).
 
Sequentially, the Company’s
 
adjusted EBITDA was relatively flat compared to the
fourth quarter of 2021.
 
See the Non-GAAP Measures section of this Item below,
 
as well as other items discussed in the Company’s
Consolidated Operations Review in the Operations section of this Item,
 
below.
The Company’s first quarter of 2022
 
operating performance in each of its four reportable segments: (i)
 
Americas; (ii) Europe,
Middle East and Africa (“EMEA”); (iii) Asia/Pacific; and (iv) Global Specialty
 
Businesses, reflect similar drivers to that of its
consolidated performance as each of the Company’s
 
reportable segments net sales benefitted from double-digit increases in selling
price and product mix and additional net sales from acquisitions, while most
 
segments were partially offset by lower sales volumes
and the unfavorable impact of foreign currency translation.
 
Operating earnings from the Global Specialty Businesses increased
compared to the prior year quarter whereas operating earnings from
 
the Americas, Asia/Pacific, and EMEA segments declined.
 
This
was a result of lower segment gross margins which
 
were unfavorably impacted by the lag in price capture compared to the continued
cost pressures on our raw materials, global supply chain and logistics networks,
 
and manufacturing, labor and other costs.
 
Additional
details of each segment’s
 
operating performance are further discussed in the Company’s
 
Reportable Segments Review,
 
in the
Operations section of this Item, below.
 
The Company had a net operating cash outflow of $6.3 million in the first quarter
 
of 2022 as compared to a net operating cash
outflow of $12.6 million in the first quarter of 2021.
 
Despite the net operating cash outflow in both periods, the increase in net
operating cash flow quarter-over-quarter
 
was primarily driven by a modest improvement in working capital compared to the prior
 
year
first quarter, notably by a lower outflow
 
related to accounts receivable partially offset by an increase in inventory
 
due to higher raw
material costs and a build in certain inventory in response to global supply
 
chain and logistics challenges.
 
The key drivers of the
Company’s operating
 
cash flow and working capital are further discussed in the Company’s
 
Liquidity and Capital Resources section
of this Item, below.
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
23
Overall, results in the first quarter of 2022 reflected the Company’s
 
ability to continue to navigate through persistent raw material
cost pressures, supply chain challenges including those impacting
 
on semiconductors for the automotive end markets and the impacts
of certain global economic events including the Russia conflict with Ukraine.
 
Increases in net sales in all segments were primarily
driven by an increase in selling price implemented to offset the ongoing
 
and significant escalation of raw material costs and a
favorable demand environment across most of the Company’s
 
markets.
 
However, raw material cost increases continued
 
to outpace
the Company’s broad-based
 
pricing initiatives in the first quarter of 2022, and the Company’s
 
margins and earnings reflect the
significantly different cost environment in the first
 
quarter of 2022 compared to the first quarter of 2021.
 
The Company continues to
implement further aggressive and strategic price increases and is actively
 
managing its cost structure to mitigate the current and
expected inflationary pressures.
 
While significant uncertainty exists, notably due to pandemic-related
 
restrictions in China and the
ongoing war in Ukraine, the Company remains committed to advancing
 
its customer intimate strategy, recovering
 
its margins and
investing in value enhancing initiatives to better position the Company
 
to continue to deliver on its growth potential.
Ongoing impact of COVID-19
The global outbreak of COVID-19 has negatively impacted all locations where
 
the Company does business.
 
Although the
Company has now operated in this COVID-19 environment for
 
two years, the full extent of the outbreak and related business impacts
continue to remain uncertain and volatile, and therefore the full extent
 
to which COVID-19 may impact the Company’s
 
future results
of operations or financial condition is uncertain.
 
This outbreak has significantly disrupted the operations of the Company and those of
its suppliers and customers and at times during the pandemic, the Company
 
has experienced volume declines and lower net sales as
compared to pre-COVID-19 levels.
 
Management continues to monitor the impact that the COVID-19 pandemic
 
is having on the
Company, the overall specialty
 
chemical industry and the economies and markets in which the Company operates.
 
The prolonged
pandemic and resurgences of the outbreak including
 
as new variants continue to emerge, and continued restrictions on
 
day-to-day life
and business operations as well as increased border controls or closures and transportation
 
disruptions may result in volume declines
and lower net sales in future periods.
 
To the extent that the Company’s
 
customers and suppliers continue to be significantly and
adversely impacted by COVID-19, this could reduce the availability,
 
or result in delays, of materials or supplies to or from the
Company, which in
 
turn could significantly interrupt the Company’s
 
business operations.
 
Given this ongoing uncertainty,
 
the
Company cautions that its future results of operations could be significantly
 
adversely impacted by COVID-19.
 
While the
circumstances have presented and are expected to continue to present challenges,
 
and have necessitated additional time and resources
to be deployed to sufficiently address the challenges
 
brought on by the pandemic, at this time, management does not believe that
COVID-19 has had a material impact on financial reporting processes, internal
 
controls over financial reporting, or disclosure controls
and procedures.
 
The Company’s top priority,
 
especially during this pandemic, is to protect the health and safety of its employees and
 
customers,
while working to ensure business continuity to meet customers’ needs.
 
The Company has taken steps to protect the health and
wellbeing of its people in affected areas through various actions, including
 
enabling work at home where needed and practicable, and
employing social distancing standards, implementing travel restrictions where
 
applicable, enhancing onsite hygiene practices, and
instituting visitation restrictions at the Company’s
 
facilities.
 
The Company has not and does not expect that it will incur material
expenses implementing these health and safety policies.
 
With the exception of its Shanghai-based operations,
 
which have been and
continue to be significantly impacted since late March 2022 due to government restrictions
 
currently in place in that province of
China, all of the Company’s more
 
than 30 other production facilities worldwide are open and operating
 
and are deemed as essential
businesses in the jurisdictions where they are operating and the Company believes
 
that to date it has been able to meet the needs of all
its customers across the globe despite the current challenges.
 
The Company continues to expect that the impacts from COVID-19 will
gradually decline subject to the effective containment
 
of the virus and its variants and successful distribution and acceptance of the
available vaccines and treatments; however,
 
the incidence of reported cases of COVID-19 or a variant in several geographies where
the Company has significant operations remains high.
 
Differing government responses to these reported cases continues to
 
evolve and
it therefore remains highly uncertain as to how long the global pandemic
 
and related economic challenges will last in each of the
jurisdictions where the Company does business and when our customers’
 
businesses will recover to pre-COVID-19 levels.
 
As a result
of the government-imposed quarantine and lockdown measures implemented
 
at the end of March 2022, which are currently in effect,
the Company’s Shanghai
 
-based locations have been and continue to be significantly impacted as of the date of
 
this Form 10-Q.
 
The
negative impact of these measures to operations and liquidity has and will be
 
experienced during the second quarter of 2022, and the
ultimate impact will depend on the duration of the quarantine and lockdown
 
measures in effect.
 
While the actions taken to date to
protect our workforce, to continue to serve our customers with excellence
 
and to conserve cash and reduce costs as applicable, have
been effective thus far, further actions
 
to respond to the pandemic and its effects may be necessary as conditions
 
continue to evolve.
Impact of Political Conflicts
 
A significant portion of the Company’s
 
revenues and earnings are generated by non-U.S. operations which subjects
 
the Company
to political and economic risks that could adversely affect the Company’s
 
business, liquidity, financial
 
position and results of
operations.
 
The existence of military conflicts, for example the Russian invasion of Ukraine, bring
 
inherent risks such as the potential
for supply chain disruptions, decreased trade activity and other consequences related
 
to economic or other sanctions.
 
The U.S.
Quaker Chemical Corporation
Management’s Discussion and Analysis
24
government and other nations have imposed significant restrictions on
 
most companies’ ability to do business in Russia as a result of
the military conflict between Russia and Ukraine.
 
It is not possible to predict the broader or longer-term consequences
 
of this conflict,
which could include further sanctions, embargoes,
 
regional instability, geopolitical
 
shifts and adverse effects on macroeconomic
conditions, security conditions, currency exchange rates and financial
 
markets.
 
Such geo-political instability and uncertainty could
have a negative impact on the Company’s
 
ability to sell to, ship products to, collect payments from, and support customers in certain
regions based on trade restrictions, embargoes and export
 
control law restrictions, and logistics restrictions including closures of
 
air
space, and could increase the costs, risks and adverse impacts from these new
 
challenges.
 
The Company may also be the subject of
increased cyber-attacks.
 
 
The Company’s operations in the
 
conflict areas including Russia, Ukraine and Belarus represent less than 2% of
 
the Company’s
consolidated net sales and less than 1% of the Company’s
 
consolidated total assets.
 
The Company’s primary
 
exposure in the conflict
area relates to outstanding customer accounts receivable.
 
The Company is actively monitoring the outstanding receivables for
collections and has recorded incremental allowance for doubtful accounts
 
where warranted.
 
The Company continues to review the
facts and circumstances of its customers and the impact of the ongoing
 
sanctions as they relate to its continued business with impacted
customers and the collectability of outstanding accounts receivable.
 
The Company also has and continues to monitor the impact of the
volatility and uncertainty in the economic outlook as a result of the conflict with respect
 
to the recoverability of its long-term and
indefinite-lived assets, including assessing potential triggering events for
 
impairment considerations related to intangible assets and
goodwill.
 
As of March 31, 2022, the Company concluded that the conflict and its current and projected
 
impact to the Company did
not represent a triggering event and the Company continues to monitor and evaluate
 
the evolving situation.
Liquidity and Capital Resources
At March 31, 2022, the Company had cash and cash equivalents of
 
$161.6 million.
 
Total cash and cash equivalents
 
was $165.2
million at December 31, 2021.
 
The $3.6 million decrease in cash and cash equivalents was the net result
 
of $18.2 million of cash used
in investing activities and $6.3 million of cash used in operating activities partiall
 
y
 
offset by $20.6 million of cash provided by
financing activities and a $0.3 million positive impact due to the effect
 
of foreign currency translation.
Net cash flows used in operating activities were $6.3 million in the first three months
 
of 2022 compared to net cash flows used in
operating activities of $12.6 million in the first three months of 2021.
 
The increase in net operating cash flows of $6.3 million was
primarily driven by a lower working capital outflow quarter-over-quarter,
 
as the Company had a smaller increase in accounts
receivable in the first quarter of 2022 due to changes in current quarter net
 
sales, which was partially offset by a higher outflow from
inventory due to increases in raw material costs and continued build
 
of stock in response to global supply chain and logistics
challenges and other recent global economic events.
 
Also, in the first quarter of 2022, the Company received a $2.8 million dividend
from the Company’s Korean
 
joint venture, with no similar dividend received in the prior year period.
 
Net cash flows used in investing activities were $18.2 million in the
 
first three months of 2022 compared to $15.8 million in the
first three months of 2021.
 
This increase in cash outflows was a result of lower cash proceeds from the disposition
 
of assets which
included the sale of certain held-for-sale real property assets related to the
 
Combination in the prior year period, and higher capital
expenditures in the current year largely related to certain
 
infrastructure and sustainability-related spending.
 
These increases in cash
used in investing activities were partially offset by
 
lower cash payments related to acquisitions as a result of the level of acquisition
activity in each year.
 
Net cash flows provided by financing activities were $20.6 million in the first
 
three months of 2022 compared to $13.0 million in
the first three months of 2021.
 
The increase in net cash flows was primarily related to an increase in borrowings
 
in the current year
under the Company’s credit
 
facility as compared to the prior year.
 
In addition, the Company paid $7.4 million of cash dividends
during the first three months of 2022, a $0.4 million or 5% increase in cash dividends
 
compared to the prior year.
 
See Note 2 of Notes
to Condensed Consolidated Financial Statements in Item 1 of this Report.
The Company’s primary credit facility
 
(the “Credit Facility”) is comprised of a $400.0 million multicurrency
 
revolver (the
“Revolver”), a $600.0 million term loan (the “U.S. Term
 
Loan”), each with the Company as borrower, and
 
a $150.0 million (as of
August 1, 2019) Euro equivalent term loan (the “Euro Term
 
Loan” and together with the U.S. Term
 
Loan”, the “Term Loans”)
 
with
Quaker Chemical B.V.,
 
a Dutch subsidiary of the Company as borrower,
 
each with a five year term maturing in August 2024.
 
Subject
to the consent of the administrative agent and certain other conditions,
 
the Company may designate additional borrowers.
 
The
maximum amount available under the Credit Facility can be increased by
 
up to $300.0 million at the Company’s request
 
if there are
lenders who agree to accept additional commitments and the Company has
 
satisfied certain other conditions.
 
Borrowings under the
Credit Facility bear interest at a base rate plus an applicable margin
 
based on the Company’s consolidated
 
net leverage ratio.
 
The
weighted average interest rate incurred on the outstanding borrowings
 
under the Credit Facility during both the first quarter of 2022
and as of March 31, 2022 was approximately 1.6%.
 
In addition to paying interest on outstanding principal under the Credit Facility,
the Company is required to pay a commitment fee ranging from 0.2%
 
to 0.3% depending on the Company’s
 
consolidated net leverage
ratio to the lenders under the Revolver in respect of the unutilized commitments
 
thereunder.
 
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
25
The Credit Facility is subject to certain financial and other covenants.
 
The Company’s initial consolidated net
 
debt to
consolidated adjusted EBITDA ratio could not exceed 4.25 to 1,
 
with step downs in the permitted ratio over the term of the Credit
Facility.
 
As of March 31, 2022, the consolidated net debt to consolidated adjusted
 
EBITDA ratio may not exceed 3.75 to 1.
 
The
Company’s consolidated
 
adjusted EBITDA to interest expense ratio may not be less than 3.0 to 1 over the
 
term of the agreement.
 
The
Credit Facility also prohibits the payment of cash dividends if the Company
 
is in default or if the amount of the dividends paid
annually exceeds the greater of $50.0 million and 20% of consolidated adjusted
 
EBITDA unless the ratio of consolidated net debt to
consolidated adjusted EBITDA is less than 2.0 to 1, in which case there is no such limitation
 
on amount.
 
As of March 31, 2022 and
December 31, 2021, the Company was in compliance with all of the Credit Facility
 
covenants.
 
The Term Loans
 
have quarterly
principal amortization during their five year terms, with 5.0% amortization
 
of the principal balance due in years 1 and 2, 7.5% in year
3, and 10.0% in years 4 and 5, with the remaining principal amount due
 
at maturity.
 
The Credit Facility is guaranteed by certain of the
Company’s domestic subsidiaries
 
and is secured by first priority liens on substantially all of the assets of the
 
Company and the
domestic subsidiary guarantors, subject to certain customary exclusions.
 
The obligations of the Dutch borrower are guaranteed only
by certain foreign subsidiaries on an unsecured basis.
The Credit Facility required the Company to fix its variable interest rates on
 
at least 20% of its total Term
 
Loans.
 
In order to
satisfy this requirement as well as to manage the Company’s
 
exposure to variable interest rate risk associated with the Credit Facility,
in November 2019, the Company entered into $170.0 million notional
 
amounts of three year interest rate swaps at a base rate of 1.64%
plus an applicable margin as provided in the Credit Facility,
 
based on the Company’s consolidated
 
net leverage ratio.
 
At the time the
Company entered into the swaps, and as of March 31, 2022, the aggregate
 
interest rate on the swaps, including the fixed base rate plus
an applicable margin, was 3.1%.
 
The Company capitalized $23.7 million of certain third-party debt issuance
 
costs in connection with executing the Credit Facility.
 
Approximately $15.5 million of the capitalized costs were attributed to the Term
 
Loans and recorded as a direct reduction of long-
term debt on the Company’s Condensed
 
Consolidated Balance Sheet.
 
Approximately $8.3 million of the capitalized costs were
attributed to the Revolver and recorded within other assets on the Company’s
 
Condensed Consolidated Balance Sheet.
 
These
capitalized costs are being amortized into interest expense over the
 
five year term of the Credit Facility.
 
As of March 31, 2022, the Company had Credit Facility borrowings outstanding
 
of $915.2 million.
 
As of December 31, 2021, the
Company had Credit Facility borrowings outstanding of $889.6
 
million.
 
The Company has unused capacity under the Revolver of
approximately $142 million, net of bank letters of credit of approximately
 
$4 million, as of March 31, 2022.
 
The Company’s other
debt obligations are primarily industrial development bonds, bank
 
lines of credit and municipality-related loans, which totaled $11.7
million and $11.8 million as of March
 
31, 2022 and December 31, 2021, respectively.
 
Total unused capacity under
 
these
arrangements as of March 31, 2022
 
was approximately $30 million.
 
The Company’s total net debt as of
 
March 31, 2022
 
was $765.3
million.
The Company incurred $6.0 million of total Combination,
 
integration and other acquisition-related expenses in the first quarter of
2022, which includes $2.0 million of other expenses related to an indemnification
 
asset, described in the Non-GAAP Measures section
of this Item below.
 
Comparatively, in the first quarter
 
of 2021, the Company incurred $0.8 million of total Combination,
 
integration
and other acquisition-related expenses, which was net of a $5.4 million gain
 
on the sale of certain held-for-sale real property assets
and also $0.4 million of accelerated depreciation.
 
The Company had aggregate net cash outflows of approximately $8.3 million
related to the Combination,
 
integration and other acquisition-related expenses during the first three months
 
of 2022 as compared to
$8.7
 
million during the first three months of 2021.
 
During the first quarter of 2022, the Company incurred $3.1 million of strategic
planning and transformation expenses.
 
The Company expects that these additional operating costs and associated
 
cash flows, as well
as higher capital expenditures related to strategic planning, process optimization
 
and the next phase of the Company’s
 
long-term
integration to further optimize its footprint, processes and other
 
functions will continue in 2022 and over the next several years.
Quaker Houghton’s management
 
approved, and the Company initiated, a global restructuring plan (the
 
“QH Program”) in the
third quarter of 2019 as part of its planned cost synergies associated
 
with the Combination.
 
The QH Program includes restructuring
and associated severance costs to reduce total headcount by approximately
 
400 people globally and plans for the closure of certain
manufacturing and non-manufacturing facilities.
 
The exact timing and total costs associated with the QH Program continues
 
to
depend on a number of factors and is subject to change; however,
 
reductions in headcount and site closures have occurred, and the
Company currently expects additional headcount reductions and
 
site closures to occur throughout the year and estimates that the
anticipated cost synergies realized under the QH Program
 
will approximate one-times restructuring costs incurred.
 
The Company
made cash payments related to the settlement of restructuring liabilities under
 
the QH Program during the first three months of 2022 of
approximately $0.4 million compared to $3.0 million in the first three months
 
of 2021.
As of March 31, 2022, the Company’s
 
gross liability for uncertain tax positions, including interest and penalties,
 
was $24.5
million.
 
The Company cannot determine a reliable estimate of the timing of cash flows
 
by period related to its uncertain tax position
liability.
 
However, should the entire liability be
 
paid, the amount of the payment may be reduced by up to $7.2 million as a result of
offsetting benefits in other tax jurisdictions.
 
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
26
In 2021, two of the Company’s locations
 
suffered significant property damage as a result of flooding
 
and fire.
 
The Company
maintains property insurance for all of its facilities globally.
 
The Company, its insurance
 
adjuster and insurance carrier are actively
managing the remediation and restoration activities associated with both
 
of these events and at this time the Company has concluded,
based on all available information and discussions with its insurance
 
adjuster and insurance carrier, that the losses incurred
 
during
2021 were covered under the Company’s
 
property insurance coverage, net of an aggregate deductible of $2.0
 
million.
 
The Company
has received payments from its insurers of $2.1 million and has recorded
 
an insurance receivable associated with these events of $0.5
million as of March 31, 2022.
 
See Note 18 of Notes to Condensed Consolidated Financial Statements in Item
 
1 of this Report.
 
The Company believes that its existing cash, anticipated cash flows from
 
operations and available additional liquidity will be
sufficient to support its operating requirements and fund
 
its business objectives for at least the next twelve months, including but not
limited to, payments of dividends to shareholders, costs related to ongoing
 
acquisition integration and optimization,
 
pension plan
contributions, capital expenditures, other business opportunities (including
 
potential acquisitions), implementing actions to achieve the
Company’s sustainability
 
goals and other potential contingencies.
 
The Company believes it has sufficient additional liquidity to
support its operating requirements and fund its business obligations for
 
the period beyond the next twelve months as well, including
the aforementioned items which are expected to recur annually,
 
as well as future principal payments on the Company’s
 
Credit Facility,
transition tax obligations and other long-term liabilities.
 
The Company’s liquidity is affected
 
by many factors, some based on normal
operations of our business and others related to the impact of the pandemic
 
and other global events on our business and on global
economic conditions as well as industry uncertainties, which we cannot predict.
 
We also cannot predict
 
economic conditions and
industry downturns or the timing, strength or duration of recoveries.
 
We may seek,
 
as we believe appropriate, additional debt or
equity financing which would provide capital for corporate purposes,
 
working capital funding, additional liquidity needs or to fund
future growth opportunities, including possible acquisitions and
 
investments.
 
The timing and amount of potential capital requirements
cannot be determined at this time and will depend on a number of factors,
 
including the actual and projected demand for our products,
specialty chemical industry conditions, competitive factors, and
 
the condition of financial markets, among others.
Non-GAAP Measures
The information in this Form 10-Q filing includes non-GAAP (unaudited)
 
financial information that includes EBITDA, adjusted
EBITDA, adjusted EBITDA margin, non-GAAP operating
 
income, non-GAAP operating margin, non-GAAP net
 
income and non-
GAAP earnings per diluted share.
 
The Company believes these non-GAAP financial measures provide meaningful supplemental
information as they enhance a reader’s understanding
 
of the financial performance of the Company,
 
are indicative of future operating
performance of the Company,
 
and facilitate a comparison among fiscal periods, as the non-GAAP financial
 
measures exclude items
that are not considered indicative of future operating performance or not
 
considered core to the Company’s operations.
 
Non-GAAP
results are presented for supplemental informational purposes only and
 
should not be considered a substitute for the financial
information presented in accordance with GAAP.
 
The Company presents EBITDA which is calculated as net income attributable
 
to the Company before depreciation and
amortization, interest expense, net, and taxes on income before equity in net income
 
of associated companies.
 
The Company also
presents adjusted EBITDA which is calculated as EBITDA plus or minus
 
certain items that are not indicative of future operating
performance or not considered core to the Company’s
 
operations.
 
In addition, the Company presents non-GAAP operating income
which is calculated as operating income plus or minus certain items that are not
 
indicative of future operating performance or not
considered core to the Company’s
 
operations.
 
Adjusted EBITDA margin and non-GAAP operating margin
 
are calculated as the
percentage of adjusted EBITDA and non-GAAP operating income
 
to consolidated net sales, respectively.
 
The Company believes
these non-GAAP measures provide transparent and useful information and
 
are widely used by analysts, investors, and competitors in
our industry as well as by management in assessing the operating performance
 
of the Company on a consistent basis.
Additionally, the
 
Company presents non-GAAP net income and non-GAAP earnings per diluted share
 
as additional performance
measures.
 
Non-GAAP net income is calculated as adjusted EBITDA, defined above,
 
less depreciation and amortization, interest
expense, net, and taxes on income before equity in net income of associated
 
companies, in each case adjusted, as applicable, for any
depreciation, amortization, interest or tax impacts resulting from the non-core
 
items identified in the reconciliation of net income
attributable to the Company to adjusted EBITDA.
 
Non-GAAP earnings per diluted share is calculated as non-GAAP net income per
diluted share as accounted for under the “two-class share method.”
 
The Company believes that non-GAAP net income and non-
GAAP earnings per diluted share provide transparent and useful information
 
and are widely used by analysts, investors, and
competitors in our industry as well as by management in assessing the operating
 
performance of the Company on a consistent basis.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
27
The following tables reconcile the Company’s
 
non-GAAP financial measures (unaudited) to their most directly comparable
GAAP (unaudited) financial measures (dollars in thousands, unless otherwise
 
noted, except per share amounts):
Non-GAAP Operating Income and Margin Reconciliations
Three Months Ended
March 31,
 
2022
2021
Operating income
$
29,403
$
44,894
Combination, integration and other acquisition-related expenses (a)
4,053
6,230
Strategic planning and transformation expenses (b)
3,088
-
Restructuring and related charges (c)
820
1,175
Fair value step up of acquired inventory sold (d)
—
801
Executive transition costs (e)
539
504
Inactive subsidiary's non-operating litigation costs (f)
92
51
Customer insolvency costs (g)
1,166
—
Non-GAAP operating income
$
39,161
$
53,655
Non-GAAP operating margin (%) (n)
8.3%
12.5%
EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin and
Non-GAAP Net Income Reconciliations
Three Months Ended
March 31,
 
2022
2021
Net income attributable to Quaker Chemical Corporation
$
19,816
$
38,615
Depreciation and amortization (a) (l)
20,727
22,448
Interest expense, net (a)
5,345
5,470
Taxes on income
 
before equity in net income of associated companies (m)
2,866
10,689
EBITDA
$
48,754
$
77,222
Equity loss (income) in a captive insurance company (h)
244
(3,080)
Combination, integration and other acquisition-related expenses (a)
6,032
427
Strategic planning and transformation expenses (b)
3,088
—
Restructuring and related charges (c)
820
1,175
Fair value step up of acquired inventory sold (d)
—
801
Executive transition costs (e)
539
504
Inactive subsidiary's non-operating litigation costs (f)
92
51
Customer insolvency costs (g)
1,166
—
Pension and postretirement benefit income, non-service components
 
(i)
(479)
(124)
Currency conversion impacts of hyper-inflationary economies (j)
188
172
Adjusted EBITDA
$
60,444
$
77,148
Adjusted EBITDA margin (%) (n)
12.7%
18.0%
Adjusted EBITDA
$
60,444
$
77,148
Less: Depreciation and amortization - adjusted (a)
20,727
22,033
Less: Interest expense, net
5,345
5,470
Less: Taxes on income
 
before equity in net income of associated companies - adjusted
 
(k)(m)
8,902
11,739
Non-GAAP net income
$
25,470
$
37,906
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
28
Non-GAAP Earnings per Diluted Share Reconciliations
Three Months Ended
March 31,
 
2022
2021
GAAP earnings per diluted share attributable to Quaker Chemical Corporation
 
 
common shareholders
$
1.11
$
2.15
Equity loss (income) in a captive insurance company per diluted share (h)
0.01
(0.17)
Combination, integration and other acquisition-related expenses per diluted
 
share (a)
0.25
0.04
Strategic planning and transformation expenses per diluted share (b)
0.14
—
Restructuring and related charges per diluted share (c)
0.03
0.05
Fair value step up of acquired inventory sold per diluted share (d)
—
0.03
Executive transition costs per diluted share (e)
0.02
0.02
Inactive subsidiary's non-operating litigation costs per diluted share (f)
 
0.00
 
 
0.00
 
Customer insolvency costs per diluted share (g)
0.06
—
Pension and postretirement benefit costs, non-service components per diluted
 
share (i)
(0.02)
 
(0.00)
Currency conversion impacts of hyper-inflationary economies per
 
diluted share (j)
0.01
0.01
Impact of certain discrete tax items per diluted share (k)
(0.19)
(0.02)
Non-GAAP earnings per diluted share (o)
$
1.42
$
2.11
(a)
Combination,
 
integration and other acquisition-related expenses include certain legal, financial,
 
and other advisory and consultant
costs incurred in connection with integration activities including internal
 
control readiness and remediation.
 
These costs are not
indicative of the future operating performance of the Company.
 
Less than $0.1 million and $0.1 million for the three months
ended March 31, 2022 and 2021, respectively,
 
of these pre-tax costs were considered non-deductible for the purpose of
determining the Company’s
 
effective tax rate, and, therefore, taxes on income before equity in
 
net income of associated
companies - adjusted reflects the impact of these items.
 
During the three months ended March 31, 2022, the Company recorded
$2.0 million of other expense related to an indemnification asset.
 
During the three months ended March 31, 2021, the Company
recorded $0.4 million of accelerated depreciation related to certain of
 
the Company’s facilities, which is included
 
in the caption
“Combination, integration and other acquisition-related expenses” in the
 
reconciliation of operating income to non-GAAP
operating income and included in the caption “Depreciation and amortization”
 
in the reconciliation of net income attributable to
the Company to EBITDA, but excluded from the caption “Depreciation
 
and amortization – adjusted” in the reconciliation of
adjusted EBITDA to non-GAAP net income attributable to the Company
 
.
 
During the three months ended March 31, 2021, the
Company recorded a $5.4 million gain on the sale of certain held-for-sale
 
real property assets related to the Combination which is
included in the caption “Combination, integration and other acquisition-related
 
expenses” in the reconciliation of GAAP earnings
per diluted share attributable to Quaker Chemical Corporation common
 
shareholders to Non-GAAP earnings per diluted share as
well as the reconciliation of net income attributable to Quaker Chemical Corporation
 
to Adjusted EBITDA and Non-GAAP net
income.
 
(b)
Strategic planning and transformation expenses include certain consultant
 
and advisory expenses for the Company’s
 
long-term
strategic planning, as well as process optimization and the next phase
 
of the Company’s long-term integration
 
to further optimize
its footprint, processes and other functions.
 
These costs are not indicative of the future operating performance of the Company.
(c)
Restructuring and related charges represent the
 
costs incurred by the Company associated with the QH restructuring program
which was initiated in the third quarter of 2019 as part of the Company’s
 
plan to realize cost synergies associated with the
Combination.
 
These costs are not indicative of the future operating performance of the Company.
 
See Note 7 of Notes to
Condensed Consolidated Financial Statements, which appears in Item
 
1 of this Report.
 
(d)
Fair value step up of acquired inventory sold relates to expense associated with selling
 
inventory from acquired businesses which
was adjusted to fair value as part of purchase accounting.
 
These increases in costs of goods sold (“COGS”) are not indicative of
the future operating performance of the Company.
(e)
Executive transition costs represent the costs related to the Company’s
 
search, hiring and transition to a new CEO in connection
with the executive transition that took place in 2021 as well as the on-going
 
search for a new Chief Human Resources Officer
during the first quarter of 2022.
 
These expenses are not indicative of the future operating performance of the
 
Company.
(f)
Inactive subsidiary’s non
 
-operating litigation costs represent the charges incurred by
 
an inactive subsidiary of the Company and
are a result of the termination of restrictions on insurance settlement reserves
 
.
 
These charges are not indicative of the future
operating performance of the Company.
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
29
(g)
Customer insolvency costs represent the costs associated with a specific
 
reserve or changes to existing reserves for trade accounts
receivable within the Company’s
 
EMEA reportable segment related to certain customers who filed for
 
bankruptcy protection as
well as costs related to specific reserves recorded for certain customer accounts
 
receivables which have been directly impacted by
the current economic conflict between Russia and Ukraine.
 
These expenses are not indicative of the future operating performance
of the Company.
 
(h)
Equity loss (income)
 
in a captive insurance company represents the after-tax
 
(loss) income attributable to the Company’s
 
interest
in Primex, Ltd. (“Primex”),
 
a captive insurance company.
 
The Company holds a 32% investment in and has significant influence
over Primex, and therefore accounts for this interest under the equity method
 
of accounting.
 
The loss (income)
 
attributable to
Primex is not indicative of the future operating performance of the
 
Company and is not considered core to the Company’s
operations.
(i)
Pension and postretirement benefit income,
 
non-service components represent the pre-tax, non-service
 
component of the
Company’s pension and postretirement
 
net periodic benefit income in each period.
 
These costs are not indicative of the future
operating performance of the Company.
 
See Note 9 of Notes to Condensed Consolidated Financial Statements, which appears
 
in
Item 1 of this Report.
(j)
Currency conversion impacts of hyper-inflationary economies represents
 
the foreign currency remeasurement impacts associated
with the Company’s affiliates
 
whose local economies are designated as hyper-inflationary under
 
U.S. GAAP.
 
During both the
three months ended March 31, 2022
 
and 2021, the Company incurred non-deductible, pre-tax charges
 
related to the Company’s
Argentine affiliates.
 
The charges incurred related to the immediate recognition of foreign currency
 
remeasurement in the
Consolidated Statements of Income associated with these entities are not indicative
 
of the future operating performance of the
Company.
 
See Note 1 of Notes to Condensed Consolidated Financial Statements, which appears
 
in Item 1 of this Report.
(k)
The impacts of certain discrete tax items include changes in valuation
 
allowances recorded on certain Brazilian branch foreign tax
credits and the recording of deferred taxes on Brazilian branch income.
 
Both of these discrete items related to a result of tax law
changes in the U.S. due to the issuance of final foreign tax credit regulations
 
during the period.
 
Additionally, the Company has
discrete items related to the release of the reserves for uncertain tax positions
 
settled during the quarter and certain taxes,
penalties, and interest due as a result of the settlements.
 
See Note 11 of Notes to Condensed Consolidated
 
Financial Statements,
which appears in Item 1 of this Report.
(l)
Depreciation and amortization for the three months ended March 31,
 
2022 and 2021 each included $0.3
 
million of amortization
expense recorded within equity in net income of associated companies
 
in the Company’s Condensed Consolidated
 
Statement of
Income,
 
which is attributable to the amortization of the fair value step up for the Company’s
 
50% interest in a Houghton joint
venture in Korea as a result of required purchase accounting.
(m)
Taxes on income
 
before equity in net income of associated companies – adjusted presents the impact
 
of any current and deferred
income tax expense (benefit), as applicable, of the reconciling items presented
 
in the reconciliation of net income attributable to
Quaker Chemical Corporation to adjusted EBITDA, and was determined
 
utilizing the applicable rates in the taxing jurisdictions in
which these adjustments occurred, subject to deductibility.
 
Combination, integration and other acquisition-related expenses
described in (a) resulted in incremental taxes of $1.4 million and $0.1
 
million during the three months ended March 31, 2022 and
2021, respectively.
 
Strategic planning and transformation expenses describes in (b) above resulted
 
in incremental taxes of $0.7
million during the three months ended March 31, 2022.
 
Restructuring and related charges described in (c) resulted in incremental
taxes of $0.2 million during each of the three months ended March 31, 2022
 
and 2021.
 
Fair value step up of acquired inventory
sold described in (d) resulted in incremental taxes of $0.2 million during
 
the three months ending March 31, 2021.
 
Executive
transition expenses described in (e) resulted in incremental taxes of $0.1
 
million during each of the three months ended March 31,
2022 and 2021.
 
Inactive subsidiary non-operating litigation costs described in (f) resulted in incremental
 
taxes of less than $0.1
million for each of the three months ended March 31, 2022 and 2021.
 
Customer insolvency costs described in (g) resulted in
incremental taxes of $0.3 million during the three months ended
 
March 31, 2022.
 
Pension and postretirement benefit income,
non-service components described in (i) resulted in a tax benefit of $0.1
 
million and less than $0.1 million for the three months
ended March 31, 2022 and 2021, respectively.
 
The impact of certain discrete items described in (k) resulted in a tax benefit of
$3.4 million and $0.4 million for the three months ended March 31, 2022
 
and 2021, respectively.
(n)
The Company calculates adjusted EBITDA margin
 
and non-GAAP operating margin as the percentage of adjusted EBITDA
 
and
non-GAAP operating income to consolidated net sales.
(o)
The Company calculates non-GAAP earnings per diluted share as non
 
-GAAP net income attributable to the Company per
weighted average diluted shares outstanding using the “two-class share method”
 
to calculate such in each given period.
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
30
Off-Balance Sheet Arrangements
The Company had no material off-balance sheet commitments or
 
obligations as of March 31, 2022.
 
The Company’s only off-
balance sheet items outstanding as of March 31, 2022 represented approximately
 
$6 million of total bank letters of credit and
guarantees.
 
The bank letters of credit and guarantees are not significant to the Company’s
 
liquidity or capital resources.
 
See Note 14
of Notes to Condensed Consolidated Financial Statements in Item
 
1 of this Report.
Operations
Consolidated Operations Review – Comparison of the First Quarter of 2022
 
with the First Quarter of 2021
Net sales were $474.2 million in the first quarter of 2022 compared to $429.8
 
million in the first quarter of 2021.
 
The net sales
increase of $44.4 million or 10% quarter-over-quarter reflects increases in
 
selling price and product mix of approximately 17% and
additional net sales from acquisitions of 2% partially offset
 
by a decline in sales volume of approximately 6% and the unfavorable
impact from foreign currency translation of 3%.
 
The increase in selling price and product mix is primarily driven by price increases
implemented to help offset the significant increases in raw
 
material and other input costs that began during 2021.
 
The decline in sales
volumes was primarily attributable to the comparison to a very strong first quarter
 
of 2021, where customers replenished their supply
chains, the impact of lower volumes related to the tolling agreement
 
for previously divested products associated with the Combination
and lower sales volumes attributable to the war in Ukraine.
COGS were $328.1 million in the first quarter of 2022 compared to $273.6
 
million in the first quarter of 2021.
 
The increase in
COGS of $54.5 million or 20% was driven by the associated COGS on the
 
increase in net sales described above as well as continued
increases in the Company’s global
 
raw material and supply chain and logistics costs compared to the prior year.
Gross profit in the first quarter of 2022 decreased $10.1 million or 6%
 
from the first quarter of 2021.
 
The Company’s reported
gross margin in the first quarter of 2022 was 30.8% compared to
 
36.3% in the first quarter of 2021.
 
The Company’s current quarter
gross margin reflects a significant increase in raw
 
material and other input costs experienced throughout the first quarter of
 
2022 and
the impacts of constraints on the global supply chain, partially offset
 
by the Company’s ongoing value
 
-based pricing initiatives.
SG&A in the first quarter of 2022 increased $7.5 million or 7% compared
 
to the first quarter of 2021 due primarily to the impact
of sales increases on direct selling costs, inflationary impacts on higher
 
operating costs, costs associated with strategic planning and
transformation initiatives (see the Non-GAAP Measures section of
 
this Item, above), and additional SG&A from recent acquisitions
partially offset by lower SG&A due to foreign currency
 
translation and lower incentive compensation compared to the prior year.
 
In
addition, SG&A was lower in the prior year period as a result of continued
 
temporary cost saving measures the Company
implemented in response to the onset of COVID-19.
 
During the first quarter of 2022, the Company incurred $4.1 million
 
of Combination,
 
integration and other acquisition-related
operating expenses primarily for professional fees related to the Houghton
 
integration and other acquisition-related activities.
 
Comparatively,
 
the Company incurred $5.8 million of expenses in the prior year first quarter,
 
primarily due to various professional
fees related to legal, financial and other advisory and consultant expenses
 
for integration activities including internal control readiness
and remediation.
 
See the Non-GAAP Measures section of this Item, above.
The Company initiated a restructuring program during the third quarter
 
of 2019 as part of its global plan to realize cost synergies
associated with the Combination.
 
The Company incurred Restructuring and related charges for reductions
 
in headcount and site
closures under this program, net of adjustments to initial estimates for severance
 
of $0.8 million and $1.2 million during the first
quarters of 2022 and 2021, respectively.
 
See the Non-GAAP Measures section of this Item, above.
Operating income in the first quarter of 2022 was $29.4 million compared
 
to $44.9 million in the first quarter of 2021.
 
Excluding
non-recurring and non-core expenses that are not indicative of the future operating
 
performance of the Company described in the Non-
GAAP Measures section of this Item, above, the Company’s
 
current quarter non-GAAP operating income decreased
 
to $39.2 million
compared to $53.7 million in the prior year first quarter primarily due
 
to the lower gross profit described above.
 
The Company had other expense, net, of $2.2 million in the first quarter
 
of 2022 compared to other income, net of $4.7 million in
the first quarter of 2021.
 
The first quarter of 2022 includes other expenses related to the impact of certain adjustment
 
to the
Company’s indemnification
 
receivables, while the prior year first quarter other income includes a gain on
 
the sale of certain held-for-
sale real property assets.
 
See the Non-GAAP Measures section of this Item, above.
 
Interest expense, net, decreased $0.1 million compared to the first quarter
 
of 2021, due to a slight decrease in the average
borrowings outstanding in the first quarter of 2022 compared to the first
 
quarter of 2021 on relatively consistent interest rates during
both the first quarter of 2022 and 2021.
The Company’s effective
 
tax rates for the first quarters of 2022 and 2021 were 13.1% and 24.2%, respectively.
 
The Company’s
effective tax rate for the three months ended March 31,
 
2022 was largely driven by changes in the valuation allowance for foreign
 
tax
credits due to recently issued legislative guidance and impacts due to settlements
 
reached on certain tax audits.
 
Comparatively, the
prior year first quarter effective tax rate was impacted by the sale of
 
a subsidiary which included certain held-for-sale real property
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
31
assets related to the Combination.
 
Excluding the impact of these items as well as all other non-core items in each quarter,
 
described in
the Non-GAAP Measures section of this Item, above, the Company
 
estimates that its effective tax rates for the first quarter of 2022
and 2021 would have been approximately 27% and 25%, respectively.
 
The Company incurred higher tax expense during the three
months ended March 31, 2022 primarily related to the Company recording earnings
 
in one of its subsidiaries at a statutory tax rate of
25% while it awaits recertification of a concessionary 15% tax rate, which
 
was available to the Company during all of 2021.
 
The
Company expects continued volatility in its effective tax
 
rates due to several factors, including the timing and scope of tax audits and
the expiration of applicable statutes of limitations as they relate to uncertain
 
tax positions, the unpredictability of the timing and
amount of certain incentives in various tax jurisdictions, the treatment of
 
certain acquisition-related costs and the timing and amount
of certain share-based compensation-related tax benefits, among
 
other factors.
Equity in net income of associated companies decreased $4.4 million
 
in the first quarter of 2022 compared to the first quarter of
2021, primarily due to lower current year income from the Company’s
 
interest in a captive insurance company and from the
Company’s 50% interest in a joint venture
 
in Korea.
 
See the Non-GAAP Measures section of this Item, above.
Net income attributable to noncontrolling interest was less than $0.1 million
 
in both the first quarters of 2022 and 2021.
 
Foreign exchange unfavorably impacted the Company’s
 
first quarter of 2022 results by approximately 4% driven by the impact
from foreign currency translation on earnings as well as higher foreign
 
exchange transaction losses in the current quarter as compared
to the prior year first quarter.
Reportable Segments Review - Comparison of the First Quarter of 2022
 
with the First Quarter of 2021
The Company’s reportable
 
segments reflect the structure of the Company’s
 
internal organization, the method by which the
Company’s resources are allocated
 
and the manner by which the chief operating decision maker of the Company
 
assesses its
performance.
 
The Company has four reportable segments: (i) Americas; (ii) EMEA; (iii)
 
Asia/Pacific; and (iv) Global Specialty
Businesses.
 
The three geographic segments are composed of the net sales and operations
 
in each respective region, excluding net
sales and operations managed globally by the Global Specialty Businesses
 
segment, which includes the Company’s
 
container, metal
finishing, mining, offshore, specialty coatings, specialty
 
grease and Norman Hay businesses.
 
Segment operating earnings for the Company’s
 
reportable segments are comprised of net sales less COGS and SG&A directly
related to the respective segment’s product
 
sales.
 
Operating expenses not directly attributable to the net sales of each respective
segment, such as certain corporate and administrative costs, Combination,
 
integration and other acquisition-related expenses,
Restructuring and related charges, and COGS related
 
to acquired inventory sold, which is adjusted to fair value as part of purchase
accounting, are not included in segment operating earnings.
 
Other items not specifically identified with the Company’s
 
reportable
segments include interest expense, net, and other (expense) income, net.
Americas
Americas represented approximately 33% of the Company’s
 
consolidated net sales in the first quarter of 2022.
 
The segment’s net
sales were $154.1 million, an increase of $19.3 million or 14% compared
 
to the first quarter of 2021.
 
The increase in net sales was
due to higher selling price and product mix of 22% and additional net sales from
 
acquisitions of 2% partially offset by decreases in
organic sales volumes of 10%.
 
The increase in selling price and product mix is primarily driven by price
 
increases implemented to
help offset the significant increases in raw material and
 
other input costs that began during 2021 and have continued in 2022.
 
The
current quarter decline in organic sales volume was largely
 
driven by the impact of lower volumes related to the tolling agreement for
previously divested products associated with the Combination
 
and the prior year period comparison,
 
which included a strong rebound
from COVID-19 impacts.
 
This segment’s operating earnings were $29.2
 
million, a decrease of $3.0 million or 9% compared to the
first quarter of 2021.
 
The decrease in segment operating earnings was primarily a result of lower gross
 
margins driven by the lag in
price increases as compared to continued raw material cost increases and global
 
supply chain and logistics pressures, as well as higher
SG&A including an increase in direct selling costs, SG&A from acquisitions
 
and year-over-year inflationary increases
 
.
EMEA
EMEA represented approximately 26% of the Company’s
 
consolidated net sales in the first quarter of 2022.
 
The segment’s net
sales were $125.7 million, an increase of $5.9 million or 5% compared
 
to the first quarter of 2021.
 
The increase in net sales was due
to higher selling price and product mix of 18% and additional net sales from
 
acquisitions of 2%, partially offset by the unfavorable
impact of foreign currency translation of 9% and a decrease in organic
 
sales volumes
 
of 6%.
 
The increase in selling price and product
mix is primarily driven by price increases implemented to help offset
 
the significant increases in raw material and other input costs
that began during 2021 and have continued in 2022.
 
The current quarter organic volume decline was primarily driven
 
by the current
economic pressures including the direct and indirect impacts of the
 
Russia-Ukraine conflict and the impact of economic and other
sanctions by other nations on Russia as well as the prior year period comparison
 
including a strong rebound from COVID-19 impacts.
 
The foreign exchange impact was primarily due to the weakening of the
 
euro against the U.S. dollar as this exchange rate averaged
1.12 in the first quarter of 2022 compared to 1.21 in the first quarter of
 
2021.
 
This segment’s operating earnings
 
were $16.8 million, a
decrease of $8.5 million or 34% compared to the first quarter of 2021.
 
The decrease in segment operating earnings was primarily a
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
32
result of lower gross margins driven by the lag in price increases as compared
 
to continued raw material cost increases and global
supply chain and logistics pressures, coupled with higher SG&A including
 
an increase in direct selling costs, SG&A from acquisitions
and year-over-year inflationary increases
 
.
Asia/Pacific
Asia/Pacific represented approximately 22% of the Company’s
 
consolidated net sales in the first quarter of 2022.
 
The segment’s
net sales were $104.2 million, an increase of $7.5 million or 8% compared
 
to the first quarter of 2021.
 
The increase in net sales was
driven by higher selling price and product mix of 12% partially offset
 
by lower organic sales volumes of 4%.
 
The increase in selling
price and product mix is primarily driven by price increases implemented
 
to help offset the significant increases in raw material and
other input costs that began during 2021 and continued throughout
 
the first quarter of 2022.
 
The current quarter decline in organic
sales volume was primarily driven by lower activity primarily in China related
 
to government mandates regarding the current year
Olympics as well as country restrictions over power and export related
 
activity compared to a very favorable demand environment in
the prior year period.
 
This segment’s operating earnings
 
were $21.9 million, a decrease of $5.6 million or 20% compared to the first
quarter of 2021.
 
The decrease in segment operating earnings was primarily a result of lower gross margins
 
driven by the lag in price
increases as compared to continued raw material cost increases and global
 
supply chain and logistics pressures, coupled with higher
SG&A including an increase in direct selling costs and year-over-year inflationary
 
increases.
Global Specialty Businesses
Global Specialty Businesses represented approximately 19% of the
 
Company’s consolidated net sales in the
 
first quarter of 2022.
 
The segment’s net sales were $90.1
 
million, an increase of $11.7 million or 15% compared
 
to the first quarter of 2021.
 
The increase
in net sales was driven by higher selling price and product mix of 10%, including
 
Norman Hay, additional net sales from
 
acquisitions
of 4% and an increase in organic sales volumes of 2%, partially offset
 
by the unfavorable impact from foreign currency transaction of
approximately 1%.
 
The increase in selling price and product mix is primarily driven by price increases implemented
 
to help offset the
significant increases in raw material and other input costs that began during
 
2021 and continued throughout the first quarter of 2022.
The increase in organic sales volumes was primarily attributable
 
to a favorable demand environment for our products.
 
The foreign
exchange impact was primarily due to the weakening of the euro
 
against the U.S. dollar described in the EMEA section above.
 
This
segment’s operating earnings were
 
$25.0 million, an increase of $0.9 million or 4% compared to the first quarter
 
of 2021.
 
The
increase in segment operating earnings reflects the aforementioned
 
higher net sales partially offset by slightly lower gross margins
 
in
the current year coupled with higher SG&A, including an increase in direct
 
selling costs, SG&A from acquisitions and year-over-year
inflationary increases.
Factors That May Affect Our Future Results
(Cautionary Statements Under the Private Securities Litigation Reform
 
Act of 1995)
Certain information included in this Report and other materials filed or
 
to be filed by Quaker Chemical Corporation with the SEC,
as well as information included in oral statements or other written statements made
 
or to be made by us, contain or may contain
forward-looking statements within the meaning of Section 27A of the
 
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended.
 
These statements can be identified by the fact that they do not relate strictly to
historical or current facts.
 
We have based
 
these forward-looking statements, including statements regarding the potential
 
effects of the
COVID-19 pandemic and global supply chain constraints on the Company’s
 
business, results of operations, and financial condition,
our expectation that we will maintain sufficient liquidity and
 
remediate any of our material weaknesses in internal control over
financial reporting, and statements regarding the impact of increased
 
raw material costs and pricing initiatives on our current
expectations about future events.
 
These forward-looking statements include statements with respect to
 
our beliefs, plans, objectives, goals, expectations,
anticipations, intentions, financial condition, results of operations, future
 
performance, and business, including:
 
•
 
the potential benefits of the Combination and other acquisitions;
 
•
 
the impacts on our business as a result of the COVID-19 pandemic;
•
the timing and extent of the projected impacts on our business as a result of the Ukrainian
 
and Russian conflict;
•
cost increases in prices of raw materials and the impacts of constraints and
 
disruptions in the global supply chain;
•
 
our current and future results and plans including our sustainability goals; and
 
•
 
statements that include the words “may,”
 
“could,” “should,” “would,” “believe,” “expect,” “anticipate,” “estimate,”
“intend,” “plan” or similar expressions.
Such statements include information relating to current and future business activities,
 
operational matters, capital spending, and
financing sources.
 
From time to time, forward-looking statements are also included in the Company’s
 
other periodic reports on Forms
10-K, 10-Q and 8-K, press releases, and other materials released to,
 
or statements made to, the public.
 
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
33
Any or all of the forward-looking statements in this Report, in the Company’s
 
Annual Report to Shareholders for 2021 and in any
other public statements we make may turn out to be wrong.
 
This can occur as a result of inaccurate assumptions or as a consequence
of known or unknown risks and uncertainties.
 
Many factors discussed in this Report will be important in determining our future
performance.
 
Consequently, actual results may
 
differ materially from those that might be anticipated from our forward-looking
statements.
We undertake
 
no obligation to publicly update any forward-looking statements, whether
 
as a result of new information, future
events or otherwise.
 
However, any further disclosures made on
 
related subjects in the Company’s subsequent
 
reports on Forms 10-K,
10-Q, 8-K and other related filings should be consulted.
 
A major risk is that demand for the Company’s
 
products and services is
largely derived from the demand for our customers’ products,
 
which subjects the Company to uncertainties related to downturns in a
customer’s business and unanticipated customer production
 
slowdowns and shutdowns, including as is currently being experienced by
many automotive industry companies as a result of supply chain disruption.
 
Other major risks and uncertainties include, but are not
limited to, the primary and secondary impacts of the COVID-19 pandemic,
 
including actions taken in response to the pandemic by
various governments, which could exacerbate some or all of the other
 
risks and uncertainties faced by the Company,
 
as well as the
potential for significant increases in raw material costs, supply chain
 
disruptions, customer financial instability,
 
worldwide economic
and political disruptions including the impacts of the military conflict
 
between Russia and Ukraine, the economic and other sanctions
imposed by other nations on Russia, suspensions of activities in Russia by
 
many multinational companies and the potential expansion
of military activity, foreign
 
currency fluctuations, significant changes in applicable tax rates and
 
regulations, future terrorist attacks
and other acts of violence.
 
Furthermore, the Company is subject to the same business cycles as those experienced by
 
our customers in
the steel, automobile, aircraft, industrial equipment, and durable goods industries.
 
The ultimate impact of COVID-19 on our business
will depend on, among other things, the extent and duration of the
 
pandemic, the severity of the disease and the number of people
infected with the virus including new variants, the continued uncertainty
 
regarding global availability,
 
administration, acceptance and
long-term efficacy of vaccines, or other treatments for
 
COVID-19 or its variants, the longer-term effects
 
on the economy of the
pandemic, including the resulting market volatility,
 
and by the measures taken by governmental authorities and other third parties
restricting day-to-day life and business operations and the length
 
of time that such measures remain in place, as well as laws and other
governmental programs implemented to address the pandemic or assist impacted
 
businesses, such as fiscal stimulus and other
legislation designed to deliver monetary aid and other relief.
 
Other factors could also adversely affect us, including those related
 
to
acquisitions and the integration of acquired businesses.
 
Our forward-looking statements are subject to risks, uncertainties and
assumptions about the Company and its operations that are subject to change
 
based on various important factors, some of which are
beyond our control.
 
These risks, uncertainties, and possible inaccurate assumptions relevant to our
 
business could cause our actual
results to differ materially from expected and historical
 
results.
 
Therefore, we caution you not to place undue reliance on our forward-looking
 
statements.
 
For more information regarding these
risks and uncertainties as well as certain additional risks that we face,
 
refer to the Risk Factors section, which appears in Item 1A in
our 2021 Form 10-K and in our quarterly and other reports filed from time to
 
time with the SEC.
 
This discussion is provided as
permitted by the Private Securities Litigation Reform Act of 1995.
Quaker Houghton on the Internet
 
Financial results, news and other information about Quaker Houghton
 
can be accessed from the Company’s
 
website at
https://www.quakerhoughton.com
 
.
 
This site includes important information on the Company’s
 
locations, products and services,
financial reports, news releases and career opportunities.
 
The Company’s periodic and current reports
 
on Forms 10-K, 10-Q, 8-K, and
other filings, including exhibits and supplemental schedules filed therewith,
 
and amendments to those reports, filed with the SEC are
available on the Company’s website,
 
free of charge, as soon as reasonably practicable after they
 
are electronically filed with or
furnished to the SEC.
 
Information contained on, or that may be accessed through, the Company’s
 
website is not incorporated by
reference in this Report and, accordingly,
 
you should not consider that information part of this Report.
34
Item 3.
 
Quantitative and Qualitative Disclosures About Market
 
Risk.
We have evaluated
 
the information required under this Item that was disclosed in Part II, Item 7A, of our Annual
 
Report on Form
10-K for the year ended December 31, 2021, and we believe there has been no material
 
change to that information.
35
Item 4.
 
Controls and Procedures.
Evaluation of disclosure controls
 
and procedures.
 
As required by Rule 13a-15(b) under the Securities Exchange Act of 1934, as
amended (the “Exchange Act”), our management, including our
 
principal executive officer and principal financial officer,
 
has
evaluated the effectiveness of our disclosure controls
 
and procedures (as defined in Rule 13a-15(e) under the Exchange Act ) as of the
end of the period covered by this Report.
 
Based on that evaluation, our principal executive officer and our principal
 
financial officer
have concluded that, as of March 31, 2022, the end of the period covered by
 
this Report, our disclosure controls and procedures (as
defined in Rule 13a-15(e) under the Exchange Act) were effective.
Changes in internal control over financial reporting.
 
As required by Rule 13a-15(d) under the Exchange Act, our
management, including our principal executive officer
 
and principal financial officer, has evaluated
 
our internal control over
financial reporting to determine whether any changes to our internal control
 
over financial reporting occurred during the
quarter ended March 31, 2022 that have materially affected, or
 
are reasonably likely to materially affect, our internal control
over financial reporting.
 
Based on that evaluation, there were no changes that have materially affected,
 
or are reasonably
likely to materially affect, our internal control over financial reporting
 
during the quarter ended March 31, 2022.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
36
PART
 
II.
 
OTHER INFORMATION
Items 3, 4 and 5 of Part II are inapplicable and have been omitted.
Item 1.
 
Legal Proceedings.
Incorporated by reference is the information in Note 18 of the Notes to the
 
Consolidated Financial Statements in Part I, Item 1, of
this Report.
Item 1A.
 
Risk Factors.
The Company’s business, financial
 
condition, results of operations and cash flows are subject to various risks that
 
could cause
actual results to vary materially from recent results or from anticipated future
 
results.
 
In addition to the other information set forth in
this Report, you should carefully consider the risk factors previously disclosed
 
in Part I, Item 1A of our 2021
 
Form 10-K.
 
While there
have been no material changes to the risk factors described in our 2021 Form 10-K,
 
reference is made to the developments discussed
under the headings
Ongoing impact of COVID-19
 
and
Impact of Political Conflicts
 
within Item 2 of this Report.
Item 2.
 
Unregistered Sales of Equity Securities and Use of Proceeds.
The following table sets forth information concerning shares of
 
the Company’s common stock acquired
 
by the Company during
the period covered by this Report:
(c)
(d)
Total
 
Number of
Approximate Dollar
(a)
(b)
Shares Purchased
 
Value of
 
Shares that
Total
 
Number
Average
as part of
May Yet
 
be
of Shares
Price Paid
Publicly Announced
Purchased Under the
Period
Purchased (1)
Per Share (2)
Plans or Programs
Plans or Programs (3)
January 1 - January 31
494
 
$
227.19
 
—
$
86,865,026
 
February 1 - February 28
4,717
 
$
189.45
 
—
$
86,865,026
 
March 1 - March 31
161
 
$
174.07
 
—
$
86,865,026
 
Total
5,372
 
$
192.46
 
—
$
86,865,026
 
(1)
All of these shares were acquired from employees related to the surrender
 
of Quaker Chemical Corporation shares in
payment of the exercise price of employee stock options exercised or
 
for the payment of taxes upon exercise of employee
stock options or the vesting of restricted stock awards or units.
(2)
The price paid for shares acquired from employees pursuant to employee
 
benefit and share-based compensation plans is
based on the closing price of the Company’s
 
common stock on the date of exercise or vesting as specified by the plan
pursuant to which the applicable option, restricted stock award, or restricted
 
stock unit was granted.
(3)
On May 6, 2015, the Board of Directors of the Company approved, and the
 
Company announced, a share repurchase
program, pursuant to which the Company is authorized to repurchase up to
 
$100,000,000 of Quaker Chemical Corporation
common stock (the “2015 Share Repurchase Program”), and it has no expiration
 
date.
 
There were no shares acquired by the
Company pursuant to the 2015 Share Repurchase Program during the
 
quarter ended March 31, 2022.
Limitation on the Payment of Dividends
The Credit Facility has certain limitations on the payment of dividends
 
and other so-called restricted payments. See Note 14 of
Notes to Condensed Consolidated Financial Statements, in Part I, Item
 
1, of this Report.
 
 
 
37
Item 6.
 
Exhibits.
(a) Exhibits
3.1
–
3.2
–
31.1
–
31.2
–
32.1
–
32.2
–
101.INS
–
Inline XBRL Instance Document*
101.SCH
–
Inline XBRL Taxonomy
 
Extension Schema Document*
101.CAL
–
Inline XBRL Taxonomy
 
Calculation Linkbase Document*
101.DEF
–
Inline XBRL Taxonomy
 
Definition Linkbase Document*
101.LAB
–
Inline XBRL Taxonomy
 
Label Linkbase Document*
101.PRE
–
Inline XBRL Taxonomy
 
Presentation Linkbase Document*
104
–
Cover Page Interactive Data File (formatted as Inline XBRL and contained
 
in Exhibit 101.INS)*
* Filed herewith.
** Furnished herewith.
† Management contract or compensatory plan.
*********
Pursuant to the requirements of the Securities Exchange Act of 1934,
 
the registrant has duly caused this report to be signed on its
behalf by the undersigned thereunto duly authorized.
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
(Registrant)
 
 
 
 
/s/ Shane W. Hostetter________________________________
Date: May 5, 2022
 
 
 
Shane W. Hostetter,
 
Senior Vice President, Chief Financial
Officer (officer duly authorized on behalf of, and principal
financial officer of, the Registrant)
EX-31.1 2 exhibit311.htm SECTION 302 CEO CERTIFICATION exhibit311
 
1
EXHIBIT 31.1
CERTIFICATION
 
OF CHIEF EXECUTIVE OFFICER OF THE COMPANY
 
PURSUANT TO RULE 13a-14(a) OF THE
SECURITIES EXCHANGE ACT OF 1934
I, Andrew E. Tometich
 
,
 
certify that:
 
1.
I have reviewed this quarterly report on Form 10-Q of Quaker Chemical
 
Corporation;
 
2.
Based on my knowledge, this report does not contain any untrue statement of
 
a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances under
 
which such statements were made, not misleading with
respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information
 
included in this report, fairly present in all
material respects the financial condition, results of operations and cash flows
 
of the registrant as of, and for, the periods presented
in this report;
 
4.
The registrant’s other certifying
 
officer and I are responsible for establishing and maintaining
 
disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
 
control over financial reporting (as defined in Exchange
Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
 
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls
 
and procedures to be designed
under our supervision, to ensure that material information relating to the
 
registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
 
during the period in which this report is
being prepared;
 
 
(b)
Designed such internal control over financial reporting, or caused such
 
internal control over financial reporting to be
designed under our supervision, to provide reasonable assurance regarding
 
the reliability of financial reporting and
the preparation of financial statements for external purposes in accordance with
 
generally accepted accounting
principles;
 
 
(c)
Evaluated the effectiveness of the registrant’s
 
disclosure controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure controls and procedures,
 
as of the end of the period covered by
this report based on such evaluation; and
 
 
(d)
Disclosed in this report any change in the registrant’s
 
internal control over financial reporting that occurred during
the registrant’s most recent fiscal quarter
 
(the registrant’s fourth fiscal quarter in the
 
case of an annual report) that
has materially affected, or is reasonably likely to materially affect,
 
the registrant’s internal control over financial
reporting; and
 
5.
The registrant’s other certifying
 
officer and I have disclosed, based on our most recent evaluation
 
of internal control over financial
reporting, to the registrant’s
 
auditors and the audit committee of the registrant’s
 
board of directors (or persons performing the
equivalent functions):
 
 
(a)
All significant deficiencies and material weaknesses in the design or operation
 
of internal control over financial
reporting which are reasonably likely to adversely affect the registrant’s
 
ability to record, process, summarize and
report financial information; and
 
 
(b)
Any fraud, whether or not material, that involves management or other
 
employees who have a significant role in the
registrant’s internal control
 
over financial reporting.
Date: May 5, 2022
 
/s/ Andrew E. Tometich
Andrew E. Tometich
Chief Executive Officer
EX-31.2 3 exhibit312.htm SECTION 302 CFO CERTIFICATION exhibit312
 
1
EXHIBIT 31.2
CERTIFICATION
 
OF CHIEF FINANCIAL OFFICER OF THE COMPANY
 
PURSUANT TO RULE 13a-14(a) OF THE
SECURITIES EXCHANGE ACT OF 1934
I, Shane W.
 
Hostetter, certify that:
 
1.
I have reviewed this quarterly report on Form 10-Q of Quaker Chemical
 
Corporation;
 
2.
Based on my knowledge, this report does not contain any untrue statement of
 
a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances under
 
which such statements were made, not misleading with
respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial
 
information included in this report, fairly present in all
material respects the financial condition, results of operations and cash flows
 
of the registrant as of, and for, the periods presented
in this report;
 
4.
The registrant’s other certifying
 
officer and I are responsible for establishing and maintaining
 
disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
 
control over financial reporting (as defined in Exchange
Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
 
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls
 
and procedures to be designed
under our supervision, to ensure that material information relating to the
 
registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
 
during the period in which this report is
being prepared;
 
 
(b)
Designed such internal control over financial reporting, or caused such
 
internal control over financial reporting to be
designed under our supervision, to provide reasonable assurance regarding
 
the reliability of financial reporting and
the preparation of financial statements for external purposes in accordance
 
with generally accepted accounting
principles;
 
 
(c)
Evaluated the effectiveness of the registrant’s
 
disclosure controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure controls and procedures,
 
as of the end of the period covered by
this report based on such evaluation; and
 
 
(d)
Disclosed in this report any change in the registrant’s
 
internal control over financial reporting that occurred during
the registrant’s most recent fiscal quarter
 
(the registrant’s fourth fiscal quarter in the
 
case of an annual report) that
has materially affected, or is reasonably likely to materially affect,
 
the registrant’s internal control over financial
reporting; and
 
5.
The registrant’s other certifying
 
officer and I have disclosed, based on our most recent evaluation
 
of internal control over financial
reporting, to the registrant’s auditors
 
and the audit committee of the registrant’s
 
board of directors (or persons performing the
equivalent functions):
 
 
(a)
All significant deficiencies and material weaknesses in the design or operation
 
of internal control over financial
reporting which are reasonably likely to adversely affect the registrant’s
 
ability to record, process, summarize and
report financial information; and
 
 
(b)
Any fraud, whether or not material, that involves management or other
 
employees who have a significant role in the
registrant’s internal control
 
over financial reporting.
Date: May 5, 2022
 
/s/ Shane W. Hostetter
Shane W.
 
Hostetter
Chief Financial Officer
EX-32.1 4 exhibit321.htm SECTION 906 CEO CERTIFICATION exhibit321
 
1
EXHIBIT 32.1
CERTIFICATION
 
PURSUANT TO 18 U.S.C. SECTION 1350
The undersigned hereby certifies that the Form 10-Q Quarterly Report
 
of Quaker Chemical Corporation (the “Company”) for the
quarterly period ended March 31, 2022 filed with the Securities and
 
Exchange Commission (the “Report”) fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange
 
Act of 1934 and that the information contained in the Report fairly
presents, in all material respects, the financial condition and results of operations
 
of the Company.
 
Dated: May 5, 2022
 
 
/s/ Andrew E. Tometich
 
 
Andrew E. Tometich
 
 
Chief Executive Officer of Quaker Chemical Corporation
EX-32.2 5 exhibit322.htm SECTION 906 CFO CERTIFICATION exhibit322
 
1
EXHIBIT 32.2
CERTIFICATION
 
PURSUANT TO 18 U.S.C. SECTION 1350
The undersigned hereby certifies that the Form 10-Q Quarterly Report
 
of Quaker Chemical Corporation (the “Company”) for the
quarterly period ended March 31, 2022 filed with the Securities and
 
Exchange Commission (the “Report”) fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange
 
Act of 1934 and that the information contained in the Report fairly
presents, in all material respects, the financial condition and results of operations
 
of the Company.
 
Dated: May 5, 2022
 
 
/s/ Shane W. Hostetter
 
 
Shane W.
 
Hostetter
 
 
Chief Financial Officer of Quaker Chemical Corporation
EX-101.SCH 6 kwr-20220331.xsd XBRL EXTENSION SCHEMA DOCUMENT 000100 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 000200 - Statement - Condensed Consolidated Statements of Income link:presentationLink link:definitionLink link:calculationLink 000400 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 000450 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 000500 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 012410 - Disclosure - Fair Value Measurements link:presentationLink link:definitionLink link:calculationLink 012415 - Disclosure - Hedging Activities link:presentationLink link:definitionLink link:calculationLink 010710 - Disclosure - Share-Based Compensation link:presentationLink link:definitionLink link:calculationLink 011010 - Disclosure - Earnings Per Share link:presentationLink link:definitionLink link:calculationLink 010409 - Disclosure - Business Segments link:presentationLink link:definitionLink link:calculationLink 011510 - Disclosure - Goodwill and Intangible Assets link:presentationLink link:definitionLink link:calculationLink 010750 - Disclosure - Pension and Postretirement Benefits link:presentationLink link:definitionLink link:calculationLink 012510 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 010910 - Disclosure - Income Taxes and Uncertain Income Tax Positions link:presentationLink link:definitionLink link:calculationLink 011910 - Disclosure - Debt link:presentationLink link:definitionLink link:calculationLink 000600 - Statement - Condensed Consolidated Statements of Changes in Equity link:presentationLink link:definitionLink link:calculationLink 042212 - Disclosure - Accumulated Other Comprehensive Income - Changes in Equity (Parentheticals) (Details) link:presentationLink link:definitionLink link:calculationLink 000300 - Statement - Condensed Consolidated Statements of Comprehensive Income link:presentationLink link:definitionLink link:calculationLink 041010 - Disclosure - Earnings Per Share - Earnings per Share Calculations Basic (Details) link:presentationLink link:definitionLink link:calculationLink 041020 - Disclosure - Earnings Per Share - Earnings per Share Calculations Diluted (Details) link:presentationLink link:definitionLink link:calculationLink 041030 - Disclosure - Earnings Per Share - Earnings per Share Calculations Antidilutive Shares (Details) link:presentationLink link:definitionLink link:calculationLink 042510 - Disclosure - Commitments and Contingencies - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 042520 - Disclosure - Commitments and Contingencies - Operating Leases (Details) link:presentationLink link:definitionLink link:calculationLink 040960 - Disclosure - Income Taxes and Uncertain Income Tax Positions - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 040970 - Disclosure - Income Taxes and Uncertain Income Tax Positions 2 - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 042410 - Disclosure - Fair Value Measurements - Assets Subject to Fair Value Measurement (Details) link:presentationLink link:definitionLink link:calculationLink 042504 - Disclosure - Hedging Activities - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 042505 - Disclosure - Hedging Activities - Balance Sheet Classification and Fair Values (Details) link:presentationLink link:definitionLink link:calculationLink 041910 - Disclosure - Debt - Table (Details) link:presentationLink link:definitionLink link:calculationLink 041940 - Disclosure - Debt - Maturity Schedules (Details) link:presentationLink link:definitionLink link:calculationLink 041940 - Disclosure - Debt - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 040315 - Disclosure - Business Segments - Performance of reportable segments (Details) link:presentationLink link:definitionLink link:calculationLink 041510 - Disclosure - Goodwill and Other Intangible Assets - Changes in Carrying Amount of Goodwill (Details) link:presentationLink link:definitionLink link:calculationLink 041520 - Disclosure - Goodwill and Other Intangible Assets - Gross Carrying Amounts and Accumulated Amortization for Definite-lived Intangible Assets (Details) link:presentationLink link:definitionLink link:calculationLink 040710 - Disclosure - Share-Based Compensation - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 040720 - Disclosure - Share-Based Compensation - Share-based Compensation Expense (Details) link:presentationLink link:definitionLink link:calculationLink 040760 - Disclosure - Share-Based Compensation - Black-Scholes Option Pricing Model (Details) link:presentationLink link:definitionLink link:calculationLink 032410 - Disclosure - Fair Value Measurements (Table) link:presentationLink link:definitionLink link:calculationLink 032411 - Disclosure - Hedging Activities (Tables) link:presentationLink link:definitionLink link:calculationLink 031750 - Disclosure - Debt (Tables) link:presentationLink link:definitionLink link:calculationLink 030710 - Disclosure - Share Based Compensation (Tables) link:presentationLink link:definitionLink link:calculationLink 030410 - Disclosure - Business Segments (Tables) link:presentationLink link:definitionLink link:calculationLink 030303 - Disclosure - Business Acquisitions (Tables) link:presentationLink link:definitionLink link:calculationLink 031510 - Disclosure - Goodwill and Intangible Assets (Tables) link:presentationLink link:definitionLink link:calculationLink 030910 - Disclosure - Taxes on Income and Uncertain Positions (Tables) link:presentationLink link:definitionLink link:calculationLink 030750 - Disclosure - Pension and Other Post Retirement Benefits (Tables) link:presentationLink link:definitionLink link:calculationLink 031010 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:definitionLink link:calculationLink 032510 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:definitionLink link:calculationLink 040815 - Disclosure - Pension and Other Postretirement Benefits - Net Periodic Benefit Cost (Details) link:presentationLink link:definitionLink link:calculationLink 040810 - Disclosure - Pension and Other Postretirement Benefits - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 042220 - Disclosure - Accumulated Other Comprehensive Income - AOCI Reclassifications (Details) link:presentationLink link:definitionLink link:calculationLink 012210 - Disclosure - Accumulated Other Comprehensive Income link:presentationLink link:definitionLink link:calculationLink 032211 - Disclosure - Accumulated Other Comprehensive Income (Tables) link:presentationLink link:definitionLink link:calculationLink 042210 - Disclosure - Accumulated Other Comprehensive Income - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 010810 - Disclosure - Other (Expense) Income, Net link:presentationLink link:definitionLink link:calculationLink 030810 - Disclosure - Other (Expense) Income, Net (Tables) link:presentationLink link:definitionLink link:calculationLink 040900 - Disclosure - Other (Expense) Income, Net (Details) link:presentationLink link:definitionLink link:calculationLink 010310 - Disclosure - Recently Issued Accounting Standards link:presentationLink link:definitionLink link:calculationLink 010640 - Disclosure - Restructuring and Related Activities link:presentationLink link:definitionLink link:calculationLink 030610 - Disclosure - Restructuring and Related Activities (Tables) link:presentationLink link:definitionLink link:calculationLink 040650 - Disclosure - Restructuring and Related Activities (Details) link:presentationLink link:definitionLink link:calculationLink 041540 - Disclosure - Goodwill and Other Intangible Assets - Intangible Assets - Future Amortization (Details) link:presentationLink link:definitionLink link:calculationLink 041550 - Disclosure - Goodwill and Other Intangible Assets - Indefinite Lived (Details) link:presentationLink link:definitionLink link:calculationLink 040640 - Disclosure - Restructuring and Related Activities - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 040310 - Disclosure - Recently Issued Accounting Standards - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 010210 - Disclosure - Business Acquisitions link:presentationLink link:definitionLink link:calculationLink 011118 - Disclosure - Restricted Cash link:presentationLink link:definitionLink link:calculationLink 010410 - Disclosure - Net Sales and Revenue Recognition link:presentationLink link:definitionLink link:calculationLink 031110 - Disclosure - Restricted Cash (Tables) link:presentationLink link:definitionLink link:calculationLink 030510 - Disclosure - Net Sales and Revenue Recognition (Tables) link:presentationLink link:definitionLink link:calculationLink 041110 - Disclosure - Restricted Cash (Details) link:presentationLink link:definitionLink link:calculationLink 040412 - Disclosure - Net Sales and Revenue Recognition - Disaggregated Revenue (Details) link:presentationLink link:definitionLink link:calculationLink 040410 - Disclosure - Net Sales and Revenue Recognition - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 010508 - Disclosure - Leases link:presentationLink link:definitionLink link:calculationLink 030609 - Disclosure - Leases (Tables) link:presentationLink link:definitionLink link:calculationLink 040415 - Disclosure - Leases - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 040416 - Disclosure - Leases - Supplemental Information (Details) link:presentationLink link:definitionLink link:calculationLink 040417 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details) link:presentationLink link:definitionLink link:calculationLink 041950 - Disclosure - Debt - Debt related expenses included within Interest expense (Details) link:presentationLink link:definitionLink link:calculationLink 040214 - Disclosure - Business Acquisitions - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 040314 - Disclosure - Business Segments - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 040215 - Disclosure - Business Acquisitions - Preliminary Estimated Fair Values of Coral Net Assets Acquired (Details) link:presentationLink link:definitionLink link:calculationLink 040216 - Disclosure - Business Acquisitions - Coral - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 010110 - Disclosure - Basis of Presentation and Description of Business link:presentationLink link:definitionLink link:calculationLink 040010 - Disclosure - Basis of Presentation and Description of Business (Details) link:presentationLink link:definitionLink link:calculationLink 020001 - Disclosure - Basis of Presentation and Description of Business (Policies) link:presentationLink link:definitionLink link:calculationLink 000650 - Statement - Condensed Consolidated Statements of Changes in Equity (Parentheticals) link:presentationLink link:calculationLink link:definitionLink 040765 - Disclosure - Share-Based Compensation - Monte Carlo Simulation on Grant Date (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 kwr-20220331_cal.xml XBRL CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 kwr-20220331_def.xml XBRL DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 kwr-20220331_lab.xml XBRL LABEL LINKBASE DOCUMENT EX-101.PRE 10 kwr-20220331_pre.xml XBRL PRESENTATION LINKBASE DOCUMENT XML 11 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Document and Entity Information - shares
 3 Months Ended
Mar. 31, 2022
Apr. 30, 2022
Document and Entity Information [Abstract]    
Document Type 10-Q  
Document Period Focus Q1  
Document quarterly report true  
Document Fiscal Year Focus 2022  
Document period end date Mar. 31, 2022  
Current fiscal year end date --12-31  
Document Transition Report false  
Amendment flag false  
Entity File Number 001-12019  
Entity registrant name QUAKER CHEMICAL CORPORATION  
Entity Incorporation State Country Code PA  
Entity Tax Identification Number 23-0993790  
Entity central index key 0000081362  
Entity Address Address Line 901 E. Hector Street  
Entity Address City Or Town Conshohocken  
Entity Address State Or Province PA  
Entity Address Postal Zip Code 19428 – 2380  
City Area Code 610  
Local Phone Number 832-4000  
Entity current reporting status Yes  
Entity Interactive Data Current Yes  
Entity filer category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Security 12(b) Title Common Stock, $1 par value  
Trading Symbol KWR  
Entity common stock shares outstanding   17,912,086
Security Exchange Name NYSE  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Income - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Net sales $ 474,171 $ 429,783
Cost of goods sold (excluding amortization expense - See Note 13) 328,100 273,589
Gross profit 146,071 156,194
Selling, general and administrative expenses 111,795 104,310
Restructuring and related charges 820 1,175
Combination, integration and other acquisition-related expenses 4,053 5,815
Operating income 29,403 44,894
Other (expense) income, net (2,206) 4,687
Interest expense, net (5,345) (5,470)
Income before taxes and equity in net income of associated companies 21,852 44,111
Taxes on income before equity in net income of associated companies 2,866 10,689
Income before equity in net income of associated companies 18,986 33,422
Equity in net income of associated companies 835 5,210
Net income 19,821 38,632
Less: Net income attributable to noncontrolling 5 17
Net income attributable to Quaker Chemical Corporation $ 19,816 $ 38,615
Per share data:    
Net income attributable to Quaker Chemical Corporation common shareholders - basic $ 1.11 $ 2.16
Net income attributable to Quaker Chemical Corporation common shareholders - diluted 1.11 2.15
Dividends declared $ 0.415 $ 0.395
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Comprehensive Income - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Statement Of Comprehensive Income [Abstract]    
Net income $ 19,821 $ 38,632
Currency translation adjustments (6,866) (25,461)
Defined Benefit Plans [Abstract]    
Defined benefit retirement plans 496 1,292
Current period change in fair value of derivatives 1,100 562
Unrealized loss on available-for-sale securities (1,000) (3,025)
Other comprehensive loss (6,270) (26,632)
Comprehensive income 13,551 12,000
Less: Comprehensive income attributable to noncontrolling interest (6) (15)
Comprehensive income attributable to Quaker Chemical Corporation $ 13,545 $ 11,985
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 161,552 $ 165,176
Accounts receivable, net 458,459 430,676
Inventories    
Raw materials and supplies 146,289 129,382
Work-in-process and finished goods 153,506 135,149
Prepaid expenses and other current assets 67,853 59,871
Total current assets 987,659 920,254
Property, plant and equipment, at cost 439,318 434,344
Less accumulated depreciation (242,203) (236,824)
Property, plant and equipment, net 197,115 197,520
Right of use lease assets 38,245 36,635
Goodwill 630,938 631,194
Other intangible assets, net 1,012,068 1,027,782
Investments in associated companies 90,003 95,278
Deferred tax assets 11,496 16,138
Other non-current assets 29,198 30,959
Total assets 2,996,722 2,955,760
Current liabilities    
Short-term borrowings and current portion of long-term debt 61,385 56,935
Accounts payable 253,906 226,656
Dividends payable 7,433 7,427
Accrued compensation 26,396 38,197
Accrued restructuring 4,435 4,087
Accrued pension and postretirement benefits 1,549 1,548
Other accrued liabilities 97,445 95,617
Total current liabilities 452,549 430,467
Long-term debt 858,287 836,412
Long-term lease liabilities 27,433 26,335
Deferred tax liabilities 170,622 179,025
Non-current accrued pension and postretirement benefits 44,667 45,984
Other non-current liabilities 47,464 49,615
Total liabilities 1,601,022 1,567,838
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]    
Common stock, $1 par value; authorized 30,000,000 shares; issued and outstanding 2022 - 17,911,583 shares; 2021 - 17,897,033 shares 17,912 17,897
Capital in excess of par value 918,699 917,053
Retained earnings 528,716 516,334
Accumulated other comprehensive loss (70,261) (63,990)
Total Quaker shareholders' equity 1,395,066 1,387,294
Noncontrolling interest 634 628
Total equity 1,395,700 1,387,922
Total liabilities and equity $ 2,996,722 $ 2,955,760
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares
Mar. 31, 2022
Dec. 31, 2021
Statement Of Financial Position [Abstract]    
Common Stock Par Value $ 1 $ 1
Common Stock Shares Authorized 30,000,000 30,000,000
Common Stock Shares, Issued 17,911,583 17,897,033
Common stock shares, outstanding 17,911,583 17,897,033
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities    
Net income $ 19,821 $ 38,632
Adjustments to reconcile net income to net cash (used in) provided by operating activities:    
Amortization of debt issuance costs 1,187 1,187
Depreciation and amortization 20,447 22,145
Equity in undistributed earnings of associated companies, net of dividends 2,135 (5,105)
Acquisition-related fair value adjustments related to inventory 0 801
Deferred compensation, deferred taxes and other, net (3,778) (9,888)
Share-based compensation 2,462 3,779
Gain on disposal of property, plant, equipment and other assets (23) (5,410)
Combination and other acquisition-related expenses, net of payments (4,246) (2,884)
Restructuring and related charges 820 1,175
Pension And Other Postretirement Benefit Expense (1,316) (1,034)
(Decrease) increase in cash from changes in current assets and current liabilities, net of acquisitions:    
Accounts receivable (26,270) (46,270)
Inventories (33,873) (24,994)
Prepaid expenses and other current assets (6,506) (8,315)
Change in restructuring liabilities (408) (3,034)
Accounts payable and accrued liabilities 23,249 26,597
Net cash used in operating activities (6,299) (12,618)
Cash flows from investing activities    
Investments in property, plant and equipment (8,847) (3,934)
Payments related to acquisitions, net of cash acquired (9,383) (26,655)
Proceeds from disposition of assets 0 14,744
Net cash used in investing activities (18,230) (15,845)
Cash flows from financing activities    
Payments of long-term debt (14,112) (9,551)
Borrowings on revolving credit facilities, net 43,000 30,000
Repayments on other debt, net (102) (188)
Dividends paid (7,428) (7,052)
Stock options exercised, other (801) (178)
Net cash provided by financing activities 20,557 13,031
Effect of foreign exchange rate changes on cash 348 (3,008)
Net decrease in cash and cash equivalents (3,624) (18,440)
Cash and cash equivalents at the beginning of the period 165,176 181,895
Cash and cash equivalents at the end of the period $ 161,552 $ 163,455
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Changes in Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Capital in Excess of Par Value [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Loss [Member]
Noncontrolling Interest [Member]
Beginning Balance at Dec. 31, 2020 $ 1,320,914 $ 17,851 $ 905,171 $ 423,940 $ (26,598) $ 550
Net income 38,632 0 0 38,615 0 17
Amounts reported in other comprehensive loss (26,632) 0 0 0 (26,630) (2)
Dividends ($0.395 per share) ($0.415 per share) (7,062) 0 0 (7,062) 0 0
Share issuance and equity-based compensation plans 3,601 24 3,577 0 0 0
Ending Balance at Mar. 31, 2021 1,329,453 17,875 908,748 455,493 (53,228) 565
Beginning Balance at Dec. 31, 2021 1,387,922 17,897 917,053 516,334 (63,990) 628
Net income 19,821 0 0 19,816 0 5
Amounts reported in other comprehensive loss (6,270) 0 0 0 (6,271) 1
Dividends ($0.395 per share) ($0.415 per share) (7,434) 0 0 (7,434) 0 0
Share issuance and equity-based compensation plans 1,661 15 1,646 0 0 0
Ending Balance at Mar. 31, 2022 $ 1,395,700 $ 17,912 $ 918,699 $ 528,716 $ (70,261) $ 634
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Changes in Equity (Parentheticals) - $ / shares
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Statement of Changes in Equity [Abstract]    
Dividend per share $ 0.415 $ 0.395
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.22.1
Basis of Presentation and Description of Business
 3 Months Ended
Mar. 31, 2022
Basis of Presentation and Description of Business [Abstract]  
Basis of Presentation and Description of Business [Text Block]
Note 1 – Basis of Presentation and Description of Business
 
Basis of Presentation
As used in these Notes to Condensed Consolidated Financial Statements, the
 
terms “Quaker,” “Quaker Houghton,” the
“Company,” “we,” and “our” refer to Quaker Chemical Corporation
 
(doing business as Quaker Houghton), its subsidiaries, and
associated companies, unless the context otherwise requires.
 
As used in these Notes to Condensed Consolidated Financial Statements,
the term Legacy Quaker refers to the Company prior to the closing of its combination
 
with Houghton International, Inc. (“Houghton”)
(herein referred to as the “Combination”).
 
The condensed consolidated financial statements included herein are unaudited and
 
have
been prepared in accordance with generally accepted accounting principles
 
in the United States (“U.S. GAAP”) for interim financial
reporting and the United States Securities and Exchange Commission (“SEC”)
 
regulations.
 
Certain information and footnote
disclosures normally included in financial statements prepared in accordance
 
with U.S. GAAP have been condensed or omitted
pursuant to such rules and regulations.
 
In the opinion of management, the financial statements reflect all adjustments
 
consisting only
of normal recurring adjustments, which are necessary for a fair statement of
 
the financial position, results of operations and cash flows
for the interim periods.
 
The results for the three months ended March 31, 2022 are not necessarily indicative
 
of the results to be
expected for the full year.
 
These financial statements should be read in conjunction with the Company’s
 
Annual Report filed on Form
10-K for the year ended December 31, 2021 (the “2021 Form 10-K”).
 
Description of Business
The Company was organized in 1918, incorporated as a Pennsylvania
 
business corporation in 1930, and in August 2019
completed the Combination with Houghton to form Quaker Houghton.
 
Quaker Houghton is the global leader in industrial process
fluids.
 
With a presence around the world, including
 
operations in over
25
 
countries, the Company’s customers
 
include thousands of
the world’s most advanced and specialized
 
steel, aluminum, automotive, aerospace, offshore, can,
 
mining, and metalworking
companies.
 
Quaker Houghton develops, produces, and markets a broad range of formulated chemical
 
specialty products and offers
chemical management services (which the Company refers to as “Fluidcare
TM
”) for various heavy industrial and manufacturing
applications throughout its
four
 
segments: Americas; Europe, Middle East and Africa (“EMEA”); Asia/Pacific; and
 
Global Specialty
Businesses.
Hyper-inflationary economies
Based on various indices or index compilations being used to monitor inflation
 
in Argentina as well as economic instability,
effective July 1, 2018, Argentina’s
 
economy was considered hyper-inflationary under U.S. GAAP.
 
As of, and for the three months
ended March 31, 2022, the Company's Argentine subsidiaries represented
 
less than
1
% of the Company’s consolidated
 
total assets and
net sales, respectively.
 
During each of the three months ended March 31, 2022 and 2021, the Company
 
recorded $
0.2
 
million of
remeasurement losses associated with the applicable currency conversions
 
related to Argentina.
 
These losses were recorded within
foreign exchange losses, net, which is a component of other (expense) income, net,
 
in the Company’s Condensed Consolidated
Statements of Income.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.22.1
Business Acquisitions
 3 Months Ended
Mar. 31, 2022
Business Acquisitions [Abstract]  
Business acquisitions disclosure [Text Block]
Note 2 – Business Acquisitions
2022 Acquisitions
 
In January 2022, the Company acquired a business that provides pickling
 
inhibitor technologies for the steel industry,
 
drawing
lubricants and stamping oil for metalworking, and various other lubrication,
 
rust preventative, and cleaner applications, for its
Americas reportable segment for approximately $
8.0
 
million.
 
This business broadens the Company’s
 
product offerings within its
existing metals and metalworking business in the Americas region.
 
The Company allocated $
5.6
 
million of the purchase price to
intangible assets, comprised of $
5.1
 
million of customer relationships to be amortized over
14
 
years; and $
0.5
 
million of existing
product technologies to be amortized over
14
 
years.
 
In addition, the Company recorded $
1.8
 
million of goodwill related to expected
value not allocated to other acquired assets, all of which is expected to be tax deductible
 
in various jurisdictions
 
in which the
Company operates.
 
In January 2022, the Company acquired a business related to the sealing and impregnation
 
of metal castings for the automotive
sector, as well as impregnation resin and
 
impregnation systems for metal parts, for its Global Specialty Business reportable segment
for approximately
1.2
 
million EUR or approximately $
1.4
 
million.
 
This business expands the Company's geographic presence in
Germany as well as broadens its product offerings and
 
service capabilities within its existing impregnation business acquired
 
as part of
the Norman Hay acquisition in 2019.
The results of operations of the 2022 acquired assets and businesses subsequent
 
to the respective acquisition dates are included in
the unaudited Condensed Consolidated Statements of Income for the quarter ended
 
March 31, 2022.
 
Applicable transaction expenses
associated with these acquisitions are included in Combination,
 
integration and other acquisition-related expenses in the Company’s
unaudited Condensed Consolidated Statements of Income.
 
Certain pro forma and other information is not presented, as the operations
of the acquired assets and businesses are not considered material to the overall operations
 
of the Company for the periods presented.
Previous Acquisitions
 
In November 2021, the Company acquired Baron Industries (“Baron”),
 
a privately held Company that provides vacuum
impregnation services of castings, powder metals and electrical components
 
for its Global Specialty Businesses reportable segment for
$
11.0
 
million, including an initial cash payment of $
7.1
 
million, subject to post-closing adjustments as well as certain earn-out
provisions initially estimated at $
3.9
 
million that are payable at different times from 2022 through
 
2025.
 
The earn-out provisions
could total a maximum of $
4.5
 
million.
 
The Company allocated $
8.0
 
million of the purchase price to intangible assets, $
1.1
 
million of
property, plant and
 
equipment and $
1.5
 
million of other assets acquired net of liabilities assumed, which includes $
0.3
 
million of cash
acquired.
 
In addition, the Company recorded $
0.4
 
million of goodwill, all of which is expected to be tax deductible.
 
Intangible assets
comprised $
7.2
 
million of customer relationships to be amortized over
15 years
; and $
0.8
 
million of existing product technology to be
amortized over
13 years
.
 
 
In November 2021, the Company acquired a business that provides
 
hydraulic fluids, coolants, cleaners, and rust preventative oils
in Turkey for its EMEA reportable segment for
3.2
 
million EUR or approximately $
3.7
 
million.
 
In September 2021, the Company acquired the remaining interest in Grindaix
 
-GmbH (“Grindaix”), a Germany-based, high-tech
provider of coolant control and delivery systems for its Global Specialty Businesses reportable
 
segment for
2.4
 
million EUR or
approximately $
2.9
 
million, which is gross of approximately $
0.3
 
million of cash acquired.
 
Previously, in February
 
2021, the
Company acquired a
38
% ownership interest in Grindaix for
1.4
 
million EUR or approximately $
1.7
 
million.
 
The Company recorded
its initial investment as an equity method investment within the Consolidated Financial
 
Statements and accounted for the purchase of
the remaining interest as a step acquisition whereby the Company remeasured
 
the previously held equity method investment to its fair
value.
 
In June 2021, the Company acquired certain assets for its chemical milling maskants
 
product line in the Global Specialty
Businesses reportable segment for
2.3
 
million EUR or approximately $
2.8
 
million.
 
In February 2021, the Company acquired a tin-plating solutions business for
 
the steel end market for $
25.0
 
million.
 
This
acquisition is part of each of the Company’s
 
geographic reportable segments.
 
The Company allocated $
19.6
 
million of the purchase
price to intangible assets, comprised of $
18.3
 
million of customer relationships, to be amortized over
19 years
; $
0.9
 
million of existing
product technology to be amortized over
14 years
; and $
0.4
 
million of a licensed trademark to be amortized over
3 years
.
 
In addition,
the Company recorded $
5.0
 
million of goodwill, all of which is expected to be tax deductible in various jurisdictions in which
 
we
operate.
 
Factors contributing to the purchase price that resulted in goodwill included the
 
acquisition of business processes and
personnel that will allow Quaker Houghton to better serve its customers.
 
As of March 31, 2022, the allocation of the purchase price of these acquisitions have
 
not been finalized and the one-year
measurement period has not ended, with the exception of the tin-plating
 
solutions business acquired in February 2021, the
measurement period for which ended in February 2022.
 
Further adjustments may be necessary as a result of the Company’s
 
on-going
assessment of additional information related to the fair value of assets acquired
 
and liabilities assumed.
 
In December 2020, the Company acquired Coral Chemical Corporation (“Coral”),
 
a privately held U.S.-based provider of metal
finishing fluid solutions.
 
Subsequent to the acquisition, the Company and the sellers of Coral (the “Sellers”) have
 
worked to finalize
certain post-closing adjustments.
 
In April 2022, after failing to reach resolution, the Sellers filed suit asserting certain
 
amounts owed
related to tax attributes of the acquisition.
 
Based on the facts and circumstances of the claim asserted by the Sellers, the Company
believes the potential range of exposure for this claim is $
0
 
to $
1.5
 
million.
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.22.1
Recently Issued Accounting Standards
 3 Months Ended
Mar. 31, 2022
Recently Issued Accounting Standards [Abstract]  
Recently Issued Accounting Standards [Text Block]
Note 3 – Recently Issued Accounting Standards
Recently Issued Accounting Standards
 
Adopted
The FASB issued ASU 2020
 
-04
, Reference Rate Reform (Topic
 
848): Facilitation of the Effects of Reference Rate Reform
 
on
Financial Reporting
 
in March 2020.
 
The FASB subsequently
 
issued ASU 2021-01
, Reference Rate Reform (Topic
 
848): Scope
 
in
January 2021 which clarified the guidance but did not materially change
 
the guidance or its applicability to the Company.
 
The
amendments provide temporary optional expedients and exceptions
 
for applying U.S. GAAP to contract modifications, hedging
relationships and other transactions to ease the potential accounting
 
and financial reporting burden associated with transitioning away
from reference rates that are expected to be discontinued, including
 
the London Interbank Offered Rate (“LIBOR”).
 
ASU 2020-04 is
effective for the Company as of March 12, 2020 and generally can
 
be applied through December 31, 2022.
 
On December 10, 2021,
the Company entered into a Second Amendment to Credit Agreement (“Second
 
Amendment”) with Bank of America N.A., an update
to provide for the use of a non-USD currency LIBOR successor rate.
 
The Company elected to apply the expedients provided in ASU
2020-04 with respect to the Second Amendment.
 
The Company will continue to monitor for potential impacts related to its USD-
based LIBOR rates.
 
See Note 14 of Notes to Condensed Consolidated Financial Statements.
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.22.1
Business Segments
 3 Months Ended
Mar. 31, 2022
Business Segment Disclosures [Abstract]  
Segment Reporting Disclosure [Text Block]
Note 4 – Business Segments
The Company’s operating
 
segments, which are consistent with its reportable segments, reflect the structure of the
 
Company’s
internal organization, the method by which the Company’s
 
resources are allocated and the manner by which the chief operating
decision maker assesses the Company’s
 
performance.
 
The Company has
four
 
reportable segments: (i) Americas; (ii) EMEA; (iii)
Asia/Pacific; and (iv) Global Specialty Businesses.
 
The three geographic segments are composed of the net sales and operations in
each respective region, excluding net sales and operations managed globally
 
by the Global Specialty Businesses segment, which
includes the Company’s container,
 
metal finishing,
 
mining, offshore, specialty coatings, specialty grease and Norman
 
Hay businesses.
Segment operating earnings for each of the Company’s
 
reportable segments are comprised of the segment’s
 
net sales less directly
related cost of goods sold (“COGS”) and selling, general and administrative
 
expenses (“SG&A”).
 
Operating expenses not directly
attributable to the net sales of each respective segment,
 
such as certain corporate and administrative costs, Combination, integration
and other acquisition-related expenses, and Restructuring and related
 
charges,
 
are not included in segment operating earnings.
 
Other
items not specifically identified with the Company’s
 
reportable segments include interest expense, net and other (expense) income,
net.
The following table presents information about the performance of the Company’s
 
reportable operating segments for the three
months ended March 31, 2022 and 2021:
Three Months Ended
March 31,
 
2022
2021
Net sales
 
 
 
 
 
 
Americas
$
154,144
$
134,871
EMEA
 
125,687
 
119,814
Asia/Pacific
 
104,234
 
96,706
Global Specialty Businesses
 
90,106
 
78,392
Total
 
net sales
$
474,171
$
429,783
Segment operating earnings
Americas
$
29,220
$
32,234
EMEA
16,766
25,244
Asia/Pacific
21,907
27,478
Global Specialty Businesses
 
25,035
 
24,169
Total
 
segment operating earnings
 
92,928
 
109,125
Combination, integration and other acquisition-related expenses
(4,053)
(5,815)
Restructuring and related charges
(820)
(1,175)
Fair value step up of acquired inventory sold
—
(801)
Non-operating and administrative expenses
 
(43,463)
 
(40,992)
Depreciation of corporate assets and amortization
 
(15,189)
 
(15,448)
Operating income
29,403
44,894
Other (expense) income, net
(2,206)
4,687
Interest expense, net
 
(5,345)
 
(5,470)
Income before taxes and equity in net income of associated companies
$
21,852
$
44,111
Inter-segment revenues for the three months ended March 31,
 
2022 and 2021 were $
2.9
 
million and $
3.3
 
million for Americas,
$
8.9
 
million and $
8.8
 
million for EMEA, $
0.3
 
million and $
0.1
 
million for Asia/Pacific and $
1.7
 
million and $
2.0
 
million for Global
Specialty Businesses, respectively.
 
However, all inter-segment transactions
 
have been eliminated from each reportable operating
segment’s net sales and earnings for
 
all periods presented in the above tables.
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.22.1
Net Sales and Revenue Recognition
 3 Months Ended
Mar. 31, 2022
Net Sales and Revenue Recognition [Abstract]  
Net Sales and Revenue Recognition [TextBlock]
Note 5 – Net Sales and Revenue Recognition
Arrangements Resulting in Net Reporting
As part of the Company’s Fluidcare
TM
 
business, certain third-party product sales to customers are managed by the Company.
 
The
Company transferred third-party products under arrangements recognized
 
on a net reporting basis of $
19.8
 
million and $
17.8
 
million
for the three months ended March 31, 2022 and 2021, respectively.
 
Customer Concentration
A significant portion of the Company’s
 
revenues are realized from the sale of process fluids and services to manufacturers of
steel, aluminum, automobiles, aircraft, industrial equipment, and durable
 
goods.
 
As previously disclosed in the 2021 Form 10-K,
during the year ended December 31, 2021, the Company’s
 
five largest customers (each composed of multiple subsidiaries or
 
divisions
with semiautonomous purchasing authority) accounted for approximately
10
% of consolidated net sales, with its largest customer
accounting for approximately
3
% of consolidated net sales.
Contract Assets and Liabilities
The Company had no material contract assets recorded on its Condensed
 
Consolidated Balance Sheets as of March 31, 2022 or
December 31, 2021.
The Company had approximately $
6.9
 
million and $
7.0
 
million of deferred revenue as of March 31, 2022 and December 31,
2021, respectively.
 
For three months ended March 31, 2022, the Company satisfied all of the associated performance
 
obligations and
recognized into revenue the advance payments received and recorded
 
as of December 31, 2021.
Disaggregated Revenue
The Company sells its various industrial process fluids, its specialty chemicals
 
and its technical expertise as a global product
portfolio.
 
The Company generally manages and evaluates its performance by segment
 
first, and then by customer industry,
 
rather than
by individual product lines.
 
Also, net sales of each of the Company’s major product
 
lines are generally spread throughout all three of
the Company’s geographic
 
regions, and in most cases, approximately proportionate to the level of total sales in each
 
region.
The following tables disaggregate the Company’s
 
net sales by segment, geographic region, customer industry,
 
and timing of
revenue recognized for the three months ended March 31, 2022 and 2021.
Three Months Ended March 31, 2022
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
56,160
$
36,839
$
55,287
 
$
148,286
Metalworking and other
97,984
88,848
48,947
235,779
154,144
125,687
104,234
384,065
Global Specialty Businesses
57,264
20,021
12,821
90,106
$
211,408
$
145,708
$
117,055
$
474,171
Timing of Revenue Recognized
Product sales at a point in time
$
201,284
$
137,203
$
114,625
 
$
453,112
Services transferred over time
10,124
8,505
2,430
21,059
$
211,408
$
145,708
$
117,055
$
474,171
Three Months Ended March 31, 2021
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
46,793
$
34,274
$
49,743
 
$
130,810
Metalworking and other
88,078
85,540
46,963
220,581
134,871
119,814
96,706
351,391
Global Specialty Businesses
45,256
20,272
12,864
78,392
$
180,127
$
140,086
$
109,570
$
429,783
Timing of Revenue Recognized
Product sales at a point in time
$
171,594
$
131,162
$
106,399
 
$
409,155
Services transferred over time
8,533
8,924
3,171
20,628
$
180,127
$
140,086
$
109,570
$
429,783
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.22.1
Leases
 3 Months Ended
Mar. 31, 2022
Leases [Abstract]  
Leases Disclosure [TextBlock]
Note 6 - Leases
The Company has operating leases for certain facilities, vehicles and machinery
 
and equipment with remaining lease terms up to
10 years
.
 
Operating lease expense is recognized on a straight-line basis over the lease term. In addition,
 
the Company has certain land
use leases with remaining lease terms up to
93 years
.
The Company has
no
 
material variable lease costs or sublease income for three months ended March
 
31, 2022 and 2021. The
following table sets forth the components of the Company’s
 
lease cost for three months ended March 31, 2022 and 2021:
Three Months Ended
March 31,
2022
2021
Operating lease expense
$
3,409
$
3,612
Short-term lease expense
219
251
Supplemental cash flow information related to the Company’s
 
leases is as follows
Three Months Ended
March 31,
2022
2021
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases
$
3,365
$
3,579
Non-cash lease liabilities activity:
Leased assets obtained in exchange for new operating lease liabilities
4,689
3,050
Supplemental balance sheet information related to the Company’s
 
leases is as follows:
March 31,
December 31,
2022
2021
Right of use lease assets
$
38,245
$
36,635
Other current liabilities
10,540
9,976
Long-term lease liabilities
27,433
26,335
Total operating lease liabilities
$
37,973
$
36,311
Weighted average
 
remaining lease term (years)
5.9
5.6
Weighted average
 
discount rate
4.14%
4.22%
Maturities of operating lease liabilities as of March 31, 2022 were as follows:
March 31,
2022
For the remainder of 2022
$
8,990
For the year ended December 31, 2023
9,513
For the year ended December 31, 2024
7,292
For the year ended December 31, 2025
5,375
For the year ended December 31, 2026
4,338
For the year ended December 31, 2027 and beyond
7,046
Total lease payments
42,554
Less: imputed interest
(4,581)
Present value of lease liabilities
$
37,973
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.22.1
Restructuring and Related Activities
 3 Months Ended
Mar. 31, 2022
Restructuring And Related Activities [Abstract]  
Restructuring And Related Activities Disclosure [Text Block]
Note 7 – Restructuring and Related Activities
The Company’s management approved a global restructuring plan (the “QH Program”) as part of its plan to realize certain cost
synergies associated with the Combination in the third quarter of 2019. The QH Program includes restructuring and associated
severance costs to reduce total headcount by approximately 400 people globally, as well as plans for the closure of certain
manufacturing and non-manufacturing facilities.
 
The exact timing and total costs associated with the QH Program will depend on
 
a
number of factors and are subject to change; however,
 
the Company currently expects reductions in headcount and site closures to
continue to occur throughout 2022 under the QH Program.
 
Employee separation benefits will vary depending on local regulations
within certain foreign countries and will include severance and other benefits.
 
All costs incurred to date relate to severance costs to reduce headcount,
 
including customary and routine adjustments to initial
estimates for employee separation costs, as well as costs to close certain
 
facilities and are recorded in Restructuring and related
charges in the Company’s
 
Condensed Consolidated Statements of Income.
 
As described in Note 4 of Notes to Condensed
Consolidated Financial Statements, restructuring and related charges
 
are not included in the Company’s
 
calculation of reportable
segments’ measure of operating earnings and therefore these costs are not
 
reviewed by or recorded to reportable segments.
Activity in the Company’s accrual
 
for restructuring under the QH Program for the three months ended March 31, 2022
 
is as
follows:
QH Program
Accrued restructuring as of December 31, 2021
$
4,087
Restructuring and related charges
820
Cash payments
(408)
Currency translation adjustments
(64)
Accrued restructuring as of March 31, 2022
$
4,435
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.22.1
Share-Based Compensation
 3 Months Ended
Mar. 31, 2022
Share-Based Compensation [Abstract]  
Share-Based Compensation [Text Block]
Note 8 – Share-Based Compensation
The Company recognized the following share-based compensation expense
 
in its Condensed Consolidated Statements of Income
for the three months ended March 31, 2022 and 2021:
Three Months Ended
March 31,
 
2022
2021
Stock options
$
267
$
308
Non-vested stock awards and restricted stock units
1,548
1,396
Non-elective and elective 401(k) matching contribution in stock
—
1,553
Director stock ownership plan
24
203
Performance stock units
623
319
Total share-based
 
compensation expense
$
2,462
$
3,779
Share-based compensation expense is recorded in SG&A, except for less than $
0.1
 
million and $
0.3
 
million during the three
months ended March 31, 2022 and 2021, respectively,
 
recorded within Combination, integration and other acquisition-related
expenses.
Stock Options
During the first quarter of 2022, the Company granted stock options under
 
its long-term incentive plan (“LTIP
 
”) that are subject
only to time vesting over a
three year
 
period.
 
For the purposes of determining the fair value of stock option awards, the Company
used a Black-Scholes option pricing model and the assumptions set forth
 
in the table below:
March 2022
Grant
Number of options granted
27,077
Dividend yield
0.80
%
Expected volatility
38.60
%
Risk-free interest rate
2.07
%
Expected term (years)
4.0
The fair value of these options is amortized on a straight-line basis over the vesting period.
 
As of March 31, 2022, unrecognized
compensation expense related to all stock options granted
 
was $
2.9
 
million, to be recognized over a weighted average remaining
period of
1.9
 
years.
Restricted Stock Awards
 
and Restricted Stock Units
During the three months ended March 31, 2022, the Company granted
17,425
 
non-vested restricted shares and
4,490
 
non-vested
restricted stock units under its LTIP,
 
subject to time-based vesting, generally over a
three year
 
period.
 
The fair value of these grants is
based on the trading price of the Company’s
 
common stock on the date of grant.
 
The Company adjusts the grant date fair value of
these awards for expected forfeitures based on historical experience.
 
As of March 31, 2022, unrecognized compensation expense
related to the nonvested restricted shares was $
6.4
 
million, to be recognized over a weighted average remaining period of
2.1
 
years,
and unrecognized compensation expense related to nonvested restricted
 
stock units was $
1.3
 
million, to be recognized over a weighted
average remaining period of
2.3
 
years.
Performance Stock Units
The Company grants performance-dependent stock awards (“PSUs”) as a component
 
of its LTIP,
 
which will be settled in a
certain number of shares subject to market-based and time-based vesting conditions.
 
The number of fully vested shares that may
ultimately be issued as settlement for each award may range from
0
% up to
200
% of the target award, subject to the achievement of
the Company’s total shareholder
 
return (“TSR”) relative to the performance of the Company’s
 
peer group, the S&P Midcap 400
Materials group.
 
The service period required for the PSUs is three years and the TSR measurement
 
period for the PSUs is generally
from January 1 of the year of grant through December 31 of the year prior
 
to issuances of the shares upon settlement.
 
Compensation expense for PSUs
 
is measured based on their grant date fair value and is recognized on
 
a straight-line basis over
the three year vesting period.
 
The grant-date fair value of the PSUs was estimated using a Monte Carlo
 
simulation on the grant date
and using the following assumptions set forth in the table below:
March 2022
Grant
Number of PSUs granted
16,820
Risk-free interest rate
2.11
%
Dividend yield
0.93
%
Expected term (years)
3.0
As of March 31, 2022, the Company estimates that it will issue 0 fully vested shares
 
as of the applicable settlement date of all
outstanding PSUs awards based on the conditions of the PSUs and performance
 
to date for each award.
 
As of March 31, 2022,
 
there
was approximately $
6.4
 
million of total unrecognized compensation cost related to PSUs which the Company
 
expects to recognize
over a weighted-average period of
2.3
 
years.
Defined Contribution Plan
The Company has a 401(k) plan with an employer match covering
 
a majority of its U.S. employees.
 
The Company matches
50
%
of the first
6
% of compensation that is contributed to the plan, with a maximum matching contribution of 3% of
 
compensation.
 
Additionally, the plan
 
provides for non-elective nondiscretionary contributions on behalf of participants
 
who have completed one year
of service equal to
3
% of the eligible participants’ compensation.
 
Beginning in April 2020 and continuing through March 2021, the
Company matched both non-elective and elective 401(k) contributions
 
in fully vested shares
 
of the Company’s common stock
 
rather
than cash.
 
There were
no
 
matching contributions in stock for the three months ended March 31, 2022. For
 
the three months ended
March 31, 2021, total contributions were $
1.5
 
million.
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.22.1
Pension and Postretirement Benefits
 3 Months Ended
Mar. 31, 2022
Pension and Postretirement Benefits [Abstract]  
Pension and Postretirement Benefits [Text Block]
Note 9 – Pension and Other Postretirement
 
Benefits
The components of net periodic benefit (income) cost for the three months
 
ended March 31, 2022 and 2021 are as follows:
Three Months Ended March 31,
 
Other
Pension Benefits
Postretirement Benefits
2022
2021
2022
2021
Service cost
$
180
$
316
$
(8)
$
1
Interest cost
1,360
1,090
9
11
Expected return on plan assets
(2,084)
(2,082)
—
—
Actuarial loss (gain) amortization
257
855
(24)
—
Prior service cost (income) amortization
2
2
1
—
Total net periodic benefit
 
(income) cost
$
(285)
$
181
$
(22)
$
12
Employer Contributions
As of March 31, 2022, $
1.0
 
million and $
0.1
 
million of contributions have been made to the Company’s
 
U.S. and foreign pension
plans and its other postretirement benefit plans, respectively.
 
Taking into consideration
 
current minimum cash contribution
requirements, the Company currently expects to make full year cash contributions
 
of approximately $
6.6
 
million to its U.S. and
foreign pension plans and approximately $
0.2
 
million to its other postretirement benefit plans in 2022.
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.22.1
Other (Expense) Income, Net
 3 Months Ended
Mar. 31, 2022
Other (Expense) Income, Net [Abstract]  
Other (Expense) Income, Net [Text Block]
Note 10 – Other (Expense) Income, Net
The components of other (expense) income, net for the three months ended
 
March 31, 2022 and 2021 are as follows:
Three Months Ended
 
March 31,
2022
2021
Income from third party license fees
$
404
$
339
Foreign exchange losses, net
(1,905)
(1,478)
Gain on disposals of property,
 
plant, equipment and other assets, net
23
5,410
Non-income tax refunds and other related (expense) credits
(1,322)
97
Pension and postretirement benefit income, non-service components
479
124
Other non-operating income, net
115
195
Total other (expense)
 
income, net
$
(2,206)
$
4,687
Non-income tax refunds and other related (expense) credits during the
 
three months ended March 31, 2022 includes other expense
related to an indemnification asset associated with the settlement of certain
 
income tax audits at one of the Company’s
 
Italian affiliates
for tax periods prior to August 1, 2019.
 
See Note 11 of Notes to Condensed Consolidated
 
Financial Statements.
 
Gain on disposals of
property, plant, equipment
 
and other assets, net, during the three months ended March 31, 2021, includes a gain on the
 
sale of certain
held-for-sale real property assets related to the Combination.
 
Foreign exchange losses, net, during each of the three months ended
March 31, 2022 and 2021 include foreign currency transaction losses of approximately
 
$
0.2
 
million related to hyper-inflationary
accounting for the Company’s Argentine
 
subsidiaries.
 
See Note 1 of Notes to Condensed Consolidated Financial Statements.
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.22.1
Income Taxes and Uncertain Income Tax Positions
 3 Months Ended
Mar. 31, 2022
Income Taxes and Uncertain Tax Positions [Abstract]  
Income Taxes and Uncertain Income Tax Positions [Text Block]
Note 11 – Income Taxes
 
and Uncertain Income Tax
 
Positions
The Company’s effective
 
tax rates for the three months ended March 31, 2022 and 2021 were
13.1
% and
24.2
%, respectively.
 
The Company’s effective
 
tax rate for the three months ended March 31, 2022 was largely driven by changes in
 
the valuation
allowance for foreign tax credits due to recently issued legislative guidance
 
and audit settlements reached with Italian tax authorities.
 
In addition, the Company incurred higher tax expense during the three months
 
ended March 31, 2022 related to the Company
recording earnings in one of its subsidiaries at a statutory tax rate of
25
% while it awaits recertification of a concessionary
15
% tax
rate, which was available to the Company during all of 2021.
 
Comparatively,
 
the prior year first quarter effective tax rate was
impacted by the sale of a subsidiary which included certain held-for-sale
 
real property assets related to the Combination.
 
As of December 31, 2021, the Company had a deferred tax liability of $
8.4
 
million on certain undistributed foreign earnings,
which primarily represents the Company’s
 
estimate of non-U.S. income taxes the Company will incur to ultimately remit certain
earnings to the U.S.
 
The balance as of March 31, 2022 was $
8.0
 
million.
As of March 31, 2022, the Company’s
 
cumulative liability for gross unrecognized tax benefits was $
20.1
 
million, a decrease of
approximately $
2.4
 
million from the cumulative liability accrued as of December 31, 2021.
 
The Company continues to recognize interest and penalties associated with uncertain
 
tax positions as a component of taxes on
income before equity in net income of associated companies in its Condensed
 
Consolidated Statements
 
of Income.
 
The Company
recognized a benefit of $
0.3
 
million for interest and a benefit of $
1.6
 
million for penalties in its Condensed Consolidated Statements of
Income for the three months ended March 31, 2022, and recognized
 
an expense of less than $
0.1
 
million for interest and a benefit of
$
0.1
 
million for penalties in its Condensed Consolidated Statements of Income for the
 
three months ended March 31, 2021.
 
As of
March 31, 2022, the Company had accrued $
2.7
 
million for cumulative interest and $
1.6
 
million for cumulative penalties in its
Condensed Consolidated Balance Sheets, compared to $
3.1
 
million for cumulative interest and $
3.1
 
million for cumulative penalties
accrued at December 31, 2021.
During the three months ended March 31, 2022 and 2021, the Company
 
recognized decreases of $
2.8
 
million and $
0.3
 
million,
respectively, in its cumulative
 
liability for gross unrecognized tax benefits due to the settlement of income
 
tax audits with the Italian
tax authorities, as well as the expiration of the applicable statutes of
 
limitations for certain tax years.
The Company estimates that during the year ending December 31, 202
 
2
 
it will reduce its cumulative liability for gross
unrecognized tax benefits by approximately $
4.2
 
million due to the settlement of income tax audits and the expiration of the statute of
limitations with regard to certain tax positions.
 
This estimated reduction in the cumulative liability for unrecognized
 
tax benefits does
not consider any increase in liability for unrecognized tax benefits with regard
 
to existing tax positions or any increase in cumulative
liability for unrecognized tax benefits with regard to new tax positions for
 
the year ending December
 
31, 2022.
The Company
 
and its subsidiaries are subject to U.S. Federal income tax, as well as the income tax of various
 
state and foreign
tax jurisdictions.
 
Tax years that remain subject
 
to examination by major tax jurisdictions include Italy from
2007
, Brazil from
2011
,
Germany from
2015
, the Netherlands, Mexico and China from
2016
, Canada, Spain, and the U.S. from
2017
, the United Kingdom
from
2018
, India from fiscal year beginning April 1, 2017 and ending March 31,
2018
, and various U.S. state tax jurisdictions from
2011
.
 
As previously reported, the Italian tax authorities have assessed additional tax due from the Company’s subsidiary, Quaker Italia
S.r.l., relating to the tax years 2007 through 2015. The Company has filed for competent authority relief from these assessments under
the Mutual Agreement Procedures (“MAP”) of the Organization for Economic Co-Operation and Development for all years except
2007. In 2020, the respective tax authorities in Italy, Spain and the Netherlands reached agreement with respect to the MAP
proceedings which the Company has accepted.
 
As of March 31, 2022, the Company has received $
1.6
 
million in refunds from the
Netherlands and Spain.
 
In February 2022, the Company received a settlement notice from the Italian taxing
 
authorities confirming the
amount due of $
2.6
 
million, having granted the Company’s request
 
to utilize its remaining net operating losses to partially offset
 
the
liability.
 
As a result of the settlement the Company recognized tax expense of $
0.8
 
million for the quarter ended March 31, 2022.
Houghton Italia, S.r.l is also involved
 
in a corporate income tax audit with the Italian tax authorities covering tax years
2014
through
2018
.
 
During the fourth quarter of 2021, the Company settled a portion of the Houghton Italia,
 
S.r.l. corporate income tax
audit with the Italian tax authorities for the tax years
2014
 
and
2015
.
 
During the three months ended March 31, 2022 the Company
settled tax years 2016 through 2018 for a total of $
2.1
 
million.
 
In total, the Company has now settled all years 2014 through 2018 for
$
3.7
 
million.
 
Accordingly, the Company has
 
released all reserves relating to this audit for the settled tax years.
 
As a result of the
settlement and reserve release the Company recognized a net benefit
 
to the tax provision of $
2.1
 
million during the first quarter of
2022.
 
The Company has established an indemnification receivable of $
3.8
 
million in connection with its claim against the former
owners of Houghton for any pre-Combination tax liabilities arising from
 
this matter.
 
Houghton Deutschland GmbH is also under audit by the German tax authorities for
 
the tax years
2015
 
through
2017
.
 
Based on
preliminary audit findings, primarily related to transfer pricing,
 
the Company has recorded reserves for $
0.3
 
million as of March 31,
2022.
 
Of this amount, $
0.3
 
million relates to tax periods prior to the Combination and therefore the Company
 
has submitted an
indemnification claim with Houghton’s
 
former owners for any tax liabilities arising pre-Combination.
 
As a result, a corresponding
indemnification receivable has also been established.
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.22.1
Earnings Per Share
 3 Months Ended
Mar. 31, 2022
Earnings Per Share [Abstract]  
Earnings Per Share [Text Block]
Note 12 – Earnings Per Share
The following table summarizes earnings per share calculations for
 
the three months ended March 31, 2022 and 2021:
Three Months Ended
March 31,
 
2022
2021
Basic earnings per common share
 
Net income attributable to Quaker Chemical Corporation
$
19,816
$
38,615
Less: income allocated to participating securities
 
(78)
 
(154)
Net income available to common shareholders
$
19,738
$
38,461
Basic weighted average common shares outstanding
17,826,061
17,785,370
Basic earnings per common share
$
1.11
$
2.16
Diluted earnings per common share
Net income attributable to Quaker Chemical Corporation
$
19,816
$
38,615
Less: income allocated to participating securities
(78)
(154)
Net income available to common shareholders
$
19,738
$
38,461
Basic weighted average common shares outstanding
17,826,061
17,785,370
Effect of dilutive securities
25,798
70,607
Diluted weighted average common shares outstanding
17,851,859
17,855,977
Diluted earnings per common
 
share
$
1.11
$
2.15
Certain stock options,
 
restricted stock units and PSUs are not included in the diluted earnings per share calculation
 
when the
effect would have been anti-dilutive.
 
The calculated amount of anti-diluted shares not included were
12,260
 
and
2,083
 
for the three
months ended March 31, 2022 and 2021, respectively.
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.22.1
Goodwill and Intangible Assets
 3 Months Ended
Mar. 31, 2022
Goodwill And Intangible Assets [Abstract]  
Goodwill And Intangible Assets [Text Block]
Note 13 – Goodwill and Other Intangible Assets
 
Changes in the carrying amount of goodwill for the three months ended
 
March 31, 2022 were as follows:
Global
Specialty
Americas
EMEA
Asia/Pacific
Businesses
Total
Balance as of December 31, 2021
$
214,023
$
135,520
$
162,458
$
119,193
 
$
631,194
Goodwill additions
1,752
—
—
32
1,784
Currency translation adjustments
 
1,376
(2,569)
(328)
(519)
 
(2,040)
Balance as of March 31, 2022
$
217,151
$
132,951
$
162,130
$
118,706
 
$
630,938
Gross carrying amounts and accumulated amortization for definite-lived
 
intangible assets as of March 31, 2022 and December 31,
2021 were as follows:
Gross Carrying
Accumulated
Amount
Amortization
2022
2021
2022
2021
Customer lists and rights to sell
$
855,309
 
$
853,122
 
$
159,576
 
$
147,858
Trademarks, formulations and product
 
technology
 
162,408
 
 
163,974
 
 
40,565
 
 
38,747
Other
 
6,361
 
 
6,309
 
 
5,989
 
 
5,900
Total definite-lived
 
intangible assets
$
1,024,078
 
$
1,023,405
 
$
206,130
 
$
192,505
The Company amortizes definite-lived intangible assets on a straight-line basis over
 
their useful lives.
 
The Company recorded
$
14.6
 
million and $
14.8
 
million of amortization expense for the three months ended March
 
31, 2022 and 2021, respectively.
 
Estimated annual aggregate amortization expense for the current year
 
and subsequent five years is as follows:
For the year ended December 31, 2022
$
59,465
For the year ended December 31, 2023
59,293
For the year ended December 31, 2024
58,701
For the year ended December 31, 2025
57,924
For the year ended December 31, 2026
57,678
For the year ended December 31, 2027 and beyond
532,124
The Company has four indefinite-lived intangible assets totaling $
194.1
 
million as of March 31, 2022, including $
193.0
 
million of
indefinite-lived intangible assets for trademarks and tradename associated
 
with the Combination.
 
Comparatively, the Company had
four indefinitely-lived intangible assets for trademarks and tradename
 
totaling $
196.9
 
million as of December 31, 2021.
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.1
Debt
 3 Months Ended
Mar. 31, 2022
Debt [Abstract]  
Debt [Text Block]
Note 14 – Debt
Debt as of March 31, 2022 and December 31, 2021 includes the following:
As of March 31, 2022
As of December 31, 2021
Interest
Outstanding
 
Interest
Outstanding
 
Rate
Balance
Rate
Balance
Credit Facilities:
Revolver
1.68%
$
254,453
1.62%
$
211,955
U.S. Term Loan
1.71%
528,750
1.65%
540,000
EURO Term Loan
1.50%
132,037
1.50%
137,616
Industrial development bonds
5.26%
10,000
5.26%
10,000
Bank lines of credit and other debt obligations
Various
1,659
Various
1,777
Total debt
$
926,899
$
901,348
Less: debt issuance costs
(7,227)
(8,001)
Less: short-term and current portion of long-term debts
(61,385)
(56,935)
Total long-term debt
$
858,287
$
836,412
Credit facilities
The Company’s primary credit facility
 
(as amended, the “Credit Facility”) is comprised of a $
400.0
 
million multicurrency
revolver (the “Revolver”), a $
600.0
 
million term loan (the “U.S. Term
 
Loan”), each with the Company as borrower,
 
and a $
150.0
million (as of August 1, 2019) Euro equivalent term loan (the “EURO Term
 
Loan” and together with the “U.S. Term
 
Loan”, the
“Term Loans”)
 
with Quaker Chemical B.V.,
 
a Dutch subsidiary of the Company as borrower, each
 
with a five year term maturing in
August 2024
.
 
Subject to the consent of the administrative agent and certain other conditions, the Company
 
may designate additional
borrowers.
 
The maximum amount available under the Credit Facility can be increased by up
 
to $
300.0
 
million at the Company’s
request if there are lenders who agree to accept additional commitments and
 
the Company has satisfied certain other conditions.
 
Borrowings under the Credit Facility bear interest at a base rate or LIBOR plus an
 
applicable margin based upon the Company’s
consolidated net leverage ratio.
 
On December 10, 2021, the Company entered into the Second Amendment with Bank of America
N.A., to include among other things, an update to provide for use of a non-USD
 
currency LIBOR successor rate.
 
The variable interest
rate incurred on the outstanding borrowings under the Credit Facility during
 
the three months ended March 31, 2022 was
approximately
1.6
%.
 
As of March 31, 2022, the interest rate of the outstanding borrowings under the Credit
 
Facility was
approximately
1.7
%.
 
In addition to paying interest on outstanding principal under the Credit Facility,
 
the Company is required to pay
a commitment fee ranging from
0.2
% to
0.3
% depending on the Company’s consolidated
 
net leverage ratio to the lenders under the
Revolver in respect of the unutilized commitments thereunder.
 
The Company has unused capacity under the Revolver of
approximately $
142
 
million, net of bank letters of credit of approximately $
4
 
million, as of March 31, 2022.
 
 
The Credit Facility is subject to certain financial and other covenants.
 
The Company’s initial consolidated net debt to
consolidated adjusted EBITDA ratio could not exceed 4.25 to 1, with step downs in the permitted ratio over the term of the Credit
Facility. As of March 31, 2021, the consolidated net debt to adjusted EBITDA may not exceed 3.75 to 1. The Company’s
consolidated adjusted EBITDA to interest expense ratio cannot be less than 3.0 to 1 over the term of the agreement. The Credit
Facility also prohibits the payment of cash dividends if the Company is in default or if the amount of the dividend paid annually
exceeds the greater of $50.0 million and 20% of consolidated adjusted EBITDA unless the ratio of consolidated net debt to
consolidated adjusted EBITDA is less than 2.0 to 1, in which case there is no such limitation on amount.
 
As of March 31, 2022 and
December 31, 2021, the Company was in compliance with all of the Credit Facility covenants
.
 
The Term Loans
 
have quarterly
principal amortization during their
five year
 
terms, with
5.0
% amortization of the principal balance due in years 1 and 2,
7.5
% in year
3, and
10.0
% in years 4 and 5, with the remaining principal amount due at maturity.
 
During the three months ended March 31, 2022,
the Company made quarterly amortization payments related to
 
the Term Loans totaling
 
$
14.1
 
million.
 
The Credit Facility is
guaranteed by certain of the Company’s
 
domestic subsidiaries and is secured by first priority liens on substantially all of the assets of
the Company and the domestic subsidiary guarantors, subject to certain
 
customary exclusions.
 
The obligations of the Dutch borrower
are guaranteed only by certain foreign subsidiaries on an unsecured basis.
The Credit Facility required the Company to fix its variable interest rates on at least
20
% of its total Term Loans.
 
In order to
satisfy this requirement as well as to manage the Company’s
 
exposure to variable interest rate risk associated with the Credit Facility,
in November 2019, the Company entered into $
170.0
 
million notional amounts of three year interest rate swaps at a base rate of
1.64
%
plus an applicable margin as provided in the Credit Facility,
 
based on the Company’s consolidated
 
net leverage ratio.
 
At the time the
Company entered into the swaps, and as of March 31, 2022, the aggregate
 
interest rate on the swaps, including the fixed base rate plus
an applicable margin, was
3.1
%.
 
See Note 17 of Notes to Condensed Consolidated Financial Statements.
The Company capitalized $
23.7
 
million of certain third-party debt issuance costs in connection with executing
 
the Credit Facility.
 
Approximately $
15.5
 
million of the capitalized costs were attributed to the Term
 
Loans and recorded as a direct reduction of long-
term debt on the Company’s Consolidated
 
Balance Sheet.
 
Approximately $
8.3
 
million of the capitalized costs were attributed to the
Revolver and recorded within other assets on the Company’s
 
Consolidated Balance Sheet.
 
These capitalized costs are being
amortized into interest expense over the
five year
 
term of the Credit Facility.
 
As of March 31, 2022 and December 31, 2021, the
Company had $
7.2
 
million and $
8.0
 
million, respectively,
 
of debt issuance costs recorded as a reduction of long-term debt.
 
As of
March 31, 2022 and December 31, 2021, the Company had $
3.9
 
million and $
4.3
 
million, respectively,
 
of debt issuance costs recorded
within other assets.
Industrial development bonds
As of March 31, 2022 and December 31, 2021, the Company had fixed rate,
 
industrial development authority bonds totaling
$
10.0
 
million in principal amount due in
2028
.
 
These bonds have similar covenants to the Credit Facility noted above.
Bank lines of credit and other debt obligations
The Company has certain unsecured bank lines of credit and discounting
 
facilities in certain foreign subsidiaries, which are not
collateralized.
 
The Company’s other debt obligations
 
primarily consist of certain domestic and foreign low interest rate or interest-
free municipality-related loans, local credit facilities of certain foreign subsidiaries
 
and capital lease obligations.
 
Total unused
capacity under these arrangements as of March 31, 2022 was approximately
 
$
30
 
million.
In addition to the bank letters of credit described in the “Credit facilities” subsection
 
above, the Company’s only other
 
off-balance
sheet arrangements include certain financial and other guarantees.
 
The Company’s total bank letters of
 
credit and guarantees
outstanding as of March 31, 2022 were approximately $
6
 
million.
The Company incurred the following debt related expenses included
 
within Interest expense, net, in the Condensed Consolidated
Statements of Income:
Three Months Ended
March 31,
 
2022
2021
Interest expense
$
4,746
$
4,650
Amortization of debt issuance costs
1,187
1,187
Total
$
5,933
$
5,837
Based on the variable interest rates associated with the Credit Facility,
 
as of March 31, 2022 and December 31, 2021, the amounts
at which the Company’s total debt
 
were recorded are not materially different from their fair market value.
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.22.1
Accumulated Other Comprehensive Income
 3 Months Ended
Mar. 31, 2022
Accumulated Other Comprehensive Income [Abstract]  
Accumulated Other Comprehensive Income [Text Block]
Note 15 – Accumulated Other Comprehensive Income
The following tables show the reclassifications from and resulting balances
 
of accumulated other comprehensive income
(“AOCI”) for the three months ended March 31, 2022 and 2021:
Defined
Unrealized
Currency
Benefit
Gain (Loss) in
 
Translation
Retirement
Available-for-
Derivative
Adjustments
Plans
Sale Securities
Instruments
Total
Balance at December 31, 2021
$
(49,843)
$
(13,172)
$
397
$
(1,372)
$
(63,990)
Other comprehensive (loss) income before
reclassifications
(6,867)
432
(1,277)
1,429
(6,283)
Amounts reclassified from AOCI
—
229
11
—
240
Related tax amounts
—
(165)
266
(329)
(228)
Balance at March 31, 2022
$
(56,710)
$
(12,676)
$
(603)
$
(272)
$
(70,261)
Balance at December 31, 2020
$
(2,875)
$
(23,467)
$
3,342
$
(3,598)
$
(26,598)
Other comprehensive (loss) income before
 
reclassifications
(25,459)
781
(745)
730
(24,693)
Amounts reclassified from AOCI
—
862
(3,085)
—
(2,223)
Related tax amounts
—
(351)
805
(168)
286
Balance at March 31, 2021
$
(28,334)
$
(22,175)
$
317
$
(3,036)
$
(53,228)
All reclassifications related to unrealized gain (loss) in available-for-sale securities
 
relate to the Company’s equity
 
interest in a
captive insurance company and are recorded in equity in net income
 
of associated companies.
 
The amounts reported in other
comprehensive income for non-controlling interest are related to
 
currency translation adjustments.
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Measurements
 3 Months Ended
Mar. 31, 2022
Fair Value Measurements [Abstract]  
Fair Value Disclosures [Text Block]
Note 16 – Fair Value
 
Measurements
The Company has valued its company-owned life insurance policies at fair value.
 
These assets are subject to fair value
measurement as follows:
Fair Value
 
Measurements at March 31, 2022
Total
Using Fair Value
 
Hierarchy
Assets
Fair Value
Level 1
Level 2
Level 3
Company-owned life insurance
$
2,395
$
—
$
2,395
$
—
Total
$
2,395
$
—
$
2,395
$
—
Fair Value
 
Measurements at December 31, 2021
Total
Using Fair Value
 
Hierarchy
Assets
Fair Value
Level 1
Level 2
Level 3
Company-owned life insurance
 
$
2,533
$
—
$
2,533
$
—
Total
$
2,533
$
—
$
2,533
$
—
The fair values of Company-owned life insurance assets are based on quotes
 
for like instruments with similar credit ratings and
terms.
 
The Company did not hold any Level 3 investments as of March 31,
 
2022 or December 31, 2021, respectively,
 
so related
disclosures have not been included.
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.22.1
Hedging Activities
 3 Months Ended
Mar. 31, 2022
Hedging Activities [Abstract]  
Hedging Activities [Text Block]
Note 17 – Hedging Activities
In order to satisfy certain requirements of the Credit Facility as well as to manage
 
the Company’s exposure to variable
 
interest
rate risk associated with the Credit Facility,
 
in November 2019, the Company entered into $
170.0
 
million notional amounts of three
year interest rate swaps.
 
See Note 14 of Notes to Condensed Consolidated Financial Statements.
 
These interest rate swaps are
designated as cash flow hedges and, as such, the contracts are marked-to-market
 
at each reporting date and any unrealized gains or
losses are included in AOCI to the extent effective and reclassified to interest
 
expense in the period during which the transaction
effects earnings or it becomes probable that the forecasted
 
transaction will not occur.
 
The balance sheet classification and fair values of the Company’s
 
derivative instruments, which are Level 2 measurements, are as
follows:
Fair Value
Consolidated
March 31,
 
December 31,
Balance Sheet Location
2022
2021
Derivatives designated as cash flow hedges:
Interest rate swaps
Other accrued liabilities
$
353
$
1,782
$
353
$
1,782
The following table presents the net unrealized loss deferred to AOCI:
March 31,
 
December 31,
2022
2021
Derivatives designated as cash flow hedges:
Interest rate swaps
AOCI
$
272
$
1,372
$
272
$
1,372
The following table presents the net gain reclassified from AOCI to earnings:
Three Months Ended
March 31,
 
2022
2021
Amount and location of expense reclassified
 
 
from AOCI into expense (Effective Portion)
Interest expense, net
$
(637)
$
(643)
Interest rate swaps are entered into with a limited number of counterparties,
 
each of which allows for net settlement of all
contracts through a single payment in a single currency in the event of a default on
 
or termination of any one contract.
 
As such, in
accordance with the Company’s accounting
 
policy, these derivative instruments
 
are recorded on a net basis within the Condensed
Consolidated Balance Sheets.
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.22.1
Commitments and Contingencies
 3 Months Ended
Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Commitments And Contingencies Disclosure [Text Block]
Note 18 – Commitments and Contingencies
The Company previously disclosed in its 2021 Form 10-K that AC Products, Inc.
 
(“ACP”), a wholly owned subsidiary,
 
has been
operating a groundwater treatment system to hydraulically contain groundwater
 
contamination emanating from ACP’s site,
 
the
principal contaminant of which is perchloroethylene.
 
As of March 31, 2022, ACP believes it is close to meeting the conditions for
closure of the groundwater treatment system, but continues to operate
 
this system while in discussions with the relevant authorities.
 
 
As of March 31, 2022, the Company believes that the range of potential-known
 
liabilities associated with the balance of the ACP
water remediation program is approximately $
0.1
 
million to $
1.0
 
million.
 
The low and high ends of the range are based on the length
of operation of the treatment system as determined by groundwater modeling.
 
Costs of operation include the operation and
maintenance of the extraction well, groundwater monitoring and
 
program management.
The Company previously disclosed in its 2021 Form 10-K that an inactive
 
subsidiary of the Company that was acquired in 1978
sold certain products containing asbestos, primarily on an installed basis, and
 
is among the defendants in numerous lawsuits alleging
injury due to exposure to asbestos.
 
During the three months ended March 31, 2022, there have been no significant
 
changes to the facts
or circumstances of this previously disclosed matter,
 
aside from on-going claims and routine payments associated with this litigation.
 
Based on a continued analysis of the existing and anticipated future claims against
 
this subsidiary, it is currently
 
projected that the
subsidiary’s total liability over
 
the next
50 years
 
for these claims is approximately $
0.3
 
million (excluding costs of defense).
The Company previously disclosed in its 2021 Form 10-K that it is party to certain environmental
 
matters related to certain
domestic and foreign properties.
 
These environmental matters primarily require the Company
 
to perform long-term monitoring as
well as operating and maintenance at each of the applicable sites.
 
During the three months ended March 31, 2022, there have been
 
no
significant changes to the facts or circumstances of these previously disclosed
 
matters, aside from on-going monitoring and
maintenance activities and routine payments associated with each of
 
the sites.
 
The Company continually evaluates its obligations
related to such matters, and based on historical costs incurred and
 
projected costs to be incurred over the next
27 years
, has estimated
the range of costs for all of these environmental matters, on a discounted
 
basis, to be between approximately $
5
 
million and $
6
 
million
as of March 31, 2022, for which $
5.9
 
million was accrued within other accrued liabilities and other non-current
 
liabilities on the
Company’s
 
Condensed Consolidated Balance Sheet as of March 31, 2022.
 
Comparatively, as of December
 
31, 2021, the Company
had $
5.6
 
million accrued for with respect to these matters.
The Company believes, although there can be no assurance regarding the
 
outcome of other unrelated environmental matters, that
it has made adequate accruals for costs associated with other environmental
 
problems of which it is aware.
 
Approximately $
0.4
million were accrued as of both March 31, 2022 and December 31, 2021,
 
respectively, to provide
 
for such anticipated future
environmental assessments and remediation costs.
 
In connection with obtaining regulatory approvals for the Combination,
 
certain steel and aluminum related product lines of
Houghton were divested in August 2019.
 
The Company previously disclosed in its 2021 Form 10-K that in July 2021, the entity
 
that
acquired these divested product lines submitted an indemnification claim
 
for certain alleged breaches of representation made by
Houghton in the agreement pursuant to which such assets had been divested.
 
The Company responded to the subject matters of the
indemnification claim and during the first quarter of 2022 the matter was resolved
 
consistent with the Company’s expectations
 
and
position that there were no amounts owed by the Company.
The Company previously disclosed in its 2021 Form 10-K that two of the Company’s
 
locations suffered property damages as a
result of flooding and fire, respectively.
 
The Company maintains property insurance for all of its facilities globally.
 
During the three
months ended March 31, 2022, there have been no significant changes to
 
the facts or circumstances of these previously disclosed
matters, aside from the on-going restoration of both sites.
 
The Company, its insurance
 
adjuster and insurance carrier are actively
managing the remediation and restoration activities associated with these
 
events and at this time the Company has concluded, based on
all available information and discussions with its insurance adjuster
 
and insurance carrier, that the losses were covered
 
under the
Company’s property insurance
 
coverage, net of an aggregate deductible of $
2.0
 
million.
 
The Company has received payments from
its insurers of $
2.1
 
million and has recorded an insurance receivable associated with these events (and
 
a gain on insurance recoveries
for losses incurred) of $
0.5
 
million as of March 31, 2022.
The Company is party to other litigation which management currently
 
believes will not have a material adverse effect on the
Company’s results of operations,
 
cash flows or financial condition.
 
In addition, the Company has an immaterial amount of contractual
purchase obligations.
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.22.1
Basis of Presentation and Description of Business (Policies)
 3 Months Ended
Mar. 31, 2022
Basis of Presentation and Description of Business [Abstract]  
Description of Business [Policy Text Block]
Description of Business
The Company was organized in 1918, incorporated as a Pennsylvania
 
business corporation in 1930, and in August 2019
completed the Combination with Houghton to form Quaker Houghton.
 
Quaker Houghton is the global leader in industrial process
fluids.
 
With a presence around the world, including
 
operations in over
25
 
countries, the Company’s customers
 
include thousands of
the world’s most advanced and specialized
 
steel, aluminum, automotive, aerospace, offshore, can,
 
mining, and metalworking
companies.
 
Quaker Houghton develops, produces, and markets a broad range of formulated chemical
 
specialty products and offers
chemical management services (which the Company refers to as “Fluidcare
TM
”) for various heavy industrial and manufacturing
applications throughout its
four
 
segments: Americas; Europe, Middle East and Africa (“EMEA”); Asia/Pacific; and
 
Global Specialty
Businesses.
Basis of Presentation [Policy Text Block]
Basis of Presentation
As used in these Notes to Condensed Consolidated Financial Statements, the
 
terms “Quaker,” “Quaker Houghton,” the
“Company,” “we,” and “our” refer to Quaker Chemical Corporation
 
(doing business as Quaker Houghton), its subsidiaries, and
associated companies, unless the context otherwise requires.
 
As used in these Notes to Condensed Consolidated Financial Statements,
the term Legacy Quaker refers to the Company prior to the closing of its combination
 
with Houghton International, Inc. (“Houghton”)
(herein referred to as the “Combination”).
 
The condensed consolidated financial statements included herein are unaudited and
 
have
been prepared in accordance with generally accepted accounting principles
 
in the United States (“U.S. GAAP”) for interim financial
reporting and the United States Securities and Exchange Commission (“SEC”)
 
regulations.
 
Certain information and footnote
disclosures normally included in financial statements prepared in accordance
 
with U.S. GAAP have been condensed or omitted
pursuant to such rules and regulations.
 
In the opinion of management, the financial statements reflect all adjustments
 
consisting only
of normal recurring adjustments, which are necessary for a fair statement of
 
the financial position, results of operations and cash flows
for the interim periods.
 
The results for the three months ended March 31, 2022 are not necessarily indicative
 
of the results to be
expected for the full year.
 
These financial statements should be read in conjunction with the Company’s
 
Annual Report filed on Form
10-K for the year ended December 31, 2021 (the “2021 Form 10-K”).
Hyper-inflationary economies [Policy Text Block]
Hyper-inflationary economies
Based on various indices or index compilations being used to monitor inflation
 
in Argentina as well as economic instability,
effective July 1, 2018, Argentina’s
 
economy was considered hyper-inflationary under U.S. GAAP.
 
As of, and for the three months
ended March 31, 2022, the Company's Argentine subsidiaries represented
 
less than
1
% of the Company’s consolidated
 
total assets and
net sales, respectively.
 
During each of the three months ended March 31, 2022 and 2021, the Company
 
recorded $
0.2
 
million of
remeasurement losses associated with the applicable currency conversions
 
related to Argentina.
 
These losses were recorded within
foreign exchange losses, net, which is a component of other (expense) income, net,
 
in the Company’s Condensed Consolidated
Statements of Income.
Segments [Policy Text Block]
The Company’s operating
 
segments, which are consistent with its reportable segments, reflect the structure of the
 
Company’s
internal organization, the method by which the Company’s
 
resources are allocated and the manner by which the chief operating
decision maker assesses the Company’s
 
performance.
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.22.1
Business Segments (Tables)
 3 Months Ended
Mar. 31, 2022
Business Segment Disclosures [Abstract]  
Schedule of information about the performance of the Company's reportable segments, sales and total assets [Table Text Block]
Three Months Ended
March 31,
 
2022
2021
Net sales
 
 
 
 
 
 
Americas
$
154,144
$
134,871
EMEA
 
125,687
 
119,814
Asia/Pacific
 
104,234
 
96,706
Global Specialty Businesses
 
90,106
 
78,392
Total
 
net sales
$
474,171
$
429,783
Segment operating earnings
Americas
$
29,220
$
32,234
EMEA
16,766
25,244
Asia/Pacific
21,907
27,478
Global Specialty Businesses
 
25,035
 
24,169
Total
 
segment operating earnings
 
92,928
 
109,125
Combination, integration and other acquisition-related expenses
(4,053)
(5,815)
Restructuring and related charges
(820)
(1,175)
Fair value step up of acquired inventory sold
—
(801)
Non-operating and administrative expenses
 
(43,463)
 
(40,992)
Depreciation of corporate assets and amortization
 
(15,189)
 
(15,448)
Operating income
29,403
44,894
Other (expense) income, net
(2,206)
4,687
Interest expense, net
 
(5,345)
 
(5,470)
Income before taxes and equity in net income of associated companies
$
21,852
$
44,111
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.22.1
Net Sales and Revenue Recognition (Tables)
 3 Months Ended
Mar. 31, 2022
Net Sales and Revenue Recognition [Abstract]  
Disaggregation of company's net sales by segment [Table Text Block]
Three Months Ended March 31, 2022
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
56,160
$
36,839
$
55,287
 
$
148,286
Metalworking and other
97,984
88,848
48,947
235,779
154,144
125,687
104,234
384,065
Global Specialty Businesses
57,264
20,021
12,821
90,106
$
211,408
$
145,708
$
117,055
$
474,171
Timing of Revenue Recognized
Product sales at a point in time
$
201,284
$
137,203
$
114,625
 
$
453,112
Services transferred over time
10,124
8,505
2,430
21,059
$
211,408
$
145,708
$
117,055
$
474,171
Three Months Ended March 31, 2021
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
46,793
$
34,274
$
49,743
 
$
130,810
Metalworking and other
88,078
85,540
46,963
220,581
134,871
119,814
96,706
351,391
Global Specialty Businesses
45,256
20,272
12,864
78,392
$
180,127
$
140,086
$
109,570
$
429,783
Timing of Revenue Recognized
Product sales at a point in time
$
171,594
$
131,162
$
106,399
 
$
409,155
Services transferred over time
8,533
8,924
3,171
20,628
$
180,127
$
140,086
$
109,570
$
429,783
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.22.1
Leases (Tables)
 3 Months Ended
Mar. 31, 2022
Leases [Abstract]  
Schedule of lease cost and supplemental information [Table Text Block]
Three Months Ended
March 31,
2022
2021
Operating lease expense
$
3,409
$
3,612
Short-term lease expense
219
251
Three Months Ended
March 31,
2022
2021
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases
$
3,365
$
3,579
Non-cash lease liabilities activity:
Leased assets obtained in exchange for new operating lease liabilities
4,689
3,050
March 31,
December 31,
2022
2021
Right of use lease assets
$
38,245
$
36,635
Other current liabilities
10,540
9,976
Long-term lease liabilities
27,433
26,335
Total operating lease liabilities
$
37,973
$
36,311
Weighted average
 
remaining lease term (years)
5.9
5.6
Weighted average
 
discount rate
4.14%
4.22%
Schedule of Company's future minimum rental commitments under operating leases [Table Text Block]
March 31,
2022
For the remainder of 2022
$
8,990
For the year ended December 31, 2023
9,513
For the year ended December 31, 2024
7,292
For the year ended December 31, 2025
5,375
For the year ended December 31, 2026
4,338
For the year ended December 31, 2027 and beyond
7,046
Total lease payments
42,554
Less: imputed interest
(4,581)
Present value of lease liabilities
$
37,973
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.22.1
Restructuring and Related Activities (Tables)
 3 Months Ended
Mar. 31, 2022
Restructuring And Related Activities [Abstract]  
Restructuring and Related Costs [Table Text Block]
QH Program
Accrued restructuring as of December 31, 2021
$
4,087
Restructuring and related charges
820
Cash payments
(408)
Currency translation adjustments
(64)
Accrued restructuring as of March 31, 2022
$
4,435
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.22.1
Share Based Compensation (Tables)
 3 Months Ended
Mar. 31, 2022
Share-Based Compensation [Abstract]  
Schedule of share-based compensation expense in its Consolidated Statements of Income [Table Text Block]
Three Months Ended
March 31,
 
2022
2021
Stock options
$
267
$
308
Non-vested stock awards and restricted stock units
1,548
1,396
Non-elective and elective 401(k) matching contribution in stock
—
1,553
Director stock ownership plan
24
203
Performance stock units
623
319
Total share-based
 
compensation expense
$
2,462
$
3,779
Schedule of Black-Scholes option pricing model and the assumptions [Table Text Block]
March 2022
Grant
Number of options granted
27,077
Dividend yield
0.80
%
Expected volatility
38.60
%
Risk-free interest rate
2.07
%
Expected term (years)
4.0
Schedule of Monte Carlo option pricing model and the assumptions [Text Block]
March 2022
Grant
Number of PSUs granted
16,820
Risk-free interest rate
2.11
%
Dividend yield
0.93
%
Expected term (years)
3.0
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.22.1
Pension and Other Post Retirement Benefits (Tables)
 3 Months Ended
Mar. 31, 2022
Defined Benefit Plan Disclosure [Line Items]  
Schedule of components of net periodic benefit costs - pension plans [Table Text Block]
Three Months Ended March 31,
 
Other
Pension Benefits
Postretirement Benefits
2022
2021
2022
2021
Service cost
$
180
$
316
$
(8)
$
1
Interest cost
1,360
1,090
9
11
Expected return on plan assets
(2,084)
(2,082)
—
—
Actuarial loss (gain) amortization
257
855
(24)
—
Prior service cost (income) amortization
2
2
1
—
Total net periodic benefit
 
(income) cost
$
(285)
$
181
$
(22)
$
12
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.22.1
Other (Expense) Income, Net (Tables)
 3 Months Ended
Mar. 31, 2022
Other (Expense) Income, Net [Abstract]  
Schedule of other expense, net [Table Text Block]
Three Months Ended
 
March 31,
2022
2021
Income from third party license fees
$
404
$
339
Foreign exchange losses, net
(1,905)
(1,478)
Gain on disposals of property,
 
plant, equipment and other assets, net
23
5,410
Non-income tax refunds and other related (expense) credits
(1,322)
97
Pension and postretirement benefit income, non-service components
479
124
Other non-operating income, net
115
195
Total other (expense)
 
income, net
$
(2,206)
$
4,687
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.22.1
Earnings Per Share (Tables)
 3 Months Ended
Mar. 31, 2022
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Three Months Ended
March 31,
 
2022
2021
Basic earnings per common share
 
Net income attributable to Quaker Chemical Corporation
$
19,816
$
38,615
Less: income allocated to participating securities
 
(78)
 
(154)
Net income available to common shareholders
$
19,738
$
38,461
Basic weighted average common shares outstanding
17,826,061
17,785,370
Basic earnings per common share
$
1.11
$
2.16
Diluted earnings per common share
Net income attributable to Quaker Chemical Corporation
$
19,816
$
38,615
Less: income allocated to participating securities
(78)
(154)
Net income available to common shareholders
$
19,738
$
38,461
Basic weighted average common shares outstanding
17,826,061
17,785,370
Effect of dilutive securities
25,798
70,607
Diluted weighted average common shares outstanding
17,851,859
17,855,977
Diluted earnings per common
 
share
$
1.11
$
2.15
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.22.1
Goodwill and Intangible Assets (Tables)
 3 Months Ended
Mar. 31, 2022
Goodwill And Intangible Assets [Abstract]  
Schedule of Goodwill [Table Text Block]
Global
Specialty
Americas
EMEA
Asia/Pacific
Businesses
Total
Balance as of December 31, 2021
$
214,023
$
135,520
$
162,458
$
119,193
 
$
631,194
Goodwill additions
1,752
—
—
32
1,784
Currency translation adjustments
 
1,376
(2,569)
(328)
(519)
 
(2,040)
Balance as of March 31, 2022
$
217,151
$
132,951
$
162,130
$
118,706
 
$
630,938
Schedule of Finite-Lived Intangible Assets [Table Text Block]
Gross Carrying
Accumulated
Amount
Amortization
2022
2021
2022
2021
Customer lists and rights to sell
$
855,309
 
$
853,122
 
$
159,576
 
$
147,858
Trademarks, formulations and product
 
technology
 
162,408
 
 
163,974
 
 
40,565
 
 
38,747
Other
 
6,361
 
 
6,309
 
 
5,989
 
 
5,900
Total definite-lived
 
intangible assets
$
1,024,078
 
$
1,023,405
 
$
206,130
 
$
192,505
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]
For the year ended December 31, 2022
$
59,465
For the year ended December 31, 2023
59,293
For the year ended December 31, 2024
58,701
For the year ended December 31, 2025
57,924
For the year ended December 31, 2026
57,678
For the year ended December 31, 2027 and beyond
532,124
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.22.1
Debt (Tables)
 3 Months Ended
Mar. 31, 2022
Debt [Abstract]  
Schedule of Debt [Table Text Block]
As of March 31, 2022
As of December 31, 2021
Interest
Outstanding
 
Interest
Outstanding
 
Rate
Balance
Rate
Balance
Credit Facilities:
Revolver
1.68%
$
254,453
1.62%
$
211,955
U.S. Term Loan
1.71%
528,750
1.65%
540,000
EURO Term Loan
1.50%
132,037
1.50%
137,616
Industrial development bonds
5.26%
10,000
5.26%
10,000
Bank lines of credit and other debt obligations
Various
1,659
Various
1,777
Total debt
$
926,899
$
901,348
Less: debt issuance costs
(7,227)
(8,001)
Less: short-term and current portion of long-term debts
(61,385)
(56,935)
Total long-term debt
$
858,287
$
836,412
Interest Income And Interest Expense Disclosure [Table Text Block]
Three Months Ended
March 31,
 
2022
2021
Interest expense
$
4,746
$
4,650
Amortization of debt issuance costs
1,187
1,187
Total
$
5,933
$
5,837
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.22.1
Accumulated Other Comprehensive Income (Tables)
 3 Months Ended
Mar. 31, 2022
Accumulated Other Comprehensive Income [Abstract]  
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]
Defined
Unrealized
Currency
Benefit
Gain (Loss) in
 
Translation
Retirement
Available-for-
Derivative
Adjustments
Plans
Sale Securities
Instruments
Total
Balance at December 31, 2021
$
(49,843)
$
(13,172)
$
397
$
(1,372)
$
(63,990)
Other comprehensive (loss) income before
reclassifications
(6,867)
432
(1,277)
1,429
(6,283)
Amounts reclassified from AOCI
—
229
11
—
240
Related tax amounts
—
(165)
266
(329)
(228)
Balance at March 31, 2022
$
(56,710)
$
(12,676)
$
(603)
$
(272)
$
(70,261)
Balance at December 31, 2020
$
(2,875)
$
(23,467)
$
3,342
$
(3,598)
$
(26,598)
Other comprehensive (loss) income before
 
reclassifications
(25,459)
781
(745)
730
(24,693)
Amounts reclassified from AOCI
—
862
(3,085)
—
(2,223)
Related tax amounts
—
(351)
805
(168)
286
Balance at March 31, 2021
$
(28,334)
$
(22,175)
$
317
$
(3,036)
$
(53,228)
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Measurements (Table)
 3 Months Ended
Mar. 31, 2022
Fair Value Measurements [Abstract]  
Fair Value, Assets Measured on Recurring Basis [Table Text Block]
Fair Value
 
Measurements at March 31, 2022
Total
Using Fair Value
 
Hierarchy
Assets
Fair Value
Level 1
Level 2
Level 3
Company-owned life insurance
$
2,395
$
—
$
2,395
$
—
Total
$
2,395
$
—
$
2,395
$
—
Fair Value
 
Measurements at December 31, 2021
Total
Using Fair Value
 
Hierarchy
Assets
Fair Value
Level 1
Level 2
Level 3
Company-owned life insurance
 
$
2,533
$
—
$
2,533
$
—
Total
$
2,533
$
—
$
2,533
$
—
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.22.1
Hedging Activities (Tables)
 3 Months Ended
Mar. 31, 2022
Hedging Activities [Abstract]  
Scheudule of fair values of the Company''s derivative instruments, Level 2 measurements [Table Text Block]
Fair Value
Consolidated
March 31,
 
December 31,
Balance Sheet Location
2022
2021
Derivatives designated as cash flow hedges:
Interest rate swaps
Other accrued liabilities
$
353
$
1,782
$
353
$
1,782
March 31,
 
December 31,
2022
2021
Derivatives designated as cash flow hedges:
Interest rate swaps
AOCI
$
272
$
1,372
$
272
$
1,372
Three Months Ended
March 31,
 
2022
2021
Amount and location of expense reclassified
 
 
from AOCI into expense (Effective Portion)
Interest expense, net
$
(637)
$
(643)
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.22.1
Basis of Presentation and Description of Business (Details)
$ in Millions
 3 Months Ended
Mar. 31, 2022
USD ($)
Mar. 31, 2021
USD ($)
Basis of Presentation and Description of Business [Abstract]    
Number Of Countries In Which Entity Operates 25  
Number Of Reportable Segments 4  
Subsidiaries [Member] | Argentina [Member]    
Currency conversion impacts of hyper-inflationary accounting $ 0.2 $ 0.2
Assets Total [Member] | Subsidiaries [Member] | Argentina [Member] | Geographic Concentration Risk [Member]    
Concentration Risk, Percentage 1.00%  
Sales Revenue Net [Member] | Subsidiaries [Member] | Argentina [Member] | Geographic Concentration Risk [Member]    
Concentration Risk, Percentage 1.00%  
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.22.1
Business Acquisitions - Narrative (Details)
$ in Thousands, € in Millions
 1 Months Ended 3 Months Ended
Jan. 31, 2022
EUR (€)
Jan. 31, 2022
USD ($)
Nov. 30, 2021
EUR (€)
Nov. 30, 2021
USD ($)
Sep. 30, 2021
EUR (€)
Sep. 30, 2021
USD ($)
Jun. 30, 2021
EUR (€)
Jun. 30, 2021
USD ($)
Feb. 28, 2021
EUR (€)
Feb. 28, 2021
USD ($)
Mar. 31, 2022
USD ($)
Mar. 31, 2021
USD ($)
Business Acquisition [Line Items]                        
Payments related to acquisitions, net of cash acquired                     $ 9,383 $ 26,655
Loss Contingency Accrual At Carrying Value                     400  
Assets Related To Sealing And Impregnation Of Metal Castings [Member]                        
Business Acquisition [Line Items]                        
Asset Acquisition, Consideration Transferred € 1.2 $ 1,400                    
Assets Related To Pickling Inhibitor Technologies [Member]                        
Business Acquisition [Line Items]                        
Goodwill, Acquired During Period   1,800                    
Asset Acquisition, Consideration Transferred   $ 8,000                    
Assets Related to Hydraulic fluids, Coolants, Cleaners, and Rust Preventative oils [Member]                        
Business Acquisition [Line Items]                        
Asset Acquisition, Consideration Transferred     € 3.2 $ 3,700                
Assets For Chemical Maskants [Member]                        
Business Acquisition [Line Items]                        
Asset Acquisition, Consideration Transferred             € 2.3 $ 2,800        
Customer Relationships [Member] | Assets Related To Pickling Inhibitor Technologies [Member]                        
Business Acquisition [Line Items]                        
Intangible Assets, Amortizable Life 14 years 14 years                    
Product technology [Member] | Assets Related To Pickling Inhibitor Technologies [Member]                        
Business Acquisition [Line Items]                        
Intangible assets   $ 500                    
Intangible Assets, Amortizable Life 14 years 14 years                    
Other Acquisitions [Member]                        
Business Acquisition [Line Items]                        
Intangible assets   $ 5,600                    
Other Acquisitions [Member] | Customer Relationships [Member]                        
Business Acquisition [Line Items]                        
Intangible assets   $ 5,100                    
Baron Industries [Member]                        
Business Acquisition [Line Items]                        
Intangible assets       8,000                
Propery, plant & equipment       1,100                
Other assets acquired net of liabilities assumed       1,500                
Cash Acquired       300                
Cash Paid for Acquisitions       11,000                
Payments To Acquire Businesses Gross       7,100                
Goodwill, Acquired During Period       400                
Post Closing Adjustment including earnouts       3,900                
Earnouts       4,500                
Baron Industries [Member] | Customer Relationships [Member]                        
Business Acquisition [Line Items]                        
Intangible assets       $ 7,200                
Intangible Assets, Amortizable Life     15 years 15 years                
Baron Industries [Member] | Product technology [Member]                        
Business Acquisition [Line Items]                        
Intangible assets       $ 800                
Intangible Assets, Amortizable Life     13 years 13 years                
Tin Plating Solutions [Member]                        
Business Acquisition [Line Items]                        
Intangible assets                   $ 19,600    
Goodwill, Acquired During Period                   5,000    
Asset Acquisition, Consideration Transferred                   25,000    
Tin Plating Solutions [Member] | Customer Relationships [Member]                        
Business Acquisition [Line Items]                        
Intangible assets                   $ 18,300    
Intangible Assets, Amortizable Life                 19 years 19 years    
Tin Plating Solutions [Member] | Licensed Trademark [Member]                        
Business Acquisition [Line Items]                        
Intangible assets                   $ 400    
Intangible Assets, Amortizable Life                 3 years 3 years    
Tin Plating Solutions [Member] | Product technology [Member]                        
Business Acquisition [Line Items]                        
Intangible assets                   $ 900    
Intangible Assets, Amortizable Life                 14 years 14 years    
Grindaix GmbH [Member]                        
Business Acquisition [Line Items]                        
Payments related to acquisitions, net of cash acquired           $ 300            
Business Acquisition, Percentage of Voting Interests Acquired         38.00% 38.00%            
Cash Paid for Acquisitions         € 2.4 $ 2,900     € 1.4 $ 1,700    
Coral Chemical Company (Coral) [Member] | Minimum [Member] | Tax attributes of the acquisition                        
Business Acquisition [Line Items]                        
Loss Contingency, Estimate of Possible Loss                     0  
Coral Chemical Company (Coral) [Member] | Maximum [Member] | Tax attributes of the acquisition                        
Business Acquisition [Line Items]                        
Loss Contingency, Estimate of Possible Loss                     $ 1,500  
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.22.1
Business Segments - Narrative (Details)
 3 Months Ended
Mar. 31, 2022
Business Segment Disclosures [Abstract]  
Number of reportable segments 4
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.22.1
Business Segments - Performance of reportable segments (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Segment Reporting Information [Line Items]    
Net sales $ 474,171 $ 429,783
Segment operating earnings 92,928 109,125
Combination, integration and other acquisition-related expenses (4,053) (5,815)
Restructuring and related charges (820) (1,175)
Fair value step up of acquired inventory sold 0 (801)
Non-operating and administrative expenses (43,463) (40,992)
Depreciation of corporate assets and amortization (15,189) (15,448)
Operating income 29,403 44,894
Other (expense) income, net (2,206) 4,687
Interest expense, net (5,345) (5,470)
Income (loss) before taxes and equity in net income of associated companies 21,852 44,111
Americas [Member]    
Segment Reporting Information [Line Items]    
Net sales 154,144 134,871
EMEA [Member]    
Segment Reporting Information [Line Items]    
Net sales 125,687 119,814
Asia Pacific [Member]    
Segment Reporting Information [Line Items]    
Net sales 104,234 96,706
Operating Segments [Member]    
Segment Reporting Information [Line Items]    
Net sales 474,171 429,783
Operating Segments [Member] | Global Specialty Businesses [Member]    
Segment Reporting Information [Line Items]    
Net sales 90,106 78,392
Segment operating earnings 25,035 24,169
Operating Segments [Member] | Americas [Member]    
Segment Reporting Information [Line Items]    
Net sales 211,408 180,127
Segment operating earnings 29,220 32,234
Operating Segments [Member] | Americas [Member] | Global Specialty Businesses [Member]    
Segment Reporting Information [Line Items]    
Net sales 57,264 45,256
Operating Segments [Member] | EMEA [Member]    
Segment Reporting Information [Line Items]    
Net sales 145,708 140,086
Segment operating earnings 16,766 25,244
Operating Segments [Member] | EMEA [Member] | Global Specialty Businesses [Member]    
Segment Reporting Information [Line Items]    
Net sales 20,021 20,272
Operating Segments [Member] | Asia Pacific [Member]    
Segment Reporting Information [Line Items]    
Net sales 117,055 109,570
Segment operating earnings 21,907 27,478
Operating Segments [Member] | Asia Pacific [Member] | Global Specialty Businesses [Member]    
Segment Reporting Information [Line Items]    
Net sales 12,821 12,864
Intersegment Elimination [Member] | Global Specialty Businesses [Member]    
Segment Reporting Information [Line Items]    
Net sales 1,700 2,000
Intersegment Elimination [Member] | Americas [Member]    
Segment Reporting Information [Line Items]    
Net sales 2,900 3,300
Intersegment Elimination [Member] | EMEA [Member]    
Segment Reporting Information [Line Items]    
Net sales 8,900 8,800
Intersegment Elimination [Member] | Asia Pacific [Member]    
Segment Reporting Information [Line Items]    
Net sales $ 300 $ 100
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.22.1
Net Sales and Revenue Recognition - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Revenues [Abstract]      
Net Reporting Amount $ 19.8 $ 17.8  
Deferred Revenue $ 6.9   $ 7.0
Customer Concentration Risk [Member] | Sales Revenue Net [Member] | Top Five Customers [Member]      
Concentration Risk [Line Items]      
Concentration Risk, Percentage 10.00%    
Customer Concentration Risk [Member] | Sales Revenue Net [Member] | Largest customer [Member]      
Concentration Risk [Line Items]      
Concentration Risk, Percentage 3.00%    
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.22.1
Net Sales and Revenue Recognition - Disaggregated Revenue (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Product Information [Line Items]    
Net sales $ 474,171 $ 429,783
Americas [Member]    
Product Information [Line Items]    
Net sales 154,144 134,871
EMEA [Member]    
Product Information [Line Items]    
Net sales 125,687 119,814
Asia Pacific [Member]    
Product Information [Line Items]    
Net sales 104,234 96,706
Operating Segments [Member]    
Product Information [Line Items]    
Net sales 474,171 429,783
Operating Segments [Member] | Product sales at a point in time [Member]    
Product Information [Line Items]    
Net sales 453,112 409,155
Operating Segments [Member] | Services transferred over time [Member]    
Product Information [Line Items]    
Net sales 21,059 20,628
Operating Segments [Member] | Product [Member]    
Product Information [Line Items]    
Net sales 384,065 351,391
Operating Segments [Member] | Metals [Member]    
Product Information [Line Items]    
Net sales 148,286 130,810
Operating Segments [Member] | Metalworking and other [Member]    
Product Information [Line Items]    
Net sales 235,779 220,581
Operating Segments [Member] | Global Specialty Businesses [Member]    
Product Information [Line Items]    
Net sales 90,106 78,392
Operating Segments [Member] | Americas [Member]    
Product Information [Line Items]    
Net sales 211,408 180,127
Operating Segments [Member] | Americas [Member] | Product sales at a point in time [Member]    
Product Information [Line Items]    
Net sales 201,284 171,594
Operating Segments [Member] | Americas [Member] | Services transferred over time [Member]    
Product Information [Line Items]    
Net sales 10,124 8,533
Operating Segments [Member] | Americas [Member] | Product [Member]    
Product Information [Line Items]    
Net sales 154,144 134,871
Operating Segments [Member] | Americas [Member] | Metals [Member]    
Product Information [Line Items]    
Net sales 56,160 46,793
Operating Segments [Member] | Americas [Member] | Metalworking and other [Member]    
Product Information [Line Items]    
Net sales 97,984 88,078
Operating Segments [Member] | Americas [Member] | Global Specialty Businesses [Member]    
Product Information [Line Items]    
Net sales 57,264 45,256
Operating Segments [Member] | EMEA [Member]    
Product Information [Line Items]    
Net sales 145,708 140,086
Operating Segments [Member] | EMEA [Member] | Product sales at a point in time [Member]    
Product Information [Line Items]    
Net sales 137,203 131,162
Operating Segments [Member] | EMEA [Member] | Services transferred over time [Member]    
Product Information [Line Items]    
Net sales 8,505 8,924
Operating Segments [Member] | EMEA [Member] | Product [Member]    
Product Information [Line Items]    
Net sales 125,687 119,814
Operating Segments [Member] | EMEA [Member] | Metals [Member]    
Product Information [Line Items]    
Net sales 36,839 34,274
Operating Segments [Member] | EMEA [Member] | Metalworking and other [Member]    
Product Information [Line Items]    
Net sales 88,848 85,540
Operating Segments [Member] | EMEA [Member] | Global Specialty Businesses [Member]    
Product Information [Line Items]    
Net sales 20,021 20,272
Operating Segments [Member] | Asia Pacific [Member]    
Product Information [Line Items]    
Net sales 117,055 109,570
Operating Segments [Member] | Asia Pacific [Member] | Product sales at a point in time [Member]    
Product Information [Line Items]    
Net sales 114,625 106,399
Operating Segments [Member] | Asia Pacific [Member] | Services transferred over time [Member]    
Product Information [Line Items]    
Net sales 2,430 3,171
Operating Segments [Member] | Asia Pacific [Member] | Product [Member]    
Product Information [Line Items]    
Net sales 104,234 96,706
Operating Segments [Member] | Asia Pacific [Member] | Metals [Member]    
Product Information [Line Items]    
Net sales 55,287 49,743
Operating Segments [Member] | Asia Pacific [Member] | Metalworking and other [Member]    
Product Information [Line Items]    
Net sales 48,947 46,963
Operating Segments [Member] | Asia Pacific [Member] | Global Specialty Businesses [Member]    
Product Information [Line Items]    
Net sales $ 12,821 $ 12,864
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.22.1
Leases - Narrative (Details) - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Lessee, Lease, Description [Line Items]    
Variable Lease Cost $ 0 $ 0
Sublease Income $ 0 $ 0
Land [Member] | Maximum [Member]    
Lessee, Lease, Description [Line Items]    
Lessee Operating Lease Term Of Contract 93 years  
Facilities vehicles and machinery and equipment [Member] | Maximum [Member]    
Lessee, Lease, Description [Line Items]    
Lessee Operating Lease Term Of Contract 10 years  
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.22.1
Leases - Supplemental Information (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Lease cost      
Operating Lease Cost $ 3,409 $ 3,612  
Short Term Lease Cost 219 251  
Supplemental cash flow information related to leases      
Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from operating leases 3,365 3,579  
Leased assets obtained in exchange for new operating lease liabilities 4,689 $ 3,050  
Supplemental balance sheet information      
Right of use lease assets 38,245   $ 36,635
Other current liabilities 10,540   9,976
Long-term lease liabilities 27,433   26,335
Total operating lease liabilities $ 37,973   $ 36,311
Weighted average remaining lease term (years) 5 years 10 months 24 days   5 years 7 months 6 days
Weighted average discount rate 4.14%   4.22%
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.22.1
Leases - Maturities of Operating Lease Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Operating Lease Liabilities Payments Due [Abstract]    
For the remainder of 2022 $ 8,990  
For the year ended December 31, 2023 9,513  
For the year ended December 31, 2024 7,292  
For the year ended December 31, 2025 5,375  
For the year ended December 31, 2026 4,338  
For the year ended December 31, 2027 and beyond 7,046  
Total lease payments 42,554  
Less: imputed interest (4,581)  
Present value of lease liabilities $ 37,973 $ 36,311
XML 60 R50.htm IDEA: XBRL DOCUMENT v3.22.1
Restructuring and Related Activities - Narrative (Details)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
USD ($)
People
Restructuring Cost and Reserve [Abstract]  
Restructuring And Related Cost Description The Company’s management approved a global restructuring plan (the “QH Program”) as part of its plan to realize certain cost synergies associated with the Combination in the third quarter of 2019. The QH Program includes restructuring and associated severance costs to reduce total headcount by approximately 400 people globally, as well as plans for the closure of certain manufacturing and non-manufacturing facilities.
Restructuring And Related Cost Expected Number Of Positions Eliminated | People 400
Restructuring, Cash Payments | $ $ 408
XML 61 R51.htm IDEA: XBRL DOCUMENT v3.22.1
Restructuring and Related Activities (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Restructuring Reserve [Roll Forward]    
Accrued Restructuring, Beginning Balance $ 4,087  
Restructuring and related charges 820 $ 1,175
Cash Payments (408)  
Currency translation adjustments (64)  
Accrued Restructuring, Ending Balance $ 4,435  
XML 62 R52.htm IDEA: XBRL DOCUMENT v3.22.1
Share-Based Compensation - Narrative (Details) - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Share Based Compensation [Line Items]    
Share-based Compensation Expense $ 2,462,000 $ 3,779,000
Risk-free Interest Rate 2.07%  
Expected Term (Years) 4 years  
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross 27,077  
Employee Stock Option [Member]    
Share Based Compensation [Line Items]    
Unrecognized Compensation Expense, Options $ 2,900,000  
Weighted Average Remaining Life, Nonvested Stock Awards 1 year 10 months 24 days  
Restricted Stock LTIP [Member]    
Share Based Compensation [Line Items]    
Nonvested Stock Awards Granted 17,425  
Unrecognized Share-based Compensation Expense, Nonvested Stock Award $ 6,400,000  
Weighted Average Remaining Life, Nonvested Stock Awards 2 years 1 month 6 days  
Restricted Stock Units (RSUs) LTIP Plan [Member]    
Share Based Compensation [Line Items]    
Option Award Vesting Period 3 years  
Nonvested Stock Awards Granted 4,490  
Unrecognized Share-based Compensation Expense, Nonvested Stock Award $ 1,300,000  
Weighted Average Remaining Life, Nonvested Stock Awards 2 years 3 months 18 days  
Combination And Other Acquisition-Related [Member]    
Share Based Compensation [Line Items]    
Share-based Compensation Expense $ 100,000 300,000
Performance Stock Units [Member]    
Share Based Compensation [Line Items]    
Share-based Compensation Expense 623,000 319,000
Unrecognized Compensation Expense, Options $ 6,400,000  
Vesting Shares Target Lower Percent 0.00%  
Vesting Shares Target Upper Percent 200.00%  
Risk-free Interest Rate 2.11%  
Expected Term (Years) 3 years  
Weighted Average Remaining Life, Nonvested Stock Awards 2 years 3 months 18 days  
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross 16,820  
Defined Contribution Plan [Member]    
Share Based Compensation [Line Items]    
Defined Contribution Plan Employer Matching Contribution Percent Of Match 50.00%  
Defined Contribution Plan, Employer Matching Contribution, Percent 6.00%  
Defined contribution plan employer matching contribution percent maximum 3.00%  
Defined Contribution Plan Employer Discretionary Contribution Amount $ 0 $ 1,500,000
Long-term incentive plan LTIP [Member]    
Share Based Compensation [Line Items]    
Option Award Vesting Period 3 years  
XML 63 R53.htm IDEA: XBRL DOCUMENT v3.22.1
Share-Based Compensation - Share-based Compensation Expense (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]    
Total share-based compensation expense $ 2,462 $ 3,779
Stock Options [Member]    
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]    
Total share-based compensation expense 267 308
Non-vested stock awards and restricted stock units [Member]    
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]    
Total share-based compensation expense 1,548 1,396
Non-elective and elective 401(k) matching contribution in stock [Member]    
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]    
Total share-based compensation expense 0 1,553
Director stock ownership plan [Member]    
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]    
Total share-based compensation expense 24 203
Performance Stock Units [Member]    
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]    
Total share-based compensation expense $ 623 $ 319
XML 64 R54.htm IDEA: XBRL DOCUMENT v3.22.1
Share-Based Compensation - Black-Scholes Option Pricing Model (Details)
 3 Months Ended
Mar. 31, 2022
shares
Black-Scholes option pricing model  
Number of options granted 27,077
Dividend Yield 0.80%
Expected Volatility 38.60%
Risk-free Interest Rate 2.07%
Expected Term (Years) 4 years
XML 65 R55.htm IDEA: XBRL DOCUMENT v3.22.1
Share-Based Compensation - Monte Carlo Simulation on Grant Date (Details)
 3 Months Ended
Mar. 31, 2022
shares
Mote Carlo option pricing model  
Number of PSUs granted 27,077
Risk-free Interest Rate 2.07%
Dividend Yield 0.80%
Expected Term (Years) 4 years
Performance Stock Units [Member]  
Mote Carlo option pricing model  
Number of PSUs granted 16,820
Risk-free Interest Rate 2.11%
Dividend Yield 0.93%
Expected Term (Years) 3 years
XML 66 R56.htm IDEA: XBRL DOCUMENT v3.22.1
Pension and Other Postretirement Benefits - Narrative (Details)
$ in Millions
 3 Months Ended
Mar. 31, 2022
USD ($)
Pension Plans, Defined Benefit [Member]  
Defined Benefit Plan Disclosure [Line Items]  
Defined Benefit Plan, Contributions by Employer $ 1.0
Defined Benefit Plan, Estimated Future Employer Contributions in Current Fiscal Year 6.6
Other Postretirement Benefit Plans Defined Benefit [Member]  
Defined Benefit Plan Disclosure [Line Items]  
Defined Benefit Plan, Contributions by Employer 0.1
Defined Benefit Plan, Estimated Future Employer Contributions in Current Fiscal Year $ 0.2
XML 67 R57.htm IDEA: XBRL DOCUMENT v3.22.1
Pension and Other Postretirement Benefits - Net Periodic Benefit Cost (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Pension Benefit [Member]    
Defined Benefit Plan, Net Periodic Benefit Cost [Abstract]    
Service cost $ 180 $ 316
Interest cost 1,360 1,090
Expected return on plan assets (2,084) (2,082)
Actuarial loss (gain) amortization 257 855
Prior service cost (income) amortization 2 2
Total net periodic benefit (income) cost (285) 181
Postretirement Benefits [Member]    
Defined Benefit Plan, Net Periodic Benefit Cost [Abstract]    
Service cost (8) 1
Interest cost 9 11
Expected return on plan assets 0 0
Actuarial loss (gain) amortization (24) 0
Prior service cost (income) amortization 1 0
Total net periodic benefit (income) cost $ (22) $ 12
XML 68 R58.htm IDEA: XBRL DOCUMENT v3.22.1
Other (Expense) Income, Net (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Other (Expense) Income, Net [Abstract]    
Income from third party license fees $ 404 $ 339
Foreign exchange losses, net (1,905) (1,478)
Gain on disposals of property, plant, equipment and other assets, net 23 5,410
Non-income tax refunds and other related (expense) credits (1,322) 97
Pension and postretirement benefit income, non-service components 479 124
Other Operating Income Expense Net 115 195
Total other (expense) income, net (2,206) 4,687
Narrative [Abstract]    
Foreign Currency Transaction Loss Before Tax $ 200 $ 200
XML 69 R59.htm IDEA: XBRL DOCUMENT v3.22.1
Income Taxes and Uncertain Income Tax Positions 2 - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Mar. 31, 2021
Dec. 31, 2021
Dec. 31, 2022
Income Taxes and Uncertain Tax Positions [Abstract]          
Effective Income Tax Rate, Continuing Operations 13.10%   24.20%    
Unrecognized Tax Benefits, Interest on Income Taxes Expense $ 0.3   $ 0.1    
Accrued Interest   $ 3.1   $ 3.1  
Accrued Penalties 1.6 3.1   $ 3.1  
Unrecognized Tax Benefits, Income Tax Penalties Expense 1.6   0.1    
Unrecognized Tax Benefits, Reductions Resulting from Lapse of Applicable Statute of Limitations 2.8   $ 0.3    
Unrecognized Tax Benefits 20.1        
Unrecognized Tax Benefits Tax Penalties Income $ 2.7        
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate 25.00%     15.00%  
Income Tax Examination [Line Items]          
Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Estimated Range of Change, Upper Bound   2.4   $ 2.4  
Income Tax Reconciliation Tax Settlements Foreign $ 0.8        
Forecast [Member]          
Income Tax Examination [Line Items]          
Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Estimated Range of Change, Upper Bound         $ 4.2
Internal Revenue Service (IRS) [Member]          
Income Tax Examination [Line Items]          
Income Tax Examination, Year under Examination 2017        
Foreign Tax Authority [Member]          
Income Tax Examination [Line Items]          
Deferred Tax Liabilities $ 8.0 $ 8.4   $ 8.4  
Foreign Tax Authority [Member] | The Netherlands [Member]          
Income Tax Examination [Line Items]          
Income Tax Examination, Year under Examination 2016        
Foreign Tax Authority [Member] | United Kingdom [Member]          
Income Tax Examination [Line Items]          
Income Tax Examination, Year under Examination 2018        
Foreign Tax Authority [Member] | Brazil [Member]          
Income Tax Examination [Line Items]          
Income Tax Examination, Year under Examination 2011        
Foreign Tax Authority [Member] | Spain [Member]          
Income Tax Examination [Line Items]          
Income Tax Examination, Year under Examination 2017        
Foreign Tax Authority [Member] | China [Member]          
Income Tax Examination [Line Items]          
Income Tax Examination, Year under Examination 2016        
Foreign Tax Authority [Member] | Italy [Member]          
Income Tax Examination [Line Items]          
Income Tax Examination, Year under Examination 2007        
Income Tax Examination Description As previously reported, the Italian tax authorities have assessed additional tax due from the Company’s subsidiary, Quaker Italia S.r.l., relating to the tax years 2007 through 2015. The Company has filed for competent authority relief from these assessments under the Mutual Agreement Procedures (“MAP”) of the Organization for Economic Co-Operation and Development for all years except 2007. In 2020, the respective tax authorities in Italy, Spain and the Netherlands reached agreement with respect to the MAP proceedings which the Company has accepted.        
Tax settlement final amount due to tax authorities $ 2.6        
Foreign Tax Authority [Member] | Italy [Member] | Houghton [Member]          
Income Tax Examination [Line Items]          
Indemnification assets 3.8        
Unrecognized Tax Benefits Period Increase (2.1)        
Tax settlement final amount due to tax authorities 3.7        
Income Tax Reconciliation Tax Settlements Foreign $ 2.1        
Foreign Tax Authority [Member] | Italy [Member] | Houghton [Member] | Maximum [Member]          
Income Tax Examination [Line Items]          
Income Tax Examination, Year under Examination 2018 2015      
Foreign Tax Authority [Member] | Italy [Member] | Houghton [Member] | Minimum [Member]          
Income Tax Examination [Line Items]          
Income Tax Examination, Year under Examination 2014 2014      
Foreign Tax Authority [Member] | Mexico [Member]          
Income Tax Examination [Line Items]          
Income Tax Examination, Year under Examination 2016        
Foreign Tax Authority [Member] | India [Member]          
Income Tax Examination [Line Items]          
Income Tax Examination, Year under Examination 2018        
Foreign Tax Authority [Member] | Canada [Member]          
Income Tax Examination [Line Items]          
Income Tax Examination, Year under Examination 2017        
Foreign Tax Authority [Member] | Germany [Member]          
Income Tax Examination [Line Items]          
Income Tax Examination, Year under Examination 2015        
Foreign Tax Authority [Member] | Germany [Member] | Houghton [Member]          
Income Tax Examination [Line Items]          
Unrecognized Tax Benefits Reserve $ 0.3        
Indemnification assets $ 0.3        
Foreign Tax Authority [Member] | Germany [Member] | Houghton [Member] | Maximum [Member]          
Income Tax Examination [Line Items]          
Income Tax Examination, Year under Examination 2015        
Foreign Tax Authority [Member] | Germany [Member] | Houghton [Member] | Minimum [Member]          
Income Tax Examination [Line Items]          
Income Tax Examination, Year under Examination 2017        
Foreign Tax Authority [Member] | Netherlands and Spain [Member]          
Income Tax Examination [Line Items]          
Income Tax Examination Liability Refund Adjustment from Settlement with Taxing Authority $ 1.6        
State and Local Jurisdiction [Member]          
Income Tax Examination [Line Items]          
Income Tax Examination, Year under Examination 2011        
XML 70 R60.htm IDEA: XBRL DOCUMENT v3.22.1
Earnings Per Share - Earnings per Share Calculations Basic (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Earnings Per Share [Abstract]    
Net income attributable to Quaker Chemical Corporation $ 19,816 $ 38,615
Less: income allocated to participating securities (78) (154)
Net income available to common shareholders $ 19,738 $ 38,461
Basic weighted average common shares outstanding 17,826,061 17,785,370
Basic earnings (loss) per common share $ 1.11 $ 2.16
XML 71 R61.htm IDEA: XBRL DOCUMENT v3.22.1
Earnings Per Share - Earnings per Share Calculations Diluted (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Earnings Per Share [Abstract]    
Net income attributable to Quaker Chemical Corporation $ 19,816 $ 38,615
Less: income allocated to participating securities (78) (154)
Net income available to common shareholders $ 19,738 $ 38,461
Basic weighted average common shares outstanding 17,826,061 17,785,370
Effect of Dilutive Securities 25,798 70,607
Diluted weighted average common shares outstanding 17,851,859 17,855,977
Diluted earnings (loss) per common share $ 1.11 $ 2.15
XML 72 R62.htm IDEA: XBRL DOCUMENT v3.22.1
Earnings Per Share - Earnings per Share Calculations Antidilutive Shares (Details) - shares
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Business Acquisition [Line Items]    
Antidilutive Shares 12,260 2,083
XML 73 R63.htm IDEA: XBRL DOCUMENT v3.22.1
Restricted Cash (Details) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Mar. 31, 2021
Dec. 31, 2020
Restricted Cash Abstract]        
Cash and cash equivalents $ 161,552 $ 165,176    
Cash cash equivalents restricted cash and restricted cash equivalents $ 161,552 $ 165,176 $ 163,455 $ 181,895
XML 74 R64.htm IDEA: XBRL DOCUMENT v3.22.1
Goodwill and Other Intangible Assets - Changes in Carrying Amount of Goodwill (Details)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
USD ($)
Goodwill Roll Forward  
Goodwill, Beginning Balance $ 631,194
Goodwill, Ending Balance 630,938
Operating Segments [Member]  
Goodwill Roll Forward  
Goodwill, Beginning Balance 631,194
Goodwill additions 1,784
Currency translation adjustments (2,040)
Goodwill, Ending Balance 630,938
Operating Segments [Member] | Global Specialty Businesses [Member]  
Goodwill Roll Forward  
Goodwill, Beginning Balance 119,193
Goodwill additions 32
Currency translation adjustments (519)
Goodwill, Ending Balance 118,706
Operating Segments [Member] | Americas [Member]  
Goodwill Roll Forward  
Goodwill, Beginning Balance 214,023
Goodwill additions 1,752
Currency translation adjustments 1,376
Goodwill, Ending Balance 217,151
Operating Segments [Member] | EMEA [Member]  
Goodwill Roll Forward  
Goodwill, Beginning Balance 135,520
Goodwill additions 0
Currency translation adjustments (2,569)
Goodwill, Ending Balance 132,951
Operating Segments [Member] | Asia Pacific [Member]  
Goodwill Roll Forward  
Goodwill, Beginning Balance 162,458
Goodwill additions 0
Currency translation adjustments (328)
Goodwill, Ending Balance $ 162,130
XML 75 R65.htm IDEA: XBRL DOCUMENT v3.22.1
Goodwill and Other Intangible Assets - Gross Carrying Amounts and Accumulated Amortization for Definite-lived Intangible Assets (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Finite Lived Intangible Assets Gross [Abstract]      
Amortization $ 14,600 $ 14,800  
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount 1,024,078   $ 1,023,405
Accumumlated Amortization 206,130   192,505
Customer lists and rights to sell [Member]      
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount 855,309   853,122
Accumumlated Amortization 159,576   147,858
Trademarks Formulations And Product Technology [Member]      
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount 162,408   163,974
Accumumlated Amortization 40,565   38,747
Other Intangible Assets [Member]      
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount 6,361   6,309
Accumumlated Amortization $ 5,989   $ 5,900
XML 76 R66.htm IDEA: XBRL DOCUMENT v3.22.1
Goodwill and Other Intangible Assets - Intangible Assets - Future Amortization (Details)
$ in Thousands
Mar. 31, 2022
USD ($)
Finite-Lived Intangible Assets, Future Amortization Expense [Abstract]  
For the year ended December 31, 2022 $ 59,465
For the Year ended December 31, 2023 59,293
For the Year ended December 31, 2024 58,701
For the Year ended December 31, 2025 57,924
For the Year ended December 31, 2026 57,678
For the Year ended December 31, 2027 and beyond $ 532,124
XML 77 R67.htm IDEA: XBRL DOCUMENT v3.22.1
Goodwill and Other Intangible Assets - Indefinite Lived (Details) - Houghton Combination [Member] - USD ($)
$ in Millions
Mar. 31, 2022
Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]    
Indefinite Lived Trademarks and Tradename $ 193.0 $ 196.9
Indefinite lived intangible assets $ 194.1  
XML 78 R68.htm IDEA: XBRL DOCUMENT v3.22.1
Debt - Table (Details) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Debt Instrument [Line Items]    
Total debt $ 926,899 $ 901,348
Less: debt issuance costs (7,227) (8,001)
Less: short-term and current portion of long-term debts (61,385) (56,935)
Total long-term debt $ 858,287 $ 836,412
Revolver [Member]    
Debt Instrument [Line Items]    
Interest Rate 1.68% 1.62%
Total debt $ 254,453 $ 211,955
U.S. Term Loan [Member]    
Debt Instrument [Line Items]    
Interest Rate 1.71% 1.65%
Total debt $ 528,750 $ 540,000
EURO Term Loan [Member]    
Debt Instrument [Line Items]    
Interest Rate 1.50% 1.50%
Total debt $ 132,037 $ 137,616
Industrial development bonds [Member]    
Debt Instrument [Line Items]    
Interest Rate 5.26% 5.26%
Total debt $ 10,000 $ 10,000
Bank lines of credit and other debt obligations [Member]    
Debt Instrument [Line Items]    
Total debt $ 1,659 $ 1,777
XML 79 R69.htm IDEA: XBRL DOCUMENT v3.22.1
Debt - Narrative (Details)
$ in Millions
 3 Months Ended
Mar. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Mar. 31, 2021
Nov. 30, 2019
USD ($)
Debt Instrument [Line Items]        
Letters Of Credit Outstanding Amount $ 4.0      
Deferred Finance Costs Noncurrent Gross 23.7      
Line of Credit Facility, Remaining Borrowing Capacity $ 300.0      
Line of Credit Facility, Covenant Compliance As of March 31, 2022 and December 31, 2021, the Company was in compliance with all of the Credit Facility covenants      
Line of Credit Facility, Covenant Terms The Company’s initial consolidated net debt to consolidated adjusted EBITDA ratio could not exceed 4.25 to 1, with step downs in the permitted ratio over the term of the Credit Facility. As of March 31, 2021, the consolidated net debt to adjusted EBITDA may not exceed 3.75 to 1. The Company’s consolidated adjusted EBITDA to interest expense ratio cannot be less than 3.0 to 1 over the term of the agreement. The Credit Facility also prohibits the payment of cash dividends if the Company is in default or if the amount of the dividend paid annually exceeds the greater of $50.0 million and 20% of consolidated adjusted EBITDA unless the ratio of consolidated net debt to consolidated adjusted EBITDA is less than 2.0 to 1, in which case there is no such limitation on amount.      
Interest Rate Swap [Member]        
Debt Instrument [Line Items]        
Derivative Liability Notional Amount       $ 170.0
Credit facility [Member]        
Debt Instrument [Line Items]        
Percentage of term loan principal amortization year one and two 5.00%      
Percentage of term loan principal amortization year three 7.50%      
Percentage of term loan principal amortization year four and five 10.00%      
Percentage of term loan borrowings       20.00%
Derivative Liability Notional Amount       $ 170.0
Derivative Fixed Interest Rate 3.10%     3.10%
Derivative, Basis Spread on Variable Rate       1.64%
Debt Instrument, Basis Spread on Variable Rate 1.60%      
Payments of long-term debt $ 14.1      
Initial consolidated net debt to consolidated EBITDA ratio 4.25      
Net debt to consolidated adjusted EBITDA ratio 2.0      
Consolidated adjusted EBITDA to interest expense ratio 3.0      
Maximum annual cash dividends restriction based on covenants $ 50.0      
Percentage of cash dividends of consolidated adjusted EBITDA 20.00%      
Debt, Weighted Average Interest Rate 1.70%      
Debt Instrument, Maturity Date Aug. 01, 2024      
Long Term Debt Term 5 years      
Credit facility [Member] | Maximum [Member]        
Debt Instrument [Line Items]        
Net debt to consolidated adjusted EBITDA ratio     3.75  
U.S. Term Loan [Member]        
Debt Instrument [Line Items]        
Debt Issuance Costs, Current, Net $ 7.2 $ 8.0    
Deferred Finance Costs Noncurrent Gross 15.5      
Line of Credit Facility, Current Borrowing Capacity 600.0      
EURO Term Loan [Member]        
Debt Instrument [Line Items]        
Line of Credit Facility, Current Borrowing Capacity 150.0      
The Revolver [Member]        
Debt Instrument [Line Items]        
Debt Instrument, Unused Borrowing Capacity, Amount 142.0      
Deferred Finance Costs Noncurrent Gross 8.3      
Line of Credit Facility, Current Borrowing Capacity $ 400.0      
The Revolver [Member] | Maximum [Member]        
Debt Instrument [Line Items]        
Line of Credit Facility, Commitment Fee Percentage 0.30%      
The Revolver [Member] | Minimum [Member]        
Debt Instrument [Line Items]        
Line of Credit Facility, Commitment Fee Percentage 0.20%      
Industrial Development Bond Due 2028 [Member]        
Debt Instrument [Line Items]        
Debt Instrument Maturity Date Description 2028      
Industrial Development Revenue Bond $ 10.0 10.0    
Bank lines of credit and other debt obligations [Member]        
Debt Instrument [Line Items]        
Letters Of Credit Outstanding Amount 6.0      
Debt Issuance Costs, Current, Net 3.9 $ 4.3    
Line of Credit Facility, Remaining Borrowing Capacity $ 30.0      
XML 80 R70.htm IDEA: XBRL DOCUMENT v3.22.1
Debt - Debt related expenses included within Interest expense (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Debt related expenses included within Interest expense:    
Interest expense $ 4,746 $ 4,650
Amortization of debt issuance costs 1,187 1,187
Total $ 5,933 $ 5,837
XML 81 R71.htm IDEA: XBRL DOCUMENT v3.22.1
Accumulated Other Comprehensive Income - Changes in Equity (Parentheticals) (Details) - $ / shares
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Consolidated Statement Of Changes In Equity Parentheticals [Abstract]    
Dividends declared $ 0.415 $ 0.395
XML 82 R72.htm IDEA: XBRL DOCUMENT v3.22.1
Accumulated Other Comprehensive Income - AOCI Reclassifications (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Beginning Balance $ (63,990) $ (26,598)
Other Comprehensive (Loss) Income, before reclassifications (6,283) (24,693)
Amounts reclassified from AOCI 240 (2,223)
Related tax amounts (228) 286
Ending Balance (70,261) (53,228)
Currency Translation Adjustments [Member]    
Beginning Balance (49,843) (2,875)
Other Comprehensive (Loss) Income, before reclassifications (6,867) (25,459)
Amounts reclassified from AOCI 0 0
Related tax amounts 0 0
Ending Balance (56,710) (28,334)
Defined Benefit Pension Plans [Member]    
Beginning Balance (13,172) (23,467)
Other Comprehensive (Loss) Income, before reclassifications 432 781
Amounts reclassified from AOCI 229 862
Related tax amounts (165) (351)
Ending Balance (12,676) (22,175)
Unrealized Gain (Loss) in Available-for-Sale Securities [Member]    
Beginning Balance 397 3,342
Other Comprehensive (Loss) Income, before reclassifications 1,429 (745)
Amounts reclassified from AOCI 11 (3,085)
Related tax amounts 266 805
Ending Balance (603) 317
Derivative Instruments    
Beginning Balance (1,372) (3,598)
Other Comprehensive (Loss) Income, before reclassifications 1,429 730
Amounts reclassified from AOCI 0 0
Related tax amounts (329) (168)
Ending Balance $ (272) $ (3,036)
XML 83 R73.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Measurements - Assets Subject to Fair Value Measurement (Details) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Company Owned Life Insurance $ 2,395 $ 2,533
Assets Fair Value Disclosure 2,395 2,533
Level 1 [Member]    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Company Owned Life Insurance 0 0
Assets Fair Value Disclosure 0 0
Level 2 [Member]    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Company Owned Life Insurance 2,395 2,533
Assets Fair Value Disclosure 2,395 2,533
Level 3 [Member]    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Company Owned Life Insurance 0 0
Assets Fair Value Disclosure $ 0 $ 0
XML 84 R74.htm IDEA: XBRL DOCUMENT v3.22.1
Hedging Activities - Narrative (Details)
$ in Millions
Nov. 30, 2019
USD ($)
Interest Rate Swap [Member]  
Derivatives, Fair Value [Line Items]  
Derivative Liability Notional Amount $ 170
XML 85 R75.htm IDEA: XBRL DOCUMENT v3.22.1
Hedging Activities - Balance Sheet Classification and Fair Values (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Derivative Instruments Gain Loss [Line Items]      
Amount and location of expense reclassified from AOCI into expense (effective portion) $ 272   $ 1,372
Interest Expense [Member]      
Derivative Instruments Gain Loss [Line Items]      
Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net (637) $ (643)  
Interest Rate Swap [Member]      
Derivative Instruments Gain Loss [Line Items]      
Amount and location of expense reclassified from AOCI into expense (effective portion) 272   1,372
Interest Rate Cash Flow Hedge Liability At Fair Value 353   1,782
Interest Rate Swap [Member] | Other accrued liabilities [Member]      
Derivative Instruments Gain Loss [Line Items]      
Interest Rate Cash Flow Hedge Liability At Fair Value $ 353   $ 1,782
XML 86 R76.htm IDEA: XBRL DOCUMENT v3.22.1
Commitments and Contingencies - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Loss Contingencies [Line Items]    
Loss Contingency Accrual At Carrying Value $ 0.4  
ACP [Member] | Maximum [Member]    
Loss Contingencies [Line Items]    
Loss Contingency, Estimate of Possible Loss 1.0  
ACP [Member] | Minimum [Member]    
Loss Contingencies [Line Items]    
Loss Contingency, Estimate of Possible Loss 0.1  
SB Decking [Member]    
Loss Contingencies [Line Items]    
Loss Contingency Accrual At Carrying Value $ 0.3  
Period Of Projected Claims Of Subusidiary 50 years  
Houghton environmental matters [Member]    
Loss Contingencies [Line Items]    
Loss Contingency Accrual At Carrying Value $ 5.9 $ 5.6
Period Of Projected Claims Of Subusidiary 27 years  
Houghton environmental matters [Member] | Maximum [Member]    
Loss Contingencies [Line Items]    
Loss Contingency, Estimate of Possible Loss $ 6.0  
Houghton environmental matters [Member] | Minimum [Member]    
Loss Contingencies [Line Items]    
Loss Contingency, Estimate of Possible Loss 5.0  
Insurance claim [Member]    
Loss Contingencies [Line Items]    
Gain (Loss) Related To Litigation Settlement 2.1  
Proceeds from Insurance Settlement, Operating Activities 0.5  
Insurance Settlements Receivable $ 2.0  
XML 87 kwr-20220331_htm.xml IDEA: XBRL DOCUMENT 0000081362 2022-01-01 2022-03-31 0000081362 us-gaap:RestrictedStockMember 2022-03-31 0000081362 us-gaap:RestrictedStockUnitsRSUMember 2022-03-31 0000081362 us-gaap:RestrictedStockMember 2022-01-01 2022-03-31 0000081362 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-03-31 0000081362 2021-01-01 2021-03-31 0000081362 kwr:StockOptionsCompensationExpenseMember 2022-01-01 2022-03-31 0000081362 kwr:StockOptionsCompensationExpenseMember 2021-01-01 2021-03-31 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2022-01-01 2022-03-31 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2021-01-01 2021-03-31 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2022-01-01 2022-03-31 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2021-01-01 2021-03-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-03-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-01-01 2021-03-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2022-01-01 2022-03-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2022-01-01 2022-03-31 0000081362 2022-03-31 0000081362 2021-12-31 0000081362 us-gaap:EmployeeStockOptionMember 2022-03-31 0000081362 us-gaap:CommonStockMember 2020-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000081362 us-gaap:RetainedEarningsMember 2020-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000081362 us-gaap:NoncontrollingInterestMember 2020-12-31 0000081362 us-gaap:OtherIntangibleAssetsMember 2021-12-31 0000081362 2021-03-31 0000081362 us-gaap:IntersegmentEliminationMember us-gaap:EMEAMember 2021-01-01 2021-03-31 0000081362 us-gaap:IntersegmentEliminationMember srt:AsiaPacificMember 2021-01-01 2021-03-31 0000081362 us-gaap:IntersegmentEliminationMember us-gaap:EMEAMember 2022-01-01 2022-03-31 0000081362 us-gaap:IntersegmentEliminationMember srt:AsiaPacificMember 2022-01-01 2022-03-31 0000081362 us-gaap:InterestRateSwapMember 2019-11-30 0000081362 us-gaap:InterestExpenseMember 2021-01-01 2021-03-31 0000081362 us-gaap:InterestExpenseMember 2022-01-01 2022-03-31 0000081362 srt:AmericasMember 2022-01-01 2022-03-31 0000081362 us-gaap:EMEAMember 2022-01-01 2022-03-31 0000081362 srt:AsiaPacificMember 2022-01-01 2022-03-31 0000081362 srt:AmericasMember 2021-01-01 2021-03-31 0000081362 us-gaap:EMEAMember 2021-01-01 2021-03-31 0000081362 srt:AsiaPacificMember 2021-01-01 2021-03-31 0000081362 us-gaap:IntersegmentEliminationMember srt:AmericasMember 2021-01-01 2021-03-31 0000081362 us-gaap:IntersegmentEliminationMember srt:AmericasMember 2022-01-01 2022-03-31 0000081362 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-03-31 0000081362 2022-04-30 0000081362 2020-12-31 0000081362 us-gaap:OtherIntangibleAssetsMember 2022-03-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2022-03-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2022-03-31 0000081362 kwr:MatchingStockContribution401KPlanCompensationExpenseMember 2021-01-01 2021-03-31 0000081362 kwr:MatchingStockContribution401KPlanCompensationExpenseMember 2022-01-01 2022-03-31 0000081362 2021-01-01 2021-12-31 0000081362 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateSwapMember 2021-12-31 0000081362 us-gaap:InterestRateSwapMember 2021-12-31 0000081362 us-gaap:FairValueInputsLevel1Member 2022-03-31 0000081362 us-gaap:FairValueInputsLevel2Member 2022-03-31 0000081362 us-gaap:FairValueInputsLevel3Member 2022-03-31 0000081362 us-gaap:FairValueInputsLevel1Member 2021-12-31 0000081362 us-gaap:FairValueInputsLevel2Member 2021-12-31 0000081362 us-gaap:FairValueInputsLevel3Member 2021-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2022-03-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-03-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-03-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2021-12-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2022-01-01 2022-03-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-01-01 2022-03-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-01-01 2022-03-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2021-03-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-03-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-03-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-03-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-01-01 2021-03-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-01-01 2021-03-31 0000081362 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0000081362 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0000081362 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0000081362 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-03-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0000081362 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0000081362 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-03-31 0000081362 us-gaap:RevolvingCreditFacilityMember 2022-03-31 0000081362 us-gaap:DomesticLineOfCreditMember 2022-03-31 0000081362 us-gaap:ForeignLineOfCreditMember 2022-03-31 0000081362 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember 2022-01-01 2022-03-31 0000081362 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember 2022-01-01 2022-03-31 0000081362 us-gaap:DomesticLineOfCreditMember 2021-12-31 0000081362 kwr:BankLinesOfCreditAndOtherDebtObligationsMember 2021-12-31 0000081362 kwr:BankLinesOfCreditAndOtherDebtObligationsMember 2022-03-31 0000081362 us-gaap:CorporateBondSecuritiesMember 2022-01-01 2022-03-31 0000081362 country:IT us-gaap:ForeignCountryMember 2022-01-01 2022-03-31 0000081362 country:BR us-gaap:ForeignCountryMember 2022-01-01 2022-03-31 0000081362 country:NL us-gaap:ForeignCountryMember 2022-01-01 2022-03-31 0000081362 country:CN us-gaap:ForeignCountryMember 2022-01-01 2022-03-31 0000081362 country:ES us-gaap:ForeignCountryMember 2022-01-01 2022-03-31 0000081362 us-gaap:StateAndLocalJurisdictionMember 2022-01-01 2022-03-31 0000081362 country:IN us-gaap:ForeignCountryMember 2022-01-01 2022-03-31 0000081362 srt:MinimumMember kwr:AcpMember 2022-03-31 0000081362 srt:MaximumMember kwr:AcpMember 2022-03-31 0000081362 kwr:SbDeckingMember 2022-03-31 0000081362 srt:MinimumMember kwr:HoughtonEnvironmentalMattersMember 2022-03-31 0000081362 srt:MaximumMember kwr:HoughtonEnvironmentalMattersMember 2022-03-31 0000081362 kwr:HoughtonEnvironmentalMattersMember 2022-03-31 0000081362 kwr:HoughtonEnvironmentalMattersMember 2021-12-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember srt:AmericasMember 2022-01-01 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember us-gaap:EMEAMember 2022-01-01 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember srt:AsiaPacificMember 2022-01-01 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2022-01-01 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AmericasMember 2022-01-01 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember us-gaap:EMEAMember 2022-01-01 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AsiaPacificMember 2022-01-01 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember 2022-01-01 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:ProductMember srt:AmericasMember 2022-01-01 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:ProductMember us-gaap:EMEAMember 2022-01-01 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:ProductMember srt:AsiaPacificMember 2022-01-01 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:ProductMember 2022-01-01 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember kwr:GlobalSpecialtyBusinessesMember 2022-01-01 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember kwr:GlobalSpecialtyBusinessesMember 2022-01-01 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember kwr:GlobalSpecialtyBusinessesMember 2022-01-01 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2022-01-01 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember 2022-01-01 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2022-01-01 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2022-01-01 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember 2022-01-01 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember us-gaap:TransferredAtPointInTimeMember 2022-01-01 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember us-gaap:TransferredAtPointInTimeMember 2022-01-01 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember 2022-01-01 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember us-gaap:TransferredOverTimeMember 2022-01-01 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember us-gaap:TransferredOverTimeMember 2022-01-01 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember us-gaap:TransferredOverTimeMember 2022-01-01 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:TransferredAtPointInTimeMember 2022-01-01 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:TransferredOverTimeMember 2022-01-01 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AmericasMember 2021-01-01 2021-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember us-gaap:EMEAMember 2021-01-01 2021-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AsiaPacificMember 2021-01-01 2021-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember srt:AmericasMember 2021-01-01 2021-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember us-gaap:EMEAMember 2021-01-01 2021-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember srt:AsiaPacificMember 2021-01-01 2021-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember 2021-01-01 2021-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2021-01-01 2021-03-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:ProductMember srt:AmericasMember 2021-01-01 2021-03-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:ProductMember us-gaap:EMEAMember 2021-01-01 2021-03-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:ProductMember srt:AsiaPacificMember 2021-01-01 2021-03-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:ProductMember 2021-01-01 2021-03-31 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-03-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-03-31 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-03-31 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember 2021-01-01 2021-03-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2021-01-01 2021-03-31 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2021-01-01 2021-03-31 0000081362 us-gaap:OperatingSegmentsMember 2021-01-01 2021-03-31 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-03-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-03-31 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-03-31 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-03-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-03-31 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-03-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-03-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-03-31 0000081362 us-gaap:IntersegmentEliminationMember kwr:GlobalSpecialtyBusinessesMember 2022-01-01 2022-03-31 0000081362 us-gaap:IntersegmentEliminationMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-03-31 0000081362 us-gaap:PerformanceSharesMember 2022-01-01 2022-03-31 0000081362 us-gaap:PerformanceSharesMember 2021-01-01 2021-03-31 0000081362 kwr:CombinationAndOtherAcquisitionRelatedMember 2022-01-01 2022-03-31 0000081362 kwr:CombinationAndOtherAcquisitionRelatedMember 2021-01-01 2021-03-31 0000081362 srt:SubsidiariesMember country:AR 2022-01-01 2022-03-31 0000081362 us-gaap:CorporateBondSecuritiesMember 2022-03-31 0000081362 us-gaap:CorporateBondSecuritiesMember 2021-12-31 0000081362 us-gaap:LineOfCreditMember 2019-11-30 0000081362 us-gaap:LineOfCreditMember 2022-03-31 0000081362 us-gaap:LineOfCreditMember 2022-01-01 2022-03-31 0000081362 srt:MaximumMember us-gaap:LineOfCreditMember 2021-03-31 0000081362 us-gaap:LineOfCreditMember 2021-12-31 0000081362 us-gaap:ForeignLineOfCreditMember 2021-12-31 0000081362 kwr:IndustrialDevelopmentBondsMember 2022-03-31 0000081362 kwr:IndustrialDevelopmentBondsMember 2021-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember 2021-12-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2021-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2021-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember 2021-12-31 0000081362 us-gaap:OperatingSegmentsMember 2022-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2021-12-31 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2022-03-31 0000081362 us-gaap:InterestRateSwapMember 2022-01-01 2022-03-31 0000081362 us-gaap:InterestRateSwapMember 2021-01-01 2021-12-31 0000081362 country:DE kwr:HoughtonMember us-gaap:ForeignCountryMember 2022-03-31 0000081362 country:IT us-gaap:ForeignCountryMember 2022-03-31 0000081362 kwr:TrademarksFormulationsandproducttechnologymemberMember 2022-03-31 0000081362 kwr:TrademarksFormulationsandproducttechnologymemberMember 2021-12-31 0000081362 kwr:TopFiveMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-03-31 0000081362 kwr:LargestCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-03-31 0000081362 us-gaap:CommonStockMember 2021-03-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0000081362 us-gaap:RetainedEarningsMember 2021-03-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0000081362 us-gaap:NoncontrollingInterestMember 2021-03-31 0000081362 us-gaap:CommonStockMember 2021-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000081362 us-gaap:RetainedEarningsMember 2021-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000081362 us-gaap:NoncontrollingInterestMember 2021-12-31 0000081362 us-gaap:CommonStockMember 2022-03-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0000081362 us-gaap:RetainedEarningsMember 2022-03-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0000081362 us-gaap:NoncontrollingInterestMember 2022-03-31 0000081362 srt:SubsidiariesMember country:AR 2021-01-01 2021-03-31 0000081362 kwr:AssetsRelatedToSealingAndImpregnationOfMetalCastingsMember 2022-01-01 2022-01-31 0000081362 kwr:AssetsRelatedToPicklingInhibitorTechnologiesMember 2022-01-01 2022-01-31 0000081362 kwr:AssetsRelatedToPicklingInhibitorTechnologiesMember us-gaap:PatentedTechnologyMember 2022-01-31 0000081362 kwr:AssetsRelatedToPicklingInhibitorTechnologiesMember us-gaap:CustomerRelationshipsMember 2022-01-01 2022-01-31 0000081362 kwr:AssetsRelatedToPicklingInhibitorTechnologiesMember us-gaap:PatentedTechnologyMember 2022-01-01 2022-01-31 0000081362 kwr:BaronIndustriesMember 2021-11-01 2021-11-30 0000081362 kwr:BaronIndustriesMember 2021-11-30 0000081362 kwr:BaronIndustriesMember us-gaap:CustomerRelationshipsMember 2021-11-30 0000081362 kwr:BaronIndustriesMember us-gaap:PatentedTechnologyMember 2021-11-30 0000081362 kwr:BaronIndustriesMember us-gaap:CustomerRelationshipsMember 2021-11-01 2021-11-30 0000081362 kwr:BaronIndustriesMember us-gaap:PatentedTechnologyMember 2021-11-01 2021-11-30 0000081362 kwr:AssetsRelatedToHydraulicFluidsCoolantsCleanersAndRustPreventativeOilsMember 2021-11-01 2021-11-30 0000081362 kwr:GrindaixGmbhMember 2021-09-01 2021-09-30 0000081362 kwr:GrindaixGmbhMember 2021-09-30 0000081362 kwr:AssetsForChemicalMaskantsMember 2021-06-01 2021-06-30 0000081362 kwr:TinplatingsolutionsMember 2021-02-01 2021-02-28 0000081362 kwr:TinplatingsolutionsMember 2021-02-28 0000081362 kwr:TinplatingsolutionsMember us-gaap:CustomerRelationshipsMember 2021-02-28 0000081362 kwr:TinplatingsolutionsMember us-gaap:PatentedTechnologyMember 2021-02-28 0000081362 kwr:TinplatingsolutionsMember us-gaap:TrademarksMember 2021-02-28 0000081362 kwr:TinplatingsolutionsMember us-gaap:CustomerRelationshipsMember 2021-02-01 2021-02-28 0000081362 kwr:TinplatingsolutionsMember us-gaap:TrademarksMember 2021-02-01 2021-02-28 0000081362 kwr:TinplatingsolutionsMember us-gaap:PatentedTechnologyMember 2021-02-01 2021-02-28 0000081362 srt:MaximumMember kwr:FacilitiesVehiclesAndMachineryAndEquipmentMember 2022-03-31 0000081362 srt:MaximumMember us-gaap:LandMember 2022-03-31 0000081362 us-gaap:PerformanceSharesMember 2022-03-31 0000081362 kwr:DefinedContributionPlanMember 2022-01-01 2022-03-31 0000081362 kwr:DefinedContributionPlanMember 2021-01-01 2021-03-31 0000081362 us-gaap:ForeignCountryMember 2021-12-31 0000081362 us-gaap:ForeignCountryMember 2022-03-31 0000081362 kwr:SbDeckingMember 2022-01-01 2022-03-31 0000081362 kwr:HoughtonEnvironmentalMattersMember 2022-01-01 2022-03-31 0000081362 us-gaap:InsuranceClaimsMember 2022-03-31 0000081362 us-gaap:InsuranceClaimsMember 2022-01-01 2022-03-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-12-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2022-01-01 2022-03-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2022-03-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-12-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-01-01 2021-03-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-03-31 0000081362 country:DE us-gaap:ForeignCountryMember 2022-01-01 2022-03-31 0000081362 country:MX us-gaap:ForeignCountryMember 2022-01-01 2022-03-31 0000081362 country:CA us-gaap:ForeignCountryMember 2022-01-01 2022-03-31 0000081362 us-gaap:InternalRevenueServiceIRSMember 2022-01-01 2022-03-31 0000081362 country:GB us-gaap:ForeignCountryMember 2022-01-01 2022-03-31 0000081362 srt:MaximumMember country:IT kwr:HoughtonMember us-gaap:ForeignCountryMember 2022-01-01 2022-03-31 0000081362 srt:MinimumMember country:IT kwr:HoughtonMember us-gaap:ForeignCountryMember 2022-01-01 2022-03-31 0000081362 srt:MaximumMember country:IT kwr:HoughtonMember us-gaap:ForeignCountryMember 2021-10-01 2021-12-31 0000081362 srt:MinimumMember country:IT kwr:HoughtonMember us-gaap:ForeignCountryMember 2021-10-01 2021-12-31 0000081362 country:IT kwr:HoughtonMember us-gaap:ForeignCountryMember 2022-03-31 0000081362 country:IT kwr:HoughtonMember us-gaap:ForeignCountryMember 2022-01-01 2022-03-31 0000081362 kwr:GrindaixGmbhMember 2021-02-01 2021-02-28 0000081362 srt:MinimumMember kwr:CoralChemicalCompanyMember kwr:TaxAttributesOfTheAcquisitionMember 2022-03-31 0000081362 srt:MaximumMember kwr:CoralChemicalCompanyMember kwr:TaxAttributesOfTheAcquisitionMember 2022-03-31 0000081362 kwr:HoughtonCombinationMember 2022-03-31 0000081362 kwr:HoughtonCombinationMember 2021-12-31 0000081362 kwr:NetherlandsAndSpainMember us-gaap:ForeignCountryMember 2022-03-31 0000081362 srt:MaximumMember country:DE kwr:HoughtonMember us-gaap:ForeignCountryMember 2022-01-01 2022-03-31 0000081362 srt:MinimumMember country:DE kwr:HoughtonMember us-gaap:ForeignCountryMember 2022-01-01 2022-03-31 0000081362 us-gaap:CustomerListsMember 2022-03-31 0000081362 us-gaap:CustomerListsMember 2021-12-31 0000081362 srt:SubsidiariesMember country:AR us-gaap:AssetsTotalMember us-gaap:GeographicConcentrationRiskMember 2022-01-01 2022-03-31 0000081362 srt:SubsidiariesMember country:AR us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2022-01-01 2022-03-31 0000081362 srt:ScenarioForecastMember 2022-12-31 0000081362 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateSwapMember 2022-03-31 0000081362 us-gaap:InterestRateSwapMember 2022-03-31 0000081362 kwr:LongTermIncentivePlanLtipMember 2022-01-01 2022-03-31 0000081362 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2022-01-31 0000081362 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:CustomerRelationshipsMember 2022-01-31 iso4217:EUR iso4217:USD pure shares iso4217:USD shares dummy:People false 2022 --12-31 30000000 Q1 0000081362 PA 1 30000000 17911583 17897033 2024-08-01 false 10-Q true 2022-03-31 false 001-12019 QUAKER CHEMICAL CORPORATION 23-0993790 901 E. Hector Street Conshohocken PA 19428 – 2380 610 832-4000 Common Stock, $1 par value KWR NYSE Yes Yes Large Accelerated Filer false false 17912086 474171000 429783000 328100000 273589000 146071000 156194000 111795000 104310000 820000 1175000 4053000 5815000 29403000 44894000 -2206000 4687000 -5345000 -5470000 21852000 44111000 2866000 10689000 18986000 33422000 835000 5210000 19821000 38632000 5000 17000 19816000 38615000 1.11 2.16 1.11 2.15 0.415 0.395 19821000 38632000 -6866000 -25461000 496000 1292000 1100000 562000 -1000000 -3025000 -6270000 -26632000 13551000 12000000 6000 15000 13545000 11985000 161552000 165176000 458459000 430676000 146289000 129382000 153506000 135149000 67853000 59871000 987659000 920254000 439318000 434344000 242203000 236824000 197115000 197520000 38245000 36635000 630938000 631194000 1012068000 1027782000 90003000 95278000 11496000 16138000 29198000 30959000 2996722000 2955760000 61385000 56935000 253906000 226656000 7433000 7427000 26396000 38197000 4435000 4087000 1549000 1548000 97445000 95617000 452549000 430467000 858287000 836412000 27433000 26335000 170622000 179025000 44667000 45984000 47464000 49615000 1601022000 1567838000 1 17911583 17897033 17912000 17897000 918699000 917053000 528716000 516334000 -70261000 -63990000 1395066000 1387294000 634000 628000 1395700000 1387922000 2996722000 2955760000 19821000 38632000 1187000 1187000 20447000 22145000 -2135000 5105000 0 801000 -3778000 -9888000 2462000 3779000 23000 5410000 -4246000 -2884000 820000 1175000 -1316000 -1034000 26270000 46270000 33873000 24994000 6506000 8315000 -408000 -3034000 23249000 26597000 -6299000 -12618000 8847000 3934000 9383000 26655000 0 14744000 -18230000 -15845000 14112000 9551000 43000000 30000000 -102000 -188000 7428000 7052000 -801000 -178000 20557000 13031000 348000 -3008000 -3624000 -18440000 165176000 181895000 161552000 163455000 17851000 905171000 423940000 -26598000 550000 1320914000 0 0 38615000 0 17000 38632000 0 0 0 -26630000 -2000 -26632000 0.395 0 0 7062000 0 0 7062000 24000 3577000 0 0 0 3601000 17875000 908748000 455493000 -53228000 565000 1329453000 17897000 917053000 516334000 -63990000 628000 1387922000 0 0 19816000 0 5000 19821000 0 0 0 -6271000 1000 -6270000 0.415 0 0 7434000 0 0 7434000 15000 1646000 0 0 0 1661000 17912000 918699000 528716000 -70261000 634000 1395700000 <div id="TextBlockContainer8" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:732px;height:539px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a2579" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 1 – Basis of Presentation and Description of Business<div style="display:inline-block;width:5px"> </div></div><div id="div_2_XBRL_TS_84e0054e89654e269d0603ff9702e4d1" style="position:absolute;left:0px;top:23px;float:left;"><div id="TextBlockContainer3" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:732px;height:223px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a2589" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:0px;">Basis of Presentation </div><div id="a2592" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">As used in these Notes to Condensed Consolidated Financial Statements, the<div style="display:inline-block;width:5px"> </div>terms “Quaker,” “Quaker Houghton,” the </div><div id="a2600" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">“Company,” “we,” and “our” refer to Quaker Chemical Corporation<div style="display:inline-block;width:5px"> </div>(doing business as Quaker Houghton), its subsidiaries, and </div><div id="a2606" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:54px;">associated companies, unless the context otherwise requires.<div style="display:inline-block;width:8px"> </div>As used in these Notes to Condensed Consolidated Financial Statements, </div><div id="a2611" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">the term Legacy Quaker refers to the Company prior to the closing of its combination<div style="display:inline-block;width:5px"> </div>with Houghton International, Inc. (“Houghton”) </div><div id="a2613" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">(herein referred to as the “Combination”).<div style="display:inline-block;width:11px"> </div>The condensed consolidated financial statements included herein are unaudited and<div style="display:inline-block;width:5px"> </div>have </div><div id="a2618" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">been prepared in accordance with generally accepted accounting principles<div style="display:inline-block;width:5px"> </div>in the United States (“U.S. GAAP”) for interim financial </div><div id="a2620" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:115px;">reporting and the United States Securities and Exchange Commission (“SEC”)<div style="display:inline-block;width:5px"> </div>regulations.<div style="display:inline-block;width:7px"> </div>Certain information and footnote </div><div id="a2624" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:131px;">disclosures normally included in financial statements prepared in accordance<div style="display:inline-block;width:5px"> </div>with U.S. GAAP have been condensed or omitted </div><div id="a2625" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:146px;">pursuant to such rules and regulations.<div style="display:inline-block;width:8px"> </div>In the opinion of management, the financial statements reflect all adjustments<div style="display:inline-block;width:5px"> </div>consisting only </div><div id="a2628" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:161px;">of normal recurring adjustments, which are necessary for a fair statement of<div style="display:inline-block;width:5px"> </div>the financial position, results of operations and cash flows </div><div id="a2633" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:177px;">for the interim periods.<div style="display:inline-block;width:7px"> </div>The results for the three months ended March 31, 2022 are not necessarily indicative<div style="display:inline-block;width:5px"> </div>of the results to be </div><div id="a2636" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:192px;">expected for the full year.<div style="display:inline-block;width:8px"> </div>These financial statements should be read in conjunction with the Company’s<div style="display:inline-block;width:5px"> </div>Annual Report filed on Form </div><div id="a2638" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:207px;">10-K for the year ended December 31, 2021 (the “2021 Form 10-K”).</div></div></div><div id="a2638_65_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:377px;top:231px;"><div style="display:inline-block;width:7px"> </div></div><div id="div_4_XBRL_TS_99b9766cc36b4659b8cf046502fd1f94" style="position:absolute;left:0px;top:254px;float:left;"><div id="TextBlockContainer5" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:722px;height:147px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a2655" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:0px;">Description of Business </div><div id="a2659" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">The Company was organized in 1918, incorporated as a Pennsylvania<div style="display:inline-block;width:5px"> </div>business corporation in 1930, and in August 2019 </div><div id="a2660" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">completed the Combination with Houghton to form Quaker Houghton.<div style="display:inline-block;width:8px"> </div>Quaker Houghton is the global leader in industrial process </div><div id="a2666" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:54px;">fluids.<div style="display:inline-block;width:7px"> </div>With a presence around the world, including<div style="display:inline-block;width:5px"> </div>operations in over </div><div id="a2666_72_2" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:385px;top:54px;">25</div><div id="a2666_74_57" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:399px;top:54px;"><div style="display:inline-block;width:3px"> </div>countries, the Company’s customers<div style="display:inline-block;width:5px"> </div>include thousands of </div><div id="a2668" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">the world’s most advanced and specialized<div style="display:inline-block;width:5px"> </div>steel, aluminum, automotive, aerospace, offshore, can,<div style="display:inline-block;width:5px"> </div>mining, and metalworking </div><div id="a2670" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">companies.<div style="display:inline-block;width:7px"> </div>Quaker Houghton develops, produces, and markets a broad range of formulated chemical<div style="display:inline-block;width:5px"> </div>specialty products and offers </div><div id="a2673" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">chemical management services (which the Company refers to as “Fluidcare</div><div id="a2681" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;font-weight:normal;font-style:normal;color:#000000;left:407px;top:100px;">TM</div><div id="a2682" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:420px;top:100px;">”) for various heavy industrial and manufacturing </div><div id="a2683" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:115px;">applications throughout its </div><div id="a2683_28_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:150px;top:115px;">four</div><div id="a2683_32_97" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:172px;top:115px;"><div style="display:inline-block;width:3px"> </div>segments: Americas; Europe, Middle East and Africa (“EMEA”); Asia/Pacific; and<div style="display:inline-block;width:5px"> </div>Global Specialty </div><div id="a2685" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:131px;">Businesses.</div></div></div><div id="div_6_XBRL_TS_98ad6fd6a9d542c3b9c3730aaa4b59bd" style="position:absolute;left:0px;top:408px;float:left;"><div id="TextBlockContainer7" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:731px;height:132px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a2688" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:0px;">Hyper-inflationary economies</div><div id="a2692" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">Based on various indices or index compilations being used to monitor inflation<div style="display:inline-block;width:5px"> </div>in Argentina as well as economic instability, </div><div id="a2693" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">effective July 1, 2018, Argentina’s<div style="display:inline-block;width:5px"> </div>economy was considered hyper-inflationary under U.S. GAAP.<div style="display:inline-block;width:9px"> </div>As of, and for the three months </div><div id="a2699" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:54px;">ended March 31, 2022, the Company's Argentine subsidiaries represented<div style="display:inline-block;width:5px"> </div>less than </div><div id="a2699_81_1" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:451px;top:54px;">1</div><div id="a2699_82_49" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:458px;top:54px;">% of the Company’s consolidated<div style="display:inline-block;width:5px"> </div>total assets and </div><div id="a2710" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">net sales, respectively.<div style="display:inline-block;width:8px"> </div>During each of the three months ended March 31, 2022 and 2021, the Company<div style="display:inline-block;width:5px"> </div>recorded $</div><div id="a2710_111_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:69px;">0.2</div><div id="a2710_114_12" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:634px;top:69px;"><div style="display:inline-block;width:3px"> </div>million of </div><div id="a2725" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">remeasurement losses associated with the applicable currency conversions<div style="display:inline-block;width:5px"> </div>related to Argentina.<div style="display:inline-block;width:7px"> </div>These losses were recorded within </div><div id="a2729" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">foreign exchange losses, net, which is a component of other (expense) income, net,<div style="display:inline-block;width:5px"> </div>in the Company’s Condensed Consolidated </div><div id="a2734" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:115px;">Statements of Income.</div></div></div></div> <div id="TextBlockContainer3" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:732px;height:223px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a2589" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:0px;">Basis of Presentation </div><div id="a2592" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">As used in these Notes to Condensed Consolidated Financial Statements, the<div style="display:inline-block;width:5px"> </div>terms “Quaker,” “Quaker Houghton,” the </div><div id="a2600" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">“Company,” “we,” and “our” refer to Quaker Chemical Corporation<div style="display:inline-block;width:5px"> </div>(doing business as Quaker Houghton), its subsidiaries, and </div><div id="a2606" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:54px;">associated companies, unless the context otherwise requires.<div style="display:inline-block;width:8px"> </div>As used in these Notes to Condensed Consolidated Financial Statements, </div><div id="a2611" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">the term Legacy Quaker refers to the Company prior to the closing of its combination<div style="display:inline-block;width:5px"> </div>with Houghton International, Inc. (“Houghton”) </div><div id="a2613" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">(herein referred to as the “Combination”).<div style="display:inline-block;width:11px"> </div>The condensed consolidated financial statements included herein are unaudited and<div style="display:inline-block;width:5px"> </div>have </div><div id="a2618" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">been prepared in accordance with generally accepted accounting principles<div style="display:inline-block;width:5px"> </div>in the United States (“U.S. GAAP”) for interim financial </div><div id="a2620" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:115px;">reporting and the United States Securities and Exchange Commission (“SEC”)<div style="display:inline-block;width:5px"> </div>regulations.<div style="display:inline-block;width:7px"> </div>Certain information and footnote </div><div id="a2624" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:131px;">disclosures normally included in financial statements prepared in accordance<div style="display:inline-block;width:5px"> </div>with U.S. GAAP have been condensed or omitted </div><div id="a2625" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:146px;">pursuant to such rules and regulations.<div style="display:inline-block;width:8px"> </div>In the opinion of management, the financial statements reflect all adjustments<div style="display:inline-block;width:5px"> </div>consisting only </div><div id="a2628" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:161px;">of normal recurring adjustments, which are necessary for a fair statement of<div style="display:inline-block;width:5px"> </div>the financial position, results of operations and cash flows </div><div id="a2633" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:177px;">for the interim periods.<div style="display:inline-block;width:7px"> </div>The results for the three months ended March 31, 2022 are not necessarily indicative<div style="display:inline-block;width:5px"> </div>of the results to be </div><div id="a2636" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:192px;">expected for the full year.<div style="display:inline-block;width:8px"> </div>These financial statements should be read in conjunction with the Company’s<div style="display:inline-block;width:5px"> </div>Annual Report filed on Form </div><div id="a2638" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:207px;">10-K for the year ended December 31, 2021 (the “2021 Form 10-K”).</div></div> <div id="TextBlockContainer5" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:722px;height:147px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a2655" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:0px;">Description of Business </div><div id="a2659" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">The Company was organized in 1918, incorporated as a Pennsylvania<div style="display:inline-block;width:5px"> </div>business corporation in 1930, and in August 2019 </div><div id="a2660" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">completed the Combination with Houghton to form Quaker Houghton.<div style="display:inline-block;width:8px"> </div>Quaker Houghton is the global leader in industrial process </div><div id="a2666" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:54px;">fluids.<div style="display:inline-block;width:7px"> </div>With a presence around the world, including<div style="display:inline-block;width:5px"> </div>operations in over </div><div id="a2666_72_2" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:385px;top:54px;">25</div><div id="a2666_74_57" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:399px;top:54px;"><div style="display:inline-block;width:3px"> </div>countries, the Company’s customers<div style="display:inline-block;width:5px"> </div>include thousands of </div><div id="a2668" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">the world’s most advanced and specialized<div style="display:inline-block;width:5px"> </div>steel, aluminum, automotive, aerospace, offshore, can,<div style="display:inline-block;width:5px"> </div>mining, and metalworking </div><div id="a2670" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">companies.<div style="display:inline-block;width:7px"> </div>Quaker Houghton develops, produces, and markets a broad range of formulated chemical<div style="display:inline-block;width:5px"> </div>specialty products and offers </div><div id="a2673" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">chemical management services (which the Company refers to as “Fluidcare</div><div id="a2681" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;font-weight:normal;font-style:normal;color:#000000;left:407px;top:100px;">TM</div><div id="a2682" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:420px;top:100px;">”) for various heavy industrial and manufacturing </div><div id="a2683" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:115px;">applications throughout its </div><div id="a2683_28_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:150px;top:115px;">four</div><div id="a2683_32_97" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:172px;top:115px;"><div style="display:inline-block;width:3px"> </div>segments: Americas; Europe, Middle East and Africa (“EMEA”); Asia/Pacific; and<div style="display:inline-block;width:5px"> </div>Global Specialty </div><div id="a2685" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:131px;">Businesses.</div></div> 25 4 <div id="TextBlockContainer7" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:731px;height:132px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a2688" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:0px;">Hyper-inflationary economies</div><div id="a2692" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">Based on various indices or index compilations being used to monitor inflation<div style="display:inline-block;width:5px"> </div>in Argentina as well as economic instability, </div><div id="a2693" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">effective July 1, 2018, Argentina’s<div style="display:inline-block;width:5px"> </div>economy was considered hyper-inflationary under U.S. GAAP.<div style="display:inline-block;width:9px"> </div>As of, and for the three months </div><div id="a2699" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:54px;">ended March 31, 2022, the Company's Argentine subsidiaries represented<div style="display:inline-block;width:5px"> </div>less than </div><div id="a2699_81_1" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:451px;top:54px;">1</div><div id="a2699_82_49" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:458px;top:54px;">% of the Company’s consolidated<div style="display:inline-block;width:5px"> </div>total assets and </div><div id="a2710" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">net sales, respectively.<div style="display:inline-block;width:8px"> </div>During each of the three months ended March 31, 2022 and 2021, the Company<div style="display:inline-block;width:5px"> </div>recorded $</div><div id="a2710_111_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:69px;">0.2</div><div id="a2710_114_12" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:634px;top:69px;"><div style="display:inline-block;width:3px"> </div>million of </div><div id="a2725" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">remeasurement losses associated with the applicable currency conversions<div style="display:inline-block;width:5px"> </div>related to Argentina.<div style="display:inline-block;width:7px"> </div>These losses were recorded within </div><div id="a2729" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">foreign exchange losses, net, which is a component of other (expense) income, net,<div style="display:inline-block;width:5px"> </div>in the Company’s Condensed Consolidated </div><div id="a2734" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:115px;">Statements of Income.</div></div> 0.01 0.01 200000 200000 <div id="TextBlockContainer10" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:733px;height:255px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a2735" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 2 – Business Acquisitions </div><div id="a2740" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:23px;">2022 Acquisitions </div><div id="a2745" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:47px;"><div style="display:inline-block;width:24px"> </div>In January 2022, the Company acquired a business that provides pickling<div style="display:inline-block;width:5px"> </div>inhibitor technologies for the steel industry,<div style="display:inline-block;width:5px"> </div>drawing </div><div id="a2749" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:62px;">lubricants and stamping oil for metalworking, and various other lubrication,<div style="display:inline-block;width:5px"> </div>rust preventative, and cleaner applications, for its </div><div id="a2751" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:77px;">Americas reportable segment for approximately $</div><div id="a2751_47_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:270px;top:77px;">8.0</div><div id="a2751_50_77" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:287px;top:77px;"><div style="display:inline-block;width:3px"> </div>million.<div style="display:inline-block;width:7px"> </div>This business broadens the Company’s<div style="display:inline-block;width:5px"> </div>product offerings within its </div><div id="a2753" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:93px;">existing metals and metalworking business in the Americas region.<div style="display:inline-block;width:8px"> </div>The Company allocated $</div><div id="a2753_90_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:506px;top:93px;">5.6</div><div id="a2753_93_34" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:523px;top:93px;"><div style="display:inline-block;width:3px"> </div>million of the purchase price to </div><div id="a2761" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:108px;">intangible assets, comprised of $</div><div id="a2761_33_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:179px;top:108px;">5.1</div><div id="a2761_36_56" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:196px;top:108px;"><div style="display:inline-block;width:3px"> </div>million of customer relationships to be amortized over </div><div id="a2761_92_2" style="position:absolute;font-family:'Times New Roman';left:492px;top:108px;">14</div><div id="a2761_94_13" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:506px;top:108px;"><div style="display:inline-block;width:3px"> </div>years; and $</div><div id="a2761_107_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:573px;top:108px;">0.5</div><div id="a2761_110_21" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:590px;top:108px;"><div style="display:inline-block;width:3px"> </div>million of existing </div><div id="a2775" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:123px;">product technologies to be amortized over </div><div id="a2775_42_2" style="position:absolute;font-family:'Times New Roman';left:233px;top:123px;">14</div><div id="a2775_44_44" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:246px;top:123px;"><div style="display:inline-block;width:3px"> </div>years.<div style="display:inline-block;width:7px"> </div>In addition, the Company recorded $</div><div id="a2775_88_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:484px;top:123px;">1.8</div><div id="a2775_91_41" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:500px;top:123px;"><div style="display:inline-block;width:3px"> </div>million of goodwill related to expected </div><div id="a2786" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:139px;">value not allocated to other acquired assets, all of which is expected to be tax deductible<div style="display:inline-block;width:5px"> </div>in various jurisdictions<div style="display:inline-block;width:4px"> </div>in which the </div><div id="a2790" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:154px;">Company operates. </div><div id="a2793" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:177px;"><div style="display:inline-block;width:24px"> </div>In January 2022, the Company acquired a business related to the sealing and impregnation<div style="display:inline-block;width:5px"> </div>of metal castings for the automotive </div><div id="a2796" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:193px;">sector, as well as impregnation resin and<div style="display:inline-block;width:5px"> </div>impregnation systems for metal parts, for its Global Specialty Business reportable segment </div><div id="a2801" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:208px;">for approximately </div><div id="a2801_18_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:104px;top:208px;">1.2</div><div id="a2801_21_31" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:120px;top:208px;"><div style="display:inline-block;width:3px"> </div>million EUR or approximately $</div><div id="a2801_52_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:297px;top:208px;">1.4</div><div id="a2801_55_70" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:314px;top:208px;"><div style="display:inline-block;width:3px"> </div>million.<div style="display:inline-block;width:7px"> </div>This business expands the Company's geographic presence in </div><div id="a2803" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:223px;">Germany as well as broadens its product offerings and<div style="display:inline-block;width:5px"> </div>service capabilities within its existing impregnation business acquired<div style="display:inline-block;width:5px"> </div>as part of </div><div id="a2807" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:239px;">the Norman Hay acquisition in 2019.</div></div><div id="TextBlockContainer12" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:732px;height:709px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a2831_1_132" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">The results of operations of the 2022 acquired assets and businesses subsequent<div style="display:inline-block;width:5px"> </div>to the respective acquisition dates are included in </div><div id="a2834" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">the unaudited Condensed Consolidated Statements of Income for the quarter ended<div style="display:inline-block;width:5px"> </div>March 31, 2022.<div style="display:inline-block;width:7px"> </div>Applicable transaction expenses </div><div id="a2836" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">associated with these acquisitions are included in Combination,<div style="display:inline-block;width:5px"> </div>integration and other acquisition-related expenses in the Company’s </div><div id="a2840" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">unaudited Condensed Consolidated Statements of Income.<div style="display:inline-block;width:8px"> </div>Certain pro forma and other information is not presented, as the operations </div><div id="a2842" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:61px;">of the acquired assets and businesses are not considered material to the overall operations<div style="display:inline-block;width:5px"> </div>of the Company for the periods presented. </div><div id="a2845" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:85px;">Previous Acquisitions </div><div id="a2849" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:108px;"><div style="display:inline-block;width:24px"> </div>In November 2021, the Company acquired Baron Industries (“Baron”),<div style="display:inline-block;width:5px"> </div>a privately held Company that provides vacuum </div><div id="a2851" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:123px;">impregnation services of castings, powder metals and electrical components<div style="display:inline-block;width:5px"> </div>for its Global Specialty Businesses reportable segment for </div><div id="a2853" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:139px;">$</div><div id="a2853_1_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:11px;top:139px;">11.0</div><div id="a2853_5_48" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:35px;top:139px;"><div style="display:inline-block;width:3px"> </div>million, including an initial cash payment of $</div><div id="a2853_53_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:285px;top:139px;">7.1</div><div id="a2853_56_74" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:301px;top:139px;"><div style="display:inline-block;width:3px"> </div>million, subject to post-closing adjustments as well as certain earn-out </div><div id="a2858" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:154px;">provisions initially estimated at $</div><div id="a2858_35_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:182px;top:154px;">3.9</div><div id="a2858_38_94" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:199px;top:154px;"><div style="display:inline-block;width:3px"> </div>million that are payable at different times from 2022 through<div style="display:inline-block;width:5px"> </div>2025.<div style="display:inline-block;width:7px"> </div>The earn-out provisions </div><div id="a2862" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:169px;">could total a maximum of $</div><div id="a2862_26_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:152px;top:169px;">4.5</div><div id="a2862_29_34" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:169px;top:169px;"><div style="display:inline-block;width:3px"> </div>million.<div style="display:inline-block;width:7px"> </div>The Company allocated $</div><div id="a2862_63_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:169px;">8.0</div><div id="a2862_66_54" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:375px;top:169px;"><div style="display:inline-block;width:3px"> </div>million of the purchase price to intangible assets, $</div><div id="a2862_120_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:650px;top:169px;">1.1</div><div id="a2862_123_12" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:667px;top:169px;"><div style="display:inline-block;width:3px"> </div>million of </div><div id="a2864" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:185px;">property, plant and<div style="display:inline-block;width:5px"> </div>equipment and $</div><div id="a2864_35_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:198px;top:185px;">1.5</div><div id="a2864_38_78" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:215px;top:185px;"><div style="display:inline-block;width:3px"> </div>million of other assets acquired net of liabilities assumed, which includes $</div><div id="a2864_116_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:185px;">0.3</div><div id="a2864_119_17" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:635px;top:185px;"><div style="display:inline-block;width:3px"> </div>million of cash </div><div id="a2866" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:200px;">acquired.<div style="display:inline-block;width:7px"> </div>In addition, the Company recorded $</div><div id="a2866_46_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:257px;top:200px;">0.4</div><div id="a2866_49_88" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:273px;top:200px;"><div style="display:inline-block;width:3px"> </div>million of goodwill, all of which is expected to be tax deductible.<div style="display:inline-block;width:8px"> </div>Intangible assets </div><div id="a2868" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:215px;">comprised $</div><div id="a2868_11_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:70px;top:215px;">7.2</div><div id="a2868_14_56" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:87px;top:215px;"><div style="display:inline-block;width:3px"> </div>million of customer relationships to be amortized over </div><div id="a2868_70_8" style="position:absolute;font-family:'Times New Roman';left:383px;top:215px;">15 years</div><div id="a2868_78_7" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:428px;top:215px;">; and $</div><div id="a2868_85_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:464px;top:215px;">0.8</div><div id="a2868_88_46" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:481px;top:215px;"><div style="display:inline-block;width:3px"> </div>million of existing product technology to be </div><div id="a2870" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:231px;">amortized over </div><div id="a2870_15_8" style="position:absolute;font-family:'Times New Roman';left:88px;top:231px;">13 years</div><div id="a2870_23_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:133px;top:231px;">.<div style="display:inline-block;width:10px"> </div></div><div id="a2872" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:254px;"><div style="display:inline-block;width:24px"> </div>In November 2021, the Company acquired a business that provides<div style="display:inline-block;width:5px"> </div>hydraulic fluids, coolants, cleaners, and rust preventative oils </div><div id="a2875" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:269px;">in Turkey for its EMEA reportable segment for </div><div id="a2875_46_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:260px;top:269px;">3.2</div><div id="a2875_49_31" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:277px;top:269px;"><div style="display:inline-block;width:3px"> </div>million EUR or approximately $</div><div id="a2875_80_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:269px;">3.7</div><div id="a2875_83_10" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:470px;top:269px;"><div style="display:inline-block;width:3px"> </div>million. </div><div id="a2877" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:293px;"><div style="display:inline-block;width:24px"> </div>In September 2021, the Company acquired the remaining interest in Grindaix<div style="display:inline-block;width:1px"> </div>-GmbH (“Grindaix”), a Germany-based, high-tech </div><div id="a2886" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:308px;">provider of coolant control and delivery systems for its Global Specialty Businesses reportable<div style="display:inline-block;width:5px"> </div>segment for </div><div id="a2886_108_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:580px;top:308px;">2.4</div><div id="a2886_111_16" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:596px;top:308px;"><div style="display:inline-block;width:3px"> </div>million EUR or </div><div id="a2888" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:323px;">approximately $</div><div id="a2888_15_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:92px;top:323px;">2.9</div><div id="a2888_18_43" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:108px;top:323px;"><div style="display:inline-block;width:3px"> </div>million, which is gross of approximately $</div><div id="a2888_61_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:338px;top:323px;">0.3</div><div id="a2888_64_62" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:355px;top:323px;"><div style="display:inline-block;width:3px"> </div>million of cash acquired.<div style="display:inline-block;width:7px"> </div>Previously, in February<div style="display:inline-block;width:5px"> </div>2021, the </div><div id="a2890" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:339px;">Company acquired a </div><div id="a2890_19_2" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:118px;top:339px;">38</div><div id="a2890_21_37" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:132px;top:339px;">% ownership interest in Grindaix for </div><div id="a2890_58_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:331px;top:339px;">1.4</div><div id="a2890_61_31" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:347px;top:339px;"><div style="display:inline-block;width:3px"> </div>million EUR or approximately $</div><div id="a2890_92_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:524px;top:339px;">1.7</div><div id="a2890_95_32" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:339px;"><div style="display:inline-block;width:3px"> </div>million.<div style="display:inline-block;width:7px"> </div>The Company recorded </div><div id="a2892" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:354px;">its initial investment as an equity method investment within the Consolidated Financial<div style="display:inline-block;width:5px"> </div>Statements and accounted for the purchase of </div><div id="a2894" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:369px;">the remaining interest as a step acquisition whereby the Company remeasured<div style="display:inline-block;width:5px"> </div>the previously held equity method investment to its fair </div><div id="a2896" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:385px;">value. </div><div id="a2898" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:408px;"><div style="display:inline-block;width:24px"> </div>In June 2021, the Company acquired certain assets for its chemical milling maskants<div style="display:inline-block;width:5px"> </div>product line in the Global Specialty </div><div id="a2900" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:423px;">Businesses reportable segment for </div><div id="a2900_34_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:191px;top:423px;">2.3</div><div id="a2900_37_31" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:207px;top:423px;"><div style="display:inline-block;width:3px"> </div>million EUR or approximately $</div><div id="a2900_68_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:384px;top:423px;">2.8</div><div id="a2900_71_10" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:400px;top:423px;"><div style="display:inline-block;width:3px"> </div>million. </div><div id="a2903" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:447px;"><div style="display:inline-block;width:24px"> </div>In February 2021, the Company acquired a tin-plating solutions business for<div style="display:inline-block;width:5px"> </div>the steel end market for $</div><div id="a2903_103_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:575px;top:447px;">25.0</div><div id="a2903_107_16" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:598px;top:447px;"><div style="display:inline-block;width:3px"> </div>million.<div style="display:inline-block;width:7px"> </div>This </div><div id="a2907" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:462px;">acquisition is part of each of the Company’s<div style="display:inline-block;width:5px"> </div>geographic reportable segments.<div style="display:inline-block;width:7px"> </div>The Company allocated $</div><div id="a2907_101_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:561px;top:462px;">19.6</div><div id="a2907_105_25" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:584px;top:462px;"><div style="display:inline-block;width:3px"> </div>million of the purchase </div><div id="a2909" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:477px;">price to intangible assets, comprised of $</div><div id="a2909_42_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:223px;top:477px;">18.3</div><div id="a2909_46_57" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:246px;top:477px;"><div style="display:inline-block;width:3px"> </div>million of customer relationships, to be amortized over </div><div id="a2909_103_8" style="position:absolute;font-family:'Times New Roman';left:546px;top:477px;">19 years</div><div id="a2909_111_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:591px;top:477px;">; $</div><div id="a2909_114_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:604px;top:477px;">0.9</div><div id="a2909_117_21" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:621px;top:477px;"><div style="display:inline-block;width:3px"> </div>million of existing </div><div id="a2912" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:493px;">product technology to be amortized over </div><div id="a2912_40_8" style="position:absolute;font-family:'Times New Roman';left:224px;top:493px;">14 years</div><div id="a2912_48_7" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:269px;top:493px;">; and $</div><div id="a2912_55_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:306px;top:493px;">0.4</div><div id="a2912_58_54" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:322px;top:493px;"><div style="display:inline-block;width:3px"> </div>million of a licensed trademark to be amortized over </div><div id="a2912_112_7" style="position:absolute;font-family:'Times New Roman';left:609px;top:493px;">3 years</div><div id="a2912_119_16" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:647px;top:493px;">.<div style="display:inline-block;width:7px"> </div>In addition, </div><div id="a2914" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:508px;">the Company recorded $</div><div id="a2914_22_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:136px;top:508px;">5.0</div><div id="a2914_25_105" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:153px;top:508px;"><div style="display:inline-block;width:3px"> </div>million of goodwill, all of which is expected to be tax deductible in various jurisdictions in which<div style="display:inline-block;width:5px"> </div>we </div><div id="a2916" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:523px;">operate.<div style="display:inline-block;width:7px"> </div>Factors contributing to the purchase price that resulted in goodwill included the<div style="display:inline-block;width:5px"> </div>acquisition of business processes and </div><div id="a2918" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:539px;">personnel that will allow Quaker Houghton to better serve its customers. </div><div id="a2920" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:562px;"><div style="display:inline-block;width:24px"> </div>As of March 31, 2022, the allocation of the purchase price of these acquisitions have<div style="display:inline-block;width:5px"> </div>not been finalized and the one-year </div><div id="a2924" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:577px;">measurement period has not ended, with the exception of the tin-plating<div style="display:inline-block;width:5px"> </div>solutions business acquired in February 2021, the </div><div id="a2927" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:593px;">measurement period for which ended in February 2022.<div style="display:inline-block;width:8px"> </div>Further adjustments may be necessary as a result of the Company’s<div style="display:inline-block;width:5px"> </div>on-going </div><div id="a2931" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:608px;">assessment of additional information related to the fair value of assets acquired<div style="display:inline-block;width:5px"> </div>and liabilities assumed. </div><div id="a2933" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:631px;"><div style="display:inline-block;width:24px"> </div>In December 2020, the Company acquired Coral Chemical Corporation (“Coral”),<div style="display:inline-block;width:5px"> </div>a privately held U.S.-based provider of metal </div><div id="a2939" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:647px;">finishing fluid solutions.<div style="display:inline-block;width:7px"> </div>Subsequent to the acquisition, the Company and the sellers of Coral (the “Sellers”) have<div style="display:inline-block;width:5px"> </div>worked to finalize </div><div id="a2941" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:662px;">certain post-closing adjustments.<div style="display:inline-block;width:7px"> </div>In April 2022, after failing to reach resolution, the Sellers filed suit asserting certain<div style="display:inline-block;width:5px"> </div>amounts owed </div><div id="a2947" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:677px;">related to tax attributes of the acquisition.<div style="display:inline-block;width:8px"> </div>Based on the facts and circumstances of the claim asserted by the Sellers, the Company </div><div id="a2950" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:693px;">believes the potential range of exposure for this claim is $</div><div id="a2950_60_1" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:313px;top:693px;">0</div><div id="a2950_61_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:693px;"><div style="display:inline-block;width:3px"> </div>to $</div><div id="a2950_66_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:344px;top:693px;">1.5</div><div id="a2950_69_9" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:360px;top:693px;"><div style="display:inline-block;width:3px"> </div>million.</div></div> 8000000.0 5600000 5100000 P14Y 500000 P14Y 1800000 1200000 1400000 11000000.0 7100000 3900000 4500000 8000000.0 1100000 1500000 300000 400000 7200000 P15Y 800000 P13Y 3200000 3700000 2400000 2900000 300000 0.38 1400000 1700000 2300000 2800000 25000000.0 19600000 18300000 P19Y 900000 P14Y 400000 P3Y 5000000.0 0 1500000 <div id="TextBlockContainer14" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:726px;height:140px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a2957" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 3 – Recently Issued Accounting Standards </div><div id="a2963" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:24px;">Recently Issued Accounting Standards<div style="display:inline-block;width:5px"> </div>Adopted </div><div id="a2973" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:48px;">The FASB issued ASU 2020<div style="display:inline-block;width:2px"> </div>-04</div><div id="a2984" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:200px;top:48px;">, Reference Rate Reform (Topic<div style="display:inline-block;width:6px"> </div>848): Facilitation of the Effects of Reference Rate Reform<div style="display:inline-block;width:5px"> </div>on </div><div id="a3015" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:63px;">Financial Reporting</div><div id="a3018" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:113px;top:63px;"><div style="display:inline-block;width:3px"> </div>in March 2020.<div style="display:inline-block;width:7px"> </div>The FASB subsequently<div style="display:inline-block;width:5px"> </div>issued ASU 2021-01</div><div id="a3038" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:450px;top:63px;">, Reference Rate Reform (Topic<div style="display:inline-block;width:5px"> </div>848): Scope</div><div id="a3052" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:686px;top:63px;"><div style="display:inline-block;width:3px"> </div>in </div><div id="a3055" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:78px;">January 2021 which clarified the guidance but did not materially change<div style="display:inline-block;width:5px"> </div>the guidance or its applicability to the Company.<div style="display:inline-block;width:8px"> </div>The </div><div id="a3095" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:94px;">amendments provide temporary optional expedients and exceptions<div style="display:inline-block;width:5px"> </div>for applying U.S. GAAP to contract modifications, hedging </div><div id="a3125" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:109px;">relationships and other transactions to ease the potential accounting<div style="display:inline-block;width:5px"> </div>and financial reporting burden associated with transitioning away </div><div id="a3159" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:124px;">from reference rates that are expected to be discontinued, including<div style="display:inline-block;width:5px"> </div>the London Interbank Offered Rate (“LIBOR”).<div style="display:inline-block;width:8px"> </div>ASU 2020-04 is </div></div><div id="TextBlockContainer16" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:728px;height:77px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a3217" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:0px;">effective for the Company as of March 12, 2020 and generally can<div style="display:inline-block;width:5px"> </div>be applied through December 31, 2022.<div style="display:inline-block;width:7px"> </div>On December 10, 2021, </div><div id="a3254" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">the Company entered into a Second Amendment to Credit Agreement (“Second<div style="display:inline-block;width:5px"> </div>Amendment”) with Bank of America N.A., an update </div><div id="a3255" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">to provide for the use of a non-USD currency LIBOR successor rate.<div style="display:inline-block;width:8px"> </div>The Company elected to apply the expedients provided in ASU </div><div id="a3259" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">2020-04 with respect to the Second Amendment.<div style="display:inline-block;width:8px"> </div>The Company will continue to monitor for potential impacts related to its USD-</div><div id="a3263" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:61px;">based LIBOR rates.<div style="display:inline-block;width:7px"> </div>See Note 14 of Notes to Condensed Consolidated Financial Statements.</div></div> <div id="TextBlockContainer20" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:729px;height:216px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a3284" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 4 – Business Segments </div><div id="div_18_XBRL_TS_aa1b1d9910814d62a65c85f86da78658" style="position:absolute;left:0px;top:23px;float:left;"><div id="TextBlockContainer19" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:708px;height:47px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a3289" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">The Company’s operating<div style="display:inline-block;width:5px"> </div>segments, which are consistent with its reportable segments, reflect the structure of the<div style="display:inline-block;width:5px"> </div>Company’s </div><div id="a3291" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">internal organization, the method by which the Company’s<div style="display:inline-block;width:5px"> </div>resources are allocated and the manner by which the chief operating </div><div id="a3292" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">decision maker assesses the Company’s<div style="display:inline-block;width:5px"> </div>performance.</div></div></div><div id="a3292_50_18" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:54px;"><div style="display:inline-block;width:7px"> </div>The Company has </div><div id="a3292_68_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:398px;top:54px;">four</div><div id="a3292_72_53" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:420px;top:54px;"><div style="display:inline-block;width:3px"> </div>reportable segments: (i) Americas; (ii) EMEA; (iii) </div><div id="a3294" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">Asia/Pacific; and (iv) Global Specialty Businesses.<div style="display:inline-block;width:8px"> </div>The three geographic segments are composed of the net sales and operations in </div><div id="a3296" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">each respective region, excluding net sales and operations managed globally<div style="display:inline-block;width:5px"> </div>by the Global Specialty Businesses segment, which </div><div id="a3298" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">includes the Company’s container,<div style="display:inline-block;width:5px"> </div>metal finishing,<div style="display:inline-block;width:4px"> </div>mining, offshore, specialty coatings, specialty grease and Norman<div style="display:inline-block;width:5px"> </div>Hay businesses. </div><div id="a3303" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:123px;">Segment operating earnings for each of the Company’s<div style="display:inline-block;width:5px"> </div>reportable segments are comprised of the segment’s<div style="display:inline-block;width:5px"> </div>net sales less directly </div><div id="a3311" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:139px;">related cost of goods sold (“COGS”) and selling, general and administrative<div style="display:inline-block;width:5px"> </div>expenses (“SG&amp;A”).<div style="display:inline-block;width:7px"> </div>Operating expenses not directly </div><div id="a3320" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:154px;">attributable to the net sales of each respective segment,<div style="display:inline-block;width:4px"> </div>such as certain corporate and administrative costs, Combination, integration </div><div id="a3327" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:169px;">and other acquisition-related expenses, and Restructuring and related<div style="display:inline-block;width:5px"> </div>charges,<div style="display:inline-block;width:4px"> </div>are not included in segment operating earnings.<div style="display:inline-block;width:7px"> </div>Other </div><div id="a3336" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:185px;">items not specifically identified with the Company’s<div style="display:inline-block;width:5px"> </div>reportable segments include interest expense, net and other (expense) income, </div><div id="a3338" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:200px;">net.</div></div><div id="TextBlockContainer22" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:711px;height:31px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a3340" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">The following table presents information about the performance of the Company’s<div style="display:inline-block;width:6px"> </div>reportable operating segments for the three </div><div id="a3342" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">months ended March 31, 2022 and 2021:</div></div><div id="TextBlockContainer26" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:673px;height:440px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_24_XBRL_CS_ff764c7c9c2843e0849dafb07fab15c2" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer25" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:673px;height:440px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a3351" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:506px;top:0px;">Three Months Ended </div><div id="a3357" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:537px;top:18px;">March 31,<div style="display:inline-block;width:4px"> </div></div><div id="a3363" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:504px;top:36px;">2022 </div><div id="a3366" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:603px;top:36px;">2021 </div><div id="a3370" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:53px;">Net sales </div><div id="a3372" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:53px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3374" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:486px;top:53px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3376" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:53px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3378" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:53px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3380" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:53px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3382" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:661px;top:53px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3386" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:70px;">Americas </div><div id="a3388" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:70px;">$ </div><div id="a3390" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:512px;top:70px;">154,144</div><div id="a3393" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:70px;">$ </div><div id="a3395" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:611px;top:70px;">134,871</div><div id="a3400" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:88px;">EMEA </div><div id="a3402" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:88px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3404" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:512px;top:88px;">125,687</div><div id="a3407" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:88px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3409" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:611px;top:88px;">119,814</div><div id="a3414" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:106px;">Asia/Pacific </div><div id="a3416" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:106px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3418" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:512px;top:106px;">104,234</div><div id="a3421" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:106px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3423" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:106px;">96,706</div><div id="a3428" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:123px;">Global Specialty Businesses </div><div id="a3430" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:123px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3432" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:519px;top:123px;">90,106</div><div id="a3435" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:123px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3437" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:123px;">78,392</div><div id="a3441" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:141px;">Total<div style="display:inline-block;width:5px"> </div>net sales </div><div id="a3443" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:141px;">$ </div><div id="a3445" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:512px;top:141px;">474,171</div><div id="a3448" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:141px;">$ </div><div id="a3450" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:611px;top:141px;">429,783</div><div id="a3463" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:176px;">Segment operating earnings </div><div id="a3473" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:194px;">Americas </div><div id="a3475" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:194px;">$ </div><div id="a3477" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:519px;top:194px;">29,220</div><div id="a3480" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:194px;">$ </div><div id="a3482" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:194px;">32,234</div><div id="a3487" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:211px;">EMEA </div><div id="a3490" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:519px;top:211px;">16,766</div><div id="a3494" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:211px;">25,244</div><div id="a3499" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:229px;">Asia/Pacific </div><div id="a3502" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:519px;top:229px;">21,907</div><div id="a3506" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:229px;">27,478</div><div id="a3511" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:246px;">Global Specialty Businesses </div><div id="a3513" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:246px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3515" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:519px;top:246px;">25,035</div><div id="a3518" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:246px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3520" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:246px;">24,169</div><div id="a3524" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:264px;">Total<div style="display:inline-block;width:5px"> </div>segment operating earnings </div><div id="a3526" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:264px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3528" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:519px;top:264px;">92,928</div><div id="a3531" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:264px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3533" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:611px;top:264px;">109,125</div><div id="a3537" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:282px;">Combination, integration and other acquisition-related expenses </div><div id="a3542" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:521px;top:282px;display:flex;">(4,053)</div><div id="a3546" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:620px;top:282px;display:flex;">(5,815)</div><div id="a3550" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:299px;">Restructuring and related charges </div><div id="a3553" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:531px;top:299px;display:flex;">(820)</div><div id="a3557" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:620px;top:299px;display:flex;">(1,175)</div><div id="a3561" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:317px;">Fair value step up of acquired inventory sold </div><div id="a3564" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:542px;top:317px;">—</div><div id="a3568" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:630px;top:317px;display:flex;">(801)</div><div id="a3572" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:334px;">Non-operating and administrative expenses </div><div id="a3576" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:334px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3578" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:514px;top:334px;display:flex;">(43,463)</div><div id="a3581" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:334px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3583" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:613px;top:334px;display:flex;">(40,992)</div><div id="a3587" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:352px;">Depreciation of corporate assets and amortization </div><div id="a3589" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:352px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3591" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:514px;top:352px;display:flex;">(15,189)</div><div id="a3594" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:352px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3596" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:613px;top:352px;display:flex;">(15,448)</div><div id="a3600" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:370px;">Operating income </div><div id="a3603" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:519px;top:370px;">29,403</div><div id="a3607" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:370px;">44,894</div><div id="a3611" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:387px;">Other (expense) income, net </div><div id="a3614" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:521px;top:387px;display:flex;">(2,206)</div><div id="a3618" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:387px;">4,687</div><div id="a3622" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:405px;">Interest expense, net </div><div id="a3624" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:405px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3626" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:521px;top:405px;display:flex;">(5,345)</div><div id="a3629" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:405px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3631" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:620px;top:405px;display:flex;">(5,470)</div><div id="a3635" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:424px;">Income before taxes and equity in net income of associated companies </div><div id="a3637" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:424px;">$ </div><div id="a3639" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:519px;top:424px;">21,852</div><div id="a3642" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:424px;">$ </div><div id="a3644" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:424px;">44,111</div></div></div></div><div id="TextBlockContainer28" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:721px;height:62px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a3647" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">Inter-segment revenues for the three months ended March 31,<div style="display:inline-block;width:5px"> </div>2022 and 2021 were $</div><div id="a3647_80_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:480px;top:0px;">2.9</div><div id="a3647_83_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:496px;top:0px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a3647_97_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:571px;top:0px;">3.3</div><div id="a3647_100_23" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:587px;top:0px;"><div style="display:inline-block;width:3px"> </div>million for Americas, </div><div id="a3662" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">$</div><div id="a3662_1_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:11px;top:15px;">8.9</div><div id="a3662_4_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:15px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a3662_18_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:102px;top:15px;">8.8</div><div id="a3662_21_20" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:119px;top:15px;"><div style="display:inline-block;width:3px"> </div>million for EMEA, $</div><div id="a3662_41_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:234px;top:15px;">0.3</div><div id="a3662_44_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:251px;top:15px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a3662_58_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:325px;top:15px;">0.1</div><div id="a3662_61_31" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:342px;top:15px;"><div style="display:inline-block;width:3px"> </div>million for Asia/Pacific and $</div><div id="a3662_92_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:504px;top:15px;">1.7</div><div id="a3662_95_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:521px;top:15px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a3662_109_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:595px;top:15px;">2.0</div><div id="a3662_112_20" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:612px;top:15px;"><div style="display:inline-block;width:3px"> </div>million for Global </div><div id="a3685" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">Specialty Businesses, respectively.<div style="display:inline-block;width:7px"> </div>However, all inter-segment transactions<div style="display:inline-block;width:5px"> </div>have been eliminated from each reportable operating </div><div id="a3689" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">segment’s net sales and earnings for<div style="display:inline-block;width:5px"> </div>all periods presented in the above tables.</div></div> <div id="TextBlockContainer19" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:708px;height:47px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a3289" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">The Company’s operating<div style="display:inline-block;width:5px"> </div>segments, which are consistent with its reportable segments, reflect the structure of the<div style="display:inline-block;width:5px"> </div>Company’s </div><div id="a3291" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">internal organization, the method by which the Company’s<div style="display:inline-block;width:5px"> </div>resources are allocated and the manner by which the chief operating </div><div id="a3292" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">decision maker assesses the Company’s<div style="display:inline-block;width:5px"> </div>performance.</div></div> 4 <div id="TextBlockContainer25" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:673px;height:440px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a3351" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:506px;top:0px;">Three Months Ended </div><div id="a3357" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:537px;top:18px;">March 31,<div style="display:inline-block;width:4px"> </div></div><div id="a3363" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:504px;top:36px;">2022 </div><div id="a3366" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:603px;top:36px;">2021 </div><div id="a3370" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:53px;">Net sales </div><div id="a3372" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:53px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3374" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:486px;top:53px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3376" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:53px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3378" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:53px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3380" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:53px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3382" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:661px;top:53px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3386" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:70px;">Americas </div><div id="a3388" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:70px;">$ </div><div id="a3390" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:512px;top:70px;">154,144</div><div id="a3393" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:70px;">$ </div><div id="a3395" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:611px;top:70px;">134,871</div><div id="a3400" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:88px;">EMEA </div><div id="a3402" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:88px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3404" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:512px;top:88px;">125,687</div><div id="a3407" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:88px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3409" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:611px;top:88px;">119,814</div><div id="a3414" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:106px;">Asia/Pacific </div><div id="a3416" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:106px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3418" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:512px;top:106px;">104,234</div><div id="a3421" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:106px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3423" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:106px;">96,706</div><div id="a3428" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:123px;">Global Specialty Businesses </div><div id="a3430" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:123px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3432" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:519px;top:123px;">90,106</div><div id="a3435" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:123px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3437" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:123px;">78,392</div><div id="a3441" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:141px;">Total<div style="display:inline-block;width:5px"> </div>net sales </div><div id="a3443" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:141px;">$ </div><div id="a3445" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:512px;top:141px;">474,171</div><div id="a3448" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:141px;">$ </div><div id="a3450" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:611px;top:141px;">429,783</div><div id="a3463" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:176px;">Segment operating earnings </div><div id="a3473" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:194px;">Americas </div><div id="a3475" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:194px;">$ </div><div id="a3477" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:519px;top:194px;">29,220</div><div id="a3480" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:194px;">$ </div><div id="a3482" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:194px;">32,234</div><div id="a3487" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:211px;">EMEA </div><div id="a3490" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:519px;top:211px;">16,766</div><div id="a3494" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:211px;">25,244</div><div id="a3499" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:229px;">Asia/Pacific </div><div id="a3502" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:519px;top:229px;">21,907</div><div id="a3506" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:229px;">27,478</div><div id="a3511" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:246px;">Global Specialty Businesses </div><div id="a3513" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:246px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3515" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:519px;top:246px;">25,035</div><div id="a3518" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:246px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3520" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:246px;">24,169</div><div id="a3524" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:264px;">Total<div style="display:inline-block;width:5px"> </div>segment operating earnings </div><div id="a3526" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:264px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3528" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:519px;top:264px;">92,928</div><div id="a3531" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:264px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3533" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:611px;top:264px;">109,125</div><div id="a3537" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:282px;">Combination, integration and other acquisition-related expenses </div><div id="a3542" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:521px;top:282px;display:flex;">(4,053)</div><div id="a3546" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:620px;top:282px;display:flex;">(5,815)</div><div id="a3550" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:299px;">Restructuring and related charges </div><div id="a3553" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:531px;top:299px;display:flex;">(820)</div><div id="a3557" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:620px;top:299px;display:flex;">(1,175)</div><div id="a3561" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:317px;">Fair value step up of acquired inventory sold </div><div id="a3564" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:542px;top:317px;">—</div><div id="a3568" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:630px;top:317px;display:flex;">(801)</div><div id="a3572" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:334px;">Non-operating and administrative expenses </div><div id="a3576" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:334px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3578" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:514px;top:334px;display:flex;">(43,463)</div><div id="a3581" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:334px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3583" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:613px;top:334px;display:flex;">(40,992)</div><div id="a3587" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:352px;">Depreciation of corporate assets and amortization </div><div id="a3589" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:352px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3591" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:514px;top:352px;display:flex;">(15,189)</div><div id="a3594" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:352px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3596" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:613px;top:352px;display:flex;">(15,448)</div><div id="a3600" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:370px;">Operating income </div><div id="a3603" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:519px;top:370px;">29,403</div><div id="a3607" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:370px;">44,894</div><div id="a3611" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:387px;">Other (expense) income, net </div><div id="a3614" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:521px;top:387px;display:flex;">(2,206)</div><div id="a3618" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:387px;">4,687</div><div id="a3622" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:405px;">Interest expense, net </div><div id="a3624" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:405px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3626" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:521px;top:405px;display:flex;">(5,345)</div><div id="a3629" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:405px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3631" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:620px;top:405px;display:flex;">(5,470)</div><div id="a3635" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:424px;">Income before taxes and equity in net income of associated companies </div><div id="a3637" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:424px;">$ </div><div id="a3639" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:519px;top:424px;">21,852</div><div id="a3642" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:424px;">$ </div><div id="a3644" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:424px;">44,111</div></div> 154144000 134871000 125687000 119814000 104234000 96706000 90106000 78392000 474171000 429783000 29220000 32234000 16766000 25244000 21907000 27478000 25035000 24169000 92928000 109125000 4053000 5815000 820000 1175000 0 801000 43463000 40992000 15189000 15448000 29403000 44894000 -2206000 4687000 -5345000 -5470000 21852000 44111000 2900000 3300000 8900000 8800000 300000 100000 1700000 2000000.0 <div id="TextBlockContainer30" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:731px;height:322px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a3712" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 5 – Net Sales and Revenue Recognition </div><div id="a3717" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:26px;">Arrangements Resulting in Net Reporting </div><div id="a3719" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:49px;">As part of the Company’s Fluidcare</div><div id="a3720" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;font-weight:normal;font-style:normal;color:#000000;left:220px;top:49px;">TM</div><div id="a3721" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:233px;top:49px;"><div style="display:inline-block;width:3px"> </div>business, certain third-party product sales to customers are managed by the Company.<div style="display:inline-block;width:9px"> </div>The </div><div id="a3727" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:64px;">Company transferred third-party products under arrangements recognized<div style="display:inline-block;width:5px"> </div>on a net reporting basis of $</div><div id="a3727_100_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:550px;top:64px;">19.8</div><div id="a3727_104_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:64px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a3727_118_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:648px;top:64px;">17.8</div><div id="a3727_122_9" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:671px;top:64px;"><div style="display:inline-block;width:3px"> </div>million </div><div id="a3741" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:80px;">for the three months ended March 31, 2022 and 2021, respectively.<div style="display:inline-block;width:5px"> </div></div><div id="a3751" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:103px;">Customer Concentration </div><div id="a3754" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:129px;">A significant portion of the Company’s<div style="display:inline-block;width:5px"> </div>revenues are realized from the sale of process fluids and services to manufacturers of </div><div id="a3756" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:144px;">steel, aluminum, automobiles, aircraft, industrial equipment, and durable<div style="display:inline-block;width:5px"> </div>goods.<div style="display:inline-block;width:7px"> </div>As previously disclosed in the 2021 Form 10-K, </div><div id="a3764" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:159px;">during the year ended December 31, 2021, the Company’s<div style="display:inline-block;width:5px"> </div>five largest customers (each composed of multiple subsidiaries or<div style="display:inline-block;width:5px"> </div>divisions </div><div id="a3771" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:175px;">with semiautonomous purchasing authority) accounted for approximately </div><div id="a3771_70_2" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:400px;top:175px;">10</div><div id="a3771_72_55" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:413px;top:175px;">% of consolidated net sales, with its largest customer </div><div id="a3776" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:190px;">accounting for approximately </div><div id="a3776_29_1" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:166px;top:190px;">3</div><div id="a3776_30_29" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:172px;top:190px;">% of consolidated net sales. </div><div id="a3780" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:213px;">Contract Assets and Liabilities </div><div id="a3782" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:237px;">The Company had no material contract assets recorded on its Condensed<div style="display:inline-block;width:5px"> </div>Consolidated Balance Sheets as of March 31, 2022 or </div><div id="a3786" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:252px;">December 31, 2021. </div><div id="a3789" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:275px;">The Company had approximately $</div><div id="a3789_31_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:217px;top:275px;">6.9</div><div id="a3789_34_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:234px;top:275px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a3789_48_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:308px;top:275px;">7.0</div><div id="a3789_51_67" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:325px;top:275px;"><div style="display:inline-block;width:3px"> </div>million of deferred revenue as of March 31, 2022 and December 31, </div><div id="a3802" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:291px;">2021, respectively.<div style="display:inline-block;width:8px"> </div>For three months ended March 31, 2022, the Company satisfied all of the associated performance<div style="display:inline-block;width:5px"> </div>obligations and </div><div id="a3807" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:306px;">recognized into revenue the advance payments received and recorded<div style="display:inline-block;width:5px"> </div>as of December 31, 2021.</div></div><div id="TextBlockContainer32" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:733px;height:124px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a3809" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:0px;">Disaggregated Revenue </div><div id="a3812" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">The Company sells its various industrial process fluids, its specialty chemicals<div style="display:inline-block;width:5px"> </div>and its technical expertise as a global product </div><div id="a3814" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">portfolio.<div style="display:inline-block;width:7px"> </div>The Company generally manages and evaluates its performance by segment<div style="display:inline-block;width:5px"> </div>first, and then by customer industry,<div style="display:inline-block;width:5px"> </div>rather than </div><div id="a3816" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:54px;">by individual product lines.<div style="display:inline-block;width:7px"> </div>Also, net sales of each of the Company’s major product<div style="display:inline-block;width:5px"> </div>lines are generally spread throughout all three of </div><div id="a3818" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">the Company’s geographic<div style="display:inline-block;width:5px"> </div>regions, and in most cases, approximately proportionate to the level of total sales in each<div style="display:inline-block;width:5px"> </div>region. </div><div id="a3821" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:93px;">The following tables disaggregate the Company’s<div style="display:inline-block;width:5px"> </div>net sales by segment, geographic region, customer industry,<div style="display:inline-block;width:5px"> </div>and timing of </div><div id="a3823" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:108px;">revenue recognized for the three months ended March 31, 2022 and 2021.</div></div><div id="TextBlockContainer35" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:724px;height:241px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a3826" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:385px;top:0px;">Three Months Ended March 31, 2022 </div><div id="a3837" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:630px;top:17px;">Consolidated </div><div id="a3840" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:289px;top:31px;">Americas </div><div id="a3843" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:414px;top:31px;">EMEA </div><div id="a3846" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:518px;top:31px;">Asia/Pacific </div><div id="a3849" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:653px;top:31px;">Total </div><div id="a3851" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:48px;">Customer Industries </div><div id="a3864" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:65px;">Metals </div><div id="a3866" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:65px;">$</div><div id="a3868" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:326px;top:65px;">56,160</div><div id="a3871" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:65px;">$ </div><div id="a3873" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:65px;">36,839</div><div id="a3876" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:65px;">$</div><div id="a3878" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:65px;">55,287</div><div id="a3880" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:609px;top:65px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3882" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:65px;">$</div><div id="a3884" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:65px;">148,286</div><div id="a3886" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:82px;">Metalworking and other </div><div id="a3889" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:326px;top:82px;">97,984</div><div id="a3893" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:82px;">88,848</div><div id="a3897" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:82px;">48,947</div><div id="a3901" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:82px;">235,779</div><div id="a3905" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:99px;">154,144</div><div id="a3909" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:99px;">125,687</div><div id="a3913" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:99px;">104,234</div><div id="a3917" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:99px;">384,065</div><div id="a3919" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:116px;">Global Specialty Businesses </div><div id="a3922" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:326px;top:116px;">57,264</div><div id="a3926" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:116px;">20,021</div><div id="a3930" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:116px;">12,821</div><div id="a3934" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:678px;top:116px;">90,106</div><div id="a3937" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:135px;">$</div><div id="a3939" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:135px;">211,408</div><div id="a3942" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:135px;">$ </div><div id="a3944" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:135px;">145,708</div><div id="a3947" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:135px;">$</div><div id="a3949" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:135px;">117,055</div><div id="a3952" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:135px;">$</div><div id="a3954" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:135px;">474,171</div><div id="a3968" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:172px;">Timing of Revenue Recognized </div><div id="a3981" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:189px;">Product sales at a point in time </div><div id="a3983" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:190px;">$</div><div id="a3985" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:190px;">201,284</div><div id="a3988" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:190px;">$ </div><div id="a3990" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:190px;">137,203</div><div id="a3993" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:190px;">$</div><div id="a3995" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:190px;">114,625</div><div id="a3997" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:609px;top:190px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3999" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:190px;">$</div><div id="a4001" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:190px;">453,112</div><div id="a4003" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:206px;">Services transferred over time </div><div id="a4006" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:326px;top:207px;">10,124</div><div id="a4010" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:451px;top:207px;">8,505</div><div id="a4014" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:207px;">2,430</div><div id="a4018" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:678px;top:207px;">21,059</div><div id="a4021" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:226px;">$</div><div id="a4023" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:226px;">211,408</div><div id="a4026" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:226px;">$ </div><div id="a4028" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:226px;">145,708</div><div id="a4031" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:226px;">$</div><div id="a4033" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:226px;">117,055</div><div id="a4036" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:226px;">$</div><div id="a4038" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:226px;">474,171</div></div><div id="TextBlockContainer39" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:724px;height:246px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a4060" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:385px;top:0px;">Three Months Ended March 31, 2021 </div><div id="a4071" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:630px;top:17px;">Consolidated </div><div id="a4074" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:289px;top:34px;">Americas </div><div id="a4077" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:414px;top:34px;">EMEA </div><div id="a4080" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:518px;top:34px;">Asia/Pacific </div><div id="a4083" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:653px;top:34px;">Total </div><div id="a4085" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:52px;">Customer Industries </div><div id="a4098" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">Metals </div><div id="a4100" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:70px;">$</div><div id="a4102" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:326px;top:70px;">46,793</div><div id="a4105" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:70px;">$ </div><div id="a4107" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:70px;">34,274</div><div id="a4110" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:70px;">$</div><div id="a4112" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:70px;">49,743</div><div id="a4114" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:609px;top:70px;"><div style="display:inline-block;width:3px"> </div></div><div id="a4116" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:70px;">$</div><div id="a4118" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:70px;">130,810</div><div id="a4120" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:86px;">Metalworking and other </div><div id="a4123" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:326px;top:87px;">88,078</div><div id="a4127" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:87px;">85,540</div><div id="a4131" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:87px;">46,963</div><div id="a4135" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:87px;">220,581</div><div id="a4139" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:103px;">134,871</div><div id="a4143" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:103px;">119,814</div><div id="a4147" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:103px;">96,706</div><div id="a4151" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:103px;">351,391</div><div id="a4153" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:120px;">Global Specialty Businesses </div><div id="a4156" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:326px;top:120px;">45,256</div><div id="a4160" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:120px;">20,272</div><div id="a4164" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:120px;">12,864</div><div id="a4169" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:678px;top:120px;">78,392</div><div id="a4172" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:139px;">$</div><div id="a4174" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:138px;">180,127</div><div id="a4177" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:139px;">$ </div><div id="a4179" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:138px;">140,086</div><div id="a4182" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:139px;">$</div><div id="a4184" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:138px;">109,570</div><div id="a4187" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:139px;">$</div><div id="a4189" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:138px;">429,783</div><div id="a4203" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:176px;">Timing of Revenue Recognized </div><div id="a4216" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:193px;">Product sales at a point in time </div><div id="a4218" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:194px;">$</div><div id="a4220" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:194px;">171,594</div><div id="a4223" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:194px;">$ </div><div id="a4225" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:194px;">131,162</div><div id="a4228" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:194px;">$</div><div id="a4230" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:194px;">106,399</div><div id="a4232" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:609px;top:194px;"><div style="display:inline-block;width:3px"> </div></div><div id="a4234" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:194px;">$</div><div id="a4236" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:194px;">409,155</div><div id="a4238" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:210px;">Services transferred over time </div><div id="a4241" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:333px;top:211px;">8,533</div><div id="a4245" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:451px;top:211px;">8,924</div><div id="a4249" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:211px;">3,171</div><div id="a4253" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:678px;top:211px;">20,628</div><div id="a4256" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:230px;">$</div><div id="a4258" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:229px;">180,127</div><div id="a4261" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:230px;">$ </div><div id="a4263" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:229px;">140,086</div><div id="a4266" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:230px;">$</div><div id="a4268" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:229px;">109,570</div><div id="a4271" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:230px;">$</div><div id="a4273" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:229px;">429,783</div></div> 19800000 17800000 0.10 0.03 6900000 7000000.0 <div id="TextBlockContainer36" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:724px;height:241px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_34_XBRL_TS_034b2fa7e8e8496cbdcf19045cee1506" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer35" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:724px;height:241px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a3826" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:385px;top:0px;">Three Months Ended March 31, 2022 </div><div id="a3837" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:630px;top:17px;">Consolidated </div><div id="a3840" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:289px;top:31px;">Americas </div><div id="a3843" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:414px;top:31px;">EMEA </div><div id="a3846" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:518px;top:31px;">Asia/Pacific </div><div id="a3849" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:653px;top:31px;">Total </div><div id="a3851" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:48px;">Customer Industries </div><div id="a3864" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:65px;">Metals </div><div id="a3866" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:65px;">$</div><div id="a3868" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:326px;top:65px;">56,160</div><div id="a3871" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:65px;">$ </div><div id="a3873" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:65px;">36,839</div><div id="a3876" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:65px;">$</div><div id="a3878" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:65px;">55,287</div><div id="a3880" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:609px;top:65px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3882" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:65px;">$</div><div id="a3884" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:65px;">148,286</div><div id="a3886" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:82px;">Metalworking and other </div><div id="a3889" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:326px;top:82px;">97,984</div><div id="a3893" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:82px;">88,848</div><div id="a3897" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:82px;">48,947</div><div id="a3901" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:82px;">235,779</div><div id="a3905" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:99px;">154,144</div><div id="a3909" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:99px;">125,687</div><div id="a3913" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:99px;">104,234</div><div id="a3917" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:99px;">384,065</div><div id="a3919" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:116px;">Global Specialty Businesses </div><div id="a3922" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:326px;top:116px;">57,264</div><div id="a3926" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:116px;">20,021</div><div id="a3930" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:116px;">12,821</div><div id="a3934" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:678px;top:116px;">90,106</div><div id="a3937" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:135px;">$</div><div id="a3939" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:135px;">211,408</div><div id="a3942" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:135px;">$ </div><div id="a3944" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:135px;">145,708</div><div id="a3947" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:135px;">$</div><div id="a3949" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:135px;">117,055</div><div id="a3952" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:135px;">$</div><div id="a3954" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:135px;">474,171</div><div id="a3968" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:172px;">Timing of Revenue Recognized </div><div id="a3981" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:189px;">Product sales at a point in time </div><div id="a3983" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:190px;">$</div><div id="a3985" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:190px;">201,284</div><div id="a3988" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:190px;">$ </div><div id="a3990" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:190px;">137,203</div><div id="a3993" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:190px;">$</div><div id="a3995" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:190px;">114,625</div><div id="a3997" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:609px;top:190px;"><div style="display:inline-block;width:3px"> </div></div><div id="a3999" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:190px;">$</div><div id="a4001" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:190px;">453,112</div><div id="a4003" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:206px;">Services transferred over time </div><div id="a4006" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:326px;top:207px;">10,124</div><div id="a4010" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:451px;top:207px;">8,505</div><div id="a4014" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:207px;">2,430</div><div id="a4018" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:678px;top:207px;">21,059</div><div id="a4021" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:226px;">$</div><div id="a4023" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:226px;">211,408</div><div id="a4026" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:226px;">$ </div><div id="a4028" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:226px;">145,708</div><div id="a4031" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:226px;">$</div><div id="a4033" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:226px;">117,055</div><div id="a4036" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:226px;">$</div><div id="a4038" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:226px;">474,171</div></div></div></div><div id="TextBlockContainer40" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:724px;height:246px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_38_XBRL_TS_0eebd7d9b80f4fd096ec458ff6ac5b0c" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer39" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:724px;height:246px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a4060" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:385px;top:0px;">Three Months Ended March 31, 2021 </div><div id="a4071" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:630px;top:17px;">Consolidated </div><div id="a4074" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:289px;top:34px;">Americas </div><div id="a4077" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:414px;top:34px;">EMEA </div><div id="a4080" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:518px;top:34px;">Asia/Pacific </div><div id="a4083" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:653px;top:34px;">Total </div><div id="a4085" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:52px;">Customer Industries </div><div id="a4098" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">Metals </div><div id="a4100" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:70px;">$</div><div id="a4102" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:326px;top:70px;">46,793</div><div id="a4105" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:70px;">$ </div><div id="a4107" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:70px;">34,274</div><div id="a4110" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:70px;">$</div><div id="a4112" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:70px;">49,743</div><div id="a4114" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:609px;top:70px;"><div style="display:inline-block;width:3px"> </div></div><div id="a4116" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:70px;">$</div><div id="a4118" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:70px;">130,810</div><div id="a4120" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:86px;">Metalworking and other </div><div id="a4123" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:326px;top:87px;">88,078</div><div id="a4127" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:87px;">85,540</div><div id="a4131" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:87px;">46,963</div><div id="a4135" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:87px;">220,581</div><div id="a4139" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:103px;">134,871</div><div id="a4143" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:103px;">119,814</div><div id="a4147" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:103px;">96,706</div><div id="a4151" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:103px;">351,391</div><div id="a4153" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:120px;">Global Specialty Businesses </div><div id="a4156" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:326px;top:120px;">45,256</div><div id="a4160" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:120px;">20,272</div><div id="a4164" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:120px;">12,864</div><div id="a4169" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:678px;top:120px;">78,392</div><div id="a4172" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:139px;">$</div><div id="a4174" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:138px;">180,127</div><div id="a4177" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:139px;">$ </div><div id="a4179" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:138px;">140,086</div><div id="a4182" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:139px;">$</div><div id="a4184" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:138px;">109,570</div><div id="a4187" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:139px;">$</div><div id="a4189" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:138px;">429,783</div><div id="a4203" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:176px;">Timing of Revenue Recognized </div><div id="a4216" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:193px;">Product sales at a point in time </div><div id="a4218" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:194px;">$</div><div id="a4220" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:194px;">171,594</div><div id="a4223" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:194px;">$ </div><div id="a4225" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:194px;">131,162</div><div id="a4228" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:194px;">$</div><div id="a4230" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:194px;">106,399</div><div id="a4232" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:609px;top:194px;"><div style="display:inline-block;width:3px"> </div></div><div id="a4234" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:194px;">$</div><div id="a4236" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:194px;">409,155</div><div id="a4238" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:210px;">Services transferred over time </div><div id="a4241" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:333px;top:211px;">8,533</div><div id="a4245" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:451px;top:211px;">8,924</div><div id="a4249" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:211px;">3,171</div><div id="a4253" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:678px;top:211px;">20,628</div><div id="a4256" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:230px;">$</div><div id="a4258" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:229px;">180,127</div><div id="a4261" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:230px;">$ </div><div id="a4263" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:229px;">140,086</div><div id="a4266" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:230px;">$</div><div id="a4268" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:229px;">109,570</div><div id="a4271" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:230px;">$</div><div id="a4273" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:229px;">429,783</div></div></div></div> 56160000 36839000 55287000 148286000 97984000 88848000 48947000 235779000 154144000 125687000 104234000 384065000 57264000 20021000 12821000 90106000 211408000 145708000 117055000 474171000 201284000 137203000 114625000 453112000 10124000 8505000 2430000 21059000 211408000 145708000 117055000 474171000 46793000 34274000 49743000 130810000 88078000 85540000 46963000 220581000 134871000 119814000 96706000 351391000 45256000 20272000 12864000 78392000 180127000 140086000 109570000 429783000 171594000 131162000 106399000 409155000 8533000 8924000 3171000 20628000 180127000 140086000 109570000 429783000 <div id="TextBlockContainer42" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:730px;height:72px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a4275" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 6 - Leases </div><div id="a4280" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:26px;">The Company has operating leases for certain facilities, vehicles and machinery<div style="display:inline-block;width:5px"> </div>and equipment with remaining lease terms up to </div><div id="a4318" style="position:absolute;font-family:'Times New Roman';left:4px;top:41px;">10 years</div><div id="a4318_8_129" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:49px;top:41px;">.<div style="display:inline-block;width:7px"> </div>Operating lease expense is recognized on a straight-line basis over the lease term. In addition,<div style="display:inline-block;width:5px"> </div>the Company has certain land </div><div id="a4366" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:56px;">use leases with remaining lease terms up to </div><div id="a4366_44_8" style="position:absolute;font-family:'Times New Roman';left:239px;top:56px;">93 years</div><div id="a4366_52_1" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:283px;top:56px;">.</div></div><div id="TextBlockContainer44" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:705px;height:31px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a4386" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">The Company has </div><div id="a4386_16_2" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:129px;top:0px;">no</div><div id="a4386_18_102" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:142px;top:0px;"><div style="display:inline-block;width:3px"> </div>material variable lease costs or sublease income for three months ended March<div style="display:inline-block;width:5px"> </div>31, 2022 and 2021. The </div><div id="a4429" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">following table sets forth the components of the Company’s<div style="display:inline-block;width:5px"> </div>lease cost for three months ended March 31, 2022 and 2021:</div></div><div id="TextBlockContainer47" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:664px;height:86px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a4474" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:496px;top:0px;">Three Months Ended </div><div id="a4480" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:527px;top:18px;">March 31, </div><div id="a4485" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:489px;top:35px;">2022 </div><div id="a4488" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:598px;top:35px;">2021 </div><div id="a4492" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:53px;">Operating lease expense </div><div id="a4494" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:454px;top:53px;">$ </div><div id="a4496" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:516px;top:53px;">3,409</div><div id="a4499" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:564px;top:53px;">$ </div><div id="a4501" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:53px;">3,612</div><div id="a4505" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:70px;">Short-term lease expense </div><div id="a4510" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:526px;top:70px;">219</div><div id="a4514" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:635px;top:70px;">251</div></div><div id="TextBlockContainer50" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:451px;height:16px;display:inline-block;"><div id="a4517" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:0px;">Supplemental cash flow information related to the Company’s<div style="display:inline-block;width:5px"> </div>leases is as follows</div></div><div id="TextBlockContainer54" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:664px;height:122px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_52_XBRL_TS_616c1a8af6694ec79dbfe9c23af26420" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer53" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:664px;height:122px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a4544" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:496px;top:0px;">Three Months Ended </div><div id="a4550" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:527px;top:18px;">March 31, </div><div id="a4555" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:489px;top:35px;">2022 </div><div id="a4558" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:598px;top:35px;">2021 </div><div id="a4562" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:53px;">Cash paid for amounts included in the measurement of lease liabilities </div><div id="a4572" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:70px;">Operating cash flows from operating leases </div><div id="a4574" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:454px;top:70px;">$ </div><div id="a4576" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:516px;top:70px;">3,365</div><div id="a4579" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:564px;top:70px;">$ </div><div id="a4581" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:70px;">3,579</div><div id="a4585" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:88px;">Non-cash lease liabilities activity: </div><div id="a4597" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:106px;">Leased assets obtained in exchange for new operating lease liabilities </div><div id="a4601" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:516px;top:106px;">4,689</div><div id="a4605" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:106px;">3,050</div></div></div></div><div id="TextBlockContainer56" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:474px;height:16px;display:inline-block;"><div id="a4608" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:0px;">Supplemental balance sheet information related to the Company’s<div style="display:inline-block;width:5px"> </div>leases is as follows:</div></div><div id="TextBlockContainer59" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:668px;height:169px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a4635" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:473px;top:0px;">March 31, </div><div id="a4638" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:572px;top:0px;">December 31, </div><div id="a4643" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:489px;top:17px;">2022 </div><div id="a4646" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:598px;top:17px;">2021 </div><div id="a4650" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:34px;">Right of use lease assets </div><div id="a4652" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:454px;top:34px;">$ </div><div id="a4654" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:509px;top:34px;">38,245</div><div id="a4657" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:564px;top:34px;">$ </div><div id="a4659" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:34px;">36,635</div><div id="a4671" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:68px;">Other current liabilities </div><div id="a4674" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:509px;top:68px;">10,540</div><div id="a4678" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:68px;">9,976</div><div id="a4682" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">Long-term lease liabilities </div><div id="a4687" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:509px;top:85px;">27,433</div><div id="a4691" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:85px;">26,335</div><div id="a4695" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:102px;">Total operating lease liabilities </div><div id="a4697" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:454px;top:102px;">$ </div><div id="a4699" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:509px;top:102px;">37,973</div><div id="a4702" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:564px;top:102px;">$ </div><div id="a4704" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:102px;">36,311</div><div id="a4717" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:136px;">Weighted average<div style="display:inline-block;width:5px"> </div>remaining lease term (years) </div><div id="a4720" style="position:absolute;font-family:'Times New Roman';left:529px;top:136px;">5.9</div><div id="a4724" style="position:absolute;font-family:'Times New Roman';left:638px;top:136px;">5.6</div><div id="a4728" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:153px;">Weighted average<div style="display:inline-block;width:5px"> </div>discount rate </div><div id="a4731" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:515px;top:153px;display:flex;">4.14%</div><div id="a4735" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:624px;top:153px;display:flex;">4.22%</div></div><div id="TextBlockContainer62" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:427px;height:16px;display:inline-block;"><div id="a4765" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:0px;">Maturities of operating lease liabilities as of March 31, 2022 were as follows:</div></div><div id="TextBlockContainer66" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:431px;height:187px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_64_XBRL_TS_98d334502fb74ccf859a992eb6022582" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer65" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:431px;height:187px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a4788" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:334px;top:0px;">March 31, </div><div id="a4794" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:350px;top:17px;">2022 </div><div id="a4799" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:35px;">For the remainder of 2022 </div><div id="a4801" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:35px;">$ </div><div id="a4803" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:388px;top:35px;">8,990</div><div id="a4808" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:52px;">For the year ended December 31, 2023 </div><div id="a4811" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:388px;top:52px;">9,513</div><div id="a4816" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">For the year ended December 31, 2024 </div><div id="a4819" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:388px;top:69px;">7,292</div><div id="a4824" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:86px;">For the year ended December 31, 2025 </div><div id="a4828" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:388px;top:86px;">5,375</div><div id="a4833" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:103px;">For the year ended December 31, 2026 </div><div id="a4836" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:388px;top:103px;">4,338</div><div id="a4841" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:120px;">For the year ended December 31, 2027 and beyond </div><div id="a4844" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:388px;top:120px;">7,046</div><div id="a4849" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:137px;">Total lease payments </div><div id="a4852" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:137px;">42,554</div><div id="a4857" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:154px;">Less: imputed interest </div><div id="a4860" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:384px;top:154px;display:flex;">(4,581)</div><div id="a4865" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:171px;">Present value of lease liabilities </div><div id="a4867" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:171px;">$ </div><div id="a4869" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:171px;">37,973</div></div></div></div> P10Y P93Y 0 0 0 0 <div id="TextBlockContainer48" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:664px;height:86px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_46_XBRL_TS_6a89d89d855b4e158a8a42049d108a90" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer47" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:664px;height:86px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a4474" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:496px;top:0px;">Three Months Ended </div><div id="a4480" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:527px;top:18px;">March 31, </div><div id="a4485" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:489px;top:35px;">2022 </div><div id="a4488" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:598px;top:35px;">2021 </div><div id="a4492" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:53px;">Operating lease expense </div><div id="a4494" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:454px;top:53px;">$ </div><div id="a4496" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:516px;top:53px;">3,409</div><div id="a4499" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:564px;top:53px;">$ </div><div id="a4501" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:53px;">3,612</div><div id="a4505" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:70px;">Short-term lease expense </div><div id="a4510" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:526px;top:70px;">219</div><div id="a4514" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:635px;top:70px;">251</div></div></div></div><div id="TextBlockContainer53" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:664px;height:122px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a4544" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:496px;top:0px;">Three Months Ended </div><div id="a4550" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:527px;top:18px;">March 31, </div><div id="a4555" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:489px;top:35px;">2022 </div><div id="a4558" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:598px;top:35px;">2021 </div><div id="a4562" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:53px;">Cash paid for amounts included in the measurement of lease liabilities </div><div id="a4572" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:70px;">Operating cash flows from operating leases </div><div id="a4574" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:454px;top:70px;">$ </div><div id="a4576" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:516px;top:70px;">3,365</div><div id="a4579" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:564px;top:70px;">$ </div><div id="a4581" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:70px;">3,579</div><div id="a4585" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:88px;">Non-cash lease liabilities activity: </div><div id="a4597" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:106px;">Leased assets obtained in exchange for new operating lease liabilities </div><div id="a4601" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:516px;top:106px;">4,689</div><div id="a4605" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:106px;">3,050</div></div><div id="TextBlockContainer60" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:668px;height:169px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_58_XBRL_TS_903fd3018b0e4527868fcf9d862370a6" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer59" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:668px;height:169px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a4635" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:473px;top:0px;">March 31, </div><div id="a4638" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:572px;top:0px;">December 31, </div><div id="a4643" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:489px;top:17px;">2022 </div><div id="a4646" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:598px;top:17px;">2021 </div><div id="a4650" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:34px;">Right of use lease assets </div><div id="a4652" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:454px;top:34px;">$ </div><div id="a4654" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:509px;top:34px;">38,245</div><div id="a4657" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:564px;top:34px;">$ </div><div id="a4659" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:34px;">36,635</div><div id="a4671" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:68px;">Other current liabilities </div><div id="a4674" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:509px;top:68px;">10,540</div><div id="a4678" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:68px;">9,976</div><div id="a4682" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">Long-term lease liabilities </div><div id="a4687" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:509px;top:85px;">27,433</div><div id="a4691" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:85px;">26,335</div><div id="a4695" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:102px;">Total operating lease liabilities </div><div id="a4697" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:454px;top:102px;">$ </div><div id="a4699" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:509px;top:102px;">37,973</div><div id="a4702" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:564px;top:102px;">$ </div><div id="a4704" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:102px;">36,311</div><div id="a4717" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:136px;">Weighted average<div style="display:inline-block;width:5px"> </div>remaining lease term (years) </div><div id="a4720" style="position:absolute;font-family:'Times New Roman';left:529px;top:136px;">5.9</div><div id="a4724" style="position:absolute;font-family:'Times New Roman';left:638px;top:136px;">5.6</div><div id="a4728" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:153px;">Weighted average<div style="display:inline-block;width:5px"> </div>discount rate </div><div id="a4731" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:515px;top:153px;display:flex;">4.14%</div><div id="a4735" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:624px;top:153px;display:flex;">4.22%</div></div></div></div> 3409000 3612000 219000 251000 3365000 3579000 4689000 3050000 38245000 36635000 10540000 9976000 27433000 26335000 37973000 36311000 P5Y10M24D P5Y7M6D 0.0414 0.0422 <div id="TextBlockContainer65" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:431px;height:187px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a4788" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:334px;top:0px;">March 31, </div><div id="a4794" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:350px;top:17px;">2022 </div><div id="a4799" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:35px;">For the remainder of 2022 </div><div id="a4801" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:35px;">$ </div><div id="a4803" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:388px;top:35px;">8,990</div><div id="a4808" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:52px;">For the year ended December 31, 2023 </div><div id="a4811" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:388px;top:52px;">9,513</div><div id="a4816" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">For the year ended December 31, 2024 </div><div id="a4819" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:388px;top:69px;">7,292</div><div id="a4824" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:86px;">For the year ended December 31, 2025 </div><div id="a4828" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:388px;top:86px;">5,375</div><div id="a4833" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:103px;">For the year ended December 31, 2026 </div><div id="a4836" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:388px;top:103px;">4,338</div><div id="a4841" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:120px;">For the year ended December 31, 2027 and beyond </div><div id="a4844" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:388px;top:120px;">7,046</div><div id="a4849" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:137px;">Total lease payments </div><div id="a4852" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:137px;">42,554</div><div id="a4857" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:154px;">Less: imputed interest </div><div id="a4860" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:384px;top:154px;display:flex;">(4,581)</div><div id="a4865" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:171px;">Present value of lease liabilities </div><div id="a4867" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:171px;">$ </div><div id="a4869" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:171px;">37,973</div></div> 8990000 9513000 7292000 5375000 4338000 7046000 42554000 4581000 37973000 <div id="TextBlockContainer68" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:717px;height:215px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a4873" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 7 – Restructuring and Related Activities </div><div id="a4878" style="position:absolute;font-family:'Times New Roman';left:28px;top:23px;">The Company’s management approved a global restructuring plan (the “QH Program”) as part of its plan to realize certain cost </div><div id="a4918" style="position:absolute;font-family:'Times New Roman';left:4px;top:39px;">synergies associated with the Combination in the third quarter of 2019. The QH Program includes restructuring and associated </div><div id="a4954" style="position:absolute;font-family:'Times New Roman';left:4px;top:54px;">severance costs to reduce total headcount by approximately 400 people globally, as well as plans for the closure of certain </div><div id="a4994" style="position:absolute;font-family:'Times New Roman';left:4px;top:69px;">manufacturing and non-manufacturing facilities.</div><div id="a4994_47_83" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:263px;top:69px;"><div style="display:inline-block;width:7px"> </div>The exact timing and total costs associated with the QH Program will depend on<div style="display:inline-block;width:5px"> </div>a </div><div id="a5035" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">number of factors and are subject to change; however,<div style="display:inline-block;width:5px"> </div>the Company currently expects reductions in headcount and site closures to </div><div id="a5075" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">continue to occur throughout 2022 under the QH Program.<div style="display:inline-block;width:8px"> </div>Employee separation benefits will vary depending on local regulations </div><div id="a5112" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:115px;">within certain foreign countries and will include severance and other benefits.<div style="display:inline-block;width:8px"> </div></div><div id="a5135" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:139px;">All costs incurred to date relate to severance costs to reduce headcount,<div style="display:inline-block;width:5px"> </div>including customary and routine adjustments to initial </div><div id="a5173" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:154px;">estimates for employee separation costs, as well as costs to close certain<div style="display:inline-block;width:5px"> </div>facilities and are recorded in Restructuring and related </div><div id="a5213" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:169px;">charges in the Company’s<div style="display:inline-block;width:5px"> </div>Condensed Consolidated Statements of Income.<div style="display:inline-block;width:8px"> </div>As described in Note 4 of Notes to Condensed </div><div id="a5250" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:185px;">Consolidated Financial Statements, restructuring and related charges<div style="display:inline-block;width:5px"> </div>are not included in the Company’s<div style="display:inline-block;width:5px"> </div>calculation of reportable </div><div id="a5282" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:200px;">segments’ measure of operating earnings and therefore these costs are not<div style="display:inline-block;width:5px"> </div>reviewed by or recorded to reportable segments.</div></div><div id="TextBlockContainer70" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:697px;height:31px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a5318" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">Activity in the Company’s accrual<div style="display:inline-block;width:5px"> </div>for restructuring under the QH Program for the three months ended March 31, 2022<div style="display:inline-block;width:5px"> </div>is as </div><div id="a5360" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">follows:</div></div><div id="TextBlockContainer74" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:667px;height:101px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_72_XBRL_TS_084b9e3fa45045daa11eed560188d9d9" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer73" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:667px;height:101px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a5365" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:578px;top:0px;">QH Program </div><div id="a5369" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:17px;">Accrued restructuring as of December 31, 2021 </div><div id="a5372" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:17px;">$ </div><div id="a5374" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:17px;">4,087</div><div id="a5379" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:34px;">Restructuring and related charges </div><div id="a5382" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:635px;top:34px;">820</div><div id="a5387" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:51px;">Cash payments </div><div id="a5390" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:630px;top:51px;display:flex;">(408)</div><div id="a5395" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:68px;">Currency translation adjustments </div><div id="a5398" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:636px;top:68px;display:flex;">(64)</div><div id="a5402" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:86px;">Accrued restructuring as of March 31, 2022 </div><div id="a5404" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:86px;">$ </div><div id="a5406" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:626px;top:86px;">4,435</div></div></div></div> The Company’s management approved a global restructuring plan (the “QH Program”) as part of its plan to realize certain cost synergies associated with the Combination in the third quarter of 2019. The QH Program includes restructuring and associated severance costs to reduce total headcount by approximately 400 people globally, as well as plans for the closure of certain manufacturing and non-manufacturing facilities. 400 <div id="TextBlockContainer73" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:667px;height:101px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a5365" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:578px;top:0px;">QH Program </div><div id="a5369" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:17px;">Accrued restructuring as of December 31, 2021 </div><div id="a5372" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:17px;">$ </div><div id="a5374" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:17px;">4,087</div><div id="a5379" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:34px;">Restructuring and related charges </div><div id="a5382" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:635px;top:34px;">820</div><div id="a5387" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:51px;">Cash payments </div><div id="a5390" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:630px;top:51px;display:flex;">(408)</div><div id="a5395" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:68px;">Currency translation adjustments </div><div id="a5398" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:636px;top:68px;display:flex;">(64)</div><div id="a5402" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:86px;">Accrued restructuring as of March 31, 2022 </div><div id="a5404" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:86px;">$ </div><div id="a5406" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:626px;top:86px;">4,435</div></div> 4087000 820000 408000 64000 4435000 <div id="TextBlockContainer76" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:726px;height:54px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a5409" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 8 – Share-Based Compensation </div><div id="a5417" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">The Company recognized the following share-based compensation expense<div style="display:inline-block;width:5px"> </div>in its Condensed Consolidated Statements of Income </div><div id="a5424" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">for the three months ended March 31, 2022 and 2021:</div></div><div id="TextBlockContainer80" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:663px;height:157px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_78_XBRL_CS_9124b2f837344956950080968fa61aa7" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer79" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:663px;height:157px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a5434" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:506px;top:0px;">Three Months Ended </div><div id="a5439" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:537px;top:18px;">March 31,<div style="display:inline-block;width:4px"> </div></div><div id="a5444" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:504px;top:35px;">2022 </div><div id="a5447" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:603px;top:35px;">2021 </div><div id="a5451" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:53px;">Stock options </div><div id="a5454" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:53px;">$ </div><div id="a5456" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:536px;top:53px;">267</div><div id="a5459" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:53px;">$ </div><div id="a5461" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:635px;top:53px;">308</div><div id="a5465" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:70px;">Non-vested stock awards and restricted stock units </div><div id="a5470" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:525px;top:70px;">1,548</div><div id="a5474" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:70px;">1,396</div><div id="a5478" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:88px;">Non-elective and elective 401(k) matching contribution in stock </div><div id="a5483" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:542px;top:88px;">—</div><div id="a5487" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:88px;">1,553</div><div id="a5491" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:106px;">Director stock ownership plan </div><div id="a5494" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:542px;top:106px;">24</div><div id="a5498" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:635px;top:106px;">203</div><div id="a5502" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:123px;">Performance stock units </div><div id="a5505" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:536px;top:123px;">623</div><div id="a5509" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:635px;top:123px;">319</div><div id="a5513" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:142px;">Total share-based<div style="display:inline-block;width:5px"> </div>compensation expense </div><div id="a5517" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:142px;">$ </div><div id="a5519" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:525px;top:142px;">2,462</div><div id="a5522" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:142px;">$ </div><div id="a5524" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:142px;">3,779</div></div></div></div><div id="TextBlockContainer82" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:721px;height:124px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a5545" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">Share-based compensation expense is recorded in SG&amp;A, except for less than $</div><div id="a5545_76_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:454px;top:0px;">0.1</div><div id="a5545_79_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:470px;top:0px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a5545_93_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:545px;top:0px;">0.3</div><div id="a5545_96_26" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:561px;top:0px;"><div style="display:inline-block;width:3px"> </div>million during the three </div><div id="a5549" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">months ended March 31, 2022 and 2021, respectively,<div style="display:inline-block;width:5px"> </div>recorded within Combination, integration and other acquisition-related </div><div id="a5552" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">expenses. </div><div id="a5554" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:54px;">Stock Options </div><div id="a5556" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:77px;">During the first quarter of 2022, the Company granted stock options under<div style="display:inline-block;width:5px"> </div>its long-term incentive plan (“LTIP<div style="display:inline-block;width:2px"> </div>”) that are subject </div><div id="a5567" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:93px;">only to time vesting over a </div><div id="a5567_28_10" style="position:absolute;font-family:'Times New Roman';left:151px;top:93px;">three year</div><div id="a5567_38_93" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:203px;top:93px;"><div style="display:inline-block;width:3px"> </div>period.<div style="display:inline-block;width:7px"> </div>For the purposes of determining the fair value of stock option awards, the Company </div><div id="a5570" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:108px;">used a Black-Scholes option pricing model and the assumptions set forth<div style="display:inline-block;width:5px"> </div>in the table below:</div></div><div id="TextBlockContainer85" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:444px;height:118px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a5582" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:349px;top:0px;">March 2022 </div><div id="a5588" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:366px;top:15px;">Grant </div><div id="a5592" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:32px;">Number of options granted </div><div id="a5595" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:32px;">27,077</div><div id="a5600" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:49px;">Dividend yield </div><div id="a5603" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:49px;">0.80</div><div id="a5605" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:425px;top:49px;">% </div><div id="a5609" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:67px;">Expected volatility </div><div id="a5612" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:390px;top:67px;">38.60</div><div id="a5614" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:425px;top:67px;">% </div><div id="a5618" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:84px;">Risk-free interest rate </div><div id="a5623" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:84px;">2.07</div><div id="a5625" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:425px;top:84px;">% </div><div id="a5629" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:102px;">Expected term (years) </div><div id="a5632" style="position:absolute;font-family:'Times New Roman';left:403px;top:102px;">4.0</div></div><div id="TextBlockContainer88" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:732px;height:185px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a5636" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">The fair value of these options is amortized on a straight-line basis over the vesting period.<div style="display:inline-block;width:8px"> </div>As of March 31, 2022, unrecognized </div><div id="a5639" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">compensation expense related to all stock options granted<div style="display:inline-block;width:5px"> </div>was $</div><div id="a5639_63_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:346px;top:15px;">2.9</div><div id="a5639_66_61" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:363px;top:15px;"><div style="display:inline-block;width:3px"> </div>million, to be recognized over a weighted average remaining </div><div id="a5642" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">period of </div><div id="a5642_10_3" style="position:absolute;font-family:'Times New Roman';left:56px;top:31px;">1.9</div><div id="a5642_13_8" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:73px;top:31px;"><div style="display:inline-block;width:3px"> </div>years. </div><div id="a5644" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:54px;">Restricted Stock Awards<div style="display:inline-block;width:5px"> </div>and Restricted Stock Units </div><div id="a5646" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:77px;">During the three months ended March 31, 2022, the Company granted </div><div id="a5646_66_6" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:407px;top:77px;">17,425</div><div id="a5646_72_34" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:443px;top:77px;"><div style="display:inline-block;width:3px"> </div>non-vested restricted shares and </div><div id="a5646_106_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:621px;top:77px;">4,490</div><div id="a5646_111_12" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:651px;top:77px;"><div style="display:inline-block;width:3px"> </div>non-vested </div><div id="a5651" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:93px;">restricted stock units under its LTIP,<div style="display:inline-block;width:7px"> </div>subject to time-based vesting, generally over a </div><div id="a5651_87_10" style="position:absolute;font-family:'Times New Roman';left:454px;top:93px;">three year</div><div id="a5651_97_44" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:507px;top:93px;"><div style="display:inline-block;width:3px"> </div>period.<div style="display:inline-block;width:7px"> </div>The fair value of these grants is </div><div id="a5654" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:108px;">based on the trading price of the Company’s<div style="display:inline-block;width:5px"> </div>common stock on the date of grant.<div style="display:inline-block;width:7px"> </div>The Company adjusts the grant date fair value of </div><div id="a5656" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:123px;">these awards for expected forfeitures based on historical experience.<div style="display:inline-block;width:8px"> </div>As of March 31, 2022, unrecognized compensation expense </div><div id="a5658" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:139px;">related to the nonvested restricted shares was $</div><div id="a5658_48_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:255px;top:139px;">6.4</div><div id="a5658_51_71" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:272px;top:139px;"><div style="display:inline-block;width:3px"> </div>million, to be recognized over a weighted average remaining period of </div><div id="a5658_122_3" style="position:absolute;font-family:'Times New Roman';left:654px;top:139px;">2.1</div><div id="a5658_125_8" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:671px;top:139px;"><div style="display:inline-block;width:3px"> </div>years, </div><div id="a5660" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:154px;">and unrecognized compensation expense related to nonvested restricted<div style="display:inline-block;width:5px"> </div>stock units was $</div><div id="a5660_87_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:481px;top:154px;">1.3</div><div id="a5660_90_43" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:498px;top:154px;"><div style="display:inline-block;width:3px"> </div>million, to be recognized over a weighted </div><div id="a5662" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:169px;">average remaining period of </div><div id="a5662_28_3" style="position:absolute;font-family:'Times New Roman';left:159px;top:169px;">2.3</div><div id="a5662_31_7" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:175px;top:169px;"><div style="display:inline-block;width:3px"> </div>years.</div></div><div id="TextBlockContainer90" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:719px;height:170px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a5664" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:0px;">Performance Stock Units </div><div id="a5666" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">The Company grants performance-dependent stock awards (“PSUs”) as a component<div style="display:inline-block;width:5px"> </div>of its LTIP,<div style="display:inline-block;width:6px"> </div>which will be settled in a </div><div id="a5676" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">certain number of shares subject to market-based and time-based vesting conditions.<div style="display:inline-block;width:8px"> </div>The number of fully vested shares that may </div><div id="a5687" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:54px;">ultimately be issued as settlement for each award may range from </div><div id="a5687_65_1" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:54px;">0</div><div id="a5687_66_8" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:365px;top:54px;">% up to </div><div id="a5687_74_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:410px;top:54px;">200</div><div id="a5687_77_53" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:430px;top:54px;">% of the target award, subject to the achievement of </div><div id="a5689" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">the Company’s total shareholder<div style="display:inline-block;width:5px"> </div>return (“TSR”) relative to the performance of the Company’s<div style="display:inline-block;width:5px"> </div>peer group, the S&amp;P Midcap 400 </div><div id="a5692" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">Materials group.<div style="display:inline-block;width:7px"> </div>The service period required for the PSUs is three years and the TSR measurement<div style="display:inline-block;width:5px"> </div>period for the PSUs is generally </div><div id="a5694" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">from January 1 of the year of grant through December 31 of the year prior<div style="display:inline-block;width:5px"> </div>to issuances of the shares upon settlement.<div style="display:inline-block;width:7px"> </div></div><div id="a5710" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:123px;">Compensation expense for PSUs<div style="display:inline-block;width:4px"> </div>is measured based on their grant date fair value and is recognized on<div style="display:inline-block;width:5px"> </div>a straight-line basis over </div><div id="a5715" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:139px;">the three year vesting period.<div style="display:inline-block;width:7px"> </div>The grant-date fair value of the PSUs was estimated using a Monte Carlo<div style="display:inline-block;width:5px"> </div>simulation on the grant date </div><div id="a5726" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:154px;">and using the following assumptions set forth in the table below:</div></div><div id="TextBlockContainer94" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:444px;height:101px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_92_XBRL_TS_74ec6baff4034ea29f2647c1838cb60f" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer93" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:444px;height:101px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a5734" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:349px;top:0px;">March 2022 </div><div id="a5740" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:366px;top:17px;">Grant </div><div id="a5744" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:34px;">Number of PSUs granted </div><div id="a5747" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:34px;">16,820</div><div id="a5752" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:51px;">Risk-free interest rate </div><div id="a5757" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:395px;top:51px;">2.11</div><div id="a5759" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:425px;top:51px;">% </div><div id="a5763" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:68px;">Dividend yield </div><div id="a5766" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:395px;top:68px;">0.93</div><div id="a5768" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:425px;top:68px;">% </div><div id="a5772" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">Expected term (years) </div><div id="a5775" style="position:absolute;font-family:'Times New Roman';left:402px;top:85px;">3.0</div></div></div></div><div id="TextBlockContainer96" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:722px;height:62px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a5779" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">As of March 31, 2022, the Company estimates that it will issue 0 fully vested shares<div style="display:inline-block;width:5px"> </div>as of the applicable settlement date of all </div><div id="a5786" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">outstanding PSUs awards based on the conditions of the PSUs and performance<div style="display:inline-block;width:5px"> </div>to date for each award.<div style="display:inline-block;width:7px"> </div>As of March 31, 2022,<div style="display:inline-block;width:4px"> </div>there </div><div id="a5793" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">was approximately $</div><div id="a5793_19_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:116px;top:31px;">6.4</div><div id="a5793_22_104" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:132px;top:31px;"><div style="display:inline-block;width:3px"> </div>million of total unrecognized compensation cost related to PSUs which the Company<div style="display:inline-block;width:5px"> </div>expects to recognize </div><div id="a5795" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">over a weighted-average period of </div><div id="a5795_34_3" style="position:absolute;font-family:'Times New Roman';left:191px;top:46px;">2.3</div><div id="a5795_37_7" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:207px;top:46px;"><div style="display:inline-block;width:3px"> </div>years.</div></div><div id="TextBlockContainer98" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:730px;height:131px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a5817" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:0px;">Defined Contribution Plan </div><div id="a5819" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">The Company has a 401(k) plan with an employer match covering<div style="display:inline-block;width:5px"> </div>a majority of its U.S. employees.<div style="display:inline-block;width:7px"> </div>The Company matches </div><div id="a5819_117_2" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:694px;top:23px;">50</div><div id="a5819_119_2" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:708px;top:23px;">% </div><div id="a5823" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">of the first </div><div id="a5823_13_1" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:63px;top:39px;">6</div><div id="a5823_14_112" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:70px;top:39px;">% of compensation that is contributed to the plan, with a maximum matching contribution of 3% of<div style="display:inline-block;width:5px"> </div>compensation.<div style="display:inline-block;width:4px"> </div></div><div id="a5825" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:54px;">Additionally, the plan<div style="display:inline-block;width:5px"> </div>provides for non-elective nondiscretionary contributions on behalf of participants<div style="display:inline-block;width:5px"> </div>who have completed one year </div><div id="a5830" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">of service equal to </div><div id="a5830_20_1" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:106px;top:69px;">3</div><div id="a5830_21_110" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:113px;top:69px;">% of the eligible participants’ compensation.<div style="display:inline-block;width:7px"> </div>Beginning in April 2020 and continuing through March 2021, the </div><div id="a5836" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">Company matched both non-elective and elective 401(k) contributions<div style="display:inline-block;width:5px"> </div>in fully vested shares<div style="display:inline-block;width:3px"> </div>of the Company’s common stock<div style="display:inline-block;width:5px"> </div>rather </div><div id="a5846" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">than cash.<div style="display:inline-block;width:7px"> </div>There were </div><div id="a5846_23_2" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:128px;top:100px;">no</div><div id="a5846_25_103" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:142px;top:100px;"><div style="display:inline-block;width:3px"> </div>matching contributions in stock for the three months ended March 31, 2022. For<div style="display:inline-block;width:5px"> </div>the three months ended </div><div id="a5851" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:115px;">March 31, 2021, total contributions were $</div><div id="a5851_42_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:233px;top:115px;">1.5</div><div id="a5851_45_9" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:249px;top:115px;"><div style="display:inline-block;width:3px"> </div>million.</div></div> <div id="TextBlockContainer79" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:663px;height:157px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a5434" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:506px;top:0px;">Three Months Ended </div><div id="a5439" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:537px;top:18px;">March 31,<div style="display:inline-block;width:4px"> </div></div><div id="a5444" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:504px;top:35px;">2022 </div><div id="a5447" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:603px;top:35px;">2021 </div><div id="a5451" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:53px;">Stock options </div><div id="a5454" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:53px;">$ </div><div id="a5456" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:536px;top:53px;">267</div><div id="a5459" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:53px;">$ </div><div id="a5461" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:635px;top:53px;">308</div><div id="a5465" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:70px;">Non-vested stock awards and restricted stock units </div><div id="a5470" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:525px;top:70px;">1,548</div><div id="a5474" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:70px;">1,396</div><div id="a5478" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:88px;">Non-elective and elective 401(k) matching contribution in stock </div><div id="a5483" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:542px;top:88px;">—</div><div id="a5487" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:88px;">1,553</div><div id="a5491" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:106px;">Director stock ownership plan </div><div id="a5494" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:542px;top:106px;">24</div><div id="a5498" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:635px;top:106px;">203</div><div id="a5502" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:123px;">Performance stock units </div><div id="a5505" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:536px;top:123px;">623</div><div id="a5509" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:635px;top:123px;">319</div><div id="a5513" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:142px;">Total share-based<div style="display:inline-block;width:5px"> </div>compensation expense </div><div id="a5517" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:142px;">$ </div><div id="a5519" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:525px;top:142px;">2,462</div><div id="a5522" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:142px;">$ </div><div id="a5524" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:142px;">3,779</div></div> 267000 308000 1548000 1396000 0 1553000 24000 203000 623000 319000 2462000 3779000 100000 300000 P3Y <div id="TextBlockContainer86" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:444px;height:118px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_84_XBRL_TS_4ec098ca5b0c4cf8add5f4d7263393bb" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer85" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:444px;height:118px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a5582" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:349px;top:0px;">March 2022 </div><div id="a5588" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:366px;top:15px;">Grant </div><div id="a5592" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:32px;">Number of options granted </div><div id="a5595" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:32px;">27,077</div><div id="a5600" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:49px;">Dividend yield </div><div id="a5603" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:49px;">0.80</div><div id="a5605" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:425px;top:49px;">% </div><div id="a5609" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:67px;">Expected volatility </div><div id="a5612" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:390px;top:67px;">38.60</div><div id="a5614" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:425px;top:67px;">% </div><div id="a5618" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:84px;">Risk-free interest rate </div><div id="a5623" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:84px;">2.07</div><div id="a5625" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:425px;top:84px;">% </div><div id="a5629" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:102px;">Expected term (years) </div><div id="a5632" style="position:absolute;font-family:'Times New Roman';left:403px;top:102px;">4.0</div></div></div></div> 27077 0.0080 0.3860 0.0207 P4Y 2900000 P1Y10M24D 17425 4490 P3Y 6400000 P2Y1M6D 1300000 P2Y3M18D 0 2 <div id="TextBlockContainer93" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:444px;height:101px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a5734" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:349px;top:0px;">March 2022 </div><div id="a5740" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:366px;top:17px;">Grant </div><div id="a5744" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:34px;">Number of PSUs granted </div><div id="a5747" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:34px;">16,820</div><div id="a5752" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:51px;">Risk-free interest rate </div><div id="a5757" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:395px;top:51px;">2.11</div><div id="a5759" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:425px;top:51px;">% </div><div id="a5763" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:68px;">Dividend yield </div><div id="a5766" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:395px;top:68px;">0.93</div><div id="a5768" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:425px;top:68px;">% </div><div id="a5772" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">Expected term (years) </div><div id="a5775" style="position:absolute;font-family:'Times New Roman';left:402px;top:85px;">3.0</div></div> 16820 0.0211 0.0093 P3Y 6400000 P2Y3M18D 0.50 0.06 0.03 0 1500000 <div id="TextBlockContainer100" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:692px;height:39px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a5862" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 9 – Pension and Other Postretirement<div style="display:inline-block;width:5px"> </div>Benefits </div><div id="a5867" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">The components of net periodic benefit (income) cost for the three months<div style="display:inline-block;width:5px"> </div>ended March 31, 2022 and 2021 are as follows:</div></div><div id="TextBlockContainer103" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:663px;height:164px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a5877" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:376px;top:0px;">Three Months Ended March 31,<div style="display:inline-block;width:5px"> </div></div><div id="a5888" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:550px;top:16px;">Other </div><div id="a5893" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:322px;top:30px;">Pension Benefits </div><div id="a5896" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:499px;top:30px;">Postretirement Benefits </div><div id="a5902" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:312px;top:46px;">2022 </div><div id="a5906" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:411px;top:46px;">2021 </div><div id="a5910" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:510px;top:46px;">2022 </div><div id="a5914" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:609px;top:46px;">2021 </div><div id="a5918" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:61px;">Service cost </div><div id="a5920" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:276px;top:61px;">$ </div><div id="a5922" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:338px;top:61px;">180</div><div id="a5925" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:376px;top:61px;">$ </div><div id="a5927" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:437px;top:61px;">316</div><div id="a5930" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:61px;">$ </div><div id="a5932" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:544px;top:61px;display:flex;">(8)</div><div id="a5935" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:61px;">$ </div><div id="a5937" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:648px;top:61px;">1</div><div id="a5941" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:77px;">Interest cost </div><div id="a5944" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:328px;top:77px;">1,360</div><div id="a5948" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:427px;top:77px;">1,090</div><div id="a5952" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:549px;top:77px;">9</div><div id="a5956" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:641px;top:77px;">11</div><div id="a5960" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:95px;">Expected return on plan assets </div><div id="a5963" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:323px;top:95px;display:flex;">(2,084)</div><div id="a5967" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:422px;top:95px;display:flex;">(2,082)</div><div id="a5971" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:542px;top:95px;">—</div><div id="a5975" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:641px;top:95px;">—</div><div id="a5979" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:113px;">Actuarial loss (gain) amortization </div><div id="a5982" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:338px;top:113px;">257</div><div id="a5986" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:437px;top:113px;">855</div><div id="a5990" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:537px;top:113px;display:flex;">(24)</div><div id="a5994" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:641px;top:113px;">—</div><div id="a5998" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:130px;">Prior service cost (income) amortization </div><div id="a6001" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:351px;top:130px;">2</div><div id="a6005" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:450px;top:130px;">2</div><div id="a6009" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:549px;top:130px;">1</div><div id="a6013" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:641px;top:130px;">—</div><div id="a6017" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:149px;">Total net periodic benefit<div style="display:inline-block;width:5px"> </div>(income) cost </div><div id="a6019" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:276px;top:149px;">$ </div><div id="a6021" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:333px;top:149px;display:flex;">(285)</div><div id="a6024" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:376px;top:149px;">$ </div><div id="a6026" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:437px;top:149px;">181</div><div id="a6029" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:149px;">$ </div><div id="a6031" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:537px;top:149px;display:flex;">(22)</div><div id="a6034" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:149px;">$ </div><div id="a6036" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:641px;top:149px;">12</div></div><div id="TextBlockContainer106" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:730px;height:86px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a6039" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:0px;">Employer Contributions </div><div id="a6041" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">As of March 31, 2022, $</div><div id="a6041_23_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:159px;top:23px;">1.0</div><div id="a6041_26_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:176px;top:23px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a6041_40_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:250px;top:23px;">0.1</div><div id="a6041_43_83" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:267px;top:23px;"><div style="display:inline-block;width:3px"> </div>million of contributions have been made to the Company’s<div style="display:inline-block;width:5px"> </div>U.S. and foreign pension </div><div id="a6058" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">plans and its other postretirement benefit plans, respectively.<div style="display:inline-block;width:5px"> </div>Taking into consideration<div style="display:inline-block;width:5px"> </div>current minimum cash contribution </div><div id="a6064" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:54px;">requirements, the Company currently expects to make full year cash contributions<div style="display:inline-block;width:5px"> </div>of approximately $</div><div id="a6064_99_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:547px;top:54px;">6.6</div><div id="a6064_102_25" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:563px;top:54px;"><div style="display:inline-block;width:3px"> </div>million to its U.S. and </div><div id="a6075" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">foreign pension plans and approximately $</div><div id="a6075_41_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:232px;top:69px;">0.2</div><div id="a6075_44_59" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:249px;top:69px;"><div style="display:inline-block;width:3px"> </div>million to its other postretirement benefit plans in 2022.</div></div> <div id="TextBlockContainer104" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:663px;height:164px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_102_XBRL_TS_07aa3ef302cd42afa99e1b5474319892" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer103" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:663px;height:164px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a5877" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:376px;top:0px;">Three Months Ended March 31,<div style="display:inline-block;width:5px"> </div></div><div id="a5888" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:550px;top:16px;">Other </div><div id="a5893" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:322px;top:30px;">Pension Benefits </div><div id="a5896" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:499px;top:30px;">Postretirement Benefits </div><div id="a5902" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:312px;top:46px;">2022 </div><div id="a5906" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:411px;top:46px;">2021 </div><div id="a5910" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:510px;top:46px;">2022 </div><div id="a5914" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:609px;top:46px;">2021 </div><div id="a5918" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:61px;">Service cost </div><div id="a5920" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:276px;top:61px;">$ </div><div id="a5922" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:338px;top:61px;">180</div><div id="a5925" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:376px;top:61px;">$ </div><div id="a5927" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:437px;top:61px;">316</div><div id="a5930" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:61px;">$ </div><div id="a5932" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:544px;top:61px;display:flex;">(8)</div><div id="a5935" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:61px;">$ </div><div id="a5937" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:648px;top:61px;">1</div><div id="a5941" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:77px;">Interest cost </div><div id="a5944" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:328px;top:77px;">1,360</div><div id="a5948" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:427px;top:77px;">1,090</div><div id="a5952" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:549px;top:77px;">9</div><div id="a5956" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:641px;top:77px;">11</div><div id="a5960" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:95px;">Expected return on plan assets </div><div id="a5963" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:323px;top:95px;display:flex;">(2,084)</div><div id="a5967" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:422px;top:95px;display:flex;">(2,082)</div><div id="a5971" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:542px;top:95px;">—</div><div id="a5975" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:641px;top:95px;">—</div><div id="a5979" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:113px;">Actuarial loss (gain) amortization </div><div id="a5982" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:338px;top:113px;">257</div><div id="a5986" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:437px;top:113px;">855</div><div id="a5990" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:537px;top:113px;display:flex;">(24)</div><div id="a5994" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:641px;top:113px;">—</div><div id="a5998" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:130px;">Prior service cost (income) amortization </div><div id="a6001" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:351px;top:130px;">2</div><div id="a6005" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:450px;top:130px;">2</div><div id="a6009" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:549px;top:130px;">1</div><div id="a6013" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:641px;top:130px;">—</div><div id="a6017" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:149px;">Total net periodic benefit<div style="display:inline-block;width:5px"> </div>(income) cost </div><div id="a6019" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:276px;top:149px;">$ </div><div id="a6021" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:333px;top:149px;display:flex;">(285)</div><div id="a6024" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:376px;top:149px;">$ </div><div id="a6026" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:437px;top:149px;">181</div><div id="a6029" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:149px;">$ </div><div id="a6031" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:537px;top:149px;display:flex;">(22)</div><div id="a6034" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:149px;">$ </div><div id="a6036" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:641px;top:149px;">12</div></div></div></div> 180000 316000 -8000 1000 1360000 1090000 9000 11000 2084000 2082000 0 0 -257000 -855000 24000 0 2000 2000 1000 0 -285000 181000 -22000 12000 1000000.0 100000 6600000 200000 <div id="TextBlockContainer108" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:660px;height:39px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a6090" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 10 – Other (Expense) Income, Net</div><div id="a6095" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">The components of other (expense) income, net for the three months ended<div style="display:inline-block;width:5px"> </div>March 31, 2022 and 2021 are as follows:</div></div><div id="TextBlockContainer112" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:667px;height:169px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_110_XBRL_TS_41e8327c4f0c4e2687870dd1e56a1a50" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer111" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:667px;height:169px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a6100" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:506px;top:0px;">Three Months Ended<div style="display:inline-block;width:4px"> </div></div><div id="a6106" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:537px;top:17px;">March 31, </div><div id="a6111" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:504px;top:34px;">2022 </div><div id="a6114" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:603px;top:34px;">2021 </div><div id="a6118" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:51px;">Income from third party license fees </div><div id="a6120" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:51px;">$ </div><div id="a6122" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:536px;top:51px;">404</div><div id="a6125" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:51px;">$ </div><div id="a6127" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:635px;top:51px;">339</div><div id="a6131" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:68px;">Foreign exchange losses, net </div><div id="a6134" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:521px;top:68px;display:flex;">(1,905)</div><div id="a6138" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:620px;top:68px;display:flex;">(1,478)</div><div id="a6142" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">Gain on disposals of property,<div style="display:inline-block;width:5px"> </div>plant, equipment and other assets, net </div><div id="a6145" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:542px;top:85px;">23</div><div id="a6149" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:85px;">5,410</div><div id="a6153" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:102px;">Non-income tax refunds and other related (expense) credits </div><div id="a6158" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:521px;top:102px;display:flex;">(1,322)</div><div id="a6162" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:641px;top:102px;">97</div><div id="a6166" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:119px;">Pension and postretirement benefit income, non-service components </div><div id="a6171" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:536px;top:119px;">479</div><div id="a6175" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:635px;top:119px;">124</div><div id="a6179" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:136px;">Other non-operating income, net </div><div id="a6184" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:536px;top:136px;">115</div><div id="a6188" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:635px;top:136px;">195</div><div id="a6192" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:153px;">Total other (expense)<div style="display:inline-block;width:5px"> </div>income, net </div><div id="a6194" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:153px;">$ </div><div id="a6196" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:521px;top:153px;display:flex;">(2,206)</div><div id="a6199" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:153px;">$ </div><div id="a6201" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:153px;">4,687</div></div></div></div><div id="TextBlockContainer114" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:733px;height:108px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a6204" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">Non-income tax refunds and other related (expense) credits during the<div style="display:inline-block;width:5px"> </div>three months ended March 31, 2022 includes other expense </div><div id="a6208" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">related to an indemnification asset associated with the settlement of certain<div style="display:inline-block;width:5px"> </div>income tax audits at one of the Company’s<div style="display:inline-block;width:5px"> </div>Italian affiliates </div><div id="a6210" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">for tax periods prior to August 1, 2019.<div style="display:inline-block;width:7px"> </div>See Note 11 of Notes to Condensed Consolidated<div style="display:inline-block;width:5px"> </div>Financial Statements.<div style="display:inline-block;width:7px"> </div>Gain on disposals of </div><div id="a6219" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">property, plant, equipment<div style="display:inline-block;width:5px"> </div>and other assets, net, during the three months ended March 31, 2021, includes a gain on the<div style="display:inline-block;width:5px"> </div>sale of certain </div><div id="a6223" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:61px;">held-for-sale real property assets related to the Combination.<div style="display:inline-block;width:8px"> </div>Foreign exchange losses, net, during each of the three months ended </div><div id="a6236" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:77px;">March 31, 2022 and 2021 include foreign currency transaction losses of approximately<div style="display:inline-block;width:5px"> </div>$</div><div id="a6236_86_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:478px;top:77px;">0.2</div><div id="a6236_89_39" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:495px;top:77px;"><div style="display:inline-block;width:3px"> </div>million related to hyper-inflationary </div><div id="a6248" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:92px;">accounting for the Company’s Argentine<div style="display:inline-block;width:5px"> </div>subsidiaries.<div style="display:inline-block;width:7px"> </div>See Note 1 of Notes to Condensed Consolidated Financial Statements.</div></div> <div id="TextBlockContainer111" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:667px;height:169px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a6100" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:506px;top:0px;">Three Months Ended<div style="display:inline-block;width:4px"> </div></div><div id="a6106" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:537px;top:17px;">March 31, </div><div id="a6111" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:504px;top:34px;">2022 </div><div id="a6114" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:603px;top:34px;">2021 </div><div id="a6118" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:51px;">Income from third party license fees </div><div id="a6120" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:51px;">$ </div><div id="a6122" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:536px;top:51px;">404</div><div id="a6125" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:51px;">$ </div><div id="a6127" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:635px;top:51px;">339</div><div id="a6131" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:68px;">Foreign exchange losses, net </div><div id="a6134" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:521px;top:68px;display:flex;">(1,905)</div><div id="a6138" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:620px;top:68px;display:flex;">(1,478)</div><div id="a6142" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">Gain on disposals of property,<div style="display:inline-block;width:5px"> </div>plant, equipment and other assets, net </div><div id="a6145" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:542px;top:85px;">23</div><div id="a6149" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:85px;">5,410</div><div id="a6153" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:102px;">Non-income tax refunds and other related (expense) credits </div><div id="a6158" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:521px;top:102px;display:flex;">(1,322)</div><div id="a6162" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:641px;top:102px;">97</div><div id="a6166" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:119px;">Pension and postretirement benefit income, non-service components </div><div id="a6171" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:536px;top:119px;">479</div><div id="a6175" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:635px;top:119px;">124</div><div id="a6179" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:136px;">Other non-operating income, net </div><div id="a6184" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:536px;top:136px;">115</div><div id="a6188" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:635px;top:136px;">195</div><div id="a6192" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:153px;">Total other (expense)<div style="display:inline-block;width:5px"> </div>income, net </div><div id="a6194" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:153px;">$ </div><div id="a6196" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:521px;top:153px;display:flex;">(2,206)</div><div id="a6199" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:153px;">$ </div><div id="a6201" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:153px;">4,687</div></div> 404000 339000 -1905000 -1478000 23000 5410000 -1322000 97000 479000 124000 115000 195000 -2206000 4687000 200000 200000 <div id="TextBlockContainer116" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:733px;height:852px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a6271" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 11 – Income Taxes<div style="display:inline-block;width:6px"> </div>and Uncertain Income Tax<div style="display:inline-block;width:5px"> </div>Positions </div><div id="a6276" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">The Company’s effective<div style="display:inline-block;width:5px"> </div>tax rates for the three months ended March 31, 2022 and 2021 were </div><div id="a6276_90_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:532px;top:23px;">13.1</div><div id="a6276_94_6" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:555px;top:23px;">% and </div><div id="a6276_100_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:592px;top:23px;">24.2</div><div id="a6276_104_18" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:616px;top:23px;">%, respectively.<div style="display:inline-block;width:4px"> </div></div><div id="a6327" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">The Company’s effective<div style="display:inline-block;width:5px"> </div>tax rate for the three months ended March 31, 2022 was largely driven by changes in<div style="display:inline-block;width:5px"> </div>the valuation </div><div id="a6371" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:54px;">allowance for foreign tax credits due to recently issued legislative guidance<div style="display:inline-block;width:5px"> </div>and audit settlements reached with Italian tax authorities.<div style="display:inline-block;width:4px"> </div></div><div id="a6410" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">In addition, the Company incurred higher tax expense during the three months<div style="display:inline-block;width:5px"> </div>ended March 31, 2022 related to the Company </div><div id="a6413" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">recording earnings in one of its subsidiaries at a statutory tax rate of </div><div id="a6413_73_2" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:370px;top:85px;">25</div><div id="a6413_75_53" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:384px;top:85px;">% while it awaits recertification of a concessionary </div><div id="a6413_128_2" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:660px;top:85px;">15</div><div id="a6413_130_6" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:673px;top:85px;">% tax </div><div id="a6418" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">rate, which was available to the Company during all of 2021.<div style="display:inline-block;width:8px"> </div>Comparatively,<div style="display:inline-block;width:5px"> </div>the prior year first quarter effective tax rate was </div><div id="a6442" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:115px;">impacted by the sale of a subsidiary which included certain held-for-sale<div style="display:inline-block;width:5px"> </div>real property assets related to the Combination.<div style="display:inline-block;width:4px"> </div></div><div id="a6483" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:139px;">As of December 31, 2021, the Company had a deferred tax liability of $</div><div id="a6483_70_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:413px;top:139px;">8.4</div><div id="a6483_73_52" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:429px;top:139px;"><div style="display:inline-block;width:3px"> </div>million on certain undistributed foreign earnings, </div><div id="a6523" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:154px;">which primarily represents the Company’s<div style="display:inline-block;width:5px"> </div>estimate of non-U.S. income taxes the Company will incur to ultimately remit certain </div><div id="a6561" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:169px;">earnings to the U.S.<div style="display:inline-block;width:7px"> </div>The balance as of March 31, 2022 was $</div><div id="a6561_60_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:333px;top:169px;">8.0</div><div id="a6561_63_10" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:349px;top:169px;"><div style="display:inline-block;width:3px"> </div>million. </div><div id="a6590" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:193px;">As of March 31, 2022, the Company’s<div style="display:inline-block;width:5px"> </div>cumulative liability for gross unrecognized tax benefits was $</div><div id="a6590_98_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:566px;top:193px;">20.1</div><div id="a6590_102_24" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:589px;top:193px;"><div style="display:inline-block;width:3px"> </div>million, a decrease of </div><div id="a6636" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:208px;">approximately $</div><div id="a6636_15_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:92px;top:208px;">2.4</div><div id="a6636_18_73" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:108px;top:208px;"><div style="display:inline-block;width:3px"> </div>million from the cumulative liability accrued as of December 31, 2021.<div style="display:inline-block;width:4px"> </div></div><div id="a6668" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:231px;">The Company continues to recognize interest and penalties associated with uncertain<div style="display:inline-block;width:5px"> </div>tax positions as a component of taxes on </div><div id="a6706" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:247px;">income before equity in net income of associated companies in its Condensed<div style="display:inline-block;width:5px"> </div>Consolidated Statements<div style="display:inline-block;width:4px"> </div>of Income.<div style="display:inline-block;width:7px"> </div>The Company </div><div id="a6744" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:262px;">recognized a benefit of $</div><div id="a6744_25_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:137px;top:262px;">0.3</div><div id="a6744_28_40" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:154px;top:262px;"><div style="display:inline-block;width:3px"> </div>million for interest and a benefit of $</div><div id="a6744_68_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:354px;top:262px;">1.6</div><div id="a6744_71_67" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:370px;top:262px;"><div style="display:inline-block;width:3px"> </div>million for penalties in its Condensed Consolidated Statements of </div><div id="a6793" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:277px;">Income for the three months ended March 31, 2022, and recognized<div style="display:inline-block;width:5px"> </div>an expense of less than $</div><div id="a6793_90_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:503px;top:277px;">0.1</div><div id="a6793_93_39" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:520px;top:277px;"><div style="display:inline-block;width:3px"> </div>million for interest and a benefit of </div><div id="a6843" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:293px;">$</div><div id="a6843_1_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:11px;top:293px;">0.1</div><div id="a6843_4_124" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:293px;"><div style="display:inline-block;width:3px"> </div>million for penalties in its Condensed Consolidated Statements of Income for the<div style="display:inline-block;width:5px"> </div>three months ended March 31, 2021.<div style="display:inline-block;width:7px"> </div>As of </div><div id="a6889" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:308px;">March 31, 2022, the Company had accrued $</div><div id="a6889_41_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:245px;top:308px;">2.7</div><div id="a6889_44_38" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:262px;top:308px;"><div style="display:inline-block;width:3px"> </div>million for cumulative interest and $</div><div id="a6889_82_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:460px;top:308px;">1.6</div><div id="a6889_85_41" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:477px;top:308px;"><div style="display:inline-block;width:3px"> </div>million for cumulative penalties in its </div><div id="a6937" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:323px;">Condensed Consolidated Balance Sheets, compared to $</div><div id="a6937_52_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:305px;top:323px;">3.1</div><div id="a6937_55_38" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:322px;top:323px;"><div style="display:inline-block;width:3px"> </div>million for cumulative interest and $</div><div id="a6937_93_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:520px;top:323px;">3.1</div><div id="a6937_96_34" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:537px;top:323px;"><div style="display:inline-block;width:3px"> </div>million for cumulative penalties </div><div id="a6974" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:339px;">accrued at December 31, 2021. </div><div id="a6987" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:362px;">During the three months ended March 31, 2022 and 2021, the Company<div style="display:inline-block;width:5px"> </div>recognized decreases of $</div><div id="a6987_92_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:553px;top:362px;">2.8</div><div id="a6987_95_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:570px;top:362px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a6987_109_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:645px;top:362px;">0.3</div><div id="a6987_112_10" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:661px;top:362px;"><div style="display:inline-block;width:3px"> </div>million, </div><div id="a7028" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:377px;">respectively, in its cumulative<div style="display:inline-block;width:5px"> </div>liability for gross unrecognized tax benefits due to the settlement of income<div style="display:inline-block;width:5px"> </div>tax audits with the Italian </div><div id="a7070" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:393px;">tax authorities, as well as the expiration of the applicable statutes of<div style="display:inline-block;width:5px"> </div>limitations for certain tax years. </div><div id="a7105" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:416px;">The Company estimates that during the year ending December 31, 202<div style="display:inline-block;width:1px"> </div>2<div style="display:inline-block;width:3px"> </div>it will reduce its cumulative liability for gross </div><div id="a7145" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:431px;">unrecognized tax benefits by approximately $</div><div id="a7145_44_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:249px;top:431px;">4.2</div><div id="a7145_47_89" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:265px;top:431px;"><div style="display:inline-block;width:3px"> </div>million due to the settlement of income tax audits and the expiration of the statute of </div><div id="a7193" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:447px;">limitations with regard to certain tax positions.<div style="display:inline-block;width:8px"> </div>This estimated reduction in the cumulative liability for unrecognized<div style="display:inline-block;width:5px"> </div>tax benefits does </div><div id="a7231" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:462px;">not consider any increase in liability for unrecognized tax benefits with regard<div style="display:inline-block;width:5px"> </div>to existing tax positions or any increase in cumulative </div><div id="a7273" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:477px;">liability for unrecognized tax benefits with regard to new tax positions for<div style="display:inline-block;width:5px"> </div>the year ending December<div style="display:inline-block;width:4px"> </div>31, 2022. </div><div id="a7312" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:498px;">The Company<div style="display:inline-block;width:4px"> </div>and its subsidiaries are subject to U.S. Federal income tax, as well as the income tax of various<div style="display:inline-block;width:5px"> </div>state and foreign </div><div id="a7359" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:513px;">tax jurisdictions.<div style="display:inline-block;width:7px"> </div>Tax years that remain subject<div style="display:inline-block;width:5px"> </div>to examination by major tax jurisdictions include Italy from </div><div id="a7359_111_4" style="position:absolute;font-family:'Times New Roman';left:583px;top:513px;">2007</div><div id="a7359_115_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:610px;top:513px;">, Brazil from </div><div id="a7359_129_4" style="position:absolute;font-family:'Times New Roman';left:681px;top:513px;">2011</div><div id="a7359_133_2" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:708px;top:513px;">, </div><div id="a7402" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:529px;">Germany from </div><div id="a7402_13_4" style="position:absolute;font-family:'Times New Roman';left:87px;top:529px;">2015</div><div id="a7402_17_41" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:113px;top:529px;">, the Netherlands, Mexico and China from </div><div id="a7402_58_4" style="position:absolute;font-family:'Times New Roman';left:342px;top:529px;">2016</div><div id="a7402_62_35" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:369px;top:529px;">, Canada, Spain, and the U.S. from </div><div id="a7402_97_4" style="position:absolute;font-family:'Times New Roman';left:557px;top:529px;">2017</div><div id="a7402_101_21" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:584px;top:529px;">, the United Kingdom </div><div id="a7448" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:544px;">from </div><div id="a7448_5_4" style="position:absolute;font-family:'Times New Roman';left:34px;top:544px;">2018</div><div id="a7448_9_70" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:60px;top:544px;">, India from fiscal year beginning April 1, 2017 and ending March 31, </div><div id="a7448_79_4" style="position:absolute;font-family:'Times New Roman';left:437px;top:544px;">2018</div><div id="a7448_83_48" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:464px;top:544px;">, and various U.S. state tax jurisdictions from </div><div id="a7495" style="position:absolute;font-family:'Times New Roman';left:4px;top:559px;">2011</div><div id="a7495_4_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:31px;top:559px;">.<div style="display:inline-block;width:6px"> </div></div><div id="a7498" style="position:absolute;font-family:'Times New Roman';left:28px;top:580px;">As previously reported, the Italian tax authorities have assessed additional tax due from the Company’s subsidiary, Quaker Italia </div><div id="a7535" style="position:absolute;font-family:'Times New Roman';left:4px;top:595px;">S.r.l., relating to the tax years 2007 through 2015. The Company has filed for competent authority relief from these assessments under </div><div id="a7577" style="position:absolute;font-family:'Times New Roman';left:4px;top:611px;">the Mutual Agreement Procedures (“MAP”) of the Organization for Economic Co-Operation and Development for all years except </div><div id="a7614" style="position:absolute;font-family:'Times New Roman';left:4px;top:626px;">2007. In 2020, the respective tax authorities in Italy, Spain and the Netherlands reached agreement with respect to the MAP </div><div id="a7654" style="position:absolute;font-family:'Times New Roman';left:4px;top:641px;">proceedings which the Company has accepted.</div><div id="a7654_43_50" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:254px;top:641px;"><div style="display:inline-block;width:7px"> </div>As of March 31, 2022, the Company has received $</div><div id="a7654_93_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:536px;top:641px;">1.6</div><div id="a7654_96_29" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:553px;top:641px;"><div style="display:inline-block;width:3px"> </div>million in refunds from the </div><div id="a7702" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:657px;">Netherlands and Spain.<div style="display:inline-block;width:7px"> </div>In February 2022, the Company received a settlement notice from the Italian taxing<div style="display:inline-block;width:5px"> </div>authorities confirming the </div><div id="a7741" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:672px;">amount due of $</div><div id="a7741_15_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:92px;top:672px;">2.6</div><div id="a7741_18_117" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:108px;top:672px;"><div style="display:inline-block;width:3px"> </div>million, having granted the Company’s request<div style="display:inline-block;width:5px"> </div>to utilize its remaining net operating losses to partially offset<div style="display:inline-block;width:5px"> </div>the </div><div id="a7783" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:687px;">liability.<div style="display:inline-block;width:8px"> </div>As a result of the settlement the Company recognized tax expense of $</div><div id="a7783_81_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:432px;top:687px;">0.8</div><div id="a7783_84_47" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:449px;top:687px;"><div style="display:inline-block;width:3px"> </div>million for the quarter ended March 31, 2022. </div><div id="a7829" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:708px;">Houghton Italia, S.r.l is also involved<div style="display:inline-block;width:5px"> </div>in a corporate income tax audit with the Italian tax authorities covering tax years </div><div id="a7829_124_4" style="position:absolute;font-family:'Times New Roman';left:665px;top:708px;">2014</div><div id="a7871" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:723px;">through </div><div id="a7871_8_4" style="position:absolute;font-family:'Times New Roman';left:49px;top:723px;">2018</div><div id="a7871_12_120" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:76px;top:723px;">.<div style="display:inline-block;width:7px"> </div>During the fourth quarter of 2021, the Company settled a portion of the Houghton Italia,<div style="display:inline-block;width:5px"> </div>S.r.l. corporate income tax </div><div id="a7913" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:739px;">audit with the Italian tax authorities for the tax years </div><div id="a7913_57_4" style="position:absolute;font-family:'Times New Roman';left:288px;top:739px;">2014</div><div id="a7913_61_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:314px;top:739px;"><div style="display:inline-block;width:3px"> </div>and </div><div id="a7913_66_4" style="position:absolute;font-family:'Times New Roman';left:340px;top:739px;">2015</div><div id="a7913_70_60" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:367px;top:739px;">.<div style="display:inline-block;width:7px"> </div>During the three months ended March 31, 2022 the Company </div><div id="a7961" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:754px;">settled tax years 2016 through 2018 for a total of $</div><div id="a7961_52_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:275px;top:754px;">2.1</div><div id="a7961_55_81" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:292px;top:754px;"><div style="display:inline-block;width:3px"> </div>million.<div style="display:inline-block;width:7px"> </div>In total, the Company has now settled all years 2014 through 2018 for </div><div id="a8017" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:769px;">$</div><div id="a8017_1_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:11px;top:769px;">3.7</div><div id="a8017_4_132" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:769px;"><div style="display:inline-block;width:3px"> </div>million.<div style="display:inline-block;width:7px"> </div>Accordingly, the Company has<div style="display:inline-block;width:5px"> </div>released all reserves relating to this audit for the settled tax years.<div style="display:inline-block;width:8px"> </div>As a result of the </div><div id="a8066" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:785px;">settlement and reserve release the Company recognized a net benefit<div style="display:inline-block;width:5px"> </div>to the tax provision of $</div><div id="a8066_93_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:785px;">2.1</div><div id="a8066_96_37" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:518px;top:785px;"><div style="display:inline-block;width:3px"> </div>million during the first quarter of </div><div id="a8111" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:800px;">2022.<div style="display:inline-block;width:7px"> </div>The Company has established an indemnification receivable of $</div><div id="a8111_69_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:387px;top:800px;">3.8</div><div id="a8111_72_57" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:404px;top:800px;"><div style="display:inline-block;width:3px"> </div>million in connection with its claim against the former </div><div id="a8149" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:815px;">owners of Houghton for any pre-Combination tax liabilities arising from<div style="display:inline-block;width:5px"> </div>this matter. </div><div id="a8175" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:836px;"><div style="display:inline-block;width:192px"> </div></div></div><div id="TextBlockContainer118" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:718px;height:77px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a8195" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">Houghton Deutschland GmbH is also under audit by the German tax authorities for<div style="display:inline-block;width:5px"> </div>the tax years </div><div id="a8195_94_4" style="position:absolute;font-family:'Times New Roman';left:547px;top:0px;">2015</div><div id="a8195_98_9" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:0px;"><div style="display:inline-block;width:3px"> </div>through </div><div id="a8195_107_4" style="position:absolute;font-family:'Times New Roman';left:622px;top:0px;">2017</div><div id="a8195_111_12" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:649px;top:0px;">.<div style="display:inline-block;width:7px"> </div>Based on </div><div id="a8238" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">preliminary audit findings, primarily related to transfer pricing,<div style="display:inline-block;width:5px"> </div>the Company has recorded reserves for $</div><div id="a8238_106_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:564px;top:15px;">0.3</div><div id="a8238_109_25" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:581px;top:15px;"><div style="display:inline-block;width:3px"> </div>million as of March 31, </div><div id="a8279" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">2022.<div style="display:inline-block;width:7px"> </div>Of this amount, $</div><div id="a8279_24_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:135px;top:31px;">0.3</div><div id="a8279_27_100" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:151px;top:31px;"><div style="display:inline-block;width:3px"> </div>million relates to tax periods prior to the Combination and therefore the Company<div style="display:inline-block;width:5px"> </div>has submitted an </div><div id="a8323" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">indemnification claim with Houghton’s<div style="display:inline-block;width:5px"> </div>former owners for any tax liabilities arising pre-Combination.<div style="display:inline-block;width:8px"> </div>As a result, a corresponding </div><div id="a8359" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:61px;">indemnification receivable has also been established.</div></div> 0.131 0.242 0.25 0.15 8400000 8000000.0 20100000 2400000 300000 1600000 100000 100000 2700000 1600000 3100000 3100000 2800000 300000 4200000 2007 2011 2015 2016 2016 2016 2017 2017 2017 2018 2018 2011 As previously reported, the Italian tax authorities have assessed additional tax due from the Company’s subsidiary, Quaker Italia S.r.l., relating to the tax years 2007 through 2015. The Company has filed for competent authority relief from these assessments under the Mutual Agreement Procedures (“MAP”) of the Organization for Economic Co-Operation and Development for all years except 2007. In 2020, the respective tax authorities in Italy, Spain and the Netherlands reached agreement with respect to the MAP proceedings which the Company has accepted. 1600000 2600000 800000 2014 2018 2014 2015 2100000 3700000 -2100000 3800000 2015 2017 300000 300000 <div id="TextBlockContainer120" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:668px;height:39px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a8371" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 12 – Earnings Per Share </div><div id="a8376" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">The following table summarizes earnings per share calculations for<div style="display:inline-block;width:5px"> </div>the three months ended March 31, 2022 and 2021:</div></div><div id="TextBlockContainer124" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:666px;height:303px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_122_XBRL_CS_5dcb52a1e43d41cf94260a6d9a167108" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer123" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:666px;height:303px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a8388" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:505px;top:0px;">Three Months Ended </div><div id="a8394" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:536px;top:17px;">March 31,<div style="display:inline-block;width:4px"> </div></div><div id="a8400" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:503px;top:34px;">2022 </div><div id="a8403" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:601px;top:34px;">2021 </div><div id="a8407" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:50px;">Basic earnings per common share </div><div id="a8410" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:485px;top:50px;"><div style="display:inline-block;width:7px"> </div></div><div id="a8418" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:67px;">Net income attributable to Quaker Chemical Corporation </div><div id="a8420" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:67px;">$ </div><div id="a8422" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:517px;top:67px;">19,816</div><div id="a8425" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:67px;">$ </div><div id="a8427" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:616px;top:67px;">38,615</div><div id="a8432" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:84px;">Less: income allocated to participating securities </div><div id="a8434" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:84px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8436" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:535px;top:84px;display:flex;">(78)</div><div id="a8439" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:84px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8441" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:628px;top:84px;display:flex;">(154)</div><div id="a8446" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:101px;">Net income available to common shareholders </div><div id="a8448" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:101px;">$ </div><div id="a8450" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:517px;top:101px;">19,738</div><div id="a8453" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:101px;">$ </div><div id="a8455" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:616px;top:101px;">38,461</div><div id="a8460" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:118px;">Basic weighted average common shares outstanding </div><div id="a8463" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:494px;top:118px;">17,826,061</div><div id="a8467" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:594px;top:118px;">17,785,370</div><div id="a8471" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:135px;">Basic earnings per common share </div><div id="a8474" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:135px;">$ </div><div id="a8476" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:530px;top:135px;">1.11</div><div id="a8479" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:135px;">$ </div><div id="a8481" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:629px;top:135px;">2.16</div><div id="a8494" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:169px;">Diluted earnings per common share </div><div id="a8504" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:186px;">Net income attributable to Quaker Chemical Corporation </div><div id="a8506" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:186px;">$ </div><div id="a8508" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:517px;top:186px;">19,816</div><div id="a8511" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:186px;">$ </div><div id="a8513" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:616px;top:186px;">38,615</div><div id="a8518" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:203px;">Less: income allocated to participating securities </div><div id="a8521" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:535px;top:203px;display:flex;">(78)</div><div id="a8525" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:628px;top:203px;display:flex;">(154)</div><div id="a8530" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:220px;">Net income available to common shareholders </div><div id="a8532" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:220px;">$ </div><div id="a8534" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:517px;top:220px;">19,738</div><div id="a8537" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:220px;">$ </div><div id="a8539" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:616px;top:220px;">38,461</div><div id="a8544" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:236px;">Basic weighted average common shares outstanding </div><div id="a8547" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:494px;top:236px;">17,826,061</div><div id="a8551" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:594px;top:236px;">17,785,370</div><div id="a8556" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:253px;">Effect of dilutive securities </div><div id="a8559" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:517px;top:253px;">25,798</div><div id="a8563" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:253px;">70,607</div><div id="a8568" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:270px;">Diluted weighted average common shares outstanding </div><div id="a8571" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:494px;top:270px;">17,851,859</div><div id="a8575" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:594px;top:270px;">17,855,977</div><div id="a8579" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:288px;">Diluted earnings per common<div style="display:inline-block;width:4px"> </div>share </div><div id="a8582" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:287px;">$ </div><div id="a8584" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:530px;top:288px;">1.11</div><div id="a8587" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:287px;">$ </div><div id="a8589" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:629px;top:288px;">2.15</div></div></div></div><div id="TextBlockContainer126" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:717px;height:46px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a8592" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">Certain stock options,<div style="display:inline-block;width:4px"> </div>restricted stock units and PSUs are not included in the diluted earnings per share calculation<div style="display:inline-block;width:5px"> </div>when the </div><div id="a8604" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">effect would have been anti-dilutive.<div style="display:inline-block;width:8px"> </div>The calculated amount of anti-diluted shares not included were </div><div id="a8604_102_6" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:547px;top:15px;">12,260</div><div id="a8604_108_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:584px;top:15px;"><div style="display:inline-block;width:3px"> </div>and </div><div id="a8604_113_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:609px;top:15px;">2,083</div><div id="a8604_118_15" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:639px;top:15px;"><div style="display:inline-block;width:3px"> </div>for the three </div><div id="a8611" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">months ended March 31, 2022 and 2021, respectively.</div></div> <div id="TextBlockContainer123" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:666px;height:303px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a8388" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:505px;top:0px;">Three Months Ended </div><div id="a8394" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:536px;top:17px;">March 31,<div style="display:inline-block;width:4px"> </div></div><div id="a8400" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:503px;top:34px;">2022 </div><div id="a8403" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:601px;top:34px;">2021 </div><div id="a8407" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:50px;">Basic earnings per common share </div><div id="a8410" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:485px;top:50px;"><div style="display:inline-block;width:7px"> </div></div><div id="a8418" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:67px;">Net income attributable to Quaker Chemical Corporation </div><div id="a8420" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:67px;">$ </div><div id="a8422" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:517px;top:67px;">19,816</div><div id="a8425" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:67px;">$ </div><div id="a8427" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:616px;top:67px;">38,615</div><div id="a8432" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:84px;">Less: income allocated to participating securities </div><div id="a8434" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:84px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8436" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:535px;top:84px;display:flex;">(78)</div><div id="a8439" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:84px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8441" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:628px;top:84px;display:flex;">(154)</div><div id="a8446" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:101px;">Net income available to common shareholders </div><div id="a8448" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:101px;">$ </div><div id="a8450" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:517px;top:101px;">19,738</div><div id="a8453" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:101px;">$ </div><div id="a8455" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:616px;top:101px;">38,461</div><div id="a8460" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:118px;">Basic weighted average common shares outstanding </div><div id="a8463" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:494px;top:118px;">17,826,061</div><div id="a8467" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:594px;top:118px;">17,785,370</div><div id="a8471" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:135px;">Basic earnings per common share </div><div id="a8474" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:135px;">$ </div><div id="a8476" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:530px;top:135px;">1.11</div><div id="a8479" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:135px;">$ </div><div id="a8481" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:629px;top:135px;">2.16</div><div id="a8494" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:169px;">Diluted earnings per common share </div><div id="a8504" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:186px;">Net income attributable to Quaker Chemical Corporation </div><div id="a8506" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:186px;">$ </div><div id="a8508" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:517px;top:186px;">19,816</div><div id="a8511" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:186px;">$ </div><div id="a8513" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:616px;top:186px;">38,615</div><div id="a8518" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:203px;">Less: income allocated to participating securities </div><div id="a8521" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:535px;top:203px;display:flex;">(78)</div><div id="a8525" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:628px;top:203px;display:flex;">(154)</div><div id="a8530" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:220px;">Net income available to common shareholders </div><div id="a8532" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:220px;">$ </div><div id="a8534" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:517px;top:220px;">19,738</div><div id="a8537" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:220px;">$ </div><div id="a8539" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:616px;top:220px;">38,461</div><div id="a8544" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:236px;">Basic weighted average common shares outstanding </div><div id="a8547" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:494px;top:236px;">17,826,061</div><div id="a8551" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:594px;top:236px;">17,785,370</div><div id="a8556" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:253px;">Effect of dilutive securities </div><div id="a8559" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:517px;top:253px;">25,798</div><div id="a8563" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:253px;">70,607</div><div id="a8568" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:270px;">Diluted weighted average common shares outstanding </div><div id="a8571" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:494px;top:270px;">17,851,859</div><div id="a8575" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:594px;top:270px;">17,855,977</div><div id="a8579" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:288px;">Diluted earnings per common<div style="display:inline-block;width:4px"> </div>share </div><div id="a8582" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:287px;">$ </div><div id="a8584" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:530px;top:288px;">1.11</div><div id="a8587" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:287px;">$ </div><div id="a8589" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:629px;top:288px;">2.15</div></div> 19816000 38615000 78000 154000 19738000 38461000 17826061 17785370 1.11 2.16 19816000 38615000 78000 154000 19738000 38461000 17826061 17785370 25798 70607 17851859 17855977 1.11 2.15 12260 2083 <div id="TextBlockContainer128" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:598px;height:39px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a8613" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 13 – Goodwill and Other Intangible Assets<div style="display:inline-block;width:4px"> </div></div><div id="a8619" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">Changes in the carrying amount of goodwill for the three months ended<div style="display:inline-block;width:5px"> </div>March 31, 2022 were as follows:</div></div><div id="TextBlockContainer131" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:731px;height:118px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a8666" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:569px;top:0px;">Global </div><div id="a8681" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:562px;top:16px;">Specialty </div><div id="a8688" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:278px;top:31px;">Americas </div><div id="a8691" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:380px;top:31px;">EMEA </div><div id="a8694" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:461px;top:31px;">Asia/Pacific </div><div id="a8697" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:558px;top:31px;">Businesses </div><div id="a8700" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:666px;top:31px;">Total </div><div id="a8702" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:49px;">Balance as of December 31, 2021 </div><div id="a8704" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:49px;">$ </div><div id="a8706" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:300px;top:49px;">214,023</div><div id="a8709" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:49px;">$ </div><div id="a8711" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:395px;top:49px;">135,520</div><div id="a8714" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:49px;">$ </div><div id="a8716" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:490px;top:49px;">162,458</div><div id="a8719" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:49px;">$ </div><div id="a8721" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:583px;top:49px;">119,193</div><div id="a8723" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:632px;top:49px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8725" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:49px;">$ </div><div id="a8727" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:676px;top:49px;">631,194</div><div id="a8730" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:19px;top:66px;">Goodwill additions </div><div id="a8733" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:312px;top:66px;">1,752</div><div id="a8737" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:424px;top:66px;">—</div><div id="a8741" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:519px;top:66px;">—</div><div id="a8745" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:612px;top:66px;">32</div><div id="a8749" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:689px;top:66px;">1,784</div><div id="a8752" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:19px;top:84px;">Currency translation adjustments </div><div id="a8754" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:84px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8756" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:312px;top:84px;">1,376</div><div id="a8760" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:403px;top:84px;display:flex;">(2,569)</div><div id="a8764" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:508px;top:84px;display:flex;">(328)</div><div id="a8768" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:601px;top:84px;display:flex;">(519)</div><div id="a8770" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:632px;top:84px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8773" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:684px;top:84px;display:flex;">(2,040)</div><div id="a8775" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:102px;">Balance as of March 31, 2022 </div><div id="a8777" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:102px;">$ </div><div id="a8779" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:300px;top:102px;">217,151</div><div id="a8782" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:102px;">$ </div><div id="a8784" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:395px;top:102px;">132,951</div><div id="a8787" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:102px;">$ </div><div id="a8789" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:490px;top:102px;">162,130</div><div id="a8792" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:102px;">$ </div><div id="a8794" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:583px;top:102px;">118,706</div><div id="a8796" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:632px;top:102px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8798" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:102px;">$ </div><div id="a8800" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:676px;top:102px;">630,938</div></div><div id="TextBlockContainer134" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:732px;height:31px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a8802" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">Gross carrying amounts and accumulated amortization for definite-lived<div style="display:inline-block;width:5px"> </div>intangible assets as of March 31, 2022 and December 31, </div><div id="a8808" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">2021 were as follows:</div></div><div id="TextBlockContainer138" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:728px;height:115px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_136_XBRL_TS_58cc4e7752f74e77946993da6a91dd27" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer137" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:728px;height:115px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a8814" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:403px;top:0px;">Gross Carrying </div><div id="a8817" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:597px;top:0px;">Accumulated </div><div id="a8821" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:424px;top:15px;">Amount </div><div id="a8824" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:596px;top:15px;">Amortization </div><div id="a8828" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:387px;top:31px;">2022 </div><div id="a8831" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:482px;top:31px;">2021 </div><div id="a8834" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:575px;top:31px;">2022 </div><div id="a8837" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:668px;top:31px;">2021 </div><div id="a8839" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:48px;">Customer lists and rights to sell </div><div id="a8841" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:48px;">$ </div><div id="a8843" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:395px;top:48px;">855,309</div><div id="a8845" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:48px;"><div style="display:inline-block;width:7px"> </div></div><div id="a8847" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:48px;">$ </div><div id="a8849" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:490px;top:48px;">853,122</div><div id="a8851" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:538px;top:48px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8853" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:48px;">$ </div><div id="a8855" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:583px;top:48px;">159,576</div><div id="a8857" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:632px;top:48px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8859" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:48px;">$ </div><div id="a8861" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:676px;top:48px;">147,858</div><div id="a8863" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:65px;">Trademarks, formulations and product<div style="display:inline-block;width:5px"> </div>technology </div><div id="a8865" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:65px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8867" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:395px;top:65px;">162,408</div><div id="a8869" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:65px;"><div style="display:inline-block;width:7px"> </div></div><div id="a8871" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:65px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8873" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:490px;top:65px;">163,974</div><div id="a8875" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:538px;top:65px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8877" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:65px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8879" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:590px;top:65px;">40,565</div><div id="a8881" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:632px;top:65px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8883" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:65px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8885" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:683px;top:65px;">38,747</div><div id="a8887" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:82px;">Other </div><div id="a8889" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:82px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8891" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:409px;top:82px;">6,361</div><div id="a8893" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:82px;"><div style="display:inline-block;width:7px"> </div></div><div id="a8895" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:82px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8897" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:504px;top:82px;">6,309</div><div id="a8899" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:538px;top:82px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8901" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:82px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8903" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:597px;top:82px;">5,989</div><div id="a8905" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:632px;top:82px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8907" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:82px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8909" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:690px;top:82px;">5,900</div><div id="a8911" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">Total definite-lived<div style="display:inline-block;width:5px"> </div>intangible assets </div><div id="a8916" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:100px;">$ </div><div id="a8918" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:385px;top:100px;">1,024,078</div><div id="a8920" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:100px;"><div style="display:inline-block;width:7px"> </div></div><div id="a8922" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:100px;">$ </div><div id="a8924" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:480px;top:100px;">1,023,405</div><div id="a8926" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:538px;top:100px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8928" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:100px;">$ </div><div id="a8930" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:583px;top:100px;">206,130</div><div id="a8932" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:632px;top:100px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8934" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:100px;">$ </div><div id="a8936" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:676px;top:100px;">192,505</div></div></div></div><div id="TextBlockContainer140" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:714px;height:47px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a8956" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">The Company amortizes definite-lived intangible assets on a straight-line basis over<div style="display:inline-block;width:5px"> </div>their useful lives.<div style="display:inline-block;width:7px"> </div>The Company recorded </div><div id="a8963" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">$</div><div id="a8963_1_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:11px;top:15px;">14.6</div><div id="a8963_5_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:35px;top:15px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a8963_19_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:109px;top:15px;">14.8</div><div id="a8963_23_100" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:132px;top:15px;"><div style="display:inline-block;width:3px"> </div>million of amortization expense for the three months ended March<div style="display:inline-block;width:5px"> </div>31, 2022 and 2021, respectively.<div style="display:inline-block;width:5px"> </div></div><div id="a8967" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">Estimated annual aggregate amortization expense for the current year<div style="display:inline-block;width:5px"> </div>and subsequent five years is as follows:</div></div><div id="TextBlockContainer144" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:427px;height:102px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_142_XBRL_TS_6f6041769ca24538b4f7f8cd03e9bb31" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer143" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:427px;height:102px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a8970" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:1px;">For the year ended December 31, 2022 </div><div id="a8972" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:1px;">$ </div><div id="a8974" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:0px;">59,465</div><div id="a8978" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:18px;">For the year ended December 31, 2023 </div><div id="a8981" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:17px;">59,293</div><div id="a8985" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:35px;">For the year ended December 31, 2024 </div><div id="a8988" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:34px;">58,701</div><div id="a8992" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:52px;">For the year ended December 31, 2025 </div><div id="a8995" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:51px;">57,924</div><div id="a8999" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">For the year ended December 31, 2026 </div><div id="a9002" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:68px;">57,678</div><div id="a9006" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:86px;">For the year ended December 31, 2027 and beyond </div><div id="a9009" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:375px;top:85px;">532,124</div></div></div></div><div id="TextBlockContainer146" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:733px;height:47px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a9012" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">The Company has four indefinite-lived intangible assets totaling $</div><div id="a9012_66_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:0px;">194.1</div><div id="a9012_71_42" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:412px;top:0px;"><div style="display:inline-block;width:3px"> </div>million as of March 31, 2022, including $</div><div id="a9012_113_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:638px;top:0px;">193.0</div><div id="a9012_118_12" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:668px;top:0px;"><div style="display:inline-block;width:3px"> </div>million of </div><div id="a9017" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">indefinite-lived intangible assets for trademarks and tradename associated<div style="display:inline-block;width:5px"> </div>with the Combination.<div style="display:inline-block;width:7px"> </div>Comparatively, the Company had </div><div id="a9020" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">four indefinitely-lived intangible assets for trademarks and tradename<div style="display:inline-block;width:5px"> </div>totaling $</div><div id="a9020_81_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:431px;top:31px;">196.9</div><div id="a9020_86_33" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:461px;top:31px;"><div style="display:inline-block;width:3px"> </div>million as of December 31, 2021.</div></div> <div id="TextBlockContainer132" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:731px;height:118px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_130_XBRL_TS_6ac2bc78a1bd475284994bf380a8c4d7" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer131" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:731px;height:118px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a8666" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:569px;top:0px;">Global </div><div id="a8681" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:562px;top:16px;">Specialty </div><div id="a8688" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:278px;top:31px;">Americas </div><div id="a8691" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:380px;top:31px;">EMEA </div><div id="a8694" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:461px;top:31px;">Asia/Pacific </div><div id="a8697" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:558px;top:31px;">Businesses </div><div id="a8700" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:666px;top:31px;">Total </div><div id="a8702" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:49px;">Balance as of December 31, 2021 </div><div id="a8704" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:49px;">$ </div><div id="a8706" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:300px;top:49px;">214,023</div><div id="a8709" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:49px;">$ </div><div id="a8711" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:395px;top:49px;">135,520</div><div id="a8714" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:49px;">$ </div><div id="a8716" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:490px;top:49px;">162,458</div><div id="a8719" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:49px;">$ </div><div id="a8721" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:583px;top:49px;">119,193</div><div id="a8723" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:632px;top:49px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8725" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:49px;">$ </div><div id="a8727" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:676px;top:49px;">631,194</div><div id="a8730" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:19px;top:66px;">Goodwill additions </div><div id="a8733" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:312px;top:66px;">1,752</div><div id="a8737" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:424px;top:66px;">—</div><div id="a8741" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:519px;top:66px;">—</div><div id="a8745" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:612px;top:66px;">32</div><div id="a8749" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:689px;top:66px;">1,784</div><div id="a8752" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:19px;top:84px;">Currency translation adjustments </div><div id="a8754" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:84px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8756" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:312px;top:84px;">1,376</div><div id="a8760" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:403px;top:84px;display:flex;">(2,569)</div><div id="a8764" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:508px;top:84px;display:flex;">(328)</div><div id="a8768" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:601px;top:84px;display:flex;">(519)</div><div id="a8770" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:632px;top:84px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8773" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:684px;top:84px;display:flex;">(2,040)</div><div id="a8775" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:102px;">Balance as of March 31, 2022 </div><div id="a8777" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:102px;">$ </div><div id="a8779" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:300px;top:102px;">217,151</div><div id="a8782" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:102px;">$ </div><div id="a8784" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:395px;top:102px;">132,951</div><div id="a8787" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:102px;">$ </div><div id="a8789" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:490px;top:102px;">162,130</div><div id="a8792" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:102px;">$ </div><div id="a8794" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:583px;top:102px;">118,706</div><div id="a8796" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:632px;top:102px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8798" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:102px;">$ </div><div id="a8800" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:676px;top:102px;">630,938</div></div></div></div> 214023000 135520000 162458000 119193000 631194000 1752000 0 0 32000 1784000 1376000 -2569000 -328000 -519000 -2040000 217151000 132951000 162130000 118706000 630938000 <div id="TextBlockContainer137" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:728px;height:115px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a8814" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:403px;top:0px;">Gross Carrying </div><div id="a8817" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:597px;top:0px;">Accumulated </div><div id="a8821" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:424px;top:15px;">Amount </div><div id="a8824" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:596px;top:15px;">Amortization </div><div id="a8828" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:387px;top:31px;">2022 </div><div id="a8831" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:482px;top:31px;">2021 </div><div id="a8834" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:575px;top:31px;">2022 </div><div id="a8837" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:668px;top:31px;">2021 </div><div id="a8839" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:48px;">Customer lists and rights to sell </div><div id="a8841" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:48px;">$ </div><div id="a8843" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:395px;top:48px;">855,309</div><div id="a8845" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:48px;"><div style="display:inline-block;width:7px"> </div></div><div id="a8847" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:48px;">$ </div><div id="a8849" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:490px;top:48px;">853,122</div><div id="a8851" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:538px;top:48px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8853" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:48px;">$ </div><div id="a8855" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:583px;top:48px;">159,576</div><div id="a8857" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:632px;top:48px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8859" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:48px;">$ </div><div id="a8861" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:676px;top:48px;">147,858</div><div id="a8863" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:65px;">Trademarks, formulations and product<div style="display:inline-block;width:5px"> </div>technology </div><div id="a8865" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:65px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8867" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:395px;top:65px;">162,408</div><div id="a8869" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:65px;"><div style="display:inline-block;width:7px"> </div></div><div id="a8871" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:65px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8873" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:490px;top:65px;">163,974</div><div id="a8875" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:538px;top:65px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8877" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:65px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8879" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:590px;top:65px;">40,565</div><div id="a8881" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:632px;top:65px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8883" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:65px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8885" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:683px;top:65px;">38,747</div><div id="a8887" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:82px;">Other </div><div id="a8889" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:82px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8891" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:409px;top:82px;">6,361</div><div id="a8893" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:82px;"><div style="display:inline-block;width:7px"> </div></div><div id="a8895" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:82px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8897" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:504px;top:82px;">6,309</div><div id="a8899" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:538px;top:82px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8901" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:82px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8903" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:597px;top:82px;">5,989</div><div id="a8905" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:632px;top:82px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8907" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:82px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8909" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:690px;top:82px;">5,900</div><div id="a8911" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">Total definite-lived<div style="display:inline-block;width:5px"> </div>intangible assets </div><div id="a8916" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:100px;">$ </div><div id="a8918" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:385px;top:100px;">1,024,078</div><div id="a8920" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:100px;"><div style="display:inline-block;width:7px"> </div></div><div id="a8922" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:100px;">$ </div><div id="a8924" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:480px;top:100px;">1,023,405</div><div id="a8926" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:538px;top:100px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8928" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:100px;">$ </div><div id="a8930" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:583px;top:100px;">206,130</div><div id="a8932" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:632px;top:100px;"><div style="display:inline-block;width:3px"> </div></div><div id="a8934" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:100px;">$ </div><div id="a8936" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:676px;top:100px;">192,505</div></div> 855309000 853122000 159576000 147858000 162408000 163974000 40565000 38747000 6361000 6309000 5989000 5900000 1024078000 1023405000 206130000 192505000 14600000 14800000 <div id="TextBlockContainer143" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:427px;height:102px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a8970" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:1px;">For the year ended December 31, 2022 </div><div id="a8972" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:1px;">$ </div><div id="a8974" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:0px;">59,465</div><div id="a8978" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:18px;">For the year ended December 31, 2023 </div><div id="a8981" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:17px;">59,293</div><div id="a8985" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:35px;">For the year ended December 31, 2024 </div><div id="a8988" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:34px;">58,701</div><div id="a8992" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:52px;">For the year ended December 31, 2025 </div><div id="a8995" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:51px;">57,924</div><div id="a8999" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">For the year ended December 31, 2026 </div><div id="a9002" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:68px;">57,678</div><div id="a9006" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:86px;">For the year ended December 31, 2027 and beyond </div><div id="a9009" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:375px;top:85px;">532,124</div></div> 59465000 59293000 58701000 57924000 57678000 532124000 194100000 193000000.0 196900000 <div id="TextBlockContainer148" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:437px;height:39px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a9026" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 14 – Debt </div><div id="a9033" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">Debt as of March 31, 2022 and December 31, 2021 includes the following:</div></div><div id="TextBlockContainer151" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:674px;height:217px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a9049" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:334px;top:0px;">As of March 31, 2022 </div><div id="a9052" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:512px;top:0px;">As of December 31, 2021 </div><div id="a9059" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:314px;top:17px;">Interest </div><div id="a9062" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:397px;top:17px;">Outstanding<div style="display:inline-block;width:4px"> </div></div><div id="a9065" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:506px;top:17px;">Interest </div><div id="a9067" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:579px;top:17px;">Outstanding<div style="display:inline-block;width:4px"> </div></div><div id="a9073" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:323px;top:31px;">Rate </div><div id="a9076" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:410px;top:31px;">Balance </div><div id="a9079" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:515px;top:31px;">Rate </div><div id="a9081" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:592px;top:31px;">Balance </div><div id="a9085" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:47px;">Credit Facilities: </div><div id="a9100" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:65px;">Revolver </div><div id="a9103" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:324px;top:65px;display:flex;">1.68%</div><div id="a9106" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:381px;top:65px;">$ </div><div id="a9108" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:436px;top:65px;">254,453</div><div id="a9111" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:506px;top:65px;display:flex;">1.62%</div><div id="a9114" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:563px;top:65px;">$ </div><div id="a9116" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:619px;top:65px;">211,955</div><div id="a9121" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:82px;">U.S. Term Loan </div><div id="a9124" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:324px;top:82px;display:flex;">1.71%</div><div id="a9128" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:436px;top:82px;">528,750</div><div id="a9131" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:506px;top:82px;display:flex;">1.65%</div><div id="a9135" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:82px;">540,000</div><div id="a9140" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:99px;">EURO Term Loan </div><div id="a9143" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:324px;top:99px;display:flex;">1.50%</div><div id="a9147" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:436px;top:99px;">132,037</div><div id="a9150" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:506px;top:99px;display:flex;">1.50%</div><div id="a9154" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:99px;">137,616</div><div id="a9158" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:115px;">Industrial development bonds </div><div id="a9161" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:324px;top:116px;display:flex;">5.26%</div><div id="a9165" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:442px;top:116px;">10,000</div><div id="a9168" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:506px;top:116px;display:flex;">5.26%</div><div id="a9172" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:624px;top:116px;">10,000</div><div id="a9176" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:132px;">Bank lines of credit and other debt obligations </div><div id="a9179" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:133px;">Various </div><div id="a9183" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:449px;top:133px;">1,659</div><div id="a9186" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:502px;top:133px;">Various </div><div id="a9190" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:631px;top:133px;">1,777</div><div id="a9194" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:149px;">Total debt </div><div id="a9200" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:381px;top:150px;">$ </div><div id="a9202" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:436px;top:150px;">926,899</div><div id="a9207" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:563px;top:150px;">$ </div><div id="a9209" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:150px;">901,348</div><div id="a9213" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:166px;">Less: debt issuance costs </div><div id="a9219" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:167px;display:flex;">(7,227)</div><div id="a9225" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:626px;top:167px;display:flex;">(8,001)</div><div id="a9229" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:183px;">Less: short-term and current portion of long-term debts </div><div id="a9239" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:437px;top:184px;display:flex;">(61,385)</div><div id="a9245" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:619px;top:184px;display:flex;">(56,935)</div><div id="a9249" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:201px;">Total long-term debt </div><div id="a9256" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:381px;top:202px;">$ </div><div id="a9258" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:437px;top:202px;">858,287</div><div id="a9263" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:563px;top:202px;">$ </div><div id="a9265" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:619px;top:202px;">836,412</div></div><div id="TextBlockContainer154" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:730px;height:292px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a9268" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:0px;">Credit facilities </div><div id="a9272" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">The Company’s primary credit facility<div style="display:inline-block;width:5px"> </div>(as amended, the “Credit Facility”) is comprised of a $</div><div id="a9272_93_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:530px;top:23px;">400.0</div><div id="a9272_98_23" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:560px;top:23px;"><div style="display:inline-block;width:3px"> </div>million multicurrency </div><div id="a9306" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">revolver (the “Revolver”), a $</div><div id="a9306_30_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:164px;top:39px;">600.0</div><div id="a9306_35_85" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:194px;top:39px;"><div style="display:inline-block;width:3px"> </div>million term loan (the “U.S. Term<div style="display:inline-block;width:5px"> </div>Loan”), each with the Company as borrower,<div style="display:inline-block;width:5px"> </div>and a $</div><div id="a9306_120_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:665px;top:39px;">150.0</div><div id="a9348" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:54px;">million (as of August 1, 2019) Euro equivalent term loan (the “EURO Term<div style="display:inline-block;width:5px"> </div>Loan” and together with the “U.S. Term<div style="display:inline-block;width:5px"> </div>Loan”, the </div><div id="a9393" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">“Term Loans”)<div style="display:inline-block;width:5px"> </div>with Quaker Chemical B.V.,<div style="display:inline-block;width:5px"> </div>a Dutch subsidiary of the Company as borrower, each<div style="display:inline-block;width:5px"> </div>with a five year term maturing in </div><div id="a9437" style="position:absolute;font-family:'Times New Roman';left:4px;top:85px;-sec-ix-hidden:ID_845;">August 2024</div><div id="a9437_11_121" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:73px;top:85px;">.<div style="display:inline-block;width:7px"> </div>Subject to the consent of the administrative agent and certain other conditions, the Company<div style="display:inline-block;width:5px"> </div>may designate additional </div><div id="a9475" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">borrowers.<div style="display:inline-block;width:7px"> </div>The maximum amount available under the Credit Facility can be increased by up<div style="display:inline-block;width:5px"> </div>to $</div><div id="a9475_94_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:524px;top:100px;">300.0</div><div id="a9475_99_26" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:554px;top:100px;"><div style="display:inline-block;width:3px"> </div>million at the Company’s </div><div id="a9515" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:115px;">request if there are lenders who agree to accept additional commitments and<div style="display:inline-block;width:5px"> </div>the Company has satisfied certain other conditions.<div style="display:inline-block;width:4px"> </div></div><div id="a9554" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:131px;">Borrowings under the Credit Facility bear interest at a base rate or LIBOR plus an<div style="display:inline-block;width:5px"> </div>applicable margin based upon the Company’s </div><div id="a9596" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:146px;">consolidated net leverage ratio.<div style="display:inline-block;width:7px"> </div>On December 10, 2021, the Company entered into the Second Amendment with Bank of America </div><div id="a9605" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:161px;">N.A., to include among other things, an update to provide for use of a non-USD<div style="display:inline-block;width:5px"> </div>currency LIBOR successor rate.<div style="display:inline-block;width:7px"> </div>The variable interest </div><div id="a9617" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:177px;">rate incurred on the outstanding borrowings under the Credit Facility during<div style="display:inline-block;width:5px"> </div>the three months ended March 31, 2022 was </div><div id="a9651" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:192px;">approximately </div><div id="a9651_14_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:85px;top:192px;">1.6</div><div id="a9651_17_104" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:102px;top:192px;">%.<div style="display:inline-block;width:7px"> </div>As of March 31, 2022, the interest rate of the outstanding borrowings under the Credit<div style="display:inline-block;width:5px"> </div>Facility was </div><div id="a9690" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:207px;">approximately </div><div id="a9690_14_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:85px;top:207px;">1.7</div><div id="a9690_17_118" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:102px;top:207px;">%.<div style="display:inline-block;width:7px"> </div>In addition to paying interest on outstanding principal under the Credit Facility,<div style="display:inline-block;width:5px"> </div>the Company is required to pay </div><div id="a9731" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:223px;">a commitment fee ranging from </div><div id="a9731_30_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:177px;top:223px;">0.2</div><div id="a9731_33_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:194px;top:223px;">% to </div><div id="a9731_38_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:222px;top:223px;">0.3</div><div id="a9731_41_86" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:239px;top:223px;">% depending on the Company’s consolidated<div style="display:inline-block;width:5px"> </div>net leverage ratio to the lenders under the </div><div id="a9773" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:238px;">Revolver in respect of the unutilized commitments thereunder.<div style="display:inline-block;width:9px"> </div>The Company has unused capacity under the Revolver of </div><div id="a9807" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:253px;">approximately $</div><div id="a9807_15_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:92px;top:253px;">142</div><div id="a9807_18_58" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:112px;top:253px;"><div style="display:inline-block;width:3px"> </div>million, net of bank letters of credit of approximately $</div><div id="a9807_76_1" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:409px;top:253px;">4</div><div id="a9807_77_34" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:416px;top:253px;"><div style="display:inline-block;width:3px"> </div>million, as of March 31, 2022.<div style="display:inline-block;width:7px"> </div></div><div id="a9843" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:277px;"><div style="display:inline-block;width:192px"> </div></div></div><div id="TextBlockContainer156" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:734px;height:446px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a9863" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">The Credit Facility is subject to certain financial and other covenants.<div style="display:inline-block;width:8px"> </div></div><div id="a9863_74_47" style="position:absolute;font-family:'Times New Roman';left:407px;top:0px;">The Company’s initial consolidated net debt to </div><div id="a9899" style="position:absolute;font-family:'Times New Roman';left:4px;top:15px;">consolidated adjusted EBITDA ratio could not exceed 4.25 to 1, with step downs in the permitted ratio over the term of the Credit </div><div id="a9945" style="position:absolute;font-family:'Times New Roman';left:4px;top:31px;">Facility. As of March 31, 2021, the consolidated net debt to adjusted EBITDA may not exceed 3.75 to 1. The Company’s </div><div id="a9988" style="position:absolute;font-family:'Times New Roman';left:4px;top:46px;">consolidated adjusted EBITDA to interest expense ratio cannot be less than 3.0 to 1 over the term of the agreement. The Credit </div><div id="a10032" style="position:absolute;font-family:'Times New Roman';left:4px;top:61px;">Facility also prohibits the payment of cash dividends if the Company is in default or if the amount of the dividend paid annually </div><div id="a10078" style="position:absolute;font-family:'Times New Roman';left:4px;top:77px;">exceeds the greater of $50.0 million and 20% of consolidated adjusted EBITDA unless the ratio of consolidated net debt to </div><div id="a10118" style="position:absolute;font-family:'Times New Roman';left:4px;top:92px;">consolidated adjusted EBITDA is less than 2.0 to 1, in which case there is no such limitation on amount.</div><div id="a10118_104_2" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:92px;"><div style="display:inline-block;width:7px"> </div></div><div id="a10118_106_25" style="position:absolute;font-family:'Times New Roman';left:569px;top:92px;">As of March 31, 2022 and </div><div id="a10164" style="position:absolute;font-family:'Times New Roman';left:4px;top:107px;">December 31, 2021, the Company was in compliance with all of the Credit Facility covenants</div><div id="a10164_90_33" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:505px;top:107px;">.<div style="display:inline-block;width:7px"> </div>The Term Loans<div style="display:inline-block;width:5px"> </div>have quarterly </div><div id="a10205" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:123px;">principal amortization during their </div><div id="a10205_36_9" style="position:absolute;font-family:'Times New Roman';left:192px;top:123px;">five year</div><div id="a10205_45_13" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:239px;top:123px;"><div style="display:inline-block;width:3px"> </div>terms, with </div><div id="a10205_58_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:306px;top:123px;">5.0</div><div id="a10205_61_62" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:322px;top:123px;">% amortization of the principal balance due in years 1 and 2, </div><div id="a10205_123_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:650px;top:123px;">7.5</div><div id="a10205_126_10" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:667px;top:123px;">% in year </div><div id="a10251" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:138px;">3, and </div><div id="a10251_7_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:40px;top:138px;">10.0</div><div id="a10251_11_120" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:64px;top:138px;">% in years 4 and 5, with the remaining principal amount due at maturity.<div style="display:inline-block;width:9px"> </div>During the three months ended March 31, 2022, </div><div id="a10291" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:153px;">the Company made quarterly amortization payments related to<div style="display:inline-block;width:5px"> </div>the Term Loans totaling<div style="display:inline-block;width:5px"> </div>$</div><div id="a10291_85_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:480px;top:153px;">14.1</div><div id="a10291_89_34" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:504px;top:153px;"><div style="display:inline-block;width:3px"> </div>million.<div style="display:inline-block;width:7px"> </div>The Credit Facility is </div><div id="a10329" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:169px;">guaranteed by certain of the Company’s<div style="display:inline-block;width:5px"> </div>domestic subsidiaries and is secured by first priority liens on substantially all of the assets of </div><div id="a10373" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:184px;">the Company and the domestic subsidiary guarantors, subject to certain<div style="display:inline-block;width:5px"> </div>customary exclusions.<div style="display:inline-block;width:7px"> </div>The obligations of the Dutch borrower </div><div id="a10409" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:199px;">are guaranteed only by certain foreign subsidiaries on an unsecured basis. </div><div id="a10431" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:223px;">The Credit Facility required the Company to fix its variable interest rates on at least </div><div id="a10431_88_2" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:478px;top:223px;">20</div><div id="a10431_90_40" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:492px;top:223px;">% of its total Term Loans.<div style="display:inline-block;width:8px"> </div>In order to </div><div id="a10433" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:238px;">satisfy this requirement as well as to manage the Company’s<div style="display:inline-block;width:5px"> </div>exposure to variable interest rate risk associated with the Credit Facility, </div><div id="a10435" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:253px;">in November 2019, the Company entered into $</div><div id="a10435_44_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:259px;top:253px;">170.0</div><div id="a10435_49_78" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:289px;top:253px;"><div style="display:inline-block;width:3px"> </div>million notional amounts of three year interest rate swaps at a base rate of </div><div id="a10435_127_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:690px;top:253px;">1.64</div><div id="a10435_131_2" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:713px;top:253px;">% </div><div id="a10437" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:269px;">plus an applicable margin as provided in the Credit Facility,<div style="display:inline-block;width:5px"> </div>based on the Company’s consolidated<div style="display:inline-block;width:5px"> </div>net leverage ratio.<div style="display:inline-block;width:7px"> </div>At the time the </div><div id="a10439" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:284px;">Company entered into the swaps, and as of March 31, 2022, the aggregate<div style="display:inline-block;width:5px"> </div>interest rate on the swaps, including the fixed base rate plus </div><div id="a10441" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:299px;">an applicable margin, was </div><div id="a10441_26_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:147px;top:299px;">3.1</div><div id="a10441_29_73" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:164px;top:299px;">%.<div style="display:inline-block;width:7px"> </div>See Note 17 of Notes to Condensed Consolidated Financial Statements. </div><div id="a10445" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:323px;">The Company capitalized $</div><div id="a10445_25_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:175px;top:323px;">23.7</div><div id="a10445_29_103" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:199px;top:323px;"><div style="display:inline-block;width:3px"> </div>million of certain third-party debt issuance costs in connection with executing<div style="display:inline-block;width:5px"> </div>the Credit Facility.<div style="display:inline-block;width:4px"> </div></div><div id="a10449" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:338px;">Approximately $</div><div id="a10449_15_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:95px;top:338px;">15.5</div><div id="a10449_19_111" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:119px;top:338px;"><div style="display:inline-block;width:3px"> </div>million of the capitalized costs were attributed to the Term<div style="display:inline-block;width:5px"> </div>Loans and recorded as a direct reduction of long-</div><div id="a10452" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:353px;">term debt on the Company’s Consolidated<div style="display:inline-block;width:5px"> </div>Balance Sheet.<div style="display:inline-block;width:7px"> </div>Approximately $</div><div id="a10452_71_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:410px;top:353px;">8.3</div><div id="a10452_74_57" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:427px;top:353px;"><div style="display:inline-block;width:3px"> </div>million of the capitalized costs were attributed to the </div><div id="a10455" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:369px;">Revolver and recorded within other assets on the Company’s<div style="display:inline-block;width:5px"> </div>Consolidated Balance Sheet.<div style="display:inline-block;width:7px"> </div>These capitalized costs are being </div><div id="a10456" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:384px;">amortized into interest expense over the </div><div id="a10456_41_9" style="position:absolute;font-family:'Times New Roman';left:221px;top:384px;">five year</div><div id="a10456_50_79" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:268px;top:384px;"><div style="display:inline-block;width:3px"> </div>term of the Credit Facility.<div style="display:inline-block;width:8px"> </div>As of March 31, 2022 and December 31, 2021, the </div><div id="a10461" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:399px;">Company had $</div><div id="a10461_13_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:89px;top:399px;">7.2</div><div id="a10461_16_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:106px;top:399px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a10461_30_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:180px;top:399px;">8.0</div><div id="a10461_33_97" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:197px;top:399px;"><div style="display:inline-block;width:3px"> </div>million, respectively,<div style="display:inline-block;width:5px"> </div>of debt issuance costs recorded as a reduction of long-term debt.<div style="display:inline-block;width:8px"> </div>As of </div><div id="a10467" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:415px;">March 31, 2022 and December 31, 2021, the Company had $</div><div id="a10467_55_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:331px;top:415px;">3.9</div><div id="a10467_58_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:348px;top:415px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a10467_72_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:422px;top:415px;">4.3</div><div id="a10467_75_56" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:439px;top:415px;"><div style="display:inline-block;width:3px"> </div>million, respectively,<div style="display:inline-block;width:5px"> </div>of debt issuance costs recorded </div><div id="a10469" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:430px;">within other assets.</div></div><div id="TextBlockContainer158" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:732px;height:240px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a10473" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:0px;">Industrial development bonds </div><div id="a10475" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">As of March 31, 2022 and December 31, 2021, the Company had fixed rate,<div style="display:inline-block;width:5px"> </div>industrial development authority bonds totaling </div><div id="a10480" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">$</div><div id="a10480_1_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:11px;top:39px;">10.0</div><div id="a10480_5_36" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:35px;top:39px;"><div style="display:inline-block;width:3px"> </div>million in principal amount due in </div><div id="a10480_41_4" style="position:absolute;font-family:'Times New Roman';left:224px;top:39px;">2028</div><div id="a10480_45_74" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:251px;top:39px;">.<div style="display:inline-block;width:7px"> </div>These bonds have similar covenants to the Credit Facility noted above. </div><div id="a10488" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:62px;">Bank lines of credit and other debt obligations</div><div id="a10490" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:85px;">The Company has certain unsecured bank lines of credit and discounting<div style="display:inline-block;width:5px"> </div>facilities in certain foreign subsidiaries, which are not </div><div id="a10497" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:101px;">collateralized.<div style="display:inline-block;width:7px"> </div>The Company’s other debt obligations<div style="display:inline-block;width:5px"> </div>primarily consist of certain domestic and foreign low interest rate or interest-</div><div id="a10502" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:116px;">free municipality-related loans, local credit facilities of certain foreign subsidiaries<div style="display:inline-block;width:5px"> </div>and capital lease obligations.<div style="display:inline-block;width:7px"> </div>Total unused </div><div id="a10508" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:131px;">capacity under these arrangements as of March 31, 2022 was approximately<div style="display:inline-block;width:5px"> </div>$</div><div id="a10508_74_2" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:420px;top:131px;">30</div><div id="a10508_76_9" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:433px;top:131px;"><div style="display:inline-block;width:3px"> </div>million.</div><div id="a10518" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:155px;">In addition to the bank letters of credit described in the “Credit facilities” subsection<div style="display:inline-block;width:5px"> </div>above, the Company’s only other<div style="display:inline-block;width:5px"> </div>off-balance </div><div id="a10521" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:170px;">sheet arrangements include certain financial and other guarantees.<div style="display:inline-block;width:8px"> </div>The Company’s total bank letters of<div style="display:inline-block;width:5px"> </div>credit and guarantees </div><div id="a10524" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:185px;">outstanding as of March 31, 2022 were approximately $</div><div id="a10524_53_1" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:303px;top:185px;">6</div><div id="a10524_54_10" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:310px;top:185px;"><div style="display:inline-block;width:3px"> </div>million. </div><div id="a10535" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:209px;">The Company incurred the following debt related expenses included<div style="display:inline-block;width:5px"> </div>within Interest expense, net, in the Condensed Consolidated </div><div id="a10539" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:224px;">Statements of Income:</div></div><div id="TextBlockContainer161" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:658px;height:101px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a10545" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:503px;top:0px;">Three Months Ended </div><div id="a10550" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:534px;top:17px;">March 31,<div style="display:inline-block;width:4px"> </div></div><div id="a10555" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:503px;top:34px;">2022 </div><div id="a10558" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:598px;top:34px;">2021 </div><div id="a10562" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:51px;">Interest expense </div><div id="a10565" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:51px;">$ </div><div id="a10567" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:524px;top:51px;">4,746</div><div id="a10570" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:570px;top:51px;">$ </div><div id="a10572" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:619px;top:51px;">4,650</div><div id="a10576" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:68px;">Amortization of debt issuance costs </div><div id="a10579" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:524px;top:68px;">1,187</div><div id="a10583" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:619px;top:68px;">1,187</div><div id="a10587" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:86px;">Total </div><div id="a10589" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:86px;">$ </div><div id="a10591" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:524px;top:86px;">5,933</div><div id="a10594" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:570px;top:86px;">$ </div><div id="a10596" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:619px;top:86px;">5,837</div></div><div id="TextBlockContainer164" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:732px;height:31px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a10599" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">Based on the variable interest rates associated with the Credit Facility,<div style="display:inline-block;width:5px"> </div>as of March 31, 2022 and December 31, 2021, the amounts </div><div id="a10602" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">at which the Company’s total debt<div style="display:inline-block;width:5px"> </div>were recorded are not materially different from their fair market value.</div></div> <div id="TextBlockContainer152" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:674px;height:217px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_150_XBRL_TS_3c2c76cd76d34f9e99f3e8fb29acffb0" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer151" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:674px;height:217px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a9049" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:334px;top:0px;">As of March 31, 2022 </div><div id="a9052" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:512px;top:0px;">As of December 31, 2021 </div><div id="a9059" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:314px;top:17px;">Interest </div><div id="a9062" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:397px;top:17px;">Outstanding<div style="display:inline-block;width:4px"> </div></div><div id="a9065" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:506px;top:17px;">Interest </div><div id="a9067" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:579px;top:17px;">Outstanding<div style="display:inline-block;width:4px"> </div></div><div id="a9073" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:323px;top:31px;">Rate </div><div id="a9076" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:410px;top:31px;">Balance </div><div id="a9079" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:515px;top:31px;">Rate </div><div id="a9081" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:592px;top:31px;">Balance </div><div id="a9085" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:47px;">Credit Facilities: </div><div id="a9100" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:65px;">Revolver </div><div id="a9103" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:324px;top:65px;display:flex;">1.68%</div><div id="a9106" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:381px;top:65px;">$ </div><div id="a9108" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:436px;top:65px;">254,453</div><div id="a9111" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:506px;top:65px;display:flex;">1.62%</div><div id="a9114" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:563px;top:65px;">$ </div><div id="a9116" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:619px;top:65px;">211,955</div><div id="a9121" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:82px;">U.S. Term Loan </div><div id="a9124" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:324px;top:82px;display:flex;">1.71%</div><div id="a9128" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:436px;top:82px;">528,750</div><div id="a9131" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:506px;top:82px;display:flex;">1.65%</div><div id="a9135" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:82px;">540,000</div><div id="a9140" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:99px;">EURO Term Loan </div><div id="a9143" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:324px;top:99px;display:flex;">1.50%</div><div id="a9147" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:436px;top:99px;">132,037</div><div id="a9150" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:506px;top:99px;display:flex;">1.50%</div><div id="a9154" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:99px;">137,616</div><div id="a9158" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:115px;">Industrial development bonds </div><div id="a9161" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:324px;top:116px;display:flex;">5.26%</div><div id="a9165" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:442px;top:116px;">10,000</div><div id="a9168" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:506px;top:116px;display:flex;">5.26%</div><div id="a9172" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:624px;top:116px;">10,000</div><div id="a9176" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:132px;">Bank lines of credit and other debt obligations </div><div id="a9179" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:133px;">Various </div><div id="a9183" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:449px;top:133px;">1,659</div><div id="a9186" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:502px;top:133px;">Various </div><div id="a9190" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:631px;top:133px;">1,777</div><div id="a9194" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:149px;">Total debt </div><div id="a9200" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:381px;top:150px;">$ </div><div id="a9202" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:436px;top:150px;">926,899</div><div id="a9207" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:563px;top:150px;">$ </div><div id="a9209" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:150px;">901,348</div><div id="a9213" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:166px;">Less: debt issuance costs </div><div id="a9219" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:167px;display:flex;">(7,227)</div><div id="a9225" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:626px;top:167px;display:flex;">(8,001)</div><div id="a9229" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:183px;">Less: short-term and current portion of long-term debts </div><div id="a9239" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:437px;top:184px;display:flex;">(61,385)</div><div id="a9245" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:619px;top:184px;display:flex;">(56,935)</div><div id="a9249" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:201px;">Total long-term debt </div><div id="a9256" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:381px;top:202px;">$ </div><div id="a9258" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:437px;top:202px;">858,287</div><div id="a9263" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:563px;top:202px;">$ </div><div id="a9265" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:619px;top:202px;">836,412</div></div></div></div> 0.0168 254453000 0.0162 211955000 0.0171 528750000 0.0165 540000000 0.0150 132037000 0.0150 137616000 0.0526 10000000 0.0526 10000000 1659000 1777000 926899000 901348000 7227000 8001000 61385000 56935000 858287000 836412000 400000000.0 600000000.0 150000000.0 300000000.0 0.016 0.017 0.002 0.003 142000000 4000000 The Company’s initial consolidated net debt to consolidated adjusted EBITDA ratio could not exceed 4.25 to 1, with step downs in the permitted ratio over the term of the Credit Facility. As of March 31, 2021, the consolidated net debt to adjusted EBITDA may not exceed 3.75 to 1. The Company’s consolidated adjusted EBITDA to interest expense ratio cannot be less than 3.0 to 1 over the term of the agreement. The Credit Facility also prohibits the payment of cash dividends if the Company is in default or if the amount of the dividend paid annually exceeds the greater of $50.0 million and 20% of consolidated adjusted EBITDA unless the ratio of consolidated net debt to consolidated adjusted EBITDA is less than 2.0 to 1, in which case there is no such limitation on amount. 4.25 3.75 3.0 50000000.0 0.20 2.0 As of March 31, 2022 and December 31, 2021, the Company was in compliance with all of the Credit Facility covenants P5Y 0.050 0.075 0.100 14100000 0.20 170000000.0 0.0164 0.031 0.031 23700000 15500000 8300000 P5Y 7200000 8000000.0 3900000 4300000 10000000.0 10000000.0 2028 30000000 6000000 <div id="TextBlockContainer162" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:658px;height:101px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_160_XBRL_TS_428080fd6e224fb3a15fbbdfb81b4cd3" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer161" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:658px;height:101px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a10545" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:503px;top:0px;">Three Months Ended </div><div id="a10550" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:534px;top:17px;">March 31,<div style="display:inline-block;width:4px"> </div></div><div id="a10555" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:503px;top:34px;">2022 </div><div id="a10558" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:598px;top:34px;">2021 </div><div id="a10562" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:51px;">Interest expense </div><div id="a10565" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:51px;">$ </div><div id="a10567" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:524px;top:51px;">4,746</div><div id="a10570" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:570px;top:51px;">$ </div><div id="a10572" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:619px;top:51px;">4,650</div><div id="a10576" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:68px;">Amortization of debt issuance costs </div><div id="a10579" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:524px;top:68px;">1,187</div><div id="a10583" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:619px;top:68px;">1,187</div><div id="a10587" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:86px;">Total </div><div id="a10589" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:86px;">$ </div><div id="a10591" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:524px;top:86px;">5,933</div><div id="a10594" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:570px;top:86px;">$ </div><div id="a10596" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:619px;top:86px;">5,837</div></div></div></div> 4746000 4650000 1187000 1187000 5933000 5837000 <div id="TextBlockContainer166" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:321px;height:16px;display:inline-block;"><div id="a10622" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 15 – Accumulated Other Comprehensive Income</div></div><div id="TextBlockContainer168" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:682px;height:32px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a10627" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">The following tables show the reclassifications from and resulting balances<div style="display:inline-block;width:5px"> </div>of accumulated other comprehensive income </div><div id="a10657" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">(“AOCI”) for the three months ended March 31, 2022 and 2021:</div></div><div id="TextBlockContainer171" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:731px;height:291px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a10683" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:404px;top:0px;">Defined </div><div id="a10686" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:486px;top:0px;">Unrealized </div><div id="a10696" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:316px;top:17px;">Currency </div><div id="a10699" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:406px;top:17px;">Benefit </div><div id="a10702" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:477px;top:17px;">Gain (Loss) in<div style="display:inline-block;width:4px"> </div></div><div id="a10712" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:310px;top:34px;">Translation </div><div id="a10716" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:394px;top:34px;">Retirement </div><div id="a10719" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:477px;top:34px;">Available-for- </div><div id="a10725" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:580px;top:34px;">Derivative </div><div id="a10733" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:307px;top:51px;">Adjustments </div><div id="a10736" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:411px;top:51px;">Plans </div><div id="a10739" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:476px;top:51px;">Sale Securities </div><div id="a10742" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:575px;top:51px;">Instruments </div><div id="a10745" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:675px;top:51px;">Total </div><div id="a10747" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:68px;">Balance at December 31, 2021 </div><div id="a10749" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:305px;top:68px;">$</div><div id="a10751" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:336px;top:68px;display:flex;">(49,843)</div><div id="a10754" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:389px;top:68px;">$</div><div id="a10756" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:419px;top:68px;display:flex;">(13,172)</div><div id="a10759" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:472px;top:68px;">$</div><div id="a10761" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:539px;top:68px;">397</div><div id="a10764" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:570px;top:68px;">$</div><div id="a10766" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:612px;top:68px;display:flex;">(1,372)</div><div id="a10769" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:658px;top:68px;">$</div><div id="a10771" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:68px;display:flex;">(63,990)</div><div id="a10774" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:12px;top:85px;">Other comprehensive (loss) income before </div><div id="a10793" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:20px;top:105px;">reclassifications </div><div id="a10796" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:343px;top:105px;display:flex;">(6,867)</div><div id="a10800" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:441px;top:105px;">432</div><div id="a10804" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:524px;top:105px;">(1,277) </div><div id="a10808" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:105px;">1,429</div><div id="a10812" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:684px;top:105px;display:flex;">(6,283)</div><div id="a10815" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:12px;top:122px;">Amounts reclassified from AOCI </div><div id="a10818" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:364px;top:122px;">—</div><div id="a10822" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:441px;top:122px;">229</div><div id="a10826" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:545px;top:122px;">11</div><div id="a10830" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:633px;top:122px;">—</div><div id="a10834" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:699px;top:122px;">240</div><div id="a10837" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:12px;top:139px;">Related tax amounts </div><div id="a10840" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:364px;top:139px;">—</div><div id="a10844" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:436px;top:139px;display:flex;">(165)</div><div id="a10848" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:539px;top:139px;">266</div><div id="a10852" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:622px;top:139px;display:flex;">(329)</div><div id="a10856" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:694px;top:139px;display:flex;">(228)</div><div id="a10858" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:156px;">Balance at March 31, 2022 </div><div id="a10860" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:305px;top:156px;">$</div><div id="a10862" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:336px;top:156px;display:flex;">(56,710)</div><div id="a10865" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:389px;top:156px;">$</div><div id="a10867" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:419px;top:156px;display:flex;">(12,676)</div><div id="a10870" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:472px;top:156px;">$</div><div id="a10872" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:534px;top:156px;display:flex;">(603)</div><div id="a10875" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:570px;top:156px;">$</div><div id="a10877" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:622px;top:156px;display:flex;">(272)</div><div id="a10880" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:658px;top:156px;">$</div><div id="a10882" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:156px;display:flex;">(70,261)</div><div id="a10901" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:190px;">Balance at December 31, 2020 </div><div id="a10903" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:305px;top:190px;">$</div><div id="a10905" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:343px;top:190px;display:flex;">(2,875)</div><div id="a10909" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:389px;top:190px;">$</div><div id="a10911" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:419px;top:190px;display:flex;">(23,467)</div><div id="a10914" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:472px;top:190px;">$</div><div id="a10916" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:529px;top:190px;">3,342</div><div id="a10919" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:570px;top:190px;">$</div><div id="a10921" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:612px;top:190px;display:flex;">(3,598)</div><div id="a10924" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:658px;top:190px;">$</div><div id="a10926" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:190px;display:flex;">(26,598)</div><div id="a10929" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:12px;top:207px;">Other comprehensive (loss) income before<div style="display:inline-block;width:4px"> </div></div><div id="a10947" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:20px;top:224px;">reclassifications </div><div id="a10950" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:336px;top:224px;display:flex;">(25,459)</div><div id="a10954" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:441px;top:224px;">781</div><div id="a10958" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:534px;top:224px;display:flex;">(745)</div><div id="a10962" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:627px;top:224px;">730</div><div id="a10966" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:224px;display:flex;">(24,693)</div><div id="a10969" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:12px;top:241px;">Amounts reclassified from AOCI </div><div id="a10972" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:364px;top:241px;">—</div><div id="a10976" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:441px;top:241px;">862</div><div id="a10980" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:524px;top:241px;display:flex;">(3,085)</div><div id="a10984" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:633px;top:241px;">—</div><div id="a10988" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:684px;top:241px;display:flex;">(2,223)</div><div id="a10991" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:12px;top:258px;">Related tax amounts </div><div id="a10994" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:364px;top:258px;">—</div><div id="a10998" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:436px;top:258px;display:flex;">(351)</div><div id="a11002" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:539px;top:258px;">805</div><div id="a11006" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:622px;top:258px;display:flex;">(168)</div><div id="a11010" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:699px;top:258px;">286</div><div id="a11012" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:275px;">Balance at March 31, 2021 </div><div id="a11014" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:305px;top:275px;">$</div><div id="a11016" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:336px;top:275px;display:flex;">(28,334)</div><div id="a11019" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:389px;top:275px;">$</div><div id="a11021" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:419px;top:275px;display:flex;">(22,175)</div><div id="a11024" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:472px;top:275px;">$</div><div id="a11026" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:539px;top:275px;">317</div><div id="a11029" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:570px;top:275px;">$</div><div id="a11031" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:612px;top:275px;display:flex;">(3,036)</div><div id="a11034" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:658px;top:275px;">$</div><div id="a11036" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:275px;display:flex;">(53,228)</div></div><div id="TextBlockContainer174" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:712px;height:47px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a11038" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">All reclassifications related to unrealized gain (loss) in available-for-sale securities<div style="display:inline-block;width:5px"> </div>relate to the Company’s equity<div style="display:inline-block;width:5px"> </div>interest in a </div><div id="a11046" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">captive insurance company and are recorded in equity in net income<div style="display:inline-block;width:5px"> </div>of associated companies.<div style="display:inline-block;width:7px"> </div>The amounts reported in other </div><div id="a11052" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">comprehensive income for non-controlling interest are related to<div style="display:inline-block;width:5px"> </div>currency translation adjustments.</div></div> <div id="TextBlockContainer172" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:731px;height:291px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_170_XBRL_TS_b56c2f72a37a4d35bb6cdf5979bcd19b" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer171" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:731px;height:291px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a10683" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:404px;top:0px;">Defined </div><div id="a10686" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:486px;top:0px;">Unrealized </div><div id="a10696" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:316px;top:17px;">Currency </div><div id="a10699" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:406px;top:17px;">Benefit </div><div id="a10702" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:477px;top:17px;">Gain (Loss) in<div style="display:inline-block;width:4px"> </div></div><div id="a10712" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:310px;top:34px;">Translation </div><div id="a10716" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:394px;top:34px;">Retirement </div><div id="a10719" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:477px;top:34px;">Available-for- </div><div id="a10725" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:580px;top:34px;">Derivative </div><div id="a10733" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:307px;top:51px;">Adjustments </div><div id="a10736" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:411px;top:51px;">Plans </div><div id="a10739" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:476px;top:51px;">Sale Securities </div><div id="a10742" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:575px;top:51px;">Instruments </div><div id="a10745" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:675px;top:51px;">Total </div><div id="a10747" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:68px;">Balance at December 31, 2021 </div><div id="a10749" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:305px;top:68px;">$</div><div id="a10751" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:336px;top:68px;display:flex;">(49,843)</div><div id="a10754" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:389px;top:68px;">$</div><div id="a10756" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:419px;top:68px;display:flex;">(13,172)</div><div id="a10759" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:472px;top:68px;">$</div><div id="a10761" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:539px;top:68px;">397</div><div id="a10764" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:570px;top:68px;">$</div><div id="a10766" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:612px;top:68px;display:flex;">(1,372)</div><div id="a10769" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:658px;top:68px;">$</div><div id="a10771" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:68px;display:flex;">(63,990)</div><div id="a10774" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:12px;top:85px;">Other comprehensive (loss) income before </div><div id="a10793" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:20px;top:105px;">reclassifications </div><div id="a10796" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:343px;top:105px;display:flex;">(6,867)</div><div id="a10800" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:441px;top:105px;">432</div><div id="a10804" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:524px;top:105px;">(1,277) </div><div id="a10808" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:105px;">1,429</div><div id="a10812" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:684px;top:105px;display:flex;">(6,283)</div><div id="a10815" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:12px;top:122px;">Amounts reclassified from AOCI </div><div id="a10818" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:364px;top:122px;">—</div><div id="a10822" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:441px;top:122px;">229</div><div id="a10826" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:545px;top:122px;">11</div><div id="a10830" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:633px;top:122px;">—</div><div id="a10834" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:699px;top:122px;">240</div><div id="a10837" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:12px;top:139px;">Related tax amounts </div><div id="a10840" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:364px;top:139px;">—</div><div id="a10844" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:436px;top:139px;display:flex;">(165)</div><div id="a10848" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:539px;top:139px;">266</div><div id="a10852" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:622px;top:139px;display:flex;">(329)</div><div id="a10856" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:694px;top:139px;display:flex;">(228)</div><div id="a10858" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:156px;">Balance at March 31, 2022 </div><div id="a10860" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:305px;top:156px;">$</div><div id="a10862" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:336px;top:156px;display:flex;">(56,710)</div><div id="a10865" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:389px;top:156px;">$</div><div id="a10867" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:419px;top:156px;display:flex;">(12,676)</div><div id="a10870" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:472px;top:156px;">$</div><div id="a10872" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:534px;top:156px;display:flex;">(603)</div><div id="a10875" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:570px;top:156px;">$</div><div id="a10877" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:622px;top:156px;display:flex;">(272)</div><div id="a10880" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:658px;top:156px;">$</div><div id="a10882" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:156px;display:flex;">(70,261)</div><div id="a10901" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:190px;">Balance at December 31, 2020 </div><div id="a10903" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:305px;top:190px;">$</div><div id="a10905" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:343px;top:190px;display:flex;">(2,875)</div><div id="a10909" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:389px;top:190px;">$</div><div id="a10911" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:419px;top:190px;display:flex;">(23,467)</div><div id="a10914" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:472px;top:190px;">$</div><div id="a10916" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:529px;top:190px;">3,342</div><div id="a10919" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:570px;top:190px;">$</div><div id="a10921" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:612px;top:190px;display:flex;">(3,598)</div><div id="a10924" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:658px;top:190px;">$</div><div id="a10926" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:190px;display:flex;">(26,598)</div><div id="a10929" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:12px;top:207px;">Other comprehensive (loss) income before<div style="display:inline-block;width:4px"> </div></div><div id="a10947" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:20px;top:224px;">reclassifications </div><div id="a10950" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:336px;top:224px;display:flex;">(25,459)</div><div id="a10954" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:441px;top:224px;">781</div><div id="a10958" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:534px;top:224px;display:flex;">(745)</div><div id="a10962" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:627px;top:224px;">730</div><div id="a10966" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:224px;display:flex;">(24,693)</div><div id="a10969" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:12px;top:241px;">Amounts reclassified from AOCI </div><div id="a10972" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:364px;top:241px;">—</div><div id="a10976" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:441px;top:241px;">862</div><div id="a10980" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:524px;top:241px;display:flex;">(3,085)</div><div id="a10984" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:633px;top:241px;">—</div><div id="a10988" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:684px;top:241px;display:flex;">(2,223)</div><div id="a10991" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:12px;top:258px;">Related tax amounts </div><div id="a10994" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:364px;top:258px;">—</div><div id="a10998" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:436px;top:258px;display:flex;">(351)</div><div id="a11002" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:539px;top:258px;">805</div><div id="a11006" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:622px;top:258px;display:flex;">(168)</div><div id="a11010" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:699px;top:258px;">286</div><div id="a11012" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:275px;">Balance at March 31, 2021 </div><div id="a11014" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:305px;top:275px;">$</div><div id="a11016" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:336px;top:275px;display:flex;">(28,334)</div><div id="a11019" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:389px;top:275px;">$</div><div id="a11021" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:419px;top:275px;display:flex;">(22,175)</div><div id="a11024" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:472px;top:275px;">$</div><div id="a11026" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:539px;top:275px;">317</div><div id="a11029" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:570px;top:275px;">$</div><div id="a11031" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:612px;top:275px;display:flex;">(3,036)</div><div id="a11034" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:658px;top:275px;">$</div><div id="a11036" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:275px;display:flex;">(53,228)</div></div></div></div> -49843000 -13172000 397000 -1372000 -63990000 -6867000 432000 1429000 1429000 -6283000 0 229000 11000 0 240000 0 -165000 266000 -329000 -228000 -56710000 -12676000 -603000 -272000 -70261000 -2875000 -23467000 3342000 -3598000 -26598000 -25459000 781000 -745000 730000 -24693000 0 862000 -3085000 0 -2223000 0 -351000 805000 -168000 286000 -28334000 -22175000 317000 -3036000 -53228000 <div id="TextBlockContainer176" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:674px;height:55px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a11056" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 16 – Fair Value<div style="display:inline-block;width:5px"> </div>Measurements</div><div id="a11062" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">The Company has valued its company-owned life insurance policies at fair value.<div style="display:inline-block;width:8px"> </div>These assets are subject to fair value </div><div id="a11065" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">measurement as follows:</div></div><div id="TextBlockContainer180" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:727px;height:81px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_178_XBRL_TS_8409ced421f94676af9b49f5f58e72bf" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer179" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:727px;height:81px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a11072" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:451px;top:0px;">Fair Value<div style="display:inline-block;width:5px"> </div>Measurements at March 31, 2022 </div><div id="a11077" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:374px;top:15px;">Total </div><div id="a11080" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:504px;top:15px;">Using Fair Value<div style="display:inline-block;width:5px"> </div>Hierarchy </div><div id="a11082" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">Assets </div><div id="a11084" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:358px;top:31px;">Fair Value </div><div id="a11087" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:465px;top:31px;">Level 1 </div><div id="a11090" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:562px;top:31px;">Level 2 </div><div id="a11093" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:659px;top:31px;">Level 3 </div><div id="a11095" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:47px;">Company-owned life insurance </div><div id="a11099" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:346px;top:47px;">$ </div><div id="a11101" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:397px;top:47px;">2,395</div><div id="a11104" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:47px;">$ </div><div id="a11106" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:511px;top:47px;">—</div><div id="a11109" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:47px;">$ </div><div id="a11111" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:592px;top:47px;">2,395</div><div id="a11114" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:638px;top:47px;">$ </div><div id="a11116" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:705px;top:47px;">—</div><div id="a11118" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:64px;">Total </div><div id="a11120" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:346px;top:64px;">$ </div><div id="a11122" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:397px;top:64px;">2,395</div><div id="a11125" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:64px;">$ </div><div id="a11127" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:511px;top:64px;">—</div><div id="a11130" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:64px;">$ </div><div id="a11132" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:592px;top:64px;">2,395</div><div id="a11135" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:638px;top:64px;">$ </div><div id="a11137" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:705px;top:64px;">—</div></div></div></div><div id="TextBlockContainer184" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:728px;height:80px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_182_XBRL_TS_43e169c323bc403f919308537470c7ec" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer183" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:728px;height:80px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a11145" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:441px;top:0px;">Fair Value<div style="display:inline-block;width:5px"> </div>Measurements at December 31, 2021 </div><div id="a11150" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:374px;top:15px;">Total </div><div id="a11153" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:504px;top:15px;">Using Fair Value<div style="display:inline-block;width:5px"> </div>Hierarchy </div><div id="a11155" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">Assets </div><div id="a11157" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:358px;top:31px;">Fair Value </div><div id="a11160" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:465px;top:31px;">Level 1 </div><div id="a11163" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:562px;top:31px;">Level 2 </div><div id="a11166" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:659px;top:31px;">Level 3 </div><div id="a11168" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:47px;">Company-owned life insurance<div style="display:inline-block;width:4px"> </div></div><div id="a11172" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:346px;top:47px;">$ </div><div id="a11174" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:398px;top:47px;">2,533</div><div id="a11177" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:47px;">$ </div><div id="a11179" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:512px;top:47px;">—</div><div id="a11182" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:47px;">$ </div><div id="a11184" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:593px;top:47px;">2,533</div><div id="a11187" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:638px;top:47px;">$ </div><div id="a11189" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:706px;top:47px;">—</div><div id="a11191" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:65px;">Total </div><div id="a11193" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:346px;top:65px;">$ </div><div id="a11195" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:398px;top:65px;">2,533</div><div id="a11198" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:65px;">$ </div><div id="a11200" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:512px;top:65px;">—</div><div id="a11203" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:65px;">$ </div><div id="a11205" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:593px;top:65px;">2,533</div><div id="a11208" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:638px;top:65px;">$ </div><div id="a11210" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:706px;top:65px;">—</div></div></div></div><div id="TextBlockContainer186" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:716px;height:47px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a11212" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">The fair values of Company-owned life insurance assets are based on quotes<div style="display:inline-block;width:5px"> </div>for like instruments with similar credit ratings and </div><div id="a11217" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">terms.<div style="display:inline-block;width:7px"> </div>The Company did not hold any Level 3 investments as of March 31,<div style="display:inline-block;width:5px"> </div>2022 or December 31, 2021, respectively,<div style="display:inline-block;width:5px"> </div>so related </div><div id="a11227" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">disclosures have not been included.</div></div> <div id="TextBlockContainer179" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:727px;height:81px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a11072" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:451px;top:0px;">Fair Value<div style="display:inline-block;width:5px"> </div>Measurements at March 31, 2022 </div><div id="a11077" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:374px;top:15px;">Total </div><div id="a11080" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:504px;top:15px;">Using Fair Value<div style="display:inline-block;width:5px"> </div>Hierarchy </div><div id="a11082" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">Assets </div><div id="a11084" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:358px;top:31px;">Fair Value </div><div id="a11087" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:465px;top:31px;">Level 1 </div><div id="a11090" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:562px;top:31px;">Level 2 </div><div id="a11093" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:659px;top:31px;">Level 3 </div><div id="a11095" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:47px;">Company-owned life insurance </div><div id="a11099" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:346px;top:47px;">$ </div><div id="a11101" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:397px;top:47px;">2,395</div><div id="a11104" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:47px;">$ </div><div id="a11106" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:511px;top:47px;">—</div><div id="a11109" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:47px;">$ </div><div id="a11111" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:592px;top:47px;">2,395</div><div id="a11114" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:638px;top:47px;">$ </div><div id="a11116" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:705px;top:47px;">—</div><div id="a11118" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:64px;">Total </div><div id="a11120" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:346px;top:64px;">$ </div><div id="a11122" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:397px;top:64px;">2,395</div><div id="a11125" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:64px;">$ </div><div id="a11127" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:511px;top:64px;">—</div><div id="a11130" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:64px;">$ </div><div id="a11132" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:592px;top:64px;">2,395</div><div id="a11135" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:638px;top:64px;">$ </div><div id="a11137" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:705px;top:64px;">—</div></div><div id="TextBlockContainer183" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:728px;height:80px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a11145" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:441px;top:0px;">Fair Value<div style="display:inline-block;width:5px"> </div>Measurements at December 31, 2021 </div><div id="a11150" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:374px;top:15px;">Total </div><div id="a11153" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:504px;top:15px;">Using Fair Value<div style="display:inline-block;width:5px"> </div>Hierarchy </div><div id="a11155" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">Assets </div><div id="a11157" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:358px;top:31px;">Fair Value </div><div id="a11160" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:465px;top:31px;">Level 1 </div><div id="a11163" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:562px;top:31px;">Level 2 </div><div id="a11166" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:659px;top:31px;">Level 3 </div><div id="a11168" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:47px;">Company-owned life insurance<div style="display:inline-block;width:4px"> </div></div><div id="a11172" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:346px;top:47px;">$ </div><div id="a11174" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:398px;top:47px;">2,533</div><div id="a11177" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:47px;">$ </div><div id="a11179" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:512px;top:47px;">—</div><div id="a11182" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:47px;">$ </div><div id="a11184" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:593px;top:47px;">2,533</div><div id="a11187" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:638px;top:47px;">$ </div><div id="a11189" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:706px;top:47px;">—</div><div id="a11191" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:65px;">Total </div><div id="a11193" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:346px;top:65px;">$ </div><div id="a11195" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:398px;top:65px;">2,533</div><div id="a11198" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:65px;">$ </div><div id="a11200" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:512px;top:65px;">—</div><div id="a11203" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:65px;">$ </div><div id="a11205" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:593px;top:65px;">2,533</div><div id="a11208" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:638px;top:65px;">$ </div><div id="a11210" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:706px;top:65px;">—</div></div> 2395000 0 2395000 0 2395000 0 2395000 0 2533000 0 2533000 0 2533000 0 2533000 0 <div id="TextBlockContainer188" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:716px;height:116px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a11229" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 17 – Hedging Activities </div><div id="a11236" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">In order to satisfy certain requirements of the Credit Facility as well as to manage<div style="display:inline-block;width:5px"> </div>the Company’s exposure to variable<div style="display:inline-block;width:5px"> </div>interest </div><div id="a11240" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">rate risk associated with the Credit Facility,<div style="display:inline-block;width:5px"> </div>in November 2019, the Company entered into $</div><div id="a11240_91_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:495px;top:39px;">170.0</div><div id="a11240_96_35" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:525px;top:39px;"><div style="display:inline-block;width:3px"> </div>million notional amounts of three </div><div id="a11243" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:54px;">year interest rate swaps.<div style="display:inline-block;width:7px"> </div>See Note 14 of Notes to Condensed Consolidated Financial Statements.<div style="display:inline-block;width:8px"> </div>These interest rate swaps are </div><div id="a11265" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">designated as cash flow hedges and, as such, the contracts are marked-to-market<div style="display:inline-block;width:5px"> </div>at each reporting date and any unrealized gains or </div><div id="a11271" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">losses are included in AOCI to the extent effective and reclassified to interest<div style="display:inline-block;width:5px"> </div>expense in the period during which the transaction </div><div id="a11273" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">effects earnings or it becomes probable that the forecasted<div style="display:inline-block;width:5px"> </div>transaction will not occur.<div style="display:inline-block;width:4px"> </div></div></div><div id="TextBlockContainer190" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:729px;height:31px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a11295" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">The balance sheet classification and fair values of the Company’s<div style="display:inline-block;width:5px"> </div>derivative instruments, which are Level 2 measurements, are as </div><div id="a11333" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">follows:</div></div><div id="TextBlockContainer194" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:664px;height:101px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_192_XBRL_TS_ec11ef80c84942428cded117ab915291" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer193" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:664px;height:101px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a11341" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:536px;top:0px;">Fair Value </div><div id="a11347" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:345px;top:17px;">Consolidated </div><div id="a11350" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:488px;top:17px;">March 31,<div style="display:inline-block;width:4px"> </div></div><div id="a11353" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:577px;top:17px;">December 31, </div><div id="a11359" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:316px;top:34px;">Balance Sheet Location </div><div id="a11362" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:504px;top:34px;">2022 </div><div id="a11365" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:603px;top:34px;">2021 </div><div id="a11369" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:51px;">Derivatives designated as cash flow hedges: </div><div id="a11382" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:68px;">Interest rate swaps </div><div id="a11384" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:302px;top:68px;">Other accrued liabilities </div><div id="a11387" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:68px;">$ </div><div id="a11389" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:537px;top:68px;">353</div><div id="a11392" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:68px;">$ </div><div id="a11394" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:626px;top:68px;">1,782</div><div id="a11403" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:86px;">$ </div><div id="a11405" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:537px;top:86px;">353</div><div id="a11408" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:86px;">$ </div><div id="a11410" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:626px;top:86px;">1,782</div></div></div></div><div id="TextBlockContainer196" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:389px;height:16px;display:inline-block;"><div id="a11413" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:0px;">The following table presents the net unrealized loss deferred to AOCI:</div></div><div id="TextBlockContainer200" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:664px;height:85px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_198_XBRL_TS_3f2e5983575c4322a1658c19c0a62b9c" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer199" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:664px;height:85px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a11421" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:488px;top:0px;">March 31,<div style="display:inline-block;width:4px"> </div></div><div id="a11424" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:577px;top:0px;">December 31, </div><div id="a11432" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:504px;top:17px;">2022 </div><div id="a11435" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:603px;top:17px;">2021 </div><div id="a11439" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:34px;">Derivatives designated as cash flow hedges: </div><div id="a11451" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:51px;">Interest rate swaps </div><div id="a11454" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:312px;top:51px;">AOCI </div><div id="a11456" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:478px;top:51px;">$ </div><div id="a11458" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:537px;top:51px;">272</div><div id="a11461" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:577px;top:51px;">$ </div><div id="a11463" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:626px;top:51px;">1,372</div><div id="a11471" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:478px;top:69px;">$ </div><div id="a11473" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:537px;top:69px;">272</div><div id="a11476" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:577px;top:69px;">$ </div><div id="a11478" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:626px;top:69px;">1,372</div></div></div></div><div id="TextBlockContainer202" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:426px;height:16px;display:inline-block;"><div id="a11481" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:0px;">The following table presents the net gain reclassified from AOCI to earnings:</div></div><div id="TextBlockContainer206" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:667px;height:84px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_204_XBRL_TS_8f14045ac09840eaa0257ccf1c6d762f" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer205" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:667px;height:84px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a11488" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:506px;top:0px;">Three Months Ended </div><div id="a11495" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:537px;top:17px;">March 31,<div style="display:inline-block;width:4px"> </div></div><div id="a11502" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:504px;top:34px;">2022 </div><div id="a11505" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:603px;top:34px;">2021 </div><div id="a11509" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:51px;">Amount and location of expense reclassified<div style="display:inline-block;width:7px"> </div></div><div id="a11520" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:68px;"><div style="display:inline-block;width:3px"> </div>from AOCI into expense (Effective Portion) </div><div id="a11524" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:312px;top:68px;">Interest expense, net </div><div id="a11526" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:68px;">$ </div><div id="a11528" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:531px;top:68px;display:flex;">(637)</div><div id="a11531" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:68px;">$ </div><div id="a11533" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:630px;top:68px;display:flex;">(643)</div></div></div></div><div id="TextBlockContainer208" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:709px;height:62px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a11536" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">Interest rate swaps are entered into with a limited number of counterparties,<div style="display:inline-block;width:5px"> </div>each of which allows for net settlement of all </div><div id="a11537" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">contracts through a single payment in a single currency in the event of a default on<div style="display:inline-block;width:5px"> </div>or termination of any one contract.<div style="display:inline-block;width:7px"> </div>As such, in </div><div id="a11540" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">accordance with the Company’s accounting<div style="display:inline-block;width:5px"> </div>policy, these derivative instruments<div style="display:inline-block;width:5px"> </div>are recorded on a net basis within the Condensed </div><div id="a11542" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">Consolidated Balance Sheets.</div></div> 170000000.0 <div id="TextBlockContainer193" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:664px;height:101px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a11341" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:536px;top:0px;">Fair Value </div><div id="a11347" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:345px;top:17px;">Consolidated </div><div id="a11350" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:488px;top:17px;">March 31,<div style="display:inline-block;width:4px"> </div></div><div id="a11353" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:577px;top:17px;">December 31, </div><div id="a11359" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:316px;top:34px;">Balance Sheet Location </div><div id="a11362" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:504px;top:34px;">2022 </div><div id="a11365" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:603px;top:34px;">2021 </div><div id="a11369" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:51px;">Derivatives designated as cash flow hedges: </div><div id="a11382" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:68px;">Interest rate swaps </div><div id="a11384" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:302px;top:68px;">Other accrued liabilities </div><div id="a11387" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:68px;">$ </div><div id="a11389" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:537px;top:68px;">353</div><div id="a11392" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:68px;">$ </div><div id="a11394" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:626px;top:68px;">1,782</div><div id="a11403" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:86px;">$ </div><div id="a11405" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:537px;top:86px;">353</div><div id="a11408" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:86px;">$ </div><div id="a11410" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:626px;top:86px;">1,782</div></div><div id="TextBlockContainer199" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:664px;height:85px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a11421" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:488px;top:0px;">March 31,<div style="display:inline-block;width:4px"> </div></div><div id="a11424" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:577px;top:0px;">December 31, </div><div id="a11432" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:504px;top:17px;">2022 </div><div id="a11435" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:603px;top:17px;">2021 </div><div id="a11439" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:34px;">Derivatives designated as cash flow hedges: </div><div id="a11451" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:51px;">Interest rate swaps </div><div id="a11454" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:312px;top:51px;">AOCI </div><div id="a11456" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:478px;top:51px;">$ </div><div id="a11458" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:537px;top:51px;">272</div><div id="a11461" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:577px;top:51px;">$ </div><div id="a11463" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:626px;top:51px;">1,372</div><div id="a11471" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:478px;top:69px;">$ </div><div id="a11473" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:537px;top:69px;">272</div><div id="a11476" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:577px;top:69px;">$ </div><div id="a11478" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:626px;top:69px;">1,372</div></div><div id="TextBlockContainer205" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:667px;height:84px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a11488" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:506px;top:0px;">Three Months Ended </div><div id="a11495" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:537px;top:17px;">March 31,<div style="display:inline-block;width:4px"> </div></div><div id="a11502" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:504px;top:34px;">2022 </div><div id="a11505" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:603px;top:34px;">2021 </div><div id="a11509" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:51px;">Amount and location of expense reclassified<div style="display:inline-block;width:7px"> </div></div><div id="a11520" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:68px;"><div style="display:inline-block;width:3px"> </div>from AOCI into expense (Effective Portion) </div><div id="a11524" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:312px;top:68px;">Interest expense, net </div><div id="a11526" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:68px;">$ </div><div id="a11528" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:531px;top:68px;display:flex;">(637)</div><div id="a11531" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:68px;">$ </div><div id="a11533" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:630px;top:68px;display:flex;">(643)</div></div> 353000 1782000 353000 1782000 272000 1372000 272000 1372000 -637000 -643000 <div id="TextBlockContainer210" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:733px;height:416px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a11544" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 18 – Commitments and Contingencies </div><div id="a11550" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">The Company previously disclosed in its 2021 Form 10-K that AC Products, Inc.<div style="display:inline-block;width:5px"> </div>(“ACP”), a wholly owned subsidiary,<div style="display:inline-block;width:5px"> </div>has been </div><div id="a11594" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">operating a groundwater treatment system to hydraulically contain groundwater<div style="display:inline-block;width:5px"> </div>contamination emanating from ACP’s site,<div style="display:inline-block;width:5px"> </div>the </div><div id="a11625" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:54px;">principal contaminant of which is perchloroethylene.<div style="display:inline-block;width:8px"> </div>As of March 31, 2022, ACP believes it is close to meeting the conditions for </div><div id="a11667" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">closure of the groundwater treatment system, but continues to operate<div style="display:inline-block;width:5px"> </div>this system while in discussions with the relevant authorities.<div style="display:inline-block;width:4px"> </div></div><div id="a11707" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:93px;"><div style="display:inline-block;width:3px"> </div>As of March 31, 2022, the Company believes that the range of potential-known<div style="display:inline-block;width:5px"> </div>liabilities associated with the balance of the ACP </div><div id="a11754" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:108px;">water remediation program is approximately $</div><div id="a11754_44_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:252px;top:108px;">0.1</div><div id="a11754_47_13" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:269px;top:108px;"><div style="display:inline-block;width:3px"> </div>million to $</div><div id="a11754_60_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:334px;top:108px;">1.0</div><div id="a11754_63_70" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:351px;top:108px;"><div style="display:inline-block;width:3px"> </div>million.<div style="display:inline-block;width:7px"> </div>The low and high ends of the range are based on the length </div><div id="a11802" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:123px;">of operation of the treatment system as determined by groundwater modeling.<div style="display:inline-block;width:8px"> </div>Costs of operation include the operation and </div><div id="a11838" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:139px;">maintenance of the extraction well, groundwater monitoring and<div style="display:inline-block;width:5px"> </div>program management. </div><div id="a11859" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:162px;">The Company previously disclosed in its 2021 Form 10-K that an inactive<div style="display:inline-block;width:5px"> </div>subsidiary of the Company that was acquired in 1978 </div><div id="a11906" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:177px;">sold certain products containing asbestos, primarily on an installed basis, and<div style="display:inline-block;width:5px"> </div>is among the defendants in numerous lawsuits alleging </div><div id="a11944" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:193px;">injury due to exposure to asbestos.<div style="display:inline-block;width:7px"> </div>During the three months ended March 31, 2022, there have been no significant<div style="display:inline-block;width:5px"> </div>changes to the facts </div><div id="a11992" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:208px;">or circumstances of this previously disclosed matter,<div style="display:inline-block;width:5px"> </div>aside from on-going claims and routine payments associated with this litigation.<div style="display:inline-block;width:5px"> </div></div><div id="a12030" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:223px;">Based on a continued analysis of the existing and anticipated future claims against<div style="display:inline-block;width:5px"> </div>this subsidiary, it is currently<div style="display:inline-block;width:5px"> </div>projected that the </div><div id="a12072" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:239px;">subsidiary’s total liability over<div style="display:inline-block;width:5px"> </div>the next </div><div id="a12072_43_8" style="position:absolute;font-family:'Times New Roman';left:217px;top:239px;">50 years</div><div id="a12072_51_36" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:262px;top:239px;"><div style="display:inline-block;width:3px"> </div>for these claims is approximately $</div><div id="a12072_87_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:452px;top:239px;">0.3</div><div id="a12072_90_39" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:469px;top:239px;"><div style="display:inline-block;width:3px"> </div>million (excluding costs of defense). </div><div id="a12112" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:262px;">The Company previously disclosed in its 2021 Form 10-K that it is party to certain environmental<div style="display:inline-block;width:5px"> </div>matters related to certain </div><div id="a12156" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:277px;">domestic and foreign properties.<div style="display:inline-block;width:7px"> </div>These environmental matters primarily require the Company<div style="display:inline-block;width:5px"> </div>to perform long-term monitoring as </div><div id="a12192" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:293px;">well as operating and maintenance at each of the applicable sites.<div style="display:inline-block;width:8px"> </div>During the three months ended March 31, 2022, there have been<div style="display:inline-block;width:5px"> </div>no </div><div id="a12240" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:308px;">significant changes to the facts or circumstances of these previously disclosed<div style="display:inline-block;width:5px"> </div>matters, aside from on-going monitoring and </div><div id="a12277" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:323px;">maintenance activities and routine payments associated with each of<div style="display:inline-block;width:5px"> </div>the sites.<div style="display:inline-block;width:7px"> </div>The Company continually evaluates its obligations </div><div id="a12311" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:339px;">related to such matters, and based on historical costs incurred and<div style="display:inline-block;width:5px"> </div>projected costs to be incurred over the next </div><div id="a12311_113_8" style="position:absolute;font-family:'Times New Roman';left:591px;top:339px;">27 years</div><div id="a12311_121_16" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:636px;top:339px;">, has estimated </div><div id="a12359" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:354px;">the range of costs for all of these environmental matters, on a discounted<div style="display:inline-block;width:5px"> </div>basis, to be between approximately $</div><div id="a12359_111_1" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:594px;top:354px;">5</div><div id="a12359_112_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:600px;top:354px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a12359_126_1" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:354px;">6</div><div id="a12359_127_9" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:681px;top:354px;"><div style="display:inline-block;width:3px"> </div>million </div><div id="a12408" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:369px;">as of March 31, 2022, for which $</div><div id="a12408_33_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:186px;top:369px;">5.9</div><div id="a12408_36_95" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:203px;top:369px;"><div style="display:inline-block;width:3px"> </div>million was accrued within other accrued liabilities and other non-current<div style="display:inline-block;width:5px"> </div>liabilities on the </div><div id="a12457" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:385px;">Company’s<div style="display:inline-block;width:4px"> </div>Condensed Consolidated Balance Sheet as of March 31, 2022.<div style="display:inline-block;width:8px"> </div>Comparatively, as of December<div style="display:inline-block;width:5px"> </div>31, 2021, the Company </div><div id="a12498" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:400px;">had $</div><div id="a12498_5_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:34px;top:400px;">5.6</div><div id="a12498_8_52" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:51px;top:400px;"><div style="display:inline-block;width:3px"> </div>million accrued for with respect to these matters. </div></div><div id="TextBlockContainer212" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:733px;height:362px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a12539" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">The Company believes, although there can be no assurance regarding the<div style="display:inline-block;width:5px"> </div>outcome of other unrelated environmental matters, that </div><div id="a12575" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">it has made adequate accruals for costs associated with other environmental<div style="display:inline-block;width:5px"> </div>problems of which it is aware.<div style="display:inline-block;width:7px"> </div>Approximately $</div><div id="a12575_123_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:670px;top:15px;">0.4</div><div id="a12614" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">million were accrued as of both March 31, 2022 and December 31, 2021,<div style="display:inline-block;width:5px"> </div>respectively, to provide<div style="display:inline-block;width:5px"> </div>for such anticipated future </div><div id="a12657" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">environmental assessments and remediation costs.<div style="display:inline-block;width:8px"> </div></div><div id="a12668" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:69px;">In connection with obtaining regulatory approvals for the Combination,<div style="display:inline-block;width:5px"> </div>certain steel and aluminum related product lines of </div><div id="a12702" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">Houghton were divested in August 2019.<div style="display:inline-block;width:8px"> </div>The Company previously disclosed in its 2021 Form 10-K that in July 2021, the entity<div style="display:inline-block;width:5px"> </div>that </div><div id="a12748" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">acquired these divested product lines submitted an indemnification claim<div style="display:inline-block;width:5px"> </div>for certain alleged breaches of representation made by </div><div id="a12782" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:115px;">Houghton in the agreement pursuant to which such assets had been divested.<div style="display:inline-block;width:8px"> </div>The Company responded to the subject matters of the </div><div id="a12824" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:131px;">indemnification claim and during the first quarter of 2022 the matter was resolved<div style="display:inline-block;width:5px"> </div>consistent with the Company’s expectations<div style="display:inline-block;width:5px"> </div>and </div><div id="a12862" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:146px;">position that there were no amounts owed by the Company. </div><div id="a12882" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:169px;">The Company previously disclosed in its 2021 Form 10-K that two of the Company’s<div style="display:inline-block;width:5px"> </div>locations suffered property damages as a </div><div id="a12925" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:185px;">result of flooding and fire, respectively.<div style="display:inline-block;width:8px"> </div>The Company maintains property insurance for all of its facilities globally.<div style="display:inline-block;width:9px"> </div>During the three </div><div id="a12965" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:200px;">months ended March 31, 2022, there have been no significant changes to<div style="display:inline-block;width:5px"> </div>the facts or circumstances of these previously disclosed </div><div id="a13005" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:215px;">matters, aside from the on-going restoration of both sites.<div style="display:inline-block;width:8px"> </div>The Company, its insurance<div style="display:inline-block;width:5px"> </div>adjuster and insurance carrier are actively </div><div id="a13045" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:231px;">managing the remediation and restoration activities associated with these<div style="display:inline-block;width:5px"> </div>events and at this time the Company has concluded, based on </div><div id="a13085" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:246px;">all available information and discussions with its insurance adjuster<div style="display:inline-block;width:5px"> </div>and insurance carrier, that the losses were covered<div style="display:inline-block;width:5px"> </div>under the </div><div id="a13124" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:261px;">Company’s property insurance<div style="display:inline-block;width:5px"> </div>coverage, net of an aggregate deductible of $</div><div id="a13124_74_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:412px;top:261px;">2.0</div><div id="a13124_77_50" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:429px;top:261px;"><div style="display:inline-block;width:3px"> </div>million.<div style="display:inline-block;width:7px"> </div>The Company has received payments from </div><div id="a13160" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:277px;">its insurers of $</div><div id="a13160_17_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:87px;top:277px;">2.1</div><div id="a13160_20_115" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:104px;top:277px;"><div style="display:inline-block;width:3px"> </div>million and has recorded an insurance receivable associated with these events (and<div style="display:inline-block;width:5px"> </div>a gain on insurance recoveries </div><div id="a13206" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:292px;">for losses incurred) of $</div><div id="a13206_25_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:132px;top:292px;">0.5</div><div id="a13206_28_31" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:149px;top:292px;"><div style="display:inline-block;width:3px"> </div>million as of March 31, 2022. </div><div id="a13230" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:315px;">The Company is party to other litigation which management currently<div style="display:inline-block;width:5px"> </div>believes will not have a material adverse effect on the </div><div id="a13270" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:331px;">Company’s results of operations,<div style="display:inline-block;width:5px"> </div>cash flows or financial condition.<div style="display:inline-block;width:7px"> </div>In addition, the Company has an immaterial amount of contractual </div><div id="a13308" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:346px;">purchase obligations.</div></div> 100000 1000000.0 P50Y 300000 P27Y 5000000 6000000 5900000 5600000 400000 2000000.0 2100000 500000 EXCEL 88 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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
  •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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 90 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 91 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 285 335 1 false 95 0 false 6 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 000200 - Statement - Condensed Consolidated Statements of Income Sheet http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome Condensed Consolidated Statements of Income Statements 2 false false R3.htm 000300 - Statement - Condensed Consolidated Statements of Comprehensive Income Sheet http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome Condensed Consolidated Statements of Comprehensive Income Statements 3 false false R4.htm 000400 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 4 false false R5.htm 000450 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) Sheet http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheetsParentheticals Condensed Consolidated Balance Sheets (Parentheticals) Statements 5 false false R6.htm 000500 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 000600 - Statement - Condensed Consolidated Statements of Changes in Equity Sheet http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfChangesInEquity Condensed Consolidated Statements of Changes in Equity Statements 7 false false R8.htm 000650 - Statement - Condensed Consolidated Statements of Changes in Equity (Parentheticals) Sheet http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfChangesInEquityParentheticals Condensed Consolidated Statements of Changes in Equity (Parentheticals) Statements 8 false false R9.htm 010110 - Disclosure - Basis of Presentation and Description of Business Sheet http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusiness Basis of Presentation and Description of Business Notes 9 false false R10.htm 010210 - Disclosure - Business Acquisitions Sheet http://www.quakerchem.com/role/BusinessAcquisitions Business Acquisitions Notes 10 false false R11.htm 010310 - Disclosure - Recently Issued Accounting Standards Sheet http://www.quakerchem.com/role/RecentlyIssuedAccountingStandards Recently Issued Accounting Standards Notes 11 false false R12.htm 010409 - Disclosure - Business Segments Sheet http://www.quakerchem.com/role/BusinessSegments Business Segments Notes 12 false false R13.htm 010410 - Disclosure - Net Sales and Revenue Recognition Sheet http://www.quakerchem.com/role/NetSalesAndRevenueRecognition Net Sales and Revenue Recognition Notes 13 false false R14.htm 010508 - Disclosure - Leases Sheet http://www.quakerchem.com/role/Leases Leases Notes 14 false false R15.htm 010640 - Disclosure - Restructuring and Related Activities Sheet http://www.quakerchem.com/role/RestructuringAndRelatedActivities Restructuring and Related Activities Notes 15 false false R16.htm 010710 - Disclosure - Share-Based Compensation Sheet http://www.quakerchem.com/role/ShareBasedCompensation Share-Based Compensation Notes 16 false false R17.htm 010750 - Disclosure - Pension and Postretirement Benefits Sheet http://www.quakerchem.com/role/PensionAndPostretirementBenefits Pension and Postretirement Benefits Notes 17 false false R18.htm 010810 - Disclosure - Other (Expense) Income, Net Sheet http://www.quakerchem.com/role/OtherExpenseIncomeNet Other (Expense) Income, Net Notes 18 false false R19.htm 010910 - Disclosure - Income Taxes and Uncertain Income Tax Positions Sheet http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions Income Taxes and Uncertain Income Tax Positions Notes 19 false false R20.htm 011010 - Disclosure - Earnings Per Share Sheet http://www.quakerchem.com/role/EarningsPerShare Earnings Per Share Notes 20 false false R21.htm 011510 - Disclosure - Goodwill and Intangible Assets Sheet http://www.quakerchem.com/role/GoodwillAndIntangibleAssets Goodwill and Intangible Assets Notes 21 false false R22.htm 011910 - Disclosure - Debt Sheet http://www.quakerchem.com/role/Debt Debt Notes 22 false false R23.htm 012210 - Disclosure - Accumulated Other Comprehensive Income Sheet http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncome Accumulated Other Comprehensive Income Notes 23 false false R24.htm 012410 - Disclosure - Fair Value Measurements Sheet http://www.quakerchem.com/role/FairValueMeasurements Fair Value Measurements Notes 24 false false R25.htm 012415 - Disclosure - Hedging Activities Sheet http://www.quakerchem.com/role/HedgingActivities Hedging Activities Notes 25 false false R26.htm 012510 - Disclosure - Commitments and Contingencies Sheet http://www.quakerchem.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 26 false false R27.htm 020001 - Disclosure - Basis of Presentation and Description of Business (Policies) Sheet http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessPolicies Basis of Presentation and Description of Business (Policies) Policies http://www.quakerchem.com/role/RecentlyIssuedAccountingStandards 27 false false R28.htm 030410 - Disclosure - Business Segments (Tables) Sheet http://www.quakerchem.com/role/BusinessSegmentsTables Business Segments (Tables) Tables http://www.quakerchem.com/role/BusinessSegments 28 false false R29.htm 030510 - Disclosure - Net Sales and Revenue Recognition (Tables) Sheet http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionTables Net Sales and Revenue Recognition (Tables) Tables http://www.quakerchem.com/role/NetSalesAndRevenueRecognition 29 false false R30.htm 030609 - Disclosure - Leases (Tables) Sheet http://www.quakerchem.com/role/LeasesTables Leases (Tables) Tables http://www.quakerchem.com/role/Leases 30 false false R31.htm 030610 - Disclosure - Restructuring and Related Activities (Tables) Sheet http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesTables Restructuring and Related Activities (Tables) Tables http://www.quakerchem.com/role/RestructuringAndRelatedActivities 31 false false R32.htm 030710 - Disclosure - Share Based Compensation (Tables) Sheet http://www.quakerchem.com/role/ShareBasedCompensationTables Share Based Compensation (Tables) Tables 32 false false R33.htm 030750 - Disclosure - Pension and Other Post Retirement Benefits (Tables) Sheet http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables Pension and Other Post Retirement Benefits (Tables) Tables 33 false false R34.htm 030810 - Disclosure - Other (Expense) Income, Net (Tables) Sheet http://www.quakerchem.com/role/OtherExpenseIncomeNetTables Other (Expense) Income, Net (Tables) Tables http://www.quakerchem.com/role/OtherExpenseIncomeNet 34 false false R35.htm 031010 - Disclosure - Earnings Per Share (Tables) Sheet http://www.quakerchem.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.quakerchem.com/role/EarningsPerShare 35 false false R36.htm 031510 - Disclosure - Goodwill and Intangible Assets (Tables) Sheet http://www.quakerchem.com/role/GoodwillAndIntangibleAssetsTables Goodwill and Intangible Assets (Tables) Tables http://www.quakerchem.com/role/GoodwillAndIntangibleAssets 36 false false R37.htm 031750 - Disclosure - Debt (Tables) Sheet http://www.quakerchem.com/role/DebtTables Debt (Tables) Tables http://www.quakerchem.com/role/Debt 37 false false R38.htm 032211 - Disclosure - Accumulated Other Comprehensive Income (Tables) Sheet http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeTables Accumulated Other Comprehensive Income (Tables) Tables http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncome 38 false false R39.htm 032410 - Disclosure - Fair Value Measurements (Table) Sheet http://www.quakerchem.com/role/FairValueMeasurementsTable Fair Value Measurements (Table) Tables http://www.quakerchem.com/role/FairValueMeasurements 39 false false R40.htm 032411 - Disclosure - Hedging Activities (Tables) Sheet http://www.quakerchem.com/role/HedgingActivitiesTables Hedging Activities (Tables) Tables http://www.quakerchem.com/role/HedgingActivities 40 false false R41.htm 040010 - Disclosure - Basis of Presentation and Description of Business (Details) Sheet http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails Basis of Presentation and Description of Business (Details) Details http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessPolicies 41 false false R42.htm 040214 - Disclosure - Business Acquisitions - Narrative (Details) Sheet http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails Business Acquisitions - Narrative (Details) Details 42 false false R43.htm 040314 - Disclosure - Business Segments - Narrative (Details) Sheet http://www.quakerchem.com/role/BusinessSegmentsNarrativeDetails Business Segments - Narrative (Details) Details 43 false false R44.htm 040315 - Disclosure - Business Segments - Performance of reportable segments (Details) Sheet http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails Business Segments - Performance of reportable segments (Details) Details 44 false false R45.htm 040410 - Disclosure - Net Sales and Revenue Recognition - Narrative (Details) Sheet http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails Net Sales and Revenue Recognition - Narrative (Details) Details 45 false false R46.htm 040412 - Disclosure - Net Sales and Revenue Recognition - Disaggregated Revenue (Details) Sheet http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDisaggregatedRevenueDetails Net Sales and Revenue Recognition - Disaggregated Revenue (Details) Details 46 false false R47.htm 040415 - Disclosure - Leases - Narrative (Details) Sheet http://www.quakerchem.com/role/LeasesNarrativeDetails Leases - Narrative (Details) Details 47 false false R48.htm 040416 - Disclosure - Leases - Supplemental Information (Details) Sheet http://www.quakerchem.com/role/LeasesSupplementalInformationDetails Leases - Supplemental Information (Details) Details 48 false false R49.htm 040417 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details) Sheet http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails Leases - Maturities of Operating Lease Liabilities (Details) Details 49 false false R50.htm 040640 - Disclosure - Restructuring and Related Activities - Narrative (Details) Sheet http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesNarrativeDetails Restructuring and Related Activities - Narrative (Details) Details 50 false false R51.htm 040650 - Disclosure - Restructuring and Related Activities (Details) Sheet http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails Restructuring and Related Activities (Details) Details http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesTables 51 false false R52.htm 040710 - Disclosure - Share-Based Compensation - Narrative (Details) Sheet http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails Share-Based Compensation - Narrative (Details) Details 52 false false R53.htm 040720 - Disclosure - Share-Based Compensation - Share-based Compensation Expense (Details) Sheet http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails Share-Based Compensation - Share-based Compensation Expense (Details) Details 53 false false R54.htm 040760 - Disclosure - Share-Based Compensation - Black-Scholes Option Pricing Model (Details) Sheet http://www.quakerchem.com/role/ShareBasedCompensationBlackScholesOptionPricingModelDetails Share-Based Compensation - Black-Scholes Option Pricing Model (Details) Details 54 false false R55.htm 040765 - Disclosure - Share-Based Compensation - Monte Carlo Simulation on Grant Date (Details) Sheet http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationOnGrantDateDetails Share-Based Compensation - Monte Carlo Simulation on Grant Date (Details) Details 55 false false R56.htm 040810 - Disclosure - Pension and Other Postretirement Benefits - Narrative (Details) Sheet http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails Pension and Other Postretirement Benefits - Narrative (Details) Details 56 false false R57.htm 040815 - Disclosure - Pension and Other Postretirement Benefits - Net Periodic Benefit Cost (Details) Sheet http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails Pension and Other Postretirement Benefits - Net Periodic Benefit Cost (Details) Details 57 false false R58.htm 040900 - Disclosure - Other (Expense) Income, Net (Details) Sheet http://www.quakerchem.com/role/OtherExpenseIncomeNetDetails Other (Expense) Income, Net (Details) Details http://www.quakerchem.com/role/OtherExpenseIncomeNetTables 58 false false R59.htm 040970 - Disclosure - Income Taxes and Uncertain Income Tax Positions 2 - Narrative (Details) Sheet http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails Income Taxes and Uncertain Income Tax Positions 2 - Narrative (Details) Details 59 false false R60.htm 041010 - Disclosure - Earnings Per Share - Earnings per Share Calculations Basic (Details) Sheet http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsBasicDetails Earnings Per Share - Earnings per Share Calculations Basic (Details) Details 60 false false R61.htm 041020 - Disclosure - Earnings Per Share - Earnings per Share Calculations Diluted (Details) Sheet http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsDilutedDetails Earnings Per Share - Earnings per Share Calculations Diluted (Details) Details 61 false false R62.htm 041030 - Disclosure - Earnings Per Share - Earnings per Share Calculations Antidilutive Shares (Details) Sheet http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsAntidilutiveSharesDetails Earnings Per Share - Earnings per Share Calculations Antidilutive Shares (Details) Details 62 false false R63.htm 041110 - Disclosure - Restricted Cash (Details) Sheet http://www.quakerchem.com/role/RestrictedCashDetails Restricted Cash (Details) Details 63 false false R64.htm 041510 - Disclosure - Goodwill and Other Intangible Assets - Changes in Carrying Amount of Goodwill (Details) Sheet http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails Goodwill and Other Intangible Assets - Changes in Carrying Amount of Goodwill (Details) Details 64 false false R65.htm 041520 - Disclosure - Goodwill and Other Intangible Assets - Gross Carrying Amounts and Accumulated Amortization for Definite-lived Intangible Assets (Details) Sheet http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails Goodwill and Other Intangible Assets - Gross Carrying Amounts and Accumulated Amortization for Definite-lived Intangible Assets (Details) Details 65 false false R66.htm 041540 - Disclosure - Goodwill and Other Intangible Assets - Intangible Assets - Future Amortization (Details) Sheet http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails Goodwill and Other Intangible Assets - Intangible Assets - Future Amortization (Details) Details 66 false false R67.htm 041550 - Disclosure - Goodwill and Other Intangible Assets - Indefinite Lived (Details) Sheet http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIndefiniteLivedDetails Goodwill and Other Intangible Assets - Indefinite Lived (Details) Details 67 false false R68.htm 041910 - Disclosure - Debt - Table (Details) Sheet http://www.quakerchem.com/role/DebtTableDetails Debt - Table (Details) Details 68 false false R69.htm 041940 - Disclosure - Debt - Narrative (Details) Sheet http://www.quakerchem.com/role/DebtNarrativeDetails Debt - Narrative (Details) Details 69 false false R70.htm 041950 - Disclosure - Debt - Debt related expenses included within Interest expense (Details) Sheet http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedWithinInterestExpenseDetails Debt - Debt related expenses included within Interest expense (Details) Details 70 false false R71.htm 042212 - Disclosure - Accumulated Other Comprehensive Income - Changes in Equity (Parentheticals) (Details) Sheet http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeChangesInEquityParentheticalsDetails Accumulated Other Comprehensive Income - Changes in Equity (Parentheticals) (Details) Details 71 false false R72.htm 042220 - Disclosure - Accumulated Other Comprehensive Income - AOCI Reclassifications (Details) Sheet http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails Accumulated Other Comprehensive Income - AOCI Reclassifications (Details) Details 72 false false R73.htm 042410 - Disclosure - Fair Value Measurements - Assets Subject to Fair Value Measurement (Details) Sheet http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjectToFairValueMeasurementDetails Fair Value Measurements - Assets Subject to Fair Value Measurement (Details) Details 73 false false R74.htm 042504 - Disclosure - Hedging Activities - Narrative (Details) Sheet http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails Hedging Activities - Narrative (Details) Details 74 false false R75.htm 042505 - Disclosure - Hedging Activities - Balance Sheet Classification and Fair Values (Details) Sheet http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails Hedging Activities - Balance Sheet Classification and Fair Values (Details) Details 75 false false R76.htm 042510 - Disclosure - Commitments and Contingencies - Narrative (Details) Sheet http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails Commitments and Contingencies - Narrative (Details) Details 76 false false All Reports Book All Reports kwr-20220331.htm exhibit311.htm exhibit312.htm exhibit321.htm exhibit322.htm kwr-20220331.xsd kwr-20220331_cal.xml kwr-20220331_def.xml kwr-20220331_lab.xml kwr-20220331_pre.xml http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021 true true JSON 94 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "kwr-20220331.htm": { "axisCustom": 0, "axisStandard": 25, "contextCount": 285, "dts": { "calculationLink": { "local": [ "kwr-20220331_cal.xml" ] }, "definitionLink": { "local": [ "kwr-20220331_def.xml" ] }, "inline": { "local": [ "kwr-20220331.htm" ] }, "labelLink": { "local": [ "kwr-20220331_lab.xml" ] }, "presentationLink": { "local": [ "kwr-20220331_pre.xml" ] }, "schema": { "local": [ "kwr-20220331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd" ] } }, "elementCount": 975, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2021-01-31": 6, "http://xbrl.sec.gov/dei/2021": 7, "total": 13 }, "keyCustom": 30, "keyStandard": 305, "memberCustom": 31, "memberStandard": 64, "nsprefix": "kwr", "nsuri": "http://www.quakerchem.com/20220331", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000100 - Document - Document and Entity Information", "role": "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010210 - Disclosure - Business Acquisitions", "role": "http://www.quakerchem.com/role/BusinessAcquisitions", "shortName": "Business Acquisitions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010310 - Disclosure - Recently Issued Accounting Standards", "role": "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandards", "shortName": "Recently Issued Accounting Standards", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010409 - Disclosure - Business Segments", "role": "http://www.quakerchem.com/role/BusinessSegments", "shortName": "Business Segments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010410 - Disclosure - Net Sales and Revenue Recognition", "role": "http://www.quakerchem.com/role/NetSalesAndRevenueRecognition", "shortName": "Net Sales and Revenue Recognition", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010508 - Disclosure - Leases", "role": "http://www.quakerchem.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010640 - Disclosure - Restructuring and Related Activities", "role": "http://www.quakerchem.com/role/RestructuringAndRelatedActivities", "shortName": "Restructuring and Related Activities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010710 - Disclosure - Share-Based Compensation", "role": "http://www.quakerchem.com/role/ShareBasedCompensation", "shortName": "Share-Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010750 - Disclosure - Pension and Postretirement Benefits", "role": "http://www.quakerchem.com/role/PensionAndPostretirementBenefits", "shortName": "Pension and Postretirement Benefits", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010810 - Disclosure - Other (Expense) Income, Net", "role": "http://www.quakerchem.com/role/OtherExpenseIncomeNet", "shortName": "Other (Expense) Income, Net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010910 - Disclosure - Income Taxes and Uncertain Income Tax Positions", "role": "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions", "shortName": "Income Taxes and Uncertain Income Tax Positions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000200 - Statement - Condensed Consolidated Statements of Income", "role": "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome", "shortName": "Condensed Consolidated Statements of Income", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011010 - Disclosure - Earnings Per Share", "role": "http://www.quakerchem.com/role/EarningsPerShare", "shortName": "Earnings Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011510 - Disclosure - Goodwill and Intangible Assets", "role": "http://www.quakerchem.com/role/GoodwillAndIntangibleAssets", "shortName": "Goodwill and Intangible Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011910 - Disclosure - Debt", "role": "http://www.quakerchem.com/role/Debt", "shortName": "Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012210 - Disclosure - Accumulated Other Comprehensive Income", "role": "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncome", "shortName": "Accumulated Other Comprehensive Income", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012410 - Disclosure - Fair Value Measurements", "role": "http://www.quakerchem.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012415 - Disclosure - Hedging Activities", "role": "http://www.quakerchem.com/role/HedgingActivities", "shortName": "Hedging Activities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012510 - Disclosure - Commitments and Contingencies", "role": "http://www.quakerchem.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "020001 - Disclosure - Basis of Presentation and Description of Business (Policies)", "role": "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessPolicies", "shortName": "Basis of Presentation and Description of Business (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030410 - Disclosure - Business Segments (Tables)", "role": "http://www.quakerchem.com/role/BusinessSegmentsTables", "shortName": "Business Segments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030510 - Disclosure - Net Sales and Revenue Recognition (Tables)", "role": "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionTables", "shortName": "Net Sales and Revenue Recognition (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000300 - Statement - Condensed Consolidated Statements of Comprehensive Income", "role": "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome", "shortName": "Condensed Consolidated Statements of Comprehensive Income", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030609 - Disclosure - Leases (Tables)", "role": "http://www.quakerchem.com/role/LeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030610 - Disclosure - Restructuring and Related Activities (Tables)", "role": "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesTables", "shortName": "Restructuring and Related Activities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030710 - Disclosure - Share Based Compensation (Tables)", "role": "http://www.quakerchem.com/role/ShareBasedCompensationTables", "shortName": "Share Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030750 - Disclosure - Pension and Other Post Retirement Benefits (Tables)", "role": "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables", "shortName": "Pension and Other Post Retirement Benefits (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030810 - Disclosure - Other (Expense) Income, Net (Tables)", "role": "http://www.quakerchem.com/role/OtherExpenseIncomeNetTables", "shortName": "Other (Expense) Income, Net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031010 - Disclosure - Earnings Per Share (Tables)", "role": "http://www.quakerchem.com/role/EarningsPerShareTables", "shortName": "Earnings Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031510 - Disclosure - Goodwill and Intangible Assets (Tables)", "role": "http://www.quakerchem.com/role/GoodwillAndIntangibleAssetsTables", "shortName": "Goodwill and Intangible Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031750 - Disclosure - Debt (Tables)", "role": "http://www.quakerchem.com/role/DebtTables", "shortName": "Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "032211 - Disclosure - Accumulated Other Comprehensive Income (Tables)", "role": "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeTables", "shortName": "Accumulated Other Comprehensive Income (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "032410 - Disclosure - Fair Value Measurements (Table)", "role": "http://www.quakerchem.com/role/FairValueMeasurementsTable", "shortName": "Fair Value Measurements (Table)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "AS_OF_Mar31_2022_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000400 - Statement - Condensed Consolidated Balance Sheets", "role": "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "AS_OF_Mar31_2022_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "032411 - Disclosure - Hedging Activities (Tables)", "role": "http://www.quakerchem.com/role/HedgingActivitiesTables", "shortName": "Hedging Activities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock", "div", "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "AS_OF_Mar31_2022_Entity_0000081362", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfCountriesInWhichEntityOperates", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040010 - Disclosure - Basis of Presentation and Description of Business (Details)", "role": "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "shortName": "Basis of Presentation and Description of Business (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock", "div", "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "AS_OF_Mar31_2022_Entity_0000081362", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfCountriesInWhichEntityOperates", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040214 - Disclosure - Business Acquisitions - Narrative (Details)", "role": "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "shortName": "Business Acquisitions - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:BusinessCombinationDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Jan31_2022_Entity_0000081362_us-gaap_AssetAcquisitionAxis_kwr_AssetsRelatedToSealingAndImpregnationOfMetalCastingsMember", "decimals": "-5", "lang": "en-US", "name": "us-gaap:AssetAcquisitionConsiderationTransferred", "reportCount": 1, "unique": true, "unitRef": "EUR", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock", "div", "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040314 - Disclosure - Business Segments - Narrative (Details)", "role": "http://www.quakerchem.com/role/BusinessSegmentsNarrativeDetails", "shortName": "Business Segments - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R44": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040315 - Disclosure - Business Segments - Performance of reportable segments (Details)", "role": "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "shortName": "Business Segments - Performance of reportable segments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "kwr:OperatingIncomeLossSegmentReporting", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "-5", "first": true, "lang": "en-US", "name": "kwr:Netreportingamount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040410 - Disclosure - Net Sales and Revenue Recognition - Narrative (Details)", "role": "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails", "shortName": "Net Sales and Revenue Recognition - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "-5", "first": true, "lang": "en-US", "name": "kwr:Netreportingamount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040412 - Disclosure - Net Sales and Revenue Recognition - Disaggregated Revenue (Details)", "role": "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDisaggregatedRevenueDetails", "shortName": "Net Sales and Revenue Recognition - Disaggregated Revenue (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_TimingOfTransferOfGoodOrServiceAxis_us-gaap_TransferredAtPointInTimeMember", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "us-gaap:VariableLeaseCost", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:VariableLeaseCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040415 - Disclosure - Leases - Narrative (Details)", "role": "http://www.quakerchem.com/role/LeasesNarrativeDetails", "shortName": "Leases - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:VariableLeaseCost", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:VariableLeaseCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:LeaseCostTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040416 - Disclosure - Leases - Supplemental Information (Details)", "role": "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails", "shortName": "Leases - Supplemental Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:LeaseCostTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "AS_OF_Mar31_2022_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040417 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details)", "role": "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails", "shortName": "Leases - Maturities of Operating Lease Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "AS_OF_Mar31_2022_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "AS_OF_Mar31_2022_Entity_0000081362", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "myUSDPerShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000450 - Statement - Condensed Consolidated Balance Sheets (Parentheticals)", "role": "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "shortName": "Condensed Consolidated Balance Sheets (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "AS_OF_Mar31_2022_Entity_0000081362", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "myUSDPerShare", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedCostDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040640 - Disclosure - Restructuring and Related Activities - Narrative (Details)", "role": "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesNarrativeDetails", "shortName": "Restructuring and Related Activities - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedCostDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "AS_OF_Dec31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringReserve", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040650 - Disclosure - Restructuring and Related Activities (Details)", "role": "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails", "shortName": "Restructuring and Related Activities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "AS_OF_Dec31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringReserve", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040710 - Disclosure - Share-Based Compensation - Narrative (Details)", "role": "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "shortName": "Share-Based Compensation - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "AS_OF_Mar31_2022_Entity_0000081362_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember", "decimals": "-5", "lang": "en-US", "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040720 - Disclosure - Share-Based Compensation - Share-based Compensation Expense (Details)", "role": "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails", "shortName": "Share-Based Compensation - Share-based Compensation Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362_us-gaap_AwardTypeAxis_kwr_StockOptionsCompensationExpenseMember", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040760 - Disclosure - Share-Based Compensation - Black-Scholes Option Pricing Model (Details)", "role": "http://www.quakerchem.com/role/ShareBasedCompensationBlackScholesOptionPricingModelDetails", "shortName": "Share-Based Compensation - Black-Scholes Option Pricing Model (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "6", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040765 - Disclosure - Share-Based Compensation - Monte Carlo Simulation on Grant Date (Details)", "role": "http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationOnGrantDateDetails", "shortName": "Share-Based Compensation - Monte Carlo Simulation on Grant Date (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "kwr:ScheduleOfMonteCarloOptionPricingModelAndTheAssumptionsTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember", "decimals": "6", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040810 - Disclosure - Pension and Other Postretirement Benefits - Narrative (Details)", "role": "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "shortName": "Pension and Other Postretirement Benefits - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanServiceCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040815 - Disclosure - Pension and Other Postretirement Benefits - Net Periodic Benefit Cost (Details)", "role": "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails", "shortName": "Pension and Other Postretirement Benefits - Net Periodic Benefit Cost (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanServiceCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040900 - Disclosure - Other (Expense) Income, Net (Details)", "role": "http://www.quakerchem.com/role/OtherExpenseIncomeNetDetails", "shortName": "Other (Expense) Income, Net (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040970 - Disclosure - Income Taxes and Uncertain Income Tax Positions 2 - Narrative (Details)", "role": "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "shortName": "Income Taxes and Uncertain Income Tax Positions 2 - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000500 - Statement - Condensed Consolidated Statements of Cash Flows", "role": "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows", "shortName": "Condensed Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041010 - Disclosure - Earnings Per Share - Earnings per Share Calculations Basic (Details)", "role": "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsBasicDetails", "shortName": "Earnings Per Share - Earnings per Share Calculations Basic (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041020 - Disclosure - Earnings Per Share - Earnings per Share Calculations Diluted (Details)", "role": "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsDilutedDetails", "shortName": "Earnings Per Share - Earnings per Share Calculations Diluted (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041030 - Disclosure - Earnings Per Share - Earnings per Share Calculations Antidilutive Shares (Details)", "role": "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsAntidilutiveSharesDetails", "shortName": "Earnings Per Share - Earnings per Share Calculations Antidilutive Shares (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "AS_OF_Mar31_2022_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041110 - Disclosure - Restricted Cash (Details)", "role": "http://www.quakerchem.com/role/RestrictedCashDetails", "shortName": "Restricted Cash (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R64": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "AS_OF_Dec31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041510 - Disclosure - Goodwill and Other Intangible Assets - Changes in Carrying Amount of Goodwill (Details)", "role": "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails", "shortName": "Goodwill and Other Intangible Assets - Changes in Carrying Amount of Goodwill (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "AS_OF_Dec31_2021_Entity_0000081362_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember", "decimals": "-3", "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AdjustmentForAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041520 - Disclosure - Goodwill and Other Intangible Assets - Gross Carrying Amounts and Accumulated Amortization for Definite-lived Intangible Assets (Details)", "role": "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails", "shortName": "Goodwill and Other Intangible Assets - Gross Carrying Amounts and Accumulated Amortization for Definite-lived Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AdjustmentForAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "AS_OF_Mar31_2022_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041540 - Disclosure - Goodwill and Other Intangible Assets - Intangible Assets - Future Amortization (Details)", "role": "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails", "shortName": "Goodwill and Other Intangible Assets - Intangible Assets - Future Amortization (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "AS_OF_Mar31_2022_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "AS_OF_Mar31_2022_Entity_0000081362_srt_StatementGeographicalAxis_kwr_HoughtonCombinationMember", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IndefiniteLivedTrademarks", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041550 - Disclosure - Goodwill and Other Intangible Assets - Indefinite Lived (Details)", "role": "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIndefiniteLivedDetails", "shortName": "Goodwill and Other Intangible Assets - Indefinite Lived (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "AS_OF_Mar31_2022_Entity_0000081362_srt_StatementGeographicalAxis_kwr_HoughtonCombinationMember", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IndefiniteLivedTrademarks", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "AS_OF_Mar31_2022_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DebtAndCapitalLeaseObligations", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041910 - Disclosure - Debt - Table (Details)", "role": "http://www.quakerchem.com/role/DebtTableDetails", "shortName": "Debt - Table (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "AS_OF_Mar31_2022_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DebtAndCapitalLeaseObligations", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "AS_OF_Mar31_2022_Entity_0000081362", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LettersOfCreditOutstandingAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041940 - Disclosure - Debt - Narrative (Details)", "role": "http://www.quakerchem.com/role/DebtNarrativeDetails", "shortName": "Debt - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "AS_OF_Mar31_2022_Entity_0000081362", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LettersOfCreditOutstandingAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "AS_OF_Dec31_2020_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000600 - Statement - Condensed Consolidated Statements of Changes in Equity", "role": "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfChangesInEquity", "shortName": "Condensed Consolidated Statements of Changes in Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "AS_OF_Dec31_2020_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InterestExpenseDebt", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041950 - Disclosure - Debt - Debt related expenses included within Interest expense (Details)", "role": "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedWithinInterestExpenseDetails", "shortName": "Debt - Debt related expenses included within Interest expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InterestExpenseDebt", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "reportCount": 1, "unitRef": "myUSDPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042212 - Disclosure - Accumulated Other Comprehensive Income - Changes in Equity (Parentheticals) (Details)", "role": "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeChangesInEquityParentheticalsDetails", "shortName": "Accumulated Other Comprehensive Income - Changes in Equity (Parentheticals) (Details)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R72": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "AS_OF_Dec31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042220 - Disclosure - Accumulated Other Comprehensive Income - AOCI Reclassifications (Details)", "role": "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails", "shortName": "Accumulated Other Comprehensive Income - AOCI Reclassifications (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "AS_OF_Dec31_2020_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "AS_OF_Mar31_2022_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashSurrenderValueFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042410 - Disclosure - Fair Value Measurements - Assets Subject to Fair Value Measurement (Details)", "role": "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjectToFairValueMeasurementDetails", "shortName": "Fair Value Measurements - Assets Subject to Fair Value Measurement (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "AS_OF_Mar31_2022_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashSurrenderValueFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "AS_OF_Nov30_2019_Entity_0000081362_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeLiabilityNotionalAmount", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042504 - Disclosure - Hedging Activities - Narrative (Details)", "role": "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails", "shortName": "Hedging Activities - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R75": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042505 - Disclosure - Hedging Activities - Balance Sheet Classification and Fair Values (Details)", "role": "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails", "shortName": "Hedging Activities - Balance Sheet Classification and Fair Values (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "AS_OF_Mar31_2022_Entity_0000081362", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyAccrualAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042510 - Disclosure - Commitments and Contingencies - Narrative (Details)", "role": "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "shortName": "Commitments and Contingencies - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "AS_OF_Mar31_2022_Entity_0000081362_srt_RangeAxis_srt_MaximumMember_us-gaap_LossContingenciesByNatureOfContingencyAxis_kwr_AcpMember", "decimals": "-5", "lang": "en-US", "name": "us-gaap:LossContingencyEstimateOfPossibleLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "reportCount": 1, "unitRef": "myUSDPerShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000650 - Statement - Condensed Consolidated Statements of Changes in Equity (Parentheticals)", "role": "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfChangesInEquityParentheticals", "shortName": "Condensed Consolidated Statements of Changes in Equity (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010110 - Disclosure - Basis of Presentation and Description of Business", "role": "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusiness", "shortName": "Basis of Presentation and Description of Business", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-20220331.htm", "contextRef": "FROM_Jan01_2022_TO_Mar31_2022_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 95, "tag": { "country_AR": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Argentina [Member]" } } }, "localname": "AR", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails" ], "xbrltype": "domainItemType" }, "country_BR": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BR", "terseLabel": "Brazil [Member]" } } }, "localname": "BR", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "domainItemType" }, "country_CA": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ca", "terseLabel": "Canada [Member]" } } }, "localname": "CA", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "domainItemType" }, "country_CN": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CN", "terseLabel": "China [Member]" } } }, "localname": "CN", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "domainItemType" }, "country_DE": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DE", "terseLabel": "Germany [Member]" } } }, "localname": "DE", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "domainItemType" }, "country_ES": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ES", "terseLabel": "Spain [Member]" } } }, "localname": "ES", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "domainItemType" }, "country_FR": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FR", "terseLabel": "France [Member]" } } }, "localname": "FR", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "domainItemType" }, "country_GB": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "GB", "terseLabel": "United Kingdom [Member]" } } }, "localname": "GB", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "domainItemType" }, "country_IN": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "IN", "terseLabel": "India [Member]" } } }, "localname": "IN", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "domainItemType" }, "country_IT": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "IT", "terseLabel": "Italy [Member]" } } }, "localname": "IT", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "domainItemType" }, "country_MX": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "MX", "terseLabel": "Mexico [Member]" } } }, "localname": "MX", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "domainItemType" }, "country_NL": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NL", "terseLabel": "The Netherlands [Member]" } } }, "localname": "NL", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "United States [Member]", "terseLabel": "Domestic plan [Member]", "verboseLabel": "U.S. [Member]" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current fiscal year end date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r955", "r957", "r958" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document period end date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r956" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document quarterly report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r959" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r953" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated By Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r960" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity central index key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity common stock shares outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity current reporting status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r960" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r960" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity filer category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r961" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity public float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r960" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity registrant name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r960" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r960" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r960" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity voluntary filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity well known seasoned issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r952" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12(b) Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r954" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "kwr_AcpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "AC Products, Inc. Subsidiary involved in groundwater contamination litigation", "label": "Acp [Member]", "terseLabel": "ACP [Member]" } } }, "localname": "AcpMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_AcquisitionRelatedFairValueAdjustments": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Non-cash adjustments to the fair value of acquisition-related contingent consideration liabilities or non-cash gains from the revaluation of an existing equity interest as the result of a business combination .", "label": "Acquisition-related fair value adjustments related to inventory", "negatedLabel": "Acquisition-related fair value adjustments related to inventory" } } }, "localname": "AcquisitionRelatedFairValueAdjustments", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kwr_AsbestosClaimsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Numerous lawsuits alleging injury due to exposure to asbestos.", "label": "Asbestos claims [Member]" } } }, "localname": "AsbestosClaimsMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_AssetsForChemicalMaskantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets For Chemical Maskants", "label": "Assets For Chemical Maskants [Member]" } } }, "localname": "AssetsForChemicalMaskantsMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_AssetsRelatedToHydraulicFluidsCoolantsCleanersAndRustPreventativeOilsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets Related to Hydraulic fluids, Coolants, Cleaners, and Rust Preventative oils", "label": "Assets Related to Hydraulic fluids, Coolants, Cleaners, and Rust Preventative oils [Member]" } } }, "localname": "AssetsRelatedToHydraulicFluidsCoolantsCleanersAndRustPreventativeOilsMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_AssetsRelatedToPicklingInhibitorTechnologiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets Related To Pickling Inhibitor Technologies", "label": "Assets Related To Pickling Inhibitor Technologies [Member]" } } }, "localname": "AssetsRelatedToPicklingInhibitorTechnologiesMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_AssetsRelatedToSealingAndImpregnationOfMetalCastingsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets Related To Sealing And Impregnation Of Metal Castings", "label": "Assets Related To Sealing And Impregnation Of Metal Castings [Member]" } } }, "localname": "AssetsRelatedToSealingAndImpregnationOfMetalCastingsMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_AvailableForSaleSecuritiesAssetsFixedIncomeRegisteredInvestmentCompaniesFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the fair value of mutual funds which are invested in fixed income common stock.", "label": "Available For Sale Securities Assets Fixed Income Registered Investment Companies Fair Value Disclosure", "terseLabel": "Fixed Income Registered Investment Companies" } } }, "localname": "AvailableForSaleSecuritiesAssetsFixedIncomeRegisteredInvestmentCompaniesFairValueDisclosure", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjectToFairValueMeasurementDetails" ], "xbrltype": "monetaryItemType" }, "kwr_AvailableForSaleSecuritiesAssetsInternationalDevelopedAndEmergingMarketsRegisteredInvestmentCompaniesFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the fair value of mutual funds which are invested in international developed and emerging markets common stock.", "label": "Available For Sale Securities Assets International Developed And Emerging Markets Registered Investment Companies Fair Value Disclosure", "terseLabel": "International Developed And Emerging Markets Registered Investment Companies" } } }, "localname": "AvailableForSaleSecuritiesAssetsInternationalDevelopedAndEmergingMarketsRegisteredInvestmentCompaniesFairValueDisclosure", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjectToFairValueMeasurementDetails" ], "xbrltype": "monetaryItemType" }, "kwr_AvailableForSaleSecuritiesAssetsLargeCapitalizationRegisteredInvestmentCompaniesFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the fair value of mutual funds which are invested in large capitalization common stock.", "label": "Available For Sale Securities Assets Large Capitalization Registered Investment Companies Fair Value Disclosure", "terseLabel": "Large Capitalization Registered Investment Companies" } } }, "localname": "AvailableForSaleSecuritiesAssetsLargeCapitalizationRegisteredInvestmentCompaniesFairValueDisclosure", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjectToFairValueMeasurementDetails" ], "xbrltype": "monetaryItemType" }, "kwr_AvailableForSaleSecuritiesAssetsMidCapitalizationRegisteredInvestmentCompaniesFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the fair value of mutual funds which are invested in mid capitalization common stock.", "label": "Available For Sale Securities Assets Mid Capitalization Registered Investment Companies Fair Value Disclosure", "terseLabel": "Mid Capitalization Registered Investment Companies" } } }, "localname": "AvailableForSaleSecuritiesAssetsMidCapitalizationRegisteredInvestmentCompaniesFairValueDisclosure", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjectToFairValueMeasurementDetails" ], "xbrltype": "monetaryItemType" }, "kwr_AvailableForSaleSecuritiesAssetsSmallCapitalizationRegisteredInvestmentCompaniesFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the fair value of mutual funds which are invested in small capitalization common stock.", "label": "Available For Sale Securities Assets Small Capitalization Registered Investment Companies Fair Value Disclosure", "terseLabel": "Small Capitalization Registered Investment Companies" } } }, "localname": "AvailableForSaleSecuritiesAssetsSmallCapitalizationRegisteredInvestmentCompaniesFairValueDisclosure", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjectToFairValueMeasurementDetails" ], "xbrltype": "monetaryItemType" }, "kwr_BankLinesOfCreditAndOtherDebtObligationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bank lines of credit and other debt obligations.", "label": "Bank lines of credit and other debt obligations [Member]" } } }, "localname": "BankLinesOfCreditAndOtherDebtObligationsMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "domainItemType" }, "kwr_BaronIndustriesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Baron Industries", "label": "Baron Industries [Member]" } } }, "localname": "BaronIndustriesMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_BrazilianIndirectTaxesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Legal claim in regards to certain Brazilian non-income (indirect) taxes.", "label": "Brazilian Indirect Taxes [Member]" } } }, "localname": "BrazilianIndirectTaxesMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_BusinessAcquisitionAcquireeIndiaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents Quaker Chemical India Private Limited business combination completed during the year.", "label": "Business Acquisition Acquiree India [Member]", "terseLabel": "India [Member]" } } }, "localname": "BusinessAcquisitionAcquireeIndiaMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_BusinessAcquisitionEquityInterestIssuedOrIssuablePercentageOfCompanyInSharesIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of equity interest issued or issuable of the total company shares issued in business acquisition.", "label": "Business Acquisition, Equity Interest Issued or Issuable, Percentage Of Company in Shares Issued" } } }, "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuablePercentageOfCompanyInSharesIssued", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsAntidilutiveSharesDetails" ], "xbrltype": "percentItemType" }, "kwr_BusinessCombinationMeasurementPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The measurement period post acquisition during which the company may record adjustments to the estimated fair value of asset acquired and liabilities assumed.", "label": "Business Combination, Measurement Period", "terseLabel": "Measurement period" } } }, "localname": "BusinessCombinationMeasurementPeriod", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "durationItemType" }, "kwr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherAccruedLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, accrued expenses and other accrued liabilities assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts payable, accrued expenses and other accrued liabilities", "terseLabel": "Accounts payable, accrued expenses and other accrued liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherAccruedLiabilities", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "kwr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebtIncludedCurrentPortions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Long-term debt included current portions", "terseLabel": "Long-term debt including current portions and finance leases" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebtIncludedCurrentPortions", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "kwr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets", "terseLabel": "Other assets acquired net of liabilities assumed" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_Businesscombinationindemnificationassetsrelatedtoformerownership": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Indemnification assets associated with business combinations", "label": "Business Combination Indemnification Assets Related to Former Ownership" } } }, "localname": "Businesscombinationindemnificationassetsrelatedtoformerownership", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_CapitalExpendituresReductionInAccrualButNoCashImpact": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of reduction in capital expenditure accruals which did not have any impact on cash.", "label": "Capital Expenditures Reduction In Accrual But No Cash Impact", "negatedLabel": "Change in accrued purchases of property, plant and equipment, net" } } }, "localname": "CapitalExpendituresReductionInAccrualButNoCashImpact", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kwr_CashSurrenderValueCompanyOwnedLifeInsuranceDeferredCompensationAssetsFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the fair value of company owned life insurance in deferred compensation assets.", "label": "Cash Surrender Value Company Owned Life Insurance Deferred Compensation Assets Fair Value Disclosure", "terseLabel": "Company Owned Life Insurance - Deferred Compensation Assets" } } }, "localname": "CashSurrenderValueCompanyOwnedLifeInsuranceDeferredCompensationAssetsFairValueDisclosure", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjectToFairValueMeasurementDetails" ], "xbrltype": "monetaryItemType" }, "kwr_CeoTransitionCosts": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome": { "order": 7.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expense recognized for the Company's former CEO's supplemental retirement plan, which relates to the former CEO's retirement.", "label": "CEO transition costs", "negatedTerseLabel": "CEO transition charges" } } }, "localname": "CeoTransitionCosts", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "kwr_ChemicalMaskantsProductLineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2021 acquisition Chemical maskants product line.", "label": "Chemical maskants product line [Member]" } } }, "localname": "ChemicalMaskantsProductLineMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_CombinationAndNormanHayMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents Combination and Norman Hay business acquisition that was completed during the period.", "label": "Combination And Norman Hay [Member]" } } }, "localname": "CombinationAndNormanHayMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_CombinationAndOtherAcquisitionRelatedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Combination And Other Acquisition-Related [Member]" } } }, "localname": "CombinationAndOtherAcquisitionRelatedMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_CombinationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The August 1, 2019 business acquisition and Combination with Houghton International", "label": "Combination [Member]" } } }, "localname": "CombinationMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeNarrativeDetails", "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsAntidilutiveSharesDetails" ], "xbrltype": "domainItemType" }, "kwr_Combinationrelatedexpensesnetofpayements": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities, net of payments.", "label": "Combination and other acquisition-related expenses, net of payments" } } }, "localname": "Combinationrelatedexpensesnetofpayements", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kwr_CommingledFundsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This category includes information about pooled institutional investments, including primarily investment trusts", "label": "Commingled funds measured at NAV [Member]" } } }, "localname": "CommingledFundsMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_CompanyStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Describes amounts and percentages of the Entity's common stock as part of the Entity's Pension and Postretirement Benefit Plans.", "label": "Company Stock [Member]" } } }, "localname": "CompanyStockMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ConsolidatedAdjustedEbitdaToInterestExpenseRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Company's consolidated adjusted EBITDA to interest expense ratio as part of debt convenants.", "label": "Consolidated adjusted EBITDA to interest expense ratio" } } }, "localname": "ConsolidatedAdjustedEbitdaToInterestExpenseRatio", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "pureItemType" }, "kwr_ConsolidatedStatementOfChangesInEquityParentheticalsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consolidated Statement Of Changes In Equity Parentheticals [Abstract]" } } }, "localname": "ConsolidatedStatementOfChangesInEquityParentheticalsAbstract", "nsuri": "http://www.quakerchem.com/20220331", "xbrltype": "stringItemType" }, "kwr_CoralChemicalCompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business acquisition of Coral, a privately held, U.S.-based provider of metal finishing fluid solutions.", "label": "Coral Chemical Company (Coral) [Member]" } } }, "localname": "CoralChemicalCompanyMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsTables" ], "xbrltype": "domainItemType" }, "kwr_Debtinstrumentmaturityyear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Year that debt instrument matures and is to be fully repaid.", "label": "Debt Instrument Maturity Year" } } }, "localname": "Debtinstrumentmaturityyear", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "gYearItemType" }, "kwr_DeferredTaxAssetsAcquiredDisallowedInterest": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Acquired Disallowed Interest.", "label": "Deferred Tax Assets, Acquired Disallowed Interest" } } }, "localname": "DeferredTaxAssetsAcquiredDisallowedInterest", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_DeferredTaxAssetsOperatingLossCarryforwardsForeignExpirationPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets Operating Loss Carryforwards Foreign Expiration Period.", "label": "Deferred Tax Assets Operating Loss Carryforwards Foreign Expiration Period" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeignExpirationPeriod", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "durationItemType" }, "kwr_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocalBasedOnReversalOfDeferredTaxLiabilities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets Operating Loss Carryforwards State And Local Based On Reversal Of Deferred Tax Liabilities.", "label": "Deferred Tax Assets Operating Loss Carryforwards State And Local Based On Reversal Of Deferred Tax Liabilities" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocalBasedOnReversalOfDeferredTaxLiabilities", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocalExpirationPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets Operating Loss Carryforwards State And Local Expiration Period.", "label": "Deferred Tax Assets Operating Loss Carryforwards State And Local Expiration Period" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocalExpirationPeriod", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "durationItemType" }, "kwr_DeferredTaxAssetsPartialValuationAllowanceNetExpectedFutureBenefit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Partial Valuation Allowance, Net Expected Future Benefit.", "label": "Deferred Tax Assets, Partial Valuation Allowance, Net Expected Future Benefit" } } }, "localname": "DeferredTaxAssetsPartialValuationAllowanceNetExpectedFutureBenefit", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_DeferredTaxAssetsTaxCreditCarryforwardsForeignExpectedToExpire": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets Tax Credit Carryforwards Foreign Expected To Expire.", "label": "Deferred Tax Assets Tax Credit Carryforwards Foreign Expected To Expire" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwardsForeignExpectedToExpire", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_DeferredTaxAssetsTaxCreditCarryforwardsForeignExpectedToExpireNextFiveYears": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets Tax Credit Carryforwards Foreign Expected To Expire Next Five Years.", "label": "Deferred Tax Assets Tax Credit Carryforwards Foreign Expected To Expire Next Five Years" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwardsForeignExpectedToExpireNextFiveYears", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_DefinedBenefitPlanAmortizationOfGainsLossesWithSettlementLoss": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "order": 15.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amortization of actuarial loss including plan settlement losses", "label": "Defined Benefit Plan, Amortization of Gains (Losses) with Settlement Loss", "terseLabel": "Actuarial Loss" } } }, "localname": "DefinedBenefitPlanAmortizationOfGainsLossesWithSettlementLoss", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "kwr_DefinedBenefitPlanForeignCurrencyExchangeRateChangesOtherComprehensiveIncomeLoss": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "order": 18.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from foreign currency exchange rate changes for an obligation of a foreign operation whose functional currency is not the reporting currency.", "label": "Defined Benefit Plan Foreign Currency Exchange Rate Changes, Other Comprehensive Income Loss", "negatedLabel": "Foreign Currency Exchange Rate Changes", "terseLabel": "Effect of exchange rates on amounts Included in AOCI" } } }, "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesOtherComprehensiveIncomeLoss", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "kwr_DefinedContributionPlanEmployerNonElectiveNondiscretionaryContributionsPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nonelective contributions funds the entity choose to direct toward their eligible workers defined contribution plan if employees make their own contributions, after employees have completed one year of service.", "label": "Defined contribution plan employer non-elective nondiscretionary contributions percent" } } }, "localname": "DefinedContributionPlanEmployerNonElectiveNondiscretionaryContributionsPercent", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_DefinedContributionPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Contribution Plan [Member]" } } }, "localname": "DefinedContributionPlanMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_Definedbenefitplanpremiumrefund": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Refund Related to Overpayment of Premium Refund", "label": "Defined Benefit Plan Premium Refund" } } }, "localname": "Definedbenefitplanpremiumrefund", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/OtherExpenseIncomeNetDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_DefinedbenefitplansettlementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined benefit plan settlement [Member]" } } }, "localname": "DefinedbenefitplansettlementMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_Definedcontributionplanemployermatchingcontributionpercentmaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of emplyee compensation that is contributed to the plan, with a maximum matching contribution made by the employer.", "label": "Defined contribution plan employer matching contribution percent maximum" } } }, "localname": "Definedcontributionplanemployermatchingcontributionpercentmaximum", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_DirectorRetainerAnnualFee": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total annual director retainer fee.", "label": "Director Retainer Annual Fee", "terseLabel": "Total annual director retainer fee" } } }, "localname": "DirectorRetainerAnnualFee", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_DirectorStockOwnershipCashRetainer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of the director retainer fee in company stock and cash.", "label": "Director Stock Ownership Cash Retainer", "terseLabel": "Director Stock Ownership Plan Terms" } } }, "localname": "DirectorStockOwnershipCashRetainer", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_DirectorStockOwnershipPercentageThreshold": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Director Stock ownership percentage threshold", "label": "Director Stock ownership Percentage Threshold" } } }, "localname": "DirectorStockOwnershipPercentageThreshold", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_DirectorsStockOwnershipPlanCompensationExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of equity based compensation cost recognized during the period in selling, general and administrative expense for the company's board of director's stock plan.", "label": "Directors Stock Ownership Plan Compensation Expense [Member]", "terseLabel": "Director stock ownership plan [Member]" } } }, "localname": "DirectorsStockOwnershipPlanCompensationExpenseMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "kwr_Directorstockownershipplanpercentagecash": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of Director Stock Ownership Plan paid in Cash", "label": "Director Stock Ownership Plan Percentage Cash" } } }, "localname": "Directorstockownershipplanpercentagecash", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_Directorstockownershipplanpercentagestock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of Director Stock Ownership Plan paid in Cash", "label": "Director Stock Ownership Plan Percentage Stock" } } }, "localname": "Directorstockownershipplanpercentagestock", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_Directorstockownershipplanpercentagetotal": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of Director Stock Ownership Plan paid in Total", "label": "Director Stock Ownership Plan Percentage Total" } } }, "localname": "Directorstockownershipplanpercentagetotal", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_DiversifiedInvestmentFundRegisteredInvestmentCompaniesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investments held in diversified investment funds or registered investments measured at NAV.", "label": "Diversified investment fund - registered investment companies measured at NAV [Member]" } } }, "localname": "DiversifiedInvestmentFundRegisteredInvestmentCompaniesMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_DocumentAndEntityInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Document and Entity Information [Abstract]" } } }, "localname": "DocumentAndEntityInformationAbstract", "nsuri": "http://www.quakerchem.com/20220331", "xbrltype": "stringItemType" }, "kwr_EffectOfTaxRateChange": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Effect on EPS of tax rate change in current period.", "label": "Effect Of Tax Rate Change" } } }, "localname": "EffectOfTaxRateChange", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_EffectofpriorservicecostChargeperdilutedshare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reflects the effect on diluted earnings per share due to a prior service cost related to pension during the period.", "label": "Effect Of Prior Service Cost Charge Per Diluted Share" } } }, "localname": "EffectofpriorservicecostChargeperdilutedshare", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "perShareItemType" }, "kwr_Effectofrestructuringcostsperdilutedshare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reflects the effect on diluted earnings per share due to restructuring costs during the period.", "label": "Effect Of Restructuring Costs Per Diluted Share" } } }, "localname": "Effectofrestructuringcostsperdilutedshare", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesNarrativeDetails" ], "xbrltype": "perShareItemType" }, "kwr_EmployeeStockPurchasePlanCompensationExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of equity basedcompensation cost recognized during the period in selling, general and administrative expense for the employee stock purchase plan.", "label": "Employee Stock Purchase Plan Compensation Expense [Member]" } } }, "localname": "EmployeeStockPurchasePlanCompensationExpenseMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationInNextYearMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of Tax Loss Carryforward Expiring in Next Year", "label": "Expiration In Next Year [Member]" } } }, "localname": "ExpirationInNextYearMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationInYearEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of tax loss carryforward expiring within eight years of the balance sheet date.", "label": "Expiration In Year Eight [Member]" } } }, "localname": "ExpirationInYearEightMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationInYearFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of tax loss carryforward expiring within five years of the balance sheet date.", "label": "Expiration In Year Five [Member]" } } }, "localname": "ExpirationInYearFiveMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationInYearFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of tax loss carryforward expiring within four years of the balance sheet date.", "label": "Expiration In Year Four [Member]" } } }, "localname": "ExpirationInYearFourMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationInYearNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of tax loss carryforward expiring within nine years of the balance sheet date.", "label": "Expiration In Year Nine [Member]" } } }, "localname": "ExpirationInYearNineMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationInYearSevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of tax loss carryforward expiring within seven years of the balance sheet date.", "label": "Expiration In Year Seven [Member]" } } }, "localname": "ExpirationInYearSevenMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationInYearSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of tax loss carryforward expiring within six years of the balance sheet date.", "label": "Expiration In Year Six [Member]" } } }, "localname": "ExpirationInYearSixMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationInYearTenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of tax loss carryforward expiring within ten years of the balance sheet date.", "label": "Expiration In Year Ten [Member]" } } }, "localname": "ExpirationInYearTenMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationInYearThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expiration In Year Three [Member]" } } }, "localname": "ExpirationInYearThreeMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationInYearTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of tax loss carryforward expiring within two years of the balance sheet date.", "label": "Expiration In Year Two [Member]" } } }, "localname": "ExpirationInYearTwoMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationinfifteenyearsmemberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of tax loss carryforward expiring within Fifteen years of the balance sheet date.", "label": "Expiration In Fifteen Years [Member]" } } }, "localname": "ExpirationinfifteenyearsmemberMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationintwentyyearsmemberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of tax loss carryforward expiring within twenty years of the balance sheet date.", "label": "Expiration In Twenty Years [Member]" } } }, "localname": "ExpirationintwentyyearsmemberMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_FacilitiesVehiclesAndMachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating leases for certain facilities, vehicles and machinery and equipment.", "label": "Facilities vehicles and machinery and equipment [Member]" } } }, "localname": "FacilitiesVehiclesAndMachineryAndEquipmentMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_FairValueStepUpOfInventorySold": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value step up of inventory sold relates to expenses associated with selling inventory from acquired businesses which was adjusted to fair value as part of purchase accounting.", "label": "Fair value step up of acquired inventory sold", "negatedLabel": "Fair value step up of acquired inventory sold" } } }, "localname": "FairValueStepUpOfInventorySold", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "kwr_FederalIncomeTaxExpenseForeign": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of federal income tax expense payable to non-domestic authorities.", "label": "Fededral income tax expense foreign" } } }, "localname": "FederalIncomeTaxExpenseForeign", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finite Lived Intangible Assets Accumulated Amortization [Abstract]" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "kwr_FiniteLivedTrademarksFormulationsAndProductTechnologyGross": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date for the trademarks formulations and product technology.", "label": "Finite Lived Trademarks Formulations And Product Technology Gross", "terseLabel": "Trademarks, Formulations And Product Technology" } } }, "localname": "FiniteLivedTrademarksFormulationsAndProductTechnologyGross", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "kwr_ForeignconsumptiontaxMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Consumption Tax Matter", "label": "Foreign Consumption Tax [Member]" } } }, "localname": "ForeignconsumptiontaxMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_GainOnDispositionOfAssets": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.", "label": "Gain (loss) on disposition of assets" } } }, "localname": "GainOnDispositionOfAssets", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/OtherExpenseIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "kwr_GlobalSpecialtyBusinessesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Global Specialty Businesses.", "label": "Global Specialty Businesses [Member]" } } }, "localname": "GlobalSpecialtyBusinessesMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDisaggregatedRevenueDetails" ], "xbrltype": "domainItemType" }, "kwr_GrindaixGmbhMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Acqusition of Grindaix-GmbH, a privately held, German-based, high-tech provider of coolant control and delivery systems.", "label": "Grindaix GmbH [Member]" } } }, "localname": "GrindaixGmbhMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_HoughtonCombinationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hougton, a business combination.", "label": "Houghton Combination [Member]", "terseLabel": "Houghton Combination [Member]" } } }, "localname": "HoughtonCombinationMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIndefiniteLivedDetails" ], "xbrltype": "domainItemType" }, "kwr_HoughtonEnvironmentalMattersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Houghton environmental matters.", "label": "Houghton environmental matters [Member]" } } }, "localname": "HoughtonEnvironmentalMattersMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_HoughtonMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business combination of Houghton.", "label": "Houghton [Member]" } } }, "localname": "HoughtonMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsTables", "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails", "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_HyperInflationaryEconomiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hyper-inflationary economies policy.", "label": "Hyper-inflationary economies [Policy Text Block]" } } }, "localname": "HyperInflationaryEconomiesPolicyTextBlock", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessPolicies" ], "xbrltype": "textBlockItemType" }, "kwr_IncludingGlobalSpecialtyBusinessesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Segment including Global Specialty Businesses.", "label": "Including Global Specialty Businesses [Member]" } } }, "localname": "IncludingGlobalSpecialtyBusinessesMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDisaggregatedRevenueDetails" ], "xbrltype": "domainItemType" }, "kwr_IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome": { "order": 15.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Income Loss From Continuing Operations Before Noncontrolling Interests and Income Loss From Equity Method Investments", "label": "Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments", "totalLabel": "Income before equity in net income of associated companies" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "kwr_IncreaseDecreaseInDeferredCompensationAndOtherNet": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future and other certain items.", "label": "Increase Decrease In Deferred Compensation And Other Net", "terseLabel": "Deferred compensation, deferred taxes and other, net" } } }, "localname": "IncreaseDecreaseInDeferredCompensationAndOtherNet", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kwr_Increasedecreaseinaccruednoncurrentincometaxespayable": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Increase decrease in accrued non current income taxes payable", "negatedTerseLabel": "Non-current income taxes payable" } } }, "localname": "Increasedecreaseinaccruednoncurrentincometaxespayable", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kwr_IndustrialDevelopmentBondsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Industrial development bonds.", "label": "Industrial development bonds [Member]" } } }, "localname": "IndustrialDevelopmentBondsMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "domainItemType" }, "kwr_Industrialdevelopmentrevenuebond": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents an Industrial Development Revenue Bond used to fund the expansion of the company's Middletown, Ohio manufacturing facility.", "label": "Industrial Development Revenue Bond" } } }, "localname": "Industrialdevelopmentrevenuebond", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_InitialConsolidatedNetDebtToConsolidatedEbitdaRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Company's initial consolidated net debt to consolidated adjusted EBITDA ratio range.", "label": "Initial consolidated net debt to consolidated EBITDA ratio" } } }, "localname": "InitialConsolidatedNetDebtToConsolidatedEbitdaRatio", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "pureItemType" }, "kwr_Insurancesolvencyrecovery": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Income associated with a cash receipt from an insolvent insurance carrier for previously submitted claims by an inative subsiary of the Company.", "label": "Insurance solvency recovery" } } }, "localname": "Insurancesolvencyrecovery", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/OtherExpenseIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "kwr_KoreaHoughtonCoporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents Korea Houghton company business combinations that was completed during the period.", "label": "Korea Houghton Coporation [Member]" } } }, "localname": "KoreaHoughtonCoporationMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_Kwr_lineofcreditremainingborrowingcapacity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line of Credit Remaining borrowing Capacity, net of letters of credit", "label": "Line of Credit Remaining borrowing Capacity, net of letters of credit" } } }, "localname": "Kwr_lineofcreditremainingborrowingcapacity", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_LargestCustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from the entity's largest customer is to net revenues.", "label": "Largest customer [Member]" } } }, "localname": "LargestCustomerMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_LegacyQuakerUsPensionPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Legacy Quaker U.S. Pension Plan [Member]" } } }, "localname": "LegacyQuakerUsPensionPlanMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_Lineofcreditfacilityinitiationdatedescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line Of Credit Facility Initiation Date Description.", "label": "Line Of Credit Facility Initiation Date Description" } } }, "localname": "Lineofcreditfacilityinitiationdatedescription", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_LongTermIncentivePlanLtipMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long-term incentive plan LTIP [Member]" } } }, "localname": "LongTermIncentivePlanLtipMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_LossCarryforwardExpirationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information about the expirations of tax loss carryforwards.", "label": "Loss Carryforward Expiration [Axis]" } } }, "localname": "LossCarryforwardExpirationAxis", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_LossCarryforwardExpirationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identifies the period in which available tax loss carryforwards expire.", "label": "Loss Carryforward Expiration [Domain]" } } }, "localname": "LossCarryforwardExpirationDomain", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_LossContingencyRangeOfOperationWellP2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated range of time that Well P-2 will operate", "label": "Loss Contingency Range Of Operation Well P 2", "terseLabel": "P-2 well operation range estimate" } } }, "localname": "LossContingencyRangeOfOperationWellP2", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_LossContingencyRangeOfOperationWellP3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated range of time that Well P-3 will operate", "label": "Loss Contingency Range Of Operation Well P 3", "terseLabel": "P-3 well operation range estimate" } } }, "localname": "LossContingencyRangeOfOperationWellP3", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_LossOnDispositionOfAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.", "label": "Loss on Disposition of Assets" } } }, "localname": "LossOnDispositionOfAssets", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/OtherExpenseIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "kwr_MatchingStockContribution401KPlanCompensationExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of equity based compensation cost recognized during the period in selling, general and administrative expense for the non-elective and elective 401 (k) match stock contribution plan.", "label": "Matching Stock Contribution 401 K Plan Compensation Expense [Member]", "terseLabel": "Non-elective and elective 401(k) matching contribution in stock [Member]" } } }, "localname": "MatchingStockContribution401KPlanCompensationExpenseMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "kwr_MaximumAnnualCashDividendsRestrictionBasedOnCovenants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of maximum cash dividends that can be paid annually per convenants.", "label": "Maximum annual cash dividends restriction based on covenants" } } }, "localname": "MaximumAnnualCashDividendsRestrictionBasedOnCovenants", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_MetalsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Metals product line.", "label": "Metals [Member]" } } }, "localname": "MetalsMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDisaggregatedRevenueDetails" ], "xbrltype": "domainItemType" }, "kwr_MetalworkingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Metals product line.", "label": "Metalworking and other [Member]" } } }, "localname": "MetalworkingMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDisaggregatedRevenueDetails" ], "xbrltype": "domainItemType" }, "kwr_MetalworkingnorthamericamemberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents Metalworking North America business combination completed during the year.", "label": "Metalworking North America [Member]" } } }, "localname": "MetalworkingnorthamericamemberMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_MiningNorthAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents Minining North America business combination completed during the year.", "label": "Mining North America [Member]" } } }, "localname": "MiningNorthAmericaMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_MiningnorthamericatrademarksformulationsandproducttechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Mining North America Trademarks Formulations And Product Technology [Member]" } } }, "localname": "MiningnorthamericatrademarksformulationsandproducttechnologyMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_NarrativeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Narrative [Abstract]" } } }, "localname": "NarrativeAbstract", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/OtherExpenseIncomeNetDetails" ], "xbrltype": "stringItemType" }, "kwr_NetDebtToConsolidatedAdjustedEbitdaRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Company's consolidated net debt to consolidated adjusted EBITDA ratio range.", "label": "Net debt to consolidated adjusted EBITDA ratio" } } }, "localname": "NetDebtToConsolidatedAdjustedEbitdaRatio", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "pureItemType" }, "kwr_NetherlandsAndSpainMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Netherlands and Spain [Member]" } } }, "localname": "NetherlandsAndSpainMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_Netreportingamount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as revenue under net reporting arrangements", "label": "Net Reporting Amount", "terseLabel": "Revenue Recognized Under Net Reporting Arrangements" } } }, "localname": "Netreportingamount", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_NonoperatingCharges": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of non-operating charges recurring against earnings in the period, which are not directly related to or being allocated to a specific segment.", "label": "Nonoperating Charges", "negatedTerseLabel": "Non-operating and administrative expenses" } } }, "localname": "NonoperatingCharges", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "kwr_NonvestedStockAwardsCompensationExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of equity based compensation cost recognized during the period in selling, general and administrative expense for nonvested stock and restricted stock unit awards.", "label": "Nonvested Stock Awards Compensation Expense [Member]", "terseLabel": "Non-vested stock awards and restricted stock units [Member]" } } }, "localname": "NonvestedStockAwardsCompensationExpenseMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "kwr_NormanHayMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business acquisition of Norman Hay.", "label": "Norman Hay [Member]" } } }, "localname": "NormanHayMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsTables", "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_OffsetInTaxLiabilitiesThroughPurchaseAccounting": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Offset In Tax Liabilities Through Purchase Accounting.", "label": "Offset In Tax Liabilities Through Purchase Accounting" } } }, "localname": "OffsetInTaxLiabilitiesThroughPurchaseAccounting", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_OldCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Syndicated multicurrency, unsecured revolving credit facility with a group of lenders.", "label": "Previous Credit Facility [Member]", "terseLabel": "Previous Credit Facility [Member]" } } }, "localname": "OldCreditFacilityMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_OneJurisdictionExposurePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of exposure represented by one jurisdiction relating to possible contingency related to unasserted claims.", "label": "One Jurisdiction Exposure Percentage", "terseLabel": "Percentage of potential exposure represented by one jurisdiction" } } }, "localname": "OneJurisdictionExposurePercentage", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_OperatingIncomeLossSegmentReporting": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues before amortization and non-operating charges.", "label": "Operating Income Loss Segment Reporting", "terseLabel": "Operating Earnings, Excluding Indirect Operating Expenses", "verboseLabel": "Segment operating earnings" } } }, "localname": "OperatingIncomeLossSegmentReporting", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "kwr_OperatingLossCarryforwardsForeignPartialValuationAllowance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating Loss Carryforwards, Foreign, Partial Valuation Allowance.", "label": "Operating Loss Carryforwards, Foreign, Partial Valuation Allowance" } } }, "localname": "OperatingLossCarryforwardsForeignPartialValuationAllowance", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_OperatingLossCarryforwardsStatePartialValuationAllowance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating Loss Carryforwards, State, Partial Valuation Allowance.", "label": "Operating Loss Carryforwards, State, Partial Valuation Allowance" } } }, "localname": "OperatingLossCarryforwardsStatePartialValuationAllowance", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_OtherLiabilitiesCurrentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line item in the statement of financial position in which the fair value amounts of the derivative instruments are included.", "label": "Other Liabilities Current [Member]" } } }, "localname": "OtherLiabilitiesCurrentMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_Othercomprehensiveincomelossplancurtailments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Other Comprehensive Income Loss Plan Curtailments" } } }, "localname": "Othercomprehensiveincomelossplancurtailments", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "kwr_Othercomprehensiveincomelossplansettlement": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Other comprehensive income loss plan settlement" } } }, "localname": "Othercomprehensiveincomelossplansettlement", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "kwr_Pensionandpostretirementbenefitcostsnonservicecomponents": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other income related to non-service pension cost components", "label": "Pension and postretirement benefit income, non-service components", "negatedTerseLabel": "Pension and post retirement benefit costs nonservice components" } } }, "localname": "Pensionandpostretirementbenefitcostsnonservicecomponents", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/OtherExpenseIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "kwr_PercentageOfCashDividendsOfConsolidatedAdjustedEbitda": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of cash dividends of consolidated adjusted EBITDA.", "label": "Percentage of cash dividends of consolidated adjusted EBITDA" } } }, "localname": "PercentageOfCashDividendsOfConsolidatedAdjustedEbitda", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_PercentageOfDefenseAndIndemnityCosts": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of defense and indemnity costs incurred by or on behalf of the subsidiary.", "label": "Percentage of defense and indemnity costs" } } }, "localname": "PercentageOfDefenseAndIndemnityCosts", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_PercentageOfTermLoanBorrowings": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of term loan borrowings.", "label": "Percentage of term loan borrowings" } } }, "localname": "PercentageOfTermLoanBorrowings", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_PercentageOfTermLoanPrincipalAmortizationYearFourAndFive": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of term loans quarterly principal amortization during their respective five-year maturities, for years four and five.", "label": "Percentage of term loan principal amortization year four and five" } } }, "localname": "PercentageOfTermLoanPrincipalAmortizationYearFourAndFive", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_PercentageOfTermLoanPrincipalAmortizationYearOneAndTwo": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of term loans quarterly principal amortization during their respective five-year maturities, for year one and two.", "label": "Percentage of term loan principal amortization year one and two" } } }, "localname": "PercentageOfTermLoanPrincipalAmortizationYearOneAndTwo", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_PercentageOfTermLoanPrincipalAmortizationYearThree": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of term loans quarterly principal amortization during their respective five-year maturities, for year three.", "label": "Percentage of term loan principal amortization year three" } } }, "localname": "PercentageOfTermLoanPrincipalAmortizationYearThree", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_PercentageOfTermLoanPrincipalAmortizationYearTwo": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of term loans quarterly principal amortization during their respective five-year maturities, for year two.", "label": "Percentage of term loan principal amortization year two" } } }, "localname": "PercentageOfTermLoanPrincipalAmortizationYearTwo", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_PeriodOfProjectedClaimsOfSubusidiary": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period of total projected claims liability of the subsidiary.", "label": "Period Of Projected Claims Of Subusidiary" } } }, "localname": "PeriodOfProjectedClaimsOfSubusidiary", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "kwr_PooledSeparateAccountPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pooled Separate account Description", "label": "Pooled Separate account percentage" } } }, "localname": "PooledSeparateAccountPercentage", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_PriorPeriodReclassifications": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of balance sheet reclassifications made to prior period financial statements in order to conform to current year presentation.", "label": "Prior Period Reclassifications" } } }, "localname": "PriorPeriodReclassifications", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_ProceedsFromNonIncomeTaxRefunds": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash received during the period as refunds for the overpayment of non-income taxes.", "label": "Proceeds From Non Income Tax Refunds", "terseLabel": "Non-income tax refunds and other related (expense) credits" } } }, "localname": "ProceedsFromNonIncomeTaxRefunds", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/OtherExpenseIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "kwr_PublicOfferingDollarAmountSecurities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregate dollar amount of securities that may be sold in a public offering.", "label": "Public Offering Dollar Amount Securities" } } }, "localname": "PublicOfferingDollarAmountSecurities", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_QhProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The Companys management approved and the Company initiated a global restructuring plan (the QH Program) as part of its plan to realize certain cost synergies associated with the Combination.", "label": "QH Program [Member]" } } }, "localname": "QhProgramMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails" ], "xbrltype": "domainItemType" }, "kwr_SbDeckingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Inactive Subsidiary involved in asbestos litigation", "label": "Sb Decking [Member]", "terseLabel": "SB Decking [Member]" } } }, "localname": "SbDeckingMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ScheduleOfDeferredTaxAssetsAndLiabilitiesBalanceSheetClassificationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the classification on the balance sheet of deferred income tax assets and liabilities", "label": "Schedule Of Deferred Tax Assets And Liabilities Balance Sheet Classification [Table Text Block]" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesBalanceSheetClassificationTableTextBlock", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/TaxesOnIncomeAndUncertainPositionsTables" ], "xbrltype": "textBlockItemType" }, "kwr_ScheduleOfMonteCarloOptionPricingModelAndTheAssumptionsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Monte Carlo option pricing model and the assumptions", "label": "Schedule of Monte Carlo option pricing model and the assumptions [Text Block]" } } }, "localname": "ScheduleOfMonteCarloOptionPricingModelAndTheAssumptionsTextBlock", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "kwr_ShareBasedCompensationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share Based Compensation [Line Items]" } } }, "localname": "ShareBasedCompensationLineItems", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuanceExpectedTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Estimated period over which the equity-based payment award remains in effect once approved.", "label": "Share Based Goods And Nonemployee Services Transaction Shares Approved For Issuance Expected Term", "terseLabel": "Director Stock Ownership Plan Life" } } }, "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuanceExpectedTerm", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_ShareRepurchaseProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share repurchase program authorized by the Board of Directors of the Company. Shares may be purchased from the open market or in private negotiated transactions.", "label": "Share Repurchase Program [Member]", "terseLabel": "2015 Share Repurchase [Member]" } } }, "localname": "ShareRepurchaseProgramMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumNumberOfSharesPercentagePerEmployee": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of the maximum number of shares to be held per employee as a percentage of outstanding common stock.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Maximum Number Of Shares Percentage Per Employee", "terseLabel": "ESPP: Maximum Ownership of Outstanding Shares" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumNumberOfSharesPercentagePerEmployee", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_SignificanceThresholdInPercentageForReportingDispositionsOfABusiness": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of significance threshold for reporting dispositions of a business, as required by significance test in SEC Regulation.", "label": "Significance threshold in percentage for reporting dispositions of a business" } } }, "localname": "SignificanceThresholdInPercentageForReportingDispositionsOfABusiness", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_SouthAfricaEquityAffiliateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "South Africa Equity Affiliate [Member]" } } }, "localname": "SouthAfricaEquityAffiliateMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_StockOptionsCompensationExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of equity based compensation cost recognized during the period in selling, general and administrative expense for the stock options plan.", "label": "Stock Options Compensation Expense [Member]", "terseLabel": "Stock Options [Member]" } } }, "localname": "StockOptionsCompensationExpenseMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "kwr_SupplementalBalanceSheetInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental balance sheet information" } } }, "localname": "SupplementalBalanceSheetInformationAbstract", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "xbrltype": "stringItemType" }, "kwr_SupplementalCashFlowInformationRelatedToLeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental cash flow information related to leases" } } }, "localname": "SupplementalCashFlowInformationRelatedToLeasesAbstract", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "xbrltype": "stringItemType" }, "kwr_TaxAttributesOfTheAcquisitionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Tax attributes of the acquisition [Member]", "terseLabel": "Tax attributes of the acquisition" } } }, "localname": "TaxAttributesOfTheAcquisitionMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityInstallmentsPaid": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tax installment paid related to accumulated foreign earnings liabilities, US Tax reforms.", "label": "Tax Cuts And Jobs Act Of 2017 Transition Tax For Accumulated Foreign Earnings Liability Installments Paid" } } }, "localname": "TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityInstallmentsPaid", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityRemainingInstallments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tax installment remining to be paid, related to accumulated foreign earnings liabilities, US Tax reforms.", "label": "Tax Cuts And Jobs Act Of 2017 Transition Tax For Accumulated Foreign Earnings Liability Remaining Installments" } } }, "localname": "TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityRemainingInstallments", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_TaxSettlementFinalAmountDueToTaxAuthoroties": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Tax settlement final amount due to tax authorities", "label": "Tax settlement final amount due to tax authorities" } } }, "localname": "TaxSettlementFinalAmountDueToTaxAuthoroties", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_Taxcutsandjobsactof2017accountingearningsofforeignsubsidiary": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Tax Cuts And Jobs Act Of 2017 Accounting Earnings Of Foreign Subsidiary" } } }, "localname": "Taxcutsandjobsactof2017accountingearningsofforeignsubsidiary", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_TelnordicMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Tel Nordic ApS[Member]" } } }, "localname": "TelnordicMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_TermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A type of credit facility.", "label": "Term loan [Member]" } } }, "localname": "TermLoanMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_TinplatingsolutionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Acquisition of a tin-plating solutions business for the steel end market.", "label": "Tin Plating Solutions [Member]" } } }, "localname": "TinplatingsolutionsMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_TopFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from the entity's top five customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk Top Five [Member]", "terseLabel": "Top Five Customers [Member]" } } }, "localname": "TopFiveMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_TotalRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveLossOrIncome": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total recognized in net periodic benefit cost and other comprehensive loss or income", "label": "Total Recognized In Net Periodic Benefit Cost And Other Comprehensive Loss Or Income", "totalLabel": "Total Recognized In Net Periodic Benefit Cost And Other Comprehensive Loss Or (Income)" } } }, "localname": "TotalRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveLossOrIncome", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "kwr_TrademarksFormulationsandproducttechnologymemberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Trademarks Formulations And Product Technology [Member]" } } }, "localname": "TrademarksFormulationsandproducttechnologymemberMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "kwr_TrademarksandformulationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Trademarks and Formulations [Member]" } } }, "localname": "TrademarksandformulationsMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_TwentyTwentyOneAcquisitionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Twenty Twenty One Acquisition.", "label": "Twenty Twenty One Acquisition [Member]", "terseLabel": "2021 Acquisitions [Member]" } } }, "localname": "TwentyTwentyOneAcquisitionMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_USTaxReformAct": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A decription of the Tax Cuts and Jobs Act (U.S. Tax Reform) tax legislation as enacted by the U.S. government on December 22,2017 and its effetcs on the Company's earnings.", "label": "U.S. Tax Reform Act" } } }, "localname": "USTaxReformAct", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_UncertainTaxPositions": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Non-cash adjustment for the non-deferred portion of the change in liability for uncertain tax positions", "label": "Uncertain Tax Positions", "terseLabel": "Uncertain tax positions (non-deferred portion)" } } }, "localname": "UncertainTaxPositions", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kwr_UnrecognizedTaxBenefitsIfRecognized": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of potential unrecognized tax benefits.", "label": "Unrecognized Tax Benefits If Recognized" } } }, "localname": "UnrecognizedTaxBenefitsIfRecognized", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_UnrecognizedTaxBenefitsIncomeTaxPenaltiesIncome": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of Income for penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits Tax Penalties Income" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesIncome", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_UnrecognizedTaxBenefitsInterestIncomeOnIncomeTaxes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest income for an overpayment of income taxes.", "label": "Unrecognized Tax Benefits Interest Income On Income Taxes" } } }, "localname": "UnrecognizedTaxBenefitsInterestIncomeOnIncomeTaxes", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_UnrecognizedTaxBenefitsReserve": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount unrecognized tax benefit reserve.", "label": "Unrecognized Tax Benefits Reserve" } } }, "localname": "UnrecognizedTaxBenefitsReserve", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_ValuationAllowanceAmountRelatedToBusinessCombination": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Valuation Allowance, Amount Related To Business Combination", "label": "Valuation Allowance, Amount Related To Business Combination", "terseLabel": "Valuation allowance, amount Related To Business Combination" } } }, "localname": "ValuationAllowanceAmountRelatedToBusinessCombination", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_Valuationallowanceamountotherforeigndeferredtaxasset": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Valuation allowance amount Other Foreign Deferred Tax Asset" } } }, "localname": "Valuationallowanceamountotherforeigndeferredtaxasset", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_Valuationallowanceamountstatedeferredtaxasset": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Valuation Allowance Amount State Deferred tax asset" } } }, "localname": "Valuationallowanceamountstatedeferredtaxasset", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_VatAssessmentThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assessment amount for VAT related matters", "label": "Vat Assessment Three [Member]", "terseLabel": "VAT Assessment Three [Member]" } } }, "localname": "VatAssessmentThreeMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_VatSettlementOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Charge taken for settlement with two jurisdictions related to VAT disputes", "label": "Vat Settlement One [Member]", "terseLabel": "VAT Settlement One [Member]" } } }, "localname": "VatSettlementOneMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_VatSettlementTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Charge taken for settlement with third jurisdictions related to VAT disputes", "label": "Vat Settlement Two [Member]", "terseLabel": "VAT Settlement Two [Member]" } } }, "localname": "VatSettlementTwoMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_VatTotalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total charge taken for VAT related matters.", "label": "Vat Total [Member]", "terseLabel": "VAT, Total [Member]" } } }, "localname": "VatTotalMember", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_Vestingsharestargetlowerpercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Vesting Shares Target Lower Percent" } } }, "localname": "Vestingsharestargetlowerpercent", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_Vestingsharestargetupperpercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Vesting Shares Target Upper Percent" } } }, "localname": "Vestingsharestargetupperpercent", "nsuri": "http://www.quakerchem.com/20220331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "srt_AmericasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Americas [Member]" } } }, "localname": "AmericasMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDisaggregatedRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_AsiaPacificMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Asia Pacific [Member]" } } }, "localname": "AsiaPacificMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDisaggregatedRevenueDetails", "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r153", "r374", "r379", "r387", "r717", "r718", "r725", "r726", "r841", "r949" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r153", "r374", "r379", "r387", "r717", "r718", "r725", "r726", "r841", "r949" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Domain]" } } }, "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r153", "r222", "r241", "r242", "r243", "r244", "r246", "r248", "r252", "r374", "r375", "r376", "r377", "r378", "r379", "r381", "r382", "r384", "r386", "r387" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDisaggregatedRevenueDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r153", "r222", "r241", "r242", "r243", "r244", "r246", "r248", "r252", "r374", "r375", "r376", "r377", "r378", "r379", "r381", "r382", "r384", "r386", "r387" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDisaggregatedRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Operating Lease Maturities [Table Text Block]" } } }, "localname": "ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember": { "auth_ref": [ "r2", "r158", "r170", "r277", "r609", "r610", "r611", "r657", "r658", "r757", "r763", "r764", "r964" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption, Adjusted Balance [Member]", "terseLabel": "Adjusted Balance [Member]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": { "auth_ref": [ "r2", "r158", "r170", "r178", "r277", "r609", "r610", "r611", "r657", "r658", "r757", "r760", "r763", "r764", "r964" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfChangesInEquity", "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAxis": { "auth_ref": [ "r2", "r158", "r170", "r178", "r277", "r609", "r610", "r611", "r657", "r658", "r757", "r760", "r763", "r764", "r964" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption [Axis]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfChangesInEquity", "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionDomain": { "auth_ref": [ "r2", "r158", "r170", "r178", "r277", "r609", "r610", "r611", "r657", "r658", "r757", "r760", "r763", "r764", "r964" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption [Domain]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfChangesInEquity", "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r259", "r466", "r470", "r918" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r392", "r425", "r572", "r582", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r915", "r919", "r950", "r951" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/LeasesNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r392", "r425", "r572", "r582", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r915", "r919", "r950", "r951" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r259", "r466", "r470", "r918" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_NorthAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "North America [Member]" } } }, "localname": "NorthAmericaMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r254", "r466", "r468", "r858", "r914", "r916" ], "lang": { "en-us": { "role": { "label": "Products and Services [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDisaggregatedRevenueDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r254", "r466", "r468", "r858", "r914", "r916" ], "lang": { "en-us": { "role": { "label": "Products and Services [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDisaggregatedRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r392", "r425", "r506", "r572", "r582", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r915", "r919", "r950", "r951" ], "lang": { "en-us": { "role": { "label": "Range [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/LeasesNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r392", "r425", "r506", "r572", "r582", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r915", "r919", "r950", "r951" ], "lang": { "en-us": { "role": { "label": "Range [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/LeasesNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RestatementAdjustmentMember": { "auth_ref": [ "r155", "r156", "r157", "r161", "r162", "r167", "r168", "r170", "r172", "r173", "r175", "r176", "r204", "r763", "r764" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period, Adjustment [Member]", "terseLabel": "Measurement period adjustments [Member]" } } }, "localname": "RestatementAdjustmentMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "domainItemType" }, "srt_RestatementAxis": { "auth_ref": [ "r3", "r155", "r156", "r157", "r161", "r162", "r167", "r168", "r169", "r170", "r172", "r173", "r174", "r175", "r176", "r178", "r204", "r280", "r281", "r613", "r658", "r758", "r763", "r764", "r765", "r922", "r923", "r924", "r925", "r926", "r927", "r928", "r929", "r930", "r931", "r965", "r966" ], "lang": { "en-us": { "role": { "label": "Restatement [Axis]" } } }, "localname": "RestatementAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "stringItemType" }, "srt_RestatementDomain": { "auth_ref": [ "r3", "r155", "r156", "r157", "r161", "r162", "r167", "r168", "r169", "r170", "r172", "r173", "r174", "r175", "r176", "r178", "r204", "r280", "r281", "r613", "r658", "r758", "r763", "r764", "r765", "r922", "r923", "r924", "r925", "r926", "r927", "r928", "r929", "r930", "r931", "r965", "r966" ], "lang": { "en-us": { "role": { "label": "Restatement [Domain]" } } }, "localname": "RestatementDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [ "r171", "r577" ], "lang": { "en-us": { "role": { "label": "Forecast [Member]" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioPreviouslyReportedMember": { "auth_ref": [ "r3", "r155", "r157", "r161", "r162", "r167", "r168", "r169", "r170", "r172", "r173", "r175", "r176", "r204", "r280", "r281", "r613", "r658", "r758", "r763", "r764", "r765", "r922", "r923", "r924", "r925", "r926", "r927", "r928", "r929", "r930", "r931", "r965", "r966" ], "lang": { "en-us": { "role": { "label": "As initially Reported [Member]" } } }, "localname": "ScenarioPreviouslyReportedMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r171", "r178", "r577" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r255", "r256", "r466", "r469", "r917", "r940", "r941", "r942", "r943", "r944", "r945", "r946", "r947", "r948" ], "lang": { "en-us": { "role": { "label": "Segment Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIndefiniteLivedDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDisaggregatedRevenueDetails", "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails" ], "xbrltype": "domainItemType" }, "srt_SouthAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "South America [Member]" } } }, "localname": "SouthAmericaMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r255", "r256", "r466", "r469", "r917", "r935", "r940", "r941", "r942", "r943", "r944", "r945", "r946", "r947", "r948" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIndefiniteLivedDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDisaggregatedRevenueDetails", "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r171", "r178", "r358", "r577", "r847" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_SubsidiariesMember": { "auth_ref": [ "r535", "r838", "r839", "r840" ], "lang": { "en-us": { "role": { "label": "Subsidiaries [Member]", "terseLabel": "Argentina [Member]" } } }, "localname": "SubsidiariesMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingStandardsUpdate201613Member": { "auth_ref": [ "r273" ], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2016-13 Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.", "label": "Accounting Standards Update 2016-13 [Member]", "terseLabel": "ASU 2016-13 [Member]" } } }, "localname": "AccountingStandardsUpdate201613Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingStandardsUpdate201811Member": { "auth_ref": [ "r816" ], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2018-11 Leases (Topic 842): Targeted Improvements.", "label": "Accounting Standards Update 2018-11 [Member]" } } }, "localname": "AccountingStandardsUpdate201811Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingStandardsUpdateExtensibleList": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r161", "r162", "r163", "r165", "r265", "r266", "r274", "r275", "r276", "r277", "r280", "r281", "r373", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r613", "r657", "r658", "r754", "r755", "r756", "r757", "r758", "r759", "r760", "r762", "r763", "r764", "r765", "r779", "r780", "r781", "r782", "r783", "r784", "r788", "r789", "r836", "r920", "r921", "r922", "r923", "r924", "r925", "r926", "r927", "r928", "r929", "r930", "r931", "r962", "r963", "r964", "r965", "r966" ], "lang": { "en-us": { "role": { "documentation": "Indicates amendment to accounting standards.", "label": "Accounting Standards Update [Extensible Enumeration]" } } }, "localname": "AccountingStandardsUpdateExtensibleList", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r49", "r844" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 25.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable", "terseLabel": "Accounts and Other Payables" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r15", "r34", "r261", "r262" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent": { "auth_ref": [ "r876", "r904" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.", "label": "Accrued Liabilities" } } }, "localname": "AccruedLiabilitiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedSalariesCurrent": { "auth_ref": [ "r19", "r20", "r54" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 27.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued compensation" } } }, "localname": "AccruedSalariesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "auth_ref": [ "r80", "r85", "r94", "r95", "r96", "r724" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment [Member]", "terseLabel": "Defined Benefit Pension Plans [Member]" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r47", "r329" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 13.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation Depletion And Amortization Property Plant And Equipment", "negatedTerseLabel": "Less accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": { "auth_ref": [ "r75", "r85", "r723" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent.", "label": "Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]", "terseLabel": "Derivative Instruments" } } }, "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": { "auth_ref": [ "r76", "r77", "r78", "r85", "r94", "r95", "r96" ], "lang": { "en-us": { "role": { "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.", "label": "Accumulated Net Unrealized Investment Gain (Loss) [Member]", "terseLabel": "Unrealized Gain (Loss) in Available-for-Sale Securities [Member]" } } }, "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r37", "r83", "r84", "r85", "r897", "r927", "r931" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 44.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated other comprehensive loss", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accumulated Other Comprehensive Income [Abstract]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r94", "r95", "r796", "r797", "r798", "r799", "r800", "r802" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r82", "r85", "r94", "r95", "r96", "r155", "r156", "r157", "r724", "r922", "r923", "r966" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "Accumulated Other Comprehensive Loss [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r73", "r85", "r94", "r95", "r96", "r724", "r797", "r798", "r799", "r800", "r802" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Translation Adjustment [Member]", "terseLabel": "Currency Translation Adjustments [Member]" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r313" ], "lang": { "en-us": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life", "terseLabel": "Intangible Assets, Amortizable Life" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r35" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 42.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Capital in excess of par value" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r155", "r156", "r157", "r609", "r610", "r611", "r763" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Capital in Excess of Par Value [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentForAmortization": { "auth_ref": [ "r136", "r318" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.", "label": "Amortization" } } }, "localname": "AdjustmentForAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsForErrorCorrectionDomain": { "auth_ref": [ "r167", "r168", "r169", "r172", "r173", "r175", "r176" ], "lang": { "en-us": { "role": { "documentation": "Type of error correction.", "label": "Error Correction, Type [Domain]" } } }, "localname": "AdjustmentsForErrorCorrectionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r161", "r162", "r163", "r165", "r178", "r265", "r266", "r274", "r275", "r276", "r277", "r280", "r281", "r373", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r613", "r655", "r656", "r657", "r658", "r754", "r755", "r756", "r757", "r758", "r759", "r760", "r762", "r763", "r764", "r765", "r779", "r780", "r781", "r782", "r783", "r784", "r788", "r789", "r836", "r860", "r861", "r862", "r920", "r921", "r922", "r923", "r924", "r925", "r926", "r927", "r928", "r929", "r930", "r931", "r962", "r963", "r964", "r965", "r966" ], "lang": { "en-us": { "role": { "documentation": "Information by amendment to accounting standards.", "label": "Adjustments For New Accounting Pronouncements [Axis]" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).", "label": "Adjustments To Additional Paid In Capital Other" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation": { "auth_ref": [ "r437", "r442", "r617" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in additional paid in capital (APIC) resulting from a tax benefit associated with share-based compensation plan other than an employee stock ownership plan (ESOP). Includes, but is not limited to, excess tax benefit.", "label": "Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation", "terseLabel": "Excess tax benefit from stock option exercises" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net income to net cash (used in) provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r585", "r602", "r615" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Allocated Share Based Compensation Expense", "terseLabel": "Share-based Compensation Expense", "verboseLabel": "Total share-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r263", "r285", "r288", "r289" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Allowance For Doubtful Accounts Receivable", "periodEndLabel": "Balance at End of Period", "periodStartLabel": "Balance at Beginning of Period", "terseLabel": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r106", "r136", "r412", "r808" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedWithinInterestExpenseDetails": { "order": 3.0, "parentTag": "us-gaap_InterestAndDebtExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of debt issuance costs" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedWithinInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmountRecognizedInIncomeDueToInflationaryAccounting": { "auth_ref": [ "r804" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount that will be recognized through the income statement (as well as the impact on the other financial statements) as part of highly inflationary accounting.", "label": "Amount Recognized In Income Due To Inflationary Accounting", "verboseLabel": "Currency conversion impacts of hyper-inflationary accounting" } } }, "localname": "AmountRecognizedInIncomeDueToInflationaryAccounting", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r201" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "terseLabel": "Antidilutive Shares" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsAntidilutiveSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AssetAcquisitionAxis": { "auth_ref": [ "r704" ], "lang": { "en-us": { "role": { "documentation": "Information by asset acquisition.", "label": "Asset Acquisition [Axis]" } } }, "localname": "AssetAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetAcquisitionConsiderationTransferred": { "auth_ref": [ "r705", "r706", "r707", "r708" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.", "label": "Asset Acquisition, Consideration Transferred" } } }, "localname": "AssetAcquisitionConsiderationTransferred", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetAcquisitionDomain": { "auth_ref": [ "r704" ], "lang": { "en-us": { "role": { "documentation": "Asset acquisition.", "label": "Asset Acquisition [Domain]" } } }, "localname": "AssetAcquisitionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r149", "r230", "r243", "r250", "r272", "r374", "r375", "r376", "r378", "r379", "r380", "r381", "r383", "r385", "r387", "r388", "r717", "r725", "r778", "r842", "r844", "r869", "r893" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Total assets", "terseLabel": "Segment assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsAndLiabilitiesLesseeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lessee, Lease, Description [Abstract]" } } }, "localname": "AssetsAndLiabilitiesLesseeAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r16", "r17", "r68", "r149", "r272", "r374", "r375", "r376", "r378", "r379", "r380", "r381", "r383", "r385", "r387", "r388", "r717", "r725", "r778", "r842", "r844" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 11.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Total current assets", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r767" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets Fair Value Disclosure" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjectToFairValueMeasurementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsTotalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total assets, when it serves as a benchmark in a concentration of risk calculation, representing the sum of all reported assets as of the balance sheet date.", "label": "Assets Total [Member]", "terseLabel": "Assets Total [Member]" } } }, "localname": "AssetsTotalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r586", "r604" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationOnGrantDateDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r735", "r738" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Presentation [Policy Text Block]" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r565", "r578" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsTables", "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsAntidilutiveSharesDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails", "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r565", "r578", "r681", "r682" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsTables", "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsAntidilutiveSharesDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails", "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date when the business acquisition agreement was executed, in YYYY-MM-DD format.", "label": "Business Acquisition, Date of Acquisition Agreement" } } }, "localname": "BusinessAcquisitionDateOfAcquisitionAgreement1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails" ], "xbrltype": "dateItemType" }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "auth_ref": [ "r701" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of equity interests issued or issuable to acquire entity.", "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares" } } }, "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsAntidilutiveSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsTables", "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsAntidilutiveSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionNameOfAcquiredEntity": { "auth_ref": [ "r676" ], "lang": { "en-us": { "role": { "documentation": "Name of the acquired entity.", "label": "Business Acquisition Name Of Acquired Entity" } } }, "localname": "BusinessAcquisitionNameOfAcquiredEntity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "auth_ref": [ "r677" ], "lang": { "en-us": { "role": { "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.", "label": "Business Acquisition, Percentage of Voting Interests Acquired", "terseLabel": "Percentage of Voting Interests Acquired" } } }, "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "auth_ref": [ "r679", "r680" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.", "label": "Schedule of unaudited Pro Forma [Text Block]" } } }, "localname": "BusinessAcquisitionProFormaInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "auth_ref": [ "r675" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome": { "order": 9.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.", "label": "Business Combination Acquisition Related Costs", "negatedLabel": "Combination, integration and other acquisition-related expenses", "negatedTerseLabel": "Combination-related expenses", "terseLabel": "Combination, integration and other acquisition-related expenses" } } }, "localname": "BusinessCombinationAcquisitionRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r696", "r697", "r699" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Total consideration paid", "terseLabel": "Purchase price", "totalLabel": "Total fair value of consideration transferred", "verboseLabel": "Total fair value of consideration transferred", "zeroTerseLabel": "Total consideration paid for Coral", "zeroVerboseLabel": "Cash Paid for Acquisitions" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": { "auth_ref": [ "r696", "r697" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.", "label": "Fair value of common stock issued as consideration", "terseLabel": "Shares issued related to the Combination", "verboseLabel": "Less: Fair value of common stock issued as consideration" } } }, "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": { "auth_ref": [ "r135", "r703" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.", "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability", "negatedTerseLabel": "Change in Fair Value Estimate", "terseLabel": "Change in Fair Value Estimate" } } }, "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherExpenseIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationAsset": { "auth_ref": [ "r695", "r698", "r702" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset recognized arising from contingent consideration in a business combination.", "label": "Contingent consideration", "terseLabel": "Earn-out provisions" } } }, "localname": "BusinessCombinationContingentConsiderationAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "auth_ref": [ "r694", "r698", "r702" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.", "label": "Business Combination, Contingent Consideration, Liability", "terseLabel": "Earnouts" } } }, "localname": "BusinessCombinationContingentConsiderationLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r709" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business acquisitions disclosure [Text Block]" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitions" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate": { "auth_ref": [ "r685" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of indemnification assets (amounts to be reimbursed if and when certain assumed liabilities are paid) recognized at the acquisition date of a business combination.", "label": "Business Combination Indemnification Assets Amount As Of Acquisition Date", "terseLabel": "Indemnification assets" } } }, "localname": "BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationIndemnificationAssetsDescription": { "auth_ref": [ "r684" ], "lang": { "en-us": { "role": { "documentation": "For indemnification assets recognized in connection with a business combination, this element represents a description of such assets.", "label": "Business Combination Indemnification Assets Description" } } }, "localname": "BusinessCombinationIndemnificationAssetsDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationIndemnificationAssetsRangeOfOutcomesValueHigh": { "auth_ref": [ "r686" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "For indemnification assets recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the indemnification benefit which may be realized.", "label": "Business Combination Indemnification Assets Range Of Outcomes Value High" } } }, "localname": "BusinessCombinationIndemnificationAssetsRangeOfOutcomesValueHigh", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationIndemnificationAssetsRangeOfOutcomesValueLow": { "auth_ref": [ "r686" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "For indemnification assets recognized in connection with a business combination, this element represents an estimate of the low-end of the potential range (undiscounted) of the indemnification benefit which may be realized.", "label": "Business Combination Indemnification Assets Range Of Outcomes Value Low" } } }, "localname": "BusinessCombinationIndemnificationAssetsRangeOfOutcomesValueLow", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred": { "auth_ref": [ "r689" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to items of consideration transferred in connection with a business combination for which the initial accounting was incomplete.", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred", "terseLabel": "Post Closing Adjustment including earnouts", "verboseLabel": "Less: estimated purchase price settlement" } } }, "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "auth_ref": [ "r687" ], "calculation": { "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets", "totalLabel": "Total Assets Purchased" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r687" ], "calculation": { "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "negatedTerseLabel": "Cash Acquired", "terseLabel": "Cash Acquired", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": { "auth_ref": [ "r687" ], "calculation": { "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets", "terseLabel": "Prepaid expenses and other assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "auth_ref": [ "r687" ], "calculation": { "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables", "terseLabel": "Accounts receivable, net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "auth_ref": [ "r687" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities", "terseLabel": "Deferred tax liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r687" ], "calculation": { "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails": { "order": 7.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill", "terseLabel": "Intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "auth_ref": [ "r683", "r687" ], "calculation": { "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of inventory recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "terseLabel": "Inventories, net", "verboseLabel": "Inventories" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "auth_ref": [ "r687" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities assumed at the acquisition date.", "label": "Business Acquisition, Purchase Price Allocation, Liabilities Assumed", "negatedTotalLabel": "Total Liabilities Assumed", "terseLabel": "Total Liabilities Assumed", "totalLabel": "Total Liabilities Assumed" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "auth_ref": [ "r683", "r687" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Net", "terseLabel": "Cash Paid for Acquisitions", "totalLabel": "Business Acquisition, Cost of Acquired Entity, Purchase Price" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r683", "r687" ], "calculation": { "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails": { "order": 6.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment", "terseLabel": "Propery, plant & equipment" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain": { "auth_ref": [ "r678" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.", "label": "Equity Method Investment Realized Gain (Loss) On Revaluation", "negatedLabel": "Non cash gain from purchase of equity affiliate", "terseLabel": "Gain on Revaluation of Existing Equity Interest in Step Purchase" } } }, "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherExpenseIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Acquisitions [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock": { "auth_ref": [ "r154", "r216" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and accounting policies concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity.", "label": "Description of Business [Policy Text Block]" } } }, "localname": "BusinessDescriptionAndAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "auth_ref": [ "r140", "r141", "r142" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.", "label": "Capital Expenditures Incurred but Not yet Paid", "terseLabel": "Change in accrued purchases of property, plant and equipment, net" } } }, "localname": "CapitalExpendituresIncurredButNotYetPaid", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAcquiredFromAcquisition": { "auth_ref": [ "r114" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).", "label": "Cash Acquired From Acquisition", "negatedTerseLabel": "Cash Acquired", "terseLabel": "Less: cash Acquired", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAcquiredFromAcquisition", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r13", "r44", "r138" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.quakerchem.com/role/RestrictedCashDetails": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents", "periodEndLabel": "Cash and cash equivalents at end of period", "periodStartLabel": "Cash and cash equivalents at begining of period" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "http://www.quakerchem.com/role/RestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsDisclosureTextBlock": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for cash and cash equivalent footnotes, which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify.", "label": "Cash And Cash Equivalents Disclosure [Text Block]" } } }, "localname": "CashAndCashEquivalentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestrictedCash" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r130", "r138", "r143" ], "calculation": { "http://www.quakerchem.com/role/RestrictedCashDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash cash equivalents restricted cash and restricted cash equivalents", "periodEndLabel": "Cash and cash equivalents at the end of the period", "periodStartLabel": "Cash and cash equivalents at the beginning of the period", "totalLabel": "Cash cash equivalents restricted cash and restricted cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.quakerchem.com/role/RestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restricted Cash Abstract]" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r130", "r794" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash And Cash Equivalents Period Increase Decrease", "terseLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash", "totalLabel": "Net decrease in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashSurrenderValueFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).", "label": "Cash Surrender Value Fair Value Disclosure", "terseLabel": "Company Owned Life Insurance" } } }, "localname": "CashSurrenderValueFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjectToFairValueMeasurementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfTreasuryStockTable": { "auth_ref": [ "r444", "r445", "r446", "r447" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.", "label": "Class of Treasury Stock [Table]" } } }, "localname": "ClassOfTreasuryStockTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r61", "r357", "r877", "r902" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 39.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r354", "r355", "r356", "r368", "r939" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments And Contingencies Disclosure [Text Block]" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockDividendsPerShareDeclared": { "auth_ref": [ "r442" ], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.", "label": "Dividends declared", "terseLabel": "Dividend per share" } } }, "localname": "CommonStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeChangesInEquityParentheticalsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfChangesInEquityParentheticals", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r155", "r156", "r763" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r33" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock Par Value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r33" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock Shares Authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r33" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock Shares, Issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r33", "r437" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock shares, outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r33", "r844" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 41.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $1 par value; authorized 30,000,000 shares; issued and outstanding 2022 - 17,911,583 shares; 2021 - 17,897,033 shares", "terseLabel": "Common stock" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonStockVotingRights": { "auth_ref": [ "r438" ], "lang": { "en-us": { "role": { "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.", "label": "Common Stock Voting Rights" } } }, "localname": "CommonStockVotingRights", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r90", "r92", "r93", "r103", "r883", "r911" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive income attributable to Quaker Chemical Corporation", "totalLabel": "Comprehensive income attributable to Quaker Chemical Corporation" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r90", "r92", "r102", "r713", "r714", "r729", "r882", "r910" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 13.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest", "negatedLabel": "Less: Comprehensive income attributable to noncontrolling interest", "terseLabel": "Less: comprehensive income attributable to noncontrolling interest" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r90", "r92", "r101", "r712", "r729", "r881", "r909" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 12.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive income", "totalLabel": "Comprehensive income" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for comprehensive income.", "label": "Comprehensive income (loss) [Policy Text Block]" } } }, "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r213", "r214", "r259", "r775", "r776", "r938" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeNarrativeDetails", "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r213", "r214", "r259", "r775", "r776", "r934", "r938" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk By Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeNarrativeDetails", "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r213", "r214", "r259", "r775", "r776", "r934", "r938" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentsOffBalanceSheetRisk": { "auth_ref": [ "r777", "r891" ], "lang": { "en-us": { "role": { "documentation": "Description of financial instruments, excluding certain derivatives, with off-balance sheet credit risk (for example, standby letters of credit or financial guarantees), including (1) information about the (shared) activity, region or economic characteristic that identifies the concentration, (2) the face or contract amount of the instrument, (3) the nature and terms of the instrument, including the market risk, cash requirements and accounting policies for it, (4) the maximum amount of loss due to credit risk that would be incurred if the counterparties failed completely to perform according to the terms of the contracts, and any security or collateral that proved to be of no value, (5) the entity's policy of requiring collateral or other security to support financial instruments subject to credit risk, information about access to collateral or other security, and a brief description of the security supporting those financial instruments, and (6) the policy of entering into and a brief description of master netting arrangements to mitigate the credit risk, and the extent to which such arrangements would reduce the maximum amount of loss due to credit risk.", "label": "Concentration Risk Credit Risk Financial Instruments Off Balance Sheet Risk", "terseLabel": "Other off balance sheet arrangements" } } }, "localname": "ConcentrationRiskCreditRiskFinancialInstrumentsOffBalanceSheetRisk", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeNarrativeDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r213", "r214", "r259", "r775", "r776" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Reclassification Percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeNarrativeDetails", "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r210", "r213", "r214", "r215", "r775", "r777", "r938" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeNarrativeDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r213", "r214", "r259", "r775", "r776", "r938" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CorporateBondSecuritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This category includes information about long-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest, original issue discount).", "label": "Industrial Development Bond Due 2028 [Member]" } } }, "localname": "CorporateBondSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r108", "r858" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of goods sold", "terseLabel": "Cost of goods sold (excluding amortization expense - See Note 13)" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CreditLossFinancialInstrumentPolicyTextBlock": { "auth_ref": [ "r282", "r283", "r284", "r286", "r287", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r303" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit loss on financial instrument measured at amortized cost basis, net investment in lease, off-balance sheet credit exposure, and available-for-sale debt security. Includes, but is not limited to, methodology used to estimate allowance for credit loss, how writeoff of uncollectible amount is recognized, and determination of past due status and nonaccrual status.", "label": "Credit Loss Financial Instrument [Policy Text Block]" } } }, "localname": "CreditLossFinancialInstrumentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r211", "r259" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerListsMember": { "auth_ref": [ "r691" ], "lang": { "en-us": { "role": { "documentation": "Information about customers such as their name and contact information; it may also be an extensive database that includes other information about the customers such as their order history and demographic information.", "label": "Customer lists and rights to sell [Member]" } } }, "localname": "CustomerListsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r692" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtAndCapitalLeaseObligations": { "auth_ref": [ "r875", "r905" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term and long-term debt and lease obligation.", "label": "Debt and Capital Lease Obligations", "terseLabel": "Total debt", "totalLabel": "Debt And Capital Lease Obligations", "verboseLabel": "Credit facilities" } } }, "localname": "DebtAndCapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtCurrent": { "auth_ref": [ "r52" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 24.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.", "label": "Short-term borrowings and current portion of long-term debt", "negatedTerseLabel": "Current portion of long-term debt" } } }, "localname": "DebtCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r146", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r406", "r413", "r414", "r416", "r422" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt [Text Block]" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/Debt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentDescriptionOfVariableRateBasis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of reference rate used for variable rate of debt instrument.", "label": "Debt Instrument, Description of Variable Rate Basis" } } }, "localname": "DebtInstrumentDescriptionOfVariableRateBasis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "auth_ref": [ "r56", "r409", "r807" ], "lang": { "en-us": { "role": { "documentation": "The average effective interest rate during the reporting period.", "label": "Debt Instrument, Interest Rate During Period" } } }, "localname": "DebtInstrumentInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r56", "r390" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument Interest Rate Stated Percentage", "terseLabel": "Interest Rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateTerms": { "auth_ref": [ "r56" ], "lang": { "en-us": { "role": { "documentation": "Description of the interest rate as being fixed or variable, and, if variable, identification of the index or rate on which the interest rate is based and the number of points or percentage added to that index or rate to set the rate, and other pertinent information, such as frequency of rate resets.", "label": "Debt Instrument, Interest Rate Terms" } } }, "localname": "DebtInstrumentInterestRateTerms", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r57", "r392", "r771" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Debt Instrument, Maturity Date", "terseLabel": "Line Of Credit Maturity Date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentMaturityDateDescription": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.", "label": "Debt Instrument Maturity Date Description" } } }, "localname": "DebtInstrumentMaturityDateDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r59", "r148", "r153", "r389", "r390", "r391", "r392", "r393", "r394", "r396", "r402", "r403", "r404", "r405", "r407", "r408", "r409", "r410", "r411", "r412", "r415", "r418", "r419", "r420", "r421", "r438", "r439", "r440", "r441", "r806", "r807", "r809", "r810", "r889" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Debt Instrument [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount": { "auth_ref": [ "r58" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unused borrowing capacity under the long-term financing arrangement that is available to the entity as of the balance sheet date.", "label": "Debt Instrument, Unused Borrowing Capacity, Amount" } } }, "localname": "DebtInstrumentUnusedBorrowingCapacityAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtWeightedAverageInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate of debt outstanding.", "label": "Debt, Weighted Average Interest Rate" } } }, "localname": "DebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": { "auth_ref": [ "r634" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.", "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Estimated Range of Change, Upper Bound" } } }, "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsCurrentNet": { "auth_ref": [ "r67", "r808" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as current. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Current, Net" } } }, "localname": "DeferredFinanceCostsCurrentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r48", "r402", "r808" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Cost Capitalized to Term loans and Long Term Debt", "negatedLabel": "Less: debt issuance costs" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNoncurrentGross": { "auth_ref": [ "r48", "r808" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Deferred Finance Costs Noncurrent Gross" } } }, "localname": "DeferredFinanceCostsNoncurrentGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r625", "r627" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 19.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Tax Assets Net Noncurrent", "terseLabel": "Deferred tax assets" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r136", "r150", "r652", "r664", "r665", "r666" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred income taxes", "negatedTerseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r30", "r31", "r643", "r871", "r892" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r625", "r627" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 35.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities Net", "terseLabel": "Deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenue": { "auth_ref": [ "r41" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Deferred Revenue" } } }, "localname": "DeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueRevenueRecognized1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously reported as deferred or unearned revenue.", "label": "Deferred Revenue Revenue Recognized 1", "negativeTerseLabel": "Deferred Revenue Revenue Recognized" } } }, "localname": "DeferredRevenueRevenueRecognized1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r646" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Net of Valuation Allowance", "terseLabel": "Deferred Tax Assets, Net", "totalLabel": "Total deferred tax assets, net" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNetCurrent": { "auth_ref": [ "r625", "r626", "r627", "r628", "r644" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards classified as current.", "label": "Current deferred tax assets" } } }, "localname": "DeferredTaxAssetsNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": { "auth_ref": [ "r650", "r651" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards, Foreign" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": { "auth_ref": [ "r650", "r651" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax": { "auth_ref": [ "r648", "r650", "r651" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible alternative minimum tax credit carryforwards.", "label": "Deferred Tax Assets, Tax Credit Carryforwards, Alternative Minimum Tax", "terseLabel": "Alternative minimum tax carryforward" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign": { "auth_ref": [ "r648", "r650", "r651" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign tax credit carryforwards.", "label": "Deferred Tax Assets, Tax Credit Carryforwards, Foreign", "terseLabel": "Foreign tax credit and other credits" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwardsForeign", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilities": { "auth_ref": [ "r627", "r646" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.", "label": "Deferred Tax Liabilities", "terseLabel": "Defered Tax Liabilties, Net", "totalLabel": "Total deferred tax liabilities" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesCurrent": { "auth_ref": [ "r625", "r627", "r628", "r650", "r651" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 30.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting and classified as current.", "label": "Current deferred tax liabilities" } } }, "localname": "DeferredTaxLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": { "auth_ref": [ "r515" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.", "label": "Defined Benefit Plan, Accumulated Benefit Obligation", "terseLabel": "Accumulated Benefit Obligation" } } }, "localname": "DefinedBenefitPlanAccumulatedBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligationIncreaseDecreaseForSettlementAndCurtailment": { "auth_ref": [ "r539" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of (increase) decrease in accumulated benefit obligation of defined benefit plan from effects of settlement and curtailment.", "label": "Defined Benefit Plan Effect Of Settlements And Curtailments On Accumulated Benefit Obligation" } } }, "localname": "DefinedBenefitPlanAccumulatedBenefitObligationIncreaseDecreaseForSettlementAndCurtailment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax": { "auth_ref": [ "r81", "r85", "r527" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).", "label": "Pension and Other Postretirement Benefit Plans, Accumulated Other Comprehensive Income (Loss), before Tax", "negatedTotalLabel": "Accumulated Other Comprehensive Loss", "terseLabel": "Gross AOCI", "totalLabel": "Accumulated Other Comprehensive Loss (\"AOCI\")" } } }, "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": { "auth_ref": [ "r482", "r522", "r553", "r559", "r560" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "order": 8.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Gains (Losses)", "negatedLabel": "Actuarial loss (gain) amortization", "terseLabel": "Actuarial Loss Amortization" } } }, "localname": "DefinedBenefitPlanAmortizationOfGainsLosses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": { "auth_ref": [ "r482", "r523", "r554", "r559", "r560" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "order": 9.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)", "negatedLabel": "Prior Service (Credit) Cost Amortization", "terseLabel": "Prior service cost (income) amortization" } } }, "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation": { "auth_ref": [ "r482", "r524", "r555" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "order": 13.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transition asset (obligation) recognized in net periodic benefit (cost) credit of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Transition Obligations (Assets)", "terseLabel": "Transition Asset Amortization" } } }, "localname": "DefinedBenefitPlanAmortizationOfTransitionAssetObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmountOfEmployerAndRelatedPartySecuritiesIncludedInPlanAssets": { "auth_ref": [ "r535", "r559" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of employer security in which defined benefit plan asset is invested. Includes, but is not limited to, security issued or managed by related party of employer.", "label": "Defined Benefit Plan, Amount of Employer and Related Party Securities Included in Plan Assets", "terseLabel": "Value of Employer Securities Included in Plan Assets" } } }, "localname": "DefinedBenefitPlanAmountOfEmployerAndRelatedPartySecuritiesIncludedInPlanAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract]" } } }, "localname": "DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForRemeasurementDueToSettlement": { "auth_ref": [ "r486" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of (increase) decrease to benefit obligation of defined benefit plan from remeasurement due to settlement. Excludes decrease to benefit obligation for settlement payment.", "label": "Defined Benefit Plan Benefit Obligation Increase Decrease For Remeasurement Due To Settlement", "terseLabel": "Pension Settlement Charge" } } }, "localname": "DefinedBenefitPlanBenefitObligationIncreaseDecreaseForRemeasurementDueToSettlement", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherExpenseIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement": { "auth_ref": [ "r486" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of payment, which decreases benefit obligation of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract. Excludes decreases to benefit obligation for remeasurement due to settlement.", "label": "Defined Benefit Plan Benefit Obligation Payment For Settlement" } } }, "localname": "DefinedBenefitPlanBenefitObligationPaymentForSettlement", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanBenefitObligationPeriodIncreaseDecrease": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in benefit obligation of defined benefit plan.", "label": "Defined Benefit Plan Benefit Obligation Period Increase (Decrease)" } } }, "localname": "DefinedBenefitPlanBenefitObligationPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": { "auth_ref": [ "r506", "r507", "r509", "r510", "r511", "r512", "r513", "r514", "r535", "r559" ], "lang": { "en-us": { "role": { "documentation": "Information by defined benefit plan asset investment.", "label": "Defined Benefit Plan, Asset Categories [Axis]" } } }, "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanContributionsByEmployer": { "auth_ref": [ "r498", "r507", "r509", "r557", "r559", "r560" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.", "label": "Defined Benefit Plan, Contributions by Employer", "terseLabel": "Employer Contributions" } } }, "localname": "DefinedBenefitPlanContributionsByEmployer", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod": { "auth_ref": [ "r538" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost of providing special or contractual termination benefits payable from defined benefit plan.", "label": "Defined Benefit Plan Cost Of Providing Special Or Contractual Termination Benefit Recognized During Period", "terseLabel": "Defined Benefit Plan, Termination" } } }, "localname": "DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanDescriptionOfNatureOfEventResultingInSpecialOrContractualTerminationBenefitsRecognizedDuringPeriod": { "auth_ref": [ "r538" ], "lang": { "en-us": { "role": { "documentation": "Description of nature of event resulting in defined benefit plan providing special or contractual termination benefits.", "label": "Defined Benefit Plan Description Of Nature Of Event Resulting In Special Or Contractual Termination Benefits Recognized During Period" } } }, "localname": "DefinedBenefitPlanDescriptionOfNatureOfEventResultingInSpecialOrContractualTerminationBenefitsRecognizedDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan Disclosure [Line Items]" } } }, "localname": "DefinedBenefitPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanEquitySecuritiesMember": { "auth_ref": [ "r507", "r559" ], "lang": { "en-us": { "role": { "documentation": "Security representing ownership in corporation or other legal entity for which ownership is represented by share of stock, in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.", "label": "Defined Benefit Plan Equity Securities [Member]" } } }, "localname": "DefinedBenefitPlanEquitySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear": { "auth_ref": [ "r557", "r560" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in remainder of current fiscal year. Excludes contribution previously paid by employer in current fiscal year.", "label": "Defined Benefit Plan, Estimated Future Employer Contributions in Current Fiscal Year" } } }, "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": { "auth_ref": [ "r482", "r521", "r552", "r559", "r560" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "order": 5.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.", "label": "Defined Benefit Plan, Expected Return on Plan Assets", "negatedLabel": "Expected return on plan assets", "terseLabel": "Expected Return on Plan Assets" } } }, "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExplanationOfSignificantChangeInBenefitObligationOrPlanAssetsNotApparentFromOtherRequiredDisclosures": { "auth_ref": [ "r539", "r562" ], "lang": { "en-us": { "role": { "documentation": "Description of reason for changes in benefit obligation and plan assets of defined benefit plan.", "label": "Defined Benefit Plan Explanation Of Significant Change In Benefit Obligation Or Plan Assets Not Apparent From Other Required Disclosures" } } }, "localname": "DefinedBenefitPlanExplanationOfSignificantChangeInBenefitObligationOrPlanAssetsNotApparentFromOtherRequiredDisclosures", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanInterestCost": { "auth_ref": [ "r482", "r487", "r520", "r551", "r559", "r560" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "order": 4.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.", "label": "Defined Benefit Plan, Interest Cost", "terseLabel": "Interest cost" } } }, "localname": "DefinedBenefitPlanInterestCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "auth_ref": [ "r518", "r549", "r559", "r560" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "order": 10.0, "parentTag": "kwr_TotalRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveLossOrIncome", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost", "terseLabel": "Net Periodic Benefit Cost", "totalLabel": "Total net periodic benefit (income) cost", "verboseLabel": "Pension and postretirement benefit costs, non-service components" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Net Periodic Benefit Cost [Abstract]" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanOtherCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of defined benefit plan cost (credit), classified as other.", "label": "Defined Benefit Plan Other Costs", "terseLabel": "Prior Service Cost Charge" } } }, "localname": "DefinedBenefitPlanOtherCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryPercentage": { "auth_ref": [ "r507", "r559" ], "lang": { "en-us": { "role": { "documentation": "Percentage of investment to total investment within defined benefit plan asset category.", "label": "Defined Benefit Plan Additional Disclosures About Plan Assets" } } }, "localname": "DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments": { "auth_ref": [ "r483", "r525", "r556" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "order": 7.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from event reducing expected years of future service of present employees or eliminating accrual of defined benefits for some or all future services of present employees.", "label": "Defined Benefit Plan, Recognized Net Gain (Loss) Due to Curtailments", "terseLabel": "Curtailment Charge" } } }, "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": { "auth_ref": [ "r483", "r525", "r556" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "order": 6.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.", "label": "Defined Benefit Plan, Recognized Net Gain (Loss) Due to Settlements", "negatedTerseLabel": "Settlement Loss" } } }, "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanServiceCost": { "auth_ref": [ "r485", "r519", "r550", "r559", "r560" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "order": 3.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.", "label": "Defined Benefit Plan, Service Cost", "terseLabel": "Service cost" } } }, "localname": "DefinedBenefitPlanServiceCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlansGeneralInformation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of defined benefit pension and other postretirement plans.", "label": "Defined Benefit Plans General Information", "terseLabel": "Defined Benefit Plans Investment Description" } } }, "localname": "DefinedBenefitPlansGeneralInformation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedContributionPlanCostRecognized": { "auth_ref": [ "r563" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost for defined contribution plan.", "label": "Defined Contribution Plan, Cost Recognized", "terseLabel": "Total Contribution Amount" } } }, "localname": "DefinedContributionPlanCostRecognized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.", "label": "Defined Contribution Plan Employer Discretionary Contribution Amount" } } }, "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.", "label": "Defined Contribution Plan, Employer Matching Contribution, Percent", "terseLabel": "Non-elective Match Percentage" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionPercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage employer matches of the employee's percentage contribution matched.", "label": "Defined Contribution Plan Employer Matching Contribution Percent Of Match" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativeAmountOfHedgedItem": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of hedged item in hedging relationship. Excludes hedged asset or liability.", "label": "Derivative Amount Of Hedged Item" } } }, "localname": "DerivativeAmountOfHedgedItem", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeBasisSpreadOnVariableRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage points added to the reference rate to compute the variable rate on the interest rate derivative.", "label": "Derivative, Basis Spread on Variable Rate" } } }, "localname": "DerivativeBasisSpreadOnVariableRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract Type [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral": { "auth_ref": [ "r69", "r70", "r72", "r749" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after offset of derivative asset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be and before offset against a right to receive collateral under a master netting arrangement. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.", "label": "Derivative Liability, Fair Value, Amount Not Offset Against Collateral", "terseLabel": "Interest Rate Swaps, Liability" } } }, "localname": "DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFixedInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fixed interest rate related to the interest rate derivative.", "label": "Derivative Fixed Interest Rate" } } }, "localname": "DerivativeFixedInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r71", "r736", "r737", "r743", "r746" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument Risk [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r753", "r766" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Hedging Activities [Text Block]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivities" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "auth_ref": [ "r734", "r736", "r743", "r746", "r747", "r750", "r752" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments Gain Loss By Hedging Relationship By Income Statement Location By Derivative Instrument Risk [Table]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments Gain Loss [Line Items]" } } }, "localname": "DerivativeInstrumentsGainLossLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": { "auth_ref": [ "r741", "r745" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.", "label": "Derivative Instruments Gain Loss Reclassified From Accumulated OCI Into Income Effective Portion Net", "terseLabel": "Amount and location of expense reclassified from AOCI into expense (effective portion)" } } }, "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet": { "auth_ref": [ "r742", "r751" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of gains and losses (net) on derivative instruments designated and qualifying as hedging instruments representing (a) the amount of the hedge ineffectiveness and (b) the amount, if any, excluded from the assessment of hedge effectiveness.", "label": "Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net" } } }, "localname": "DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityNotionalAmount": { "auth_ref": [ "r731", "r732", "r733" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payments on the derivative liability.", "label": "Derivative Liability Notional Amount" } } }, "localname": "DerivativeLiabilityNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeRemainingMaturity1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period remaining until the derivative contract matures, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Derivative Remaining Maturity 1" } } }, "localname": "DerivativeRemainingMaturity1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DerivativeTermOfContract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Derivative, Term of Contract" } } }, "localname": "DerivativeTermOfContract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DerivativeVariableInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Variable interest rate in effect as of the balance sheet date related to the interest rate derivative.", "label": "Derivative Variable Interest Rate" } } }, "localname": "DerivativeVariableInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativesFairValueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivatives, Fair Value [Line Items]" } } }, "localname": "DerivativesFairValueLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of defined contribution pension and other postretirement plans.", "label": "Description of Defined Contribution Pension and Other Postretirement Plans", "terseLabel": "Description of Defined Contribution Plan" } } }, "localname": "DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DescriptionOfLesseeLeasingArrangementsOperatingLeases": { "auth_ref": [ "r811", "r812" ], "lang": { "en-us": { "role": { "documentation": "A general description of the nature of the existing leasing arrangements of a lessee for all operating leases including, but not limited to: (1) rental escalation clauses; (2) renewal or purchase options; (3) guarantees or indemnities, if any, (4) restrictions imposed by lease arrangements; (5) unusual provisions or conditions; (6) contingent rentals, if any; and (7) lease expiration dates.", "label": "Operating Lease Terms" } } }, "localname": "DescriptionOfLesseeLeasingArrangementsOperatingLeases", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesOperatingLeasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r466" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of company's net sales by segment [Table Text Block]" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r618" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-Based Compensation [Text Block]" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationChangesToPlanOfSale": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "Description of the facts and circumstances leading to the decision to change the plan to sell the disposal group, including discontinued operation, and its effect on the results of operations of the period and any prior periods presented.", "label": "Disposal Group Including Discontinued Operation Changes To Plan Of Sale" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationChangesToPlanOfSale", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent": { "auth_ref": [ "r6", "r7", "r10", "r326", "r334" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Intangible Assets, Current", "terseLabel": "Intangible Assets Reclassified as Held for Sale" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsCash": { "auth_ref": [ "r442", "r888" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.", "label": "Cash dividends" } } }, "localname": "DividendsCash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsCommonStock": { "auth_ref": [ "r442", "r888" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).", "label": "Dividends Common Stock", "negatedLabel": "Dividends common stock", "negatedTerseLabel": "Dividends ($0.395 per share) ($0.415 per share)" } } }, "localname": "DividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPayableCurrent": { "auth_ref": [ "r20", "r54" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 26.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Dividends payable" } } }, "localname": "DividendsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DomesticCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.", "label": "Domestic Country [Member]" } } }, "localname": "DomesticCountryMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DomesticLineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars, inside the reporting entity's home country.", "label": "Domestic Line of Credit [Member]", "terseLabel": "U.S. Term Loan [Member]" } } }, "localname": "DomesticLineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EMEAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Regions of Europe, Middle East and Africa.", "label": "EMEA [Member]" } } }, "localname": "EMEAMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDisaggregatedRevenueDetails", "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Per share data:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r104", "r167", "r168", "r170", "r171", "r172", "r181", "r184", "r196", "r199", "r200", "r204", "r205", "r764", "r765", "r884", "r912" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Net income attributable to Quaker Chemical Corporation common shareholders - basic", "terseLabel": "Basic earnings (loss) per common share" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome", "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsBasicDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r104", "r167", "r168", "r170", "r171", "r172", "r184", "r196", "r199", "r200", "r204", "r205", "r764", "r765", "r884", "r912" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Net income attributable to Quaker Chemical Corporation common shareholders - diluted", "terseLabel": "Diluted earnings (loss) per common share" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome", "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsDilutedDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r201", "r202", "r203", "r206" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r794" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 45.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of foreign exchange rate changes on cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r630" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate, Continuing Operations" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r151", "r630", "r667" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": { "auth_ref": [ "r630", "r667" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.", "label": "Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationOnGrantDateDetails", "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r603" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1", "terseLabel": "Weighted Average Remaining Life, Nonvested Stock Awards" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": { "auth_ref": [ "r603" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options", "terseLabel": "Unrecognized Share-based Compensation Expense, Nonvested Stock Award" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r603" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options", "terseLabel": "Unrecognized Compensation Expense, Options" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r600" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Employee Stock Option [Member]", "terseLabel": "Stock Options [Member]" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityClassOfTreasuryStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Equity Class Of Treasury Stock [Line Items]" } } }, "localname": "EquityClassOfTreasuryStockLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r2", "r94", "r95", "r96", "r155", "r156", "r157", "r162", "r173", "r176", "r209", "r277", "r437", "r442", "r609", "r610", "r611", "r657", "r658", "r763", "r796", "r797", "r798", "r799", "r800", "r802", "r922", "r923", "r924", "r966" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r271" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment Ownership Percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r45", "r231", "r270" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 18.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Investments in associated companies", "terseLabel": "Equity Method Investments" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ErrorCorrectionOtherMember": { "auth_ref": [ "r167", "r168", "r169", "r172", "r173", "r175", "r176" ], "lang": { "en-us": { "role": { "documentation": "Error correction to previously issued financial statement classified as other.", "label": "Error Correction Other [Member]" } } }, "localname": "ErrorCorrectionOtherMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis": { "auth_ref": [ "r167", "r168", "r169", "r172", "r173", "r175", "r176" ], "lang": { "en-us": { "role": { "documentation": "Information by type of error correction.", "label": "Error Corrections And Prior Period Adjustments Restatement By Restatement Period And Amount Axis" } } }, "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjectToFairValueMeasurementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r767", "r768", "r769", "r774" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjectToFairValueMeasurementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r770" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [TableTextBlock]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsTable" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r767", "r768" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsTable" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r404", "r418", "r419", "r507", "r509", "r510", "r511", "r512", "r513", "r514", "r559", "r768", "r848", "r849", "r850" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value By Fair Value Hierarchy Level [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjectToFairValueMeasurementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Measurements [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r773" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r404", "r507", "r509", "r514", "r559", "r768", "r848" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjectToFairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r404", "r418", "r419", "r507", "r509", "r514", "r559", "r768", "r849" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjectToFairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r404", "r418", "r419", "r507", "r509", "r510", "r511", "r512", "r513", "r514", "r559", "r768", "r850" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjectToFairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r767", "r768" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.", "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsTable" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r772", "r774" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsTable" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r404", "r418", "r419", "r507", "r509", "r510", "r511", "r512", "r513", "r514", "r559", "r848", "r849", "r850" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Measurements Fair Value Hierarchy [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjectToFairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "auth_ref": [ "r735", "r739", "r750" ], "lang": { "en-us": { "role": { "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Fair Values Derivatives Balance Sheet Location By Derivative Contract Type By Hedging Designation [Table]" } } }, "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinanceLeaseLiabilityCurrent": { "auth_ref": [ "r818" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.", "label": "Finance Lease Liability Current" } } }, "localname": "FinanceLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "auth_ref": [ "r818" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.", "label": "Long-term lease liabilities" } } }, "localname": "FinanceLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedCustomerListsGross": { "auth_ref": [ "r317" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date of an asset comprised of customer information, acquired in a business combination or other transaction, having a finite beneficial life.", "label": "Finite Lived Customer Lists, Gross" } } }, "localname": "FiniteLivedCustomerListsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r317" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite Lived Intangible Assets Accumulated Amortization", "terseLabel": "Accumumlated Amortization", "totalLabel": "Total" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r319" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite Lived Intangible Assets Amortization Expense Next Twelve Months", "terseLabel": "For the Year ended December 31, 2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.", "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year", "terseLabel": "For the year ended December 31, 2022" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r319" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite Lived Intangible Assets Amortization Expense Year Five", "terseLabel": "For the Year ended December 31, 2027 and beyond" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r319" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite Lived Intangible Assets Amortization Expense Year Four", "terseLabel": "For the Year ended December 31, 2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r319" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite Lived Intangible Assets Amortization Expense Year Three", "terseLabel": "For the Year ended December 31, 2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r319" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite Lived Intangible Assets Amortization Expense Year Two", "terseLabel": "For the Year ended December 31, 2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r312", "r314", "r317", "r321", "r859", "r866" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Future Amortization Expense [Abstract]" } } }, "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r317", "r866" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite Lived Intangible Assets Gross", "terseLabel": "Gross Carrying Amount", "totalLabel": "Gross Carrying Amount" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGrossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finite Lived Intangible Assets Gross [Abstract]" } } }, "localname": "FiniteLivedIntangibleAssetsGrossAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIndefiniteLivedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r312", "r316" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedTrademarksGross": { "auth_ref": [ "r317" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a specified period of time.", "label": "Finite Lived Trademarks, Gross" } } }, "localname": "FiniteLivedTrademarksGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FixedIncomeSecuritiesMember": { "auth_ref": [ "r507", "r559" ], "lang": { "en-us": { "role": { "documentation": "Investment that provides a return in the form of fixed periodic payments and eventual return of principal at maturity.", "label": "Fixed Income Securities [Member]" } } }, "localname": "FixedIncomeSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.", "label": "Foreign Tax Authority [Member]" } } }, "localname": "ForeignCountryMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyTransactionGainBeforeTax": { "auth_ref": [ "r792", "r793" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain recognized in the income statement.", "label": "Foreign Currency Transaction Gain, before Tax" } } }, "localname": "ForeignCurrencyTransactionGainBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherExpenseIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossRealized": { "auth_ref": [ "r792", "r793" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain (Loss), Realized", "terseLabel": "Foreign exchange losses, net" } } }, "localname": "ForeignCurrencyTransactionGainLossRealized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherExpenseIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionLossBeforeTax": { "auth_ref": [ "r792", "r793" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized loss recognized in the income statement.", "label": "Foreign Currency Transaction Loss Before Tax" } } }, "localname": "ForeignCurrencyTransactionLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherExpenseIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of transaction giving rise to foreign currency transaction gain (loss), including but not limited to, nature of the transaction, the foreign currency involved, the accounting for the transaction.", "label": "Foreign Currency Transactions Description" } } }, "localname": "ForeignCurrencyTransactionsDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherExpenseIncomeNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ForeignLineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars, outside the reporting entity's home country.", "label": "Foreign Line of Credit [Member]", "terseLabel": "EURO Term Loan [Member]" } } }, "localname": "ForeignLineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignPlanMember": { "auth_ref": [ "r564", "r568", "r581" ], "lang": { "en-us": { "role": { "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Foreign Plan [Member]", "terseLabel": "Foreign [Member]" } } }, "localname": "ForeignPlanMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnDispositionOfAssets": { "auth_ref": [ "r136", "r325", "r332" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Assets", "terseLabel": "Gain on disposals of property, plant, equipment and other assets, net" } } }, "localname": "GainLossOnDispositionOfAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherExpenseIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfOtherAssets": { "auth_ref": [ "r136" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of other assets.", "label": "Gain Loss On Sale Of Other Assets" } } }, "localname": "GainLossOnSaleOfOtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "auth_ref": [ "r136" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.", "label": "Gain on disposal of property, plant and equipment", "negatedLabel": "Gain on disposal of property, plant, equipment and other assets" } } }, "localname": "GainLossOnSaleOfPropertyPlantEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossRelatedToLitigationSettlement": { "auth_ref": [ "r357" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.", "label": "Gain (Loss) Related To Litigation Settlement" } } }, "localname": "GainLossRelatedToLitigationSettlement", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralDiscussionOfDerivativeInstrumentsAndHedgingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Hedging Activities [Abstract]" } } }, "localname": "GeneralDiscussionOfDerivativeInstrumentsAndHedgingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Pension and Postretirement Benefits [Abstract]" } } }, "localname": "GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_GeographicConcentrationRiskMember": { "auth_ref": [ "r212", "r938" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa).", "label": "Geographic Concentration Risk [Member]" } } }, "localname": "GeographicConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r304", "r305", "r844", "r868" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 16.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "Goodwill, Ending Balance", "periodStartLabel": "Goodwill, Beginning Balance", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAcquiredDuringPeriod": { "auth_ref": [ "r306" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.", "label": "Goodwill, Acquired During Period", "terseLabel": "Goodwill additions" } } }, "localname": "GoodwillAcquiredDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill And Intangible Assets [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r323" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill And Intangible Assets [Text Block]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndIntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": { "auth_ref": [ "r309" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.", "label": "Goodwill And Intangible Assets, Goodwill, Policy [Policy Text Block]" } } }, "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r307" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Currency translation adjustments" } } }, "localname": "GoodwillForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillPeriodIncreaseDecrease": { "auth_ref": [ "r309" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill Period Increase Decrease" } } }, "localname": "GoodwillPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillPurchaseAccountingAdjustments": { "auth_ref": [ "r308", "r674" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill Purchase Accounting Adjustments", "terseLabel": "Goodwill Reductions" } } }, "localname": "GoodwillPurchaseAccountingAdjustments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Goodwill Roll Forward" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r107", "r149", "r230", "r242", "r246", "r249", "r252", "r272", "r374", "r375", "r376", "r379", "r380", "r381", "r383", "r385", "r387", "r388", "r778" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": { "auth_ref": [ "r136", "r322" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome": { "order": 6.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.", "label": "Indefinite-lived intangible asset impairment", "negatedLabel": "Indefinite-lived intangible asset impairment" } } }, "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIndefiniteLivedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": { "auth_ref": [ "r136", "r324", "r331" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).", "label": "Impairment of Long-Lived Assets Held-for-use", "negatedTerseLabel": "Impairment of Long-Lived Assets Held-for-use" } } }, "localname": "ImpairmentOfLongLivedAssetsHeldForUse", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherExpenseIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r230", "r242", "r246", "r249", "r252" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome": { "order": 13.0, "parentTag": "kwr_IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.", "label": "Income (loss) before taxes and equity in net income of associated companies", "totalLabel": "Income before taxes and equity in net income of associated companies" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r98", "r136", "r227", "r270", "r878", "r906" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome": { "order": 16.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Equity in net income of associated companies", "verboseLabel": "Total equity in net income of associated companies" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions": { "auth_ref": [ "r136" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.", "label": "Equity in net (income) loss of associated companies, net of dividends", "negatedLabel": "Equity in undistributed earnings of associated companies, net of dividends" } } }, "localname": "IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r333", "r340" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r340" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r635" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxCreditsAndAdjustments": { "auth_ref": [ "r137" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A credit or adjustment for government or taxing authority authorized decrease in taxes owed as a result of meeting certain tax policy conditions.", "label": "Income Tax Credits and Adjustments", "terseLabel": "Certain indirect tax credits" } } }, "localname": "IncomeTaxCreditsAndAdjustments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherExpenseIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r151", "r631", "r642", "r647", "r662", "r668", "r670", "r671", "r673" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Taxes and Uncertain Income Tax Positions [Text Block]" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExaminationDescription": { "auth_ref": [ "r633" ], "lang": { "en-us": { "role": { "documentation": "A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings.", "label": "Income Tax Examination Description" } } }, "localname": "IncomeTaxExaminationDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of the additional liability or refund received or expected based on a final settlement with a taxing authority.", "label": "Income Tax Examination Liability Refund Adjustment from Settlement with Taxing Authority" } } }, "localname": "IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxExaminationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Tax Examination [Line Items]" } } }, "localname": "IncomeTaxExaminationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExaminationTable": { "auth_ref": [ "r636" ], "lang": { "en-us": { "role": { "documentation": "A summary of income tax examinations that an enterprise is currently subject to or that have been completed in the current period typically including a description of the examination, the jurisdiction conducting the examination, the tax year(s) under examination, the likelihood of an unfavorable settlement, the range of possible losses, the liability recorded, the Increase or Decrease in the liability from the prior period, and any penalties and interest that have been incurred or accrued.", "label": "Income Tax Examination [Table]" } } }, "localname": "IncomeTaxExaminationTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExaminationYearUnderExamination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax year being audited in the income tax examination, in YYYY format.", "label": "Income Tax Examination, Year under Examination" } } }, "localname": "IncomeTaxExaminationYearUnderExamination", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "gYearListItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r152", "r175", "r176", "r228", "r629", "r663", "r669", "r913" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome": { "order": 14.0, "parentTag": "kwr_IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Taxes on income before equity in net income of associated companies", "terseLabel": "Income Tax Expense (Benefit)", "totalLabel": "Income Tax Expense (Benefit), Total" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": { "auth_ref": [ "r624", "r630" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.", "label": "Income Tax Reconciliation Change In Enacted Tax Rate", "terseLabel": "Transition Tax", "verboseLabel": "U.S. Tax Reform Charges" } } }, "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationTaxSettlementsForeign": { "auth_ref": [ "r630" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax settlement.", "label": "Income Tax Reconciliation Tax Settlements Foreign" } } }, "localname": "IncomeTaxReconciliationTaxSettlementsForeign", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Taxes and Uncertain Tax Positions [Abstract]" } } }, "localname": "IncomeTaxUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r132", "r139" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "terseLabel": "Income taxes, net of refunds" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r135" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 26.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Accounts payable and accrued liabilities", "negatedLabel": "Accounts payable and accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r135" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 22.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Accounts receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": { "auth_ref": [ "r135" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 27.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.", "label": "Estimated taxes on income" } } }, "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r135" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 23.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase Decrease In Inventories", "negatedLabel": "Inventories", "terseLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "(Decrease) increase in cash from changes in current assets and current liabilities, net of acquisitions:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r135" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 24.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "negatedLabel": "Prepaid expenses and other current assets", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInRestrictedCash": { "auth_ref": [ "r116", "r119" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 34.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net cash inflow or outflow for the increase (decrease) associated with funds that are not available for withdrawal or use (such as funds held in escrow) and are associated with underlying transactions that are classified as investing activities.", "label": "Change in restricted cash, net", "negatedLabel": "Change in restricted cash, net" } } }, "localname": "IncreaseDecreaseInRestrictedCash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInRestructuringReserve": { "auth_ref": [ "r135" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 25.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the carrying amount (including both current and noncurrent portions of the accrual) of the liability pertaining to the exit from or disposal of business activities or restructuring pursuant to a duly authorized plan, excluding costs or losses pertaining to an entity newly acquired in a business combination and to asset retirement obligations.", "label": "Change in restructuring liabilities" } } }, "localname": "IncreaseDecreaseInRestructuringReserve", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": { "auth_ref": [ "r634" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase reasonably possible in the next twelve months for the unrecognized tax benefit.", "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Estimated Range of Change, Lower Bound" } } }, "localname": "IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r185", "r186", "r187", "r200" ], "calculation": { "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsDilutedDetails": { "order": 5.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Effect of Dilutive Securities" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsDilutedDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r320" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite Lived Intangible Assets Excluding Goodwill", "terseLabel": "Indefinite lived intangible assets" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIndefiniteLivedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Indefinite Lived Intangible Assets Excluding Goodwill [Abstract]" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedTrademarks": { "auth_ref": [ "r320" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a projected indefinite period of benefit.", "label": "Indefinite Lived Trademarks and Tradename" } } }, "localname": "IndefiniteLivedTrademarks", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIndefiniteLivedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InsuranceClaimsMember": { "auth_ref": [ "r364", "r932" ], "lang": { "en-us": { "role": { "documentation": "A demand for payment of a policy benefit because of the occurrence of an insured event, such as the death or disability of the insured; the maturity of an endowment; the incurrence of hospital or medical bills; the destruction or damage of property and related deaths or injuries; defects in, liens on, or challenges to the title to real estate; or the occurrence of a surety loss; and the costs to process claims.", "label": "Insurance claim [Member]" } } }, "localname": "InsuranceClaimsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InsuranceSettlementsReceivable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due in settlement of a claim for reimbursement from an insurance company when the Company has suffered a loss covered under an insurance policy.", "label": "Insurance Settlements Receivable" } } }, "localname": "InsuranceSettlementsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r311", "r315" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 17.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Other intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestAndDebtExpense": { "auth_ref": [ "r805" ], "calculation": { "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedWithinInterestExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest and debt related expenses associated with nonoperating financing activities of the entity.", "label": "Interest and Debt Expense", "totalLabel": "Total" } } }, "localname": "InterestAndDebtExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedWithinInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestAndDebtExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "InterestAndDebtExpenseAbstract", "terseLabel": "Debt related expenses included within Interest expense:" } } }, "localname": "InterestAndDebtExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedWithinInterestExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r112", "r410", "r417", "r420", "r421" ], "calculation": { "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedWithinInterestExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_InterestAndDebtExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest Expense Debt", "terseLabel": "Interest expense" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedWithinInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseMember": { "auth_ref": [ "r745" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing interest expense.", "label": "Interest Expense [Member]" } } }, "localname": "InterestExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.", "label": "Interest Income And Interest Expense Disclosure [Table Text Block]" } } }, "localname": "InterestIncomeAndInterestExpenseDisclosureTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r885" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome": { "order": 12.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest Income Expense Net", "negatedLabel": "Interest Income Expense Net", "terseLabel": "Interest expense, net", "verboseLabel": "Interest Income Expense Net" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest income earned from interest bearing assets classified as other.", "label": "Interest Income Other" } } }, "localname": "InterestIncomeOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://www.quakerchem.com/role/RestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r126", "r131", "r139" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue": { "auth_ref": [ "r737" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value as of the balance sheet date of all interest rate derivative liabilities designated as cash flow hedging instruments.", "label": "Interest Rate Cash Flow Hedge Liability At Fair Value" } } }, "localname": "InterestRateCashFlowHedgeLiabilityAtFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateSwapMember": { "auth_ref": [ "r744" ], "lang": { "en-us": { "role": { "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.", "label": "Interest Rate Swap [Member]" } } }, "localname": "InterestRateSwapMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InternalRevenueServiceIRSMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity.", "label": "Internal Revenue Service (IRS) [Member]" } } }, "localname": "InternalRevenueServiceIRSMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IntersegmentEliminationMember": { "auth_ref": [ "r222", "r241", "r242", "r243", "r244", "r246", "r248", "r252" ], "lang": { "en-us": { "role": { "documentation": "Eliminating entries used in operating segment consolidation.", "label": "Intersegment Elimination [Member]", "terseLabel": "Intersegment Sales Elimination [Member]" } } }, "localname": "IntersegmentEliminationMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryFinishedGoodsAndWorkInProcess": { "auth_ref": [ "r64" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation reserves of merchandise or goods held by the entity that are readily available for sale and items held by the entity which are partially complete or in the process of being readied for sale.", "label": "Work-in-process and finished goods" } } }, "localname": "InventoryFinishedGoodsAndWorkInProcess", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r14", "r66", "r844" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventories, net", "totalLabel": "Inventories, net" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventories" } } }, "localname": "InventoryNetAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryRawMaterialsAndSupplies": { "auth_ref": [ "r65" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed.", "label": "Raw materials and supplies" } } }, "localname": "InventoryRawMaterialsAndSupplies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LandMember": { "auth_ref": [ "r468" ], "lang": { "en-us": { "role": { "documentation": "Part of earth's surface not covered by water.", "label": "Land [Member]" } } }, "localname": "LandMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseAndRentalExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "Operating Leases, Rent Expense" } } }, "localname": "LeaseAndRentalExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lease cost" } } }, "localname": "LeaseCostAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r832" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Schedule of lease cost and supplemental information [Table Text Block]" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee, Lease, Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r823" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee, Lease, Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r821" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee Leases [Policy Text Block]" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r833" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Schedule of Company's future minimum rental commitments under operating leases [Table Text Block]" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r833" ], "calculation": { "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee Operating Lease Liability Payments Due", "totalLabel": "Total lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r833" ], "calculation": { "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": { "order": 8.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due After Year Five", "terseLabel": "For the year ended December 31, 2027 and beyond" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r833" ], "calculation": { "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Next Twelve Months", "terseLabel": "For the year ended December 31, 2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r833" ], "calculation": { "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": { "order": 7.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Five", "terseLabel": "For the year ended December 31, 2027" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r833" ], "calculation": { "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Four", "terseLabel": "For the year ended December 31, 2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r833" ], "calculation": { "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Three", "terseLabel": "For the year ended December 31, 2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r833" ], "calculation": { "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Two", "terseLabel": "For the year ended December 31, 2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r833" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.", "label": "Lessee Operating Lease Liability Payments Remainder Of Fiscal Year", "terseLabel": "For the remainder of 2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r833" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee Operating Lease Liability Undiscounted Excess Amount", "negatedLabel": "Less: imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": { "auth_ref": [ "r822" ], "lang": { "en-us": { "role": { "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee Operating Lease Term Of Contract" } } }, "localname": "LesseeOperatingLeaseRemainingLeaseTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r835" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Leases Disclosure [TextBlock]" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_LetterOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).", "label": "Letter of Credit [Member]" } } }, "localname": "LetterOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LettersOfCreditOutstandingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.", "label": "Letters Of Credit Outstanding Amount" } } }, "localname": "LettersOfCreditOutstandingAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r53", "r149", "r244", "r272", "r374", "r375", "r376", "r379", "r380", "r381", "r383", "r385", "r387", "r388", "r718", "r725", "r726", "r778", "r842", "r843" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 38.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Total liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r40", "r149", "r272", "r778", "r844", "r874", "r900" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Total liabilities and equity", "totalLabel": "Total liabilities and equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r55", "r149", "r272", "r374", "r375", "r376", "r379", "r380", "r381", "r383", "r385", "r387", "r388", "r718", "r725", "r726", "r778", "r842", "r843", "r844" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 32.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Total current liabilities", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilityForUncertainTaxPositionsNoncurrent": { "auth_ref": [ "r60" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for uncertainty in income taxes classified as noncurrent.", "label": "Liability For Uncertain Tax Positions Noncurrent", "terseLabel": "Uncertain Tax Positions (Includes Interest and Penalties)" } } }, "localname": "LiabilityForUncertainTaxPositionsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.", "label": "Line of Credit Facility, Commitment Fee Percentage" } } }, "localname": "LineOfCreditFacilityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityCovenantCompliance": { "auth_ref": [ "r25", "r27" ], "lang": { "en-us": { "role": { "documentation": "Identification of whether the entity has been in compliance with any credit facility debt covenants during the period.", "label": "Line of Credit Facility, Covenant Compliance" } } }, "localname": "LineOfCreditFacilityCovenantCompliance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityCovenantTerms": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "Description of the conditions for borrowing under the credit facility including the nature of any restrictions.", "label": "Line of Credit Facility, Covenant Terms" } } }, "localname": "LineOfCreditFacilityCovenantTerms", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": { "auth_ref": [ "r50" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Current Borrowing Capacity" } } }, "localname": "LineOfCreditFacilityCurrentBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet": { "auth_ref": [ "r148" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of the credit facility.", "label": "Line of Credit Facility, Increase (Decrease), Net" } } }, "localname": "LineOfCreditFacilityIncreaseDecreaseForPeriodNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityInitiationDate1": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "Date the credit facility first became available, in YYYY-MM-DD format.", "label": "Line Of Credit Facility Initiation Date 1" } } }, "localname": "LineOfCreditFacilityInitiationDate1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "dateItemType" }, "us-gaap_LineOfCreditFacilityInterestRateDescription": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "Description of interest rate for borrowing under credit facility. Includes, but is not limited to, terms and method for determining interest rate.", "label": "Line Of Credit Facility Interest Rate Description" } } }, "localname": "LineOfCreditFacilityInterestRateDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r50" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line Of Credit Facility Maximum Borrowing Capacity", "terseLabel": "Total debt", "totalLabel": "Debt And Capital Lease Obligations", "verboseLabel": "Credit facilities" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "auth_ref": [ "r50" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).", "label": "Line of Credit Facility, Remaining Borrowing Capacity" } } }, "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Revolver [Member]", "terseLabel": "Line of Credit, Current Facility [Member]", "verboseLabel": "Credit facility [Member]" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": { "auth_ref": [ "r257" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.", "label": "Long-lived Assets by Geographic Areas [Table Text Block]", "verboseLabel": "Schedule of reportable segments' long-lived assets, including certain identifiable assets [Table Text Block]" } } }, "localname": "LongLivedAssetsByGeographicAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligations": { "auth_ref": [ "r28" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.", "label": "Long-term Debt and Capital Lease Obligations", "terseLabel": "Total long-term debt", "totalLabel": "Long Term Debt And Capital Lease Obligations" } } }, "localname": "LongTermDebtAndCapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtByMaturityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long Term Debt By Maturity Abstract" } } }, "localname": "LongTermDebtByMaturityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtMaturitySchedulesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r153", "r371", "r408" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long Term Debt Maturities Repayments Of Principal In Next Twelve Months", "terseLabel": "2021" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtMaturitySchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": { "auth_ref": [ "r153", "r371", "r408" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long Term Debt Maturities Repayments Of Principal In Year Five", "terseLabel": "2025" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtMaturitySchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "auth_ref": [ "r153", "r371", "r408" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long Term Debt Maturities Repayments Of Principal In Year Four", "terseLabel": "2024" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtMaturitySchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "auth_ref": [ "r153", "r371", "r408" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long Term Debt Maturities Repayments Of Principal In Year Three", "terseLabel": "2023" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtMaturitySchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r153", "r371", "r408" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long Term Debt Maturities Repayments Of Principal In Year Two", "terseLabel": "2022" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtMaturitySchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r59" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 33.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term debt" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtPercentageBearingVariableInterestRate": { "auth_ref": [ "r56" ], "lang": { "en-us": { "role": { "documentation": "The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a rate subject to change from time to time.", "label": "Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate" } } }, "localname": "LongTermDebtPercentageBearingVariableInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LongTermDebtTerm": { "auth_ref": [ "r771" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Long Term Debt Term" } } }, "localname": "LongTermDebtTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r59" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r59", "r372" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingenciesByNatureOfContingencyAxis": { "auth_ref": [ "r357", "r358", "r359", "r362", "r363", "r364", "r367", "r369", "r370" ], "lang": { "en-us": { "role": { "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.", "label": "Loss Contingencies by Nature of Contingency [Axis]" } } }, "localname": "LossContingenciesByNatureOfContingencyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r357", "r358", "r359", "r362", "r363", "r364", "r367", "r369", "r370" ], "lang": { "en-us": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyAccrualAtCarryingValue": { "auth_ref": [ "r357" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of loss contingency liability.", "label": "Loss Contingency Accrual At Carrying Value", "terseLabel": "Unrelated Environmental Liability Accruals" } } }, "localname": "LossContingencyAccrualAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease": { "auth_ref": [ "r357" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in loss contingency liability.", "label": "Loss Contingency Accrual, Period Increase (Decrease)", "verboseLabel": "(Reversal) of previously recorded liability of best estimate of indirect tax owed" } } }, "localname": "LossContingencyAccrualCarryingValuePeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyAccrualPayments": { "auth_ref": [ "r357" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow reducing loss contingency liability.", "label": "Payments Of Settlement and Release Agreements" } } }, "localname": "LossContingencyAccrualPayments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyEstimateOfPossibleLoss": { "auth_ref": [ "r361", "r366", "r369" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.", "label": "Loss Contingency, Estimate of Possible Loss" } } }, "localname": "LossContingencyEstimateOfPossibleLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyLossInPeriod": { "auth_ref": [ "r357" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome": { "order": 5.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.", "label": "Non-Income Tax Contingency Charge", "negatedTerseLabel": "Non-income tax contingency charge" } } }, "localname": "LossContingencyLossInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyManagementsAssessmentAndProcess": { "auth_ref": [ "r361", "r366" ], "lang": { "en-us": { "role": { "documentation": "Describes management's process to evaluate the contingency matter and to estimate the impact on the financial statements and ongoing operations, such as added credit risk or loss of customers, including pertinent information to adequately disclose the matter and significant assumptions underlying the estimates.", "label": "Loss Contingency Actions Taken By Defendant" } } }, "localname": "LossContingencyManagementsAssessmentAndProcess", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyNatureDomain": { "auth_ref": [ "r357", "r358", "r359", "r362", "r363", "r364", "r367", "r369", "r370" ], "lang": { "en-us": { "role": { "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.", "label": "Loss Contingency, Nature [Domain]" } } }, "localname": "LossContingencyNatureDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingencyReceivableProceeds": { "auth_ref": [ "r127", "r370" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from the collection of receivables related to a loss contingency.", "label": "Proceeds Of Settlement And Release Agreements" } } }, "localname": "LossContingencyReceivableProceeds", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyRelatedReceivableCarryingValuePeriodIncreaseDecrease": { "auth_ref": [ "r370" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of receivables pertaining to a loss contingency.", "label": "Loss Contingency, Receivable, Period Increase (Decrease)", "verboseLabel": "(Reversal) of indemnification receivable" } } }, "localname": "LossContingencyRelatedReceivableCarryingValuePeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencySettlementAgreementTerms": { "auth_ref": [ "r357", "r360", "r365" ], "lang": { "en-us": { "role": { "documentation": "Description of the terms of a settlement agreement which resolved the legal matter, including the nature of the consideration, timing of payment, and the nature of rights obtained or lost (for example, but not limited to, patent, trademark, copyright, license and franchise rights).", "label": "Loss Contingency, Settlement Agreement, Terms" } } }, "localname": "LossContingencySettlementAgreementTerms", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestrictedCashDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r63", "r149", "r272", "r374", "r379", "r380", "r381", "r387", "r388", "r778", "r873", "r899" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 46.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Noncontrolling interest" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": { "auth_ref": [ "r442" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.", "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders", "negatedLabel": "Distributions to noncontrolling affiliate shareholders" } } }, "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestDecreaseFromRedemptions": { "auth_ref": [ "r442", "r715", "r716" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).", "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests", "negatedLabel": "Acquisition of noncontrolling interest", "terseLabel": "Acquisition of noncontrolling interest" } } }, "localname": "MinorityInterestDecreaseFromRedemptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r130" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 44.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net cash provided (used in) by financing activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r130" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 35.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net cash (used in) provided by investing activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r130", "r134", "r137" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 28.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net cash provided by operating activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r11", "r88", "r91", "r96", "r99", "r137", "r149", "r161", "r167", "r168", "r170", "r171", "r175", "r176", "r193", "r230", "r242", "r246", "r249", "r252", "r272", "r374", "r375", "r376", "r379", "r380", "r381", "r383", "r385", "r387", "r388", "r765", "r778", "r879", "r907" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsBasicDetails": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 }, "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsDilutedDetails": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net income attributable to Quaker Chemical Corporation", "terseLabel": "Net income", "totalLabel": "Net income attributable to Quaker Chemical Corporation" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome", "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsBasicDetails", "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsDilutedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r88", "r91", "r96", "r175", "r176", "r720", "r728" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome": { "order": 18.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Less: Net income attributable to noncontrolling" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r167", "r168", "r170", "r171", "r181", "r182", "r195", "r200", "r230", "r242", "r246", "r249", "r252" ], "calculation": { "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsBasicDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "NetIncomeLossAvailableToCommonStockholdersBasic", "totalLabel": "Net income available to common shareholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsBasicDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "auth_ref": [ "r183", "r188", "r189", "r190", "r191", "r195", "r200" ], "calculation": { "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsDilutedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.", "label": "NetIncomeLossAvailableToCommonStockholdersDiluted", "totalLabel": "Net income available to common shareholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsDilutedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleDescription": { "auth_ref": [ "r159", "r170", "r177", "r179", "r207", "r208" ], "lang": { "en-us": { "role": { "documentation": "Disclosure related to a new accounting pronouncement or a change in accounting principle, including the nature and reason for the change and the effect of the change on prior periods and the current period.", "label": "New Accounting Pronouncement Or Change In Accounting Principle Description" } } }, "localname": "NewAccountingPronouncementOrChangeInAccountingPrincipleDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Recently Issued Accounting Standards [Abstract]" } } }, "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "auth_ref": [ "r5", "r159", "r160", "r163", "r164", "r178", "r179", "r180", "r267", "r268", "r278", "r279", "r472", "r473", "r474", "r475", "r612", "r659", "r660", "r661", "r761", "r785", "r786", "r787", "r837", "r863", "r864", "r865", "r926", "r927", "r928", "r929", "r931", "r967" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.", "label": "Recently Issued Accounting Standards [Text Block]" } } }, "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandards" ], "xbrltype": "textBlockItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "New Accounting Pronouncements Or Change In Accounting Principle [Line Items]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r158", "r161", "r162", "r163", "r165", "r166", "r170", "r178", "r204", "r265", "r266", "r274", "r275", "r276", "r277", "r280", "r281", "r373", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r613", "r655", "r656", "r657", "r658", "r754", "r755", "r756", "r757", "r758", "r759", "r760", "r762", "r763", "r764", "r765", "r779", "r780", "r781", "r782", "r783", "r784", "r788", "r789", "r836", "r860", "r861", "r862", "r920", "r921", "r922", "r923", "r924", "r925", "r926", "r927", "r928", "r929", "r930", "r931", "r962", "r963", "r964", "r965", "r966" ], "lang": { "en-us": { "role": { "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.", "label": "New Accounting Pronouncements or Change in Accounting Principle [Table]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NonUsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Countries excluding the United States of America (US).", "label": "Non Domestic [Member]" } } }, "localname": "NonUsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation": { "auth_ref": [ "r443", "r722" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of the reduction or elimination during the period of a noncontrolling interest resulting from the parent's loss of control and deconsolidation of the entity in which one or more outside parties had a noncontrolling interest.", "label": "Noncontrolling Interest Decrease From Deconsolidation", "negatedLabel": "Disposition of noncontrolling interest", "terseLabel": "Disposition of Noncontrolling Interest" } } }, "localname": "NoncontrollingInterestDecreaseFromDeconsolidation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r155", "r156", "r157", "r442", "r710" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r111" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome": { "order": 11.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Other (expense) income, net", "negatedLabel": "Other expense, net", "terseLabel": "Total other (expense) income, net", "totalLabel": "Other Income (Expense), Net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome", "http://www.quakerchem.com/role/OtherExpenseIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NumberOfCountriesInWhichEntityOperates": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of countries in which the entity operates as of balance sheet date.", "label": "Number Of Countries In Which Entity Operates" } } }, "localname": "NumberOfCountriesInWhichEntityOperates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [ "r218" ], "lang": { "en-us": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number Of Reportable Segments", "terseLabel": "Number of reportable segments" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/BusinessSegmentsNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingExpenseMember": { "auth_ref": [ "r745" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing expenses associated with normal operations.", "label": "Operating Expense [Member]" } } }, "localname": "OperatingExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r230", "r242", "r246", "r249", "r252" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome": { "order": 10.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating income (loss)", "terseLabel": "Operating income for reportable segments", "totalLabel": "Operating income", "verboseLabel": "Operating income" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r824", "r834" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease Cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Lease Liabilities Payments Due [Abstract]" } } }, "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r818" ], "calculation": { "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating lease liabilities", "terseLabel": "Present value of lease liabilities", "totalLabel": "Total operating lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails", "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r818" ], "calculation": { "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails": { "order": 10.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease Liability Current", "terseLabel": "Short-term lease liabilities", "verboseLabel": "Other current liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r818" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 34.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails": { "order": 11.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating lease liaiblity noncurrent", "terseLabel": "Long-term lease liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r819" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes operating lease liability.", "label": "Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r820", "r828" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease Payments", "verboseLabel": "Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from operating leases" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r817" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 15.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Right of use lease assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r819" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.", "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]" } } }, "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r831", "r834" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease Weighted Average Discount Rate Percent", "terseLabel": "Weighted average discount rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r830", "r834" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease Weighted Average Remaining Lease Term", "terseLabel": "Weighted average remaining lease term (years)" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": { "auth_ref": [ "r813", "r814" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Future Operating Lease Minimum Payments, Due Next Year", "terseLabel": "For the year ended 2019" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears": { "auth_ref": [ "r813", "r814" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Future Operating Lease Minimum Payments, Due in Five Years", "terseLabel": "For the year ended 2023" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFiveYears", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears": { "auth_ref": [ "r813", "r814" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Future Operating Lease Minimum Payments, Due in Four Years", "terseLabel": "For the year ended 2022" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourYears", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears": { "auth_ref": [ "r813", "r814" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Future Operating Lease Minimum Payments, Due in Three Years", "terseLabel": "For the year ended 2021" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInThreeYears", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": { "auth_ref": [ "r813", "r814" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Future Operating Lease Minimum Payments, Due in Two Years", "terseLabel": "For the year ended 2020" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter": { "auth_ref": [ "r813", "r814" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Future Operating Lease Minimum Payments, Due Therafter", "terseLabel": "For the year ended 2024 and beyond" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueThereafter", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r648" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsLimitationsOnUse": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A description of the limitations on the use of all operating loss carryforwards available to reduce future taxable income.", "label": "Operating Loss Carryforwards, Limitations on Use" } } }, "localname": "OperatingLossCarryforwardsLimitationsOnUse", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsTable": { "auth_ref": [ "r649" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.", "label": "Operating Loss Carryforwards [Table]" } } }, "localname": "OperatingLossCarryforwardsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsValuationAllowance": { "auth_ref": [ "r645" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.", "label": "Operating Loss Carryforwards, Valuation Allowance" } } }, "localname": "OperatingLossCarryforwardsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r241", "r242", "r243", "r244", "r246", "r252" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDisaggregatedRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basis of Presentation and Description of Business [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r12", "r730" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Basis of Presentation and Description of Business [Text Block]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusiness" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsMember": { "auth_ref": [ "r735", "r750" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other assets.", "label": "Other Assets [Member]" } } }, "localname": "OtherAssetsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherAssetsMiscellaneousCurrent": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other miscellaneous assets expected to be realized or consumed within one year or operating cycle, if longer.", "label": "Other Assets Miscellaneous Current" } } }, "localname": "OtherAssetsMiscellaneousCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r48" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 20.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other non-current assets", "totalLabel": "Total other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plans [Abstract]" } } }, "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax": { "auth_ref": [ "r79", "r83", "r526" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 4.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.", "label": "Net gain (loss) arising during the period, other", "negatedLabel": "Net gain (loss) arising during the period, other" } } }, "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": { "auth_ref": [ "r74", "r83", "r790", "r791", "r795" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax", "terseLabel": "Currency translation adjustments" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax": { "auth_ref": [ "r83", "r86", "r87", "r526" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "order": 14.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), before Tax", "terseLabel": "Prior service credit (cost)", "totalLabel": "Total Recognized in Other Comprehensive (Income) Loss", "verboseLabel": "Recognition of amortization in net periodic benefit cost Prior service credit (cost)" } } }, "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax": { "auth_ref": [ "r83", "r86", "r87", "r526" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 6.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.", "label": "Other Comprehensive Income (Loss), Amortization Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Prior Service (Cost) Credit, Net of Tax", "negatedTerseLabel": "Amortization of prior service cost", "terseLabel": "Amortization of prior service gain" } } }, "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": { "auth_ref": [ "r85", "r94", "r95", "r796", "r798", "r802" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive (Loss) Income, before reclassifications" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": { "auth_ref": [ "r75", "r83" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 9.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Current period change in fair value of derivatives" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r89", "r92", "r94", "r95", "r97", "r100", "r437", "r796", "r801", "r802", "r880", "r908" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 11.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Amounts reported in other comprehensive loss", "totalLabel": "Other comprehensive loss" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfChangesInEquity", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "auth_ref": [ "r81", "r83" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 8.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.", "label": "Defined benefit retirement plans", "negatedLabel": "Defined benefit retirement plans" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax": { "auth_ref": [ "r79", "r83", "r526" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "order": 12.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.", "label": "Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Net Unamortized Gain (Loss) Arising During Period, before Tax", "negatedLabel": "Net Loss (Gain) Arising During The Period", "terseLabel": "Net Loss (Gain) Arising During The Period" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax": { "auth_ref": [ "r83", "r86", "r87", "r526" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "order": 19.0, "parentTag": "kwr_TotalRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveLossOrIncome", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for net period benefit cost (credit) of defined benefit plan.", "label": "Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, before Tax", "terseLabel": "Total Recognized in Other Comprehensive Income (Loss)", "totalLabel": "Total Recognized in Other Comprehensive (Income) Loss" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax": { "auth_ref": [ "r83", "r86", "r87", "r526" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 5.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net (Gain) Loss, Net of Tax", "negatedTerseLabel": "Amortization of actuarial loss", "terseLabel": "Amortization of actuarial loss" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax": { "auth_ref": [ "r83", "r86", "r87", "r526" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 7.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for transition asset (obligation) of defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Transition (Asset) Obligation, Net of Tax", "terseLabel": "Amortization of Initial Net Asset" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1": { "auth_ref": [ "r712", "r713", "r723" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent", "terseLabel": "Related tax amounts" } } }, "localname": "OtherComprehensiveIncomeLossTaxPortionAttributableToParent1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": { "auth_ref": [ "r76", "r83" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 10.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.", "label": "Unrealized loss on available-for-sale securities" } } }, "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherDebtSecuritiesMember": { "auth_ref": [ "r269", "r302", "r507", "r773" ], "lang": { "en-us": { "role": { "documentation": "Investments in debt securities classified as other.", "label": "Other Debt Securities [Member]" } } }, "localname": "OtherDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherDepreciationAndAmortization": { "auth_ref": [ "r109", "r136", "r327" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.", "label": "Other Depreciation And Amortization", "negatedLabel": "Depreciation of corporate assets and amortization", "terseLabel": "Depreciation" } } }, "localname": "OtherDepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherFiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r317" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of finite-lived intangible assets classified as other.", "label": "Other Finite Lived Intangible Assets, Gross" } } }, "localname": "OtherFiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIncomeAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other (Expense) Income, Net [Abstract]" } } }, "localname": "OtherIncomeAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock": { "auth_ref": [ "r477", "r619" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.", "label": "Other (Expense) Income, Net [Text Block]" } } }, "localname": "OtherIncomeAndOtherExpenseDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherExpenseIncomeNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherIncomeMember": { "auth_ref": [ "r748" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other revenue.", "label": "Other Income [Member]" } } }, "localname": "OtherIncomeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intangible assets classified as other.", "label": "Other Intangible Assets [Member]" } } }, "localname": "OtherIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r18", "r19", "r54", "r844" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 31.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other accrued liabilities", "terseLabel": "Other Current Liabilities", "totalLabel": "Accrued Liabilities, Current, Total" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r60" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 37.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other non-current liabilities", "totalLabel": "Total" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLongTermDebt": { "auth_ref": [ "r28", "r872", "r895" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt classified as other.", "label": "Other Long Term Debt", "terseLabel": "Other debt obligations (including capital leases)" } } }, "localname": "OtherLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashIncome": { "auth_ref": [ "r137" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income or gain included in net income that result in no cash inflow (outflow), classified as other.", "label": "OtherNoncashIncome", "negatedLabel": "Gain on inactive subsidiary litigation and settlement reserve", "terseLabel": "Gain on inactive subsidiary litigation and settlement reserve" } } }, "localname": "OtherNoncashIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Noncash Investing And Financing Items [Abstract]" } } }, "localname": "OtherNoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_OtherNoncurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.", "label": "Other Noncurrent Liabilities [Member]", "terseLabel": "Other accrued liabilities [Member]" } } }, "localname": "OtherNoncurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNonoperatingExpense": { "auth_ref": [ "r113" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense related to nonoperating activities, classified as other.", "label": "Other Nonoperating Expense", "negatedLabel": "Other non-operating expense" } } }, "localname": "OtherNonoperatingExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherExpenseIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncome": { "auth_ref": [ "r105" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income related to nonoperating activities, classified as other.", "label": "Other non-operating income, net" } } }, "localname": "OtherNonoperatingIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherExpenseIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherOperatingIncomeExpenseNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.", "label": "Other Operating Income Expense Net" } } }, "localname": "OtherOperatingIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherExpenseIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": { "auth_ref": [ "r479", "r480", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r506", "r507", "r509", "r510", "r511", "r512", "r513", "r514", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r529", "r531", "r532", "r535", "r538", "r544", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r563", "r564", "r565", "r566", "r567", "r568" ], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.", "label": "Other Postretirement Benefit Plans Defined Benefit [Member]", "terseLabel": "Domestic Other Postretirement Benefits [Member]", "verboseLabel": "Postretirement Benefits [Member]" } } }, "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherRestrictedAssetsCurrent": { "auth_ref": [ "r67", "r936", "r937" ], "calculation": { "http://www.quakerchem.com/role/RestrictedCashDetails": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets that are pledged or subject to withdrawal restrictions, classified as other.", "label": "OtherRestrictedAssetsCurrent", "terseLabel": "Restricted cash included in other current assets" } } }, "localname": "OtherRestrictedAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherSellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r110" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of selling, general and administrative expense classified as other.", "label": "Other Selling General And Administrative Expense" } } }, "localname": "OtherSellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PatentedTechnologyMember": { "auth_ref": [ "r693" ], "lang": { "en-us": { "role": { "documentation": "Exclusive legal right granted by the government to the owner of the patented technology to exploit the technology for a period of time specified by law.", "label": "Product technology [Member]" } } }, "localname": "PatentedTechnologyMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForLegalSettlements": { "auth_ref": [ "r133" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period.", "label": "Insurance settlement realized", "negatedLabel": "Insurance settlement realized", "terseLabel": "Payments Made, Restricted Cash" } } }, "localname": "PaymentsForLegalSettlements", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r121" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments For Repurchase Of Common Stock", "negatedLabel": "Payments for repurchase of common stock" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest": { "auth_ref": [ "r121" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 42.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period for redemption of redeemable noncontrolling interests.", "label": "Payments To Acquire Additional Interest In Subsidiaries", "negatedLabel": "Purchase of noncontrolling interest in affiliates, net" } } }, "localname": "PaymentsForRepurchaseOfRedeemableNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRestructuring": { "auth_ref": [ "r127", "r339" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.", "label": "Cash Payments", "negatedLabel": "Cash Payments", "terseLabel": "Restructuring, Cash Payments" } } }, "localname": "PaymentsForRestructuring", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails", "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r124" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Financing-related debt issuance costs", "negatedLabel": "Financing-related debt issuance costs" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsCommonStock": { "auth_ref": [ "r121" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 40.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.", "label": "Dividends paid", "negatedLabel": "Dividends paid" } } }, "localname": "PaymentsOfDividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsMinorityInterest": { "auth_ref": [ "r121" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 43.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.", "label": "Distributions to noncontrolling shareholders", "negatedTerseLabel": "Distributions to noncontrolling affiliate shareholders" } } }, "localname": "PaymentsOfDividendsMinorityInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r117", "r700" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments To Acquire Businesses Gross", "negatedTerseLabel": "Gross Cash Paid for Acquisition", "terseLabel": "Cash transferred to Houghton shareholders", "totalLabel": "Net cash paid", "verboseLabel": "Net cash paid for Coral" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r117" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 31.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments related to acquisitions, net of cash acquired", "negatedLabel": "Payments related to acquisitions, net of cash acquired", "terseLabel": "Net cash paid for Coral", "totalLabel": "Net cash paid for Coral", "verboseLabel": "Net cash paid for Coral" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r118" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 30.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Investments in property, plant and equipment", "negatedLabel": "Investments in property, plant and equipment", "terseLabel": "Capital Expenditures" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitContributions": { "auth_ref": [ "r133" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for pension and other postretirement benefits. Includes, but is not limited to, employer contribution to fund plan asset and payment to retiree.", "label": "Pension and other postretirement benefits contributions", "negatedLabel": "Pension and other postretirement benefits" } } }, "localname": "PensionAndOtherPostretirementBenefitContributions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitExpense": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost (reversal of cost) for pension and other postretirement benefits.", "label": "Pension And Other Postretirement Benefit Expense", "negatedLabel": "Pension And Other Postretirement Benefit Expense" } } }, "localname": "PensionAndOtherPostretirementBenefitExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "auth_ref": [ "r506", "r508", "r514", "r533", "r536", "r537", "r538", "r540", "r541", "r559", "r561", "r562", "r563", "r583" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for retirement benefits.", "label": "Pension and Postretirement Benefits [Text Block]" } } }, "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndPostretirementBenefits" ], "xbrltype": "textBlockItemType" }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities": { "auth_ref": [ "r26", "r480", "r481", "r504", "r559" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 29.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.", "label": "Accrued pension and postretirement benefits", "negatedLabel": "Current Liabilities", "terseLabel": "Current Liabilities" } } }, "localname": "PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": { "auth_ref": [ "r29", "r480", "r481", "r504", "r559" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 36.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.", "label": "Accrued Pension and Postretirement Benefits, Non-current", "negatedLabel": "Non-current Liabilities", "terseLabel": "Non-current accrued pension and postretirement benefits" } } }, "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionPlansDefinedBenefitMember": { "auth_ref": [ "r478", "r480", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r506", "r507", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r529", "r531", "r532", "r535", "r538", "r544", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r563", "r564", "r578", "r579", "r580", "r581" ], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.", "label": "Pension Plans, Defined Benefit [Member]", "terseLabel": "Total Pension Plans [Member]", "verboseLabel": "Pension Benefit [Member]" } } }, "localname": "PensionPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PerformanceSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement awarded for meeting performance target.", "label": "Performance Stock Units [Member]", "terseLabel": "Performance Stock Units [Member]" } } }, "localname": "PerformanceSharesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationOnGrantDateDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PlanAssetCategoriesDomain": { "auth_ref": [ "r506", "r507", "r509", "r510", "r511", "r512", "r513", "r514", "r535", "r559" ], "lang": { "en-us": { "role": { "documentation": "Defined benefit plan asset investment.", "label": "Plan Asset Categories [Domain]" } } }, "localname": "PlanAssetCategoriesDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r32", "r423" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock Par Or Stated Value Per Share" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r32" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock Shares Authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r16", "r42", "r43" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 10.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromInsuranceSettlementInvestingActivities": { "auth_ref": [ "r116", "r129" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 33.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow for proceeds from settlement of insurance claim, classified as investing activities. Excludes insurance settlement classified as operating activities.", "label": "Insurance settlement interest earned" } } }, "localname": "ProceedsFromInsuranceSettlementInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromInsuranceSettlementOperatingActivities": { "auth_ref": [ "r125", "r129" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow for proceeds from settlement of insurance claim, classified as operating activities. Excludes insurance settlement classified as investing activities.", "label": "Proceeds from Insurance Settlement, Operating Activities" } } }, "localname": "ProceedsFromInsuranceSettlementOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r120" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "auth_ref": [ "r120" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 41.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.", "label": "Stock options exercised, other" } } }, "localname": "ProceedsFromIssuanceOrSaleOfEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfLinesOfCredit": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 38.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The net cash inflow or cash outflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets).", "label": "Borrowings on revolving credit facilities, net" } } }, "localname": "ProceedsFromRepaymentsOfLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfOtherDebt": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 39.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) for debt classified as other.", "label": "Repayments on other debt, net" } } }, "localname": "ProceedsFromRepaymentsOfOtherDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "auth_ref": [ "r115" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 32.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.", "label": "Proceeds from disposition of assets" } } }, "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDisaggregatedRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ProductMember": { "auth_ref": [ "r468" ], "lang": { "en-us": { "role": { "documentation": "Article or substance produced by nature, labor or machinery.", "label": "Product [Member]" } } }, "localname": "ProductMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDisaggregatedRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r11", "r88", "r91", "r96", "r128", "r149", "r161", "r175", "r176", "r230", "r242", "r246", "r249", "r252", "r272", "r374", "r375", "r376", "r379", "r380", "r381", "r383", "r385", "r387", "r388", "r712", "r719", "r721", "r728", "r729", "r765", "r778", "r886" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome": { "order": 17.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net income", "totalLabel": "Net income" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfChangesInEquity", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAdditionalDisclosures": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Additional information disclosed pertaining to property, plant and equipment.", "label": "Property Plant And Equipment Additional Disclosures" } } }, "localname": "PropertyPlantAndEquipmentAdditionalDisclosures", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherExpenseIncomeNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r47", "r330" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Property, Plant and Equipment, Type [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r46", "r328" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 12.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Property, plant and equipment, at cost", "totalLabel": "Property, Plant and Equipment, Gross, Total" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r22", "r23", "r330", "r844", "r887", "r901" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 14.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Net property, plant and equipment", "terseLabel": "Property, plant and equipment, net", "totalLabel": "Property, plant and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r22", "r328" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Property, Plant and Equipment, Type [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RealEstateHeldforsale": { "auth_ref": [ "r903" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of investments in land and buildings held for sale, excluding real estate considered to be inventory of the entity.", "label": "Real Estate Held for sale" } } }, "localname": "RealEstateHeldforsale", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": { "auth_ref": [ "r85", "r94", "r95", "r796", "r800", "r802" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax", "terseLabel": "Amounts reclassified from AOCI" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": { "auth_ref": [ "r242", "r246" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.", "label": "Schedule of information about the performance of the Company's reportable segments, operating earnings [Table Text Block]" } } }, "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock": { "auth_ref": [ "r244", "r246" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of each significant reconciling item, other than profit (loss), revenues, or assets, in the reconciliation of totals of such items in reportable segments to the entity's corresponding consolidated amount.", "label": "Reconciliation of capital expenditures and depreciation for identifiable assets [Table Text Block]" } } }, "localname": "ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r123" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 37.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "RepaymentsOfLongTermDebt", "negatedLabel": "Payments of long-term debt", "terseLabel": "Payments of long-term debt" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities": { "auth_ref": [ "r122" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation.", "label": "Payments of long-term debt", "negatedLabel": "Payments of long-term debt" } } }, "localname": "RepaymentsOfLongTermDebtAndCapitalSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCash": { "auth_ref": [ "r143", "r867", "r896" ], "calculation": { "http://www.quakerchem.com/role/RestrictedCashDetails": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash", "terseLabel": "Restricted cash included in other assets" } } }, "localname": "RestrictedCash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r201" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock LTIP [Member]" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) LTIP Plan [Member]" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restructuring And Related Activities [Abstract]" } } }, "localname": "RestructuringAndRelatedActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RestructuringAndRelatedActivitiesCompletionDate": { "auth_ref": [ "r337", "r348" ], "lang": { "en-us": { "role": { "documentation": "Date the exit and disposal activities were completed or are expected to be completed, in YYYY-MM-DD format.", "label": "Restructuring and Related Activities, Completion Date" } } }, "localname": "RestructuringAndRelatedActivitiesCompletionDate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesNarrativeDetails" ], "xbrltype": "dateItemType" }, "us-gaap_RestructuringAndRelatedActivitiesDescription": { "auth_ref": [ "r337", "r348" ], "lang": { "en-us": { "role": { "documentation": "Description of a specific restructuring plan and related activities including the facts and circumstances leading to the restructuring or decision to exit an activity, and the expected completion date. This concept and related items would be utilized for each plan if multiple exit plans have been implemented in the period.", "label": "Restructuring and Related Activities, Description" } } }, "localname": "RestructuringAndRelatedActivitiesDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "auth_ref": [ "r337", "r339", "r342", "r352", "r353" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.", "label": "Restructuring And Related Activities Disclosure [Text Block]" } } }, "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivities" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestructuringAndRelatedActivitiesInitiationDate": { "auth_ref": [ "r337", "r348" ], "lang": { "en-us": { "role": { "documentation": "Date the restructuring activities were initiated or are expected to be initiated, in YYYY-MM-DD format.", "label": "Restructuring and Related Activities, Initiation Date" } } }, "localname": "RestructuringAndRelatedActivitiesInitiationDate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesNarrativeDetails" ], "xbrltype": "dateItemType" }, "us-gaap_RestructuringAndRelatedCostDescription": { "auth_ref": [ "r337" ], "lang": { "en-us": { "role": { "documentation": "Information pertinent to an understanding of the specified type of restructuring cost, including the facts and circumstances leading to the expected activity, discussion of the level and quantity of personnel to be terminated, and the expected completion date.", "label": "Restructuring And Related Cost Description" } } }, "localname": "RestructuringAndRelatedCostDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expected cost remaining for the specified restructuring cost.", "label": "Restructuring And Related Cost Expected Cost Remaining" } } }, "localname": "RestructuringAndRelatedCostExpectedCostRemaining1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The expected number of positions to be eliminated as a result of restructuring activities.", "label": "Restructuring And Related Cost Expected Number Of Positions Eliminated" } } }, "localname": "RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_RestructuringCharges": { "auth_ref": [ "r136", "r336", "r345", "r349" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome": { "order": 8.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.", "label": "Restructuring and related charges", "negatedLabel": "Restructuring and related charges", "negatedTerseLabel": "Restructuring charges", "verboseLabel": "Restructuring Charges (Credits)" } } }, "localname": "RestructuringCharges", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome", "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restructuring Cost and Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringCostsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restructuring Cost and Reserve [Abstract]" } } }, "localname": "RestructuringCostsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringPlanAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by individual restructuring plan.", "label": "Restructuring Plan [Axis]" } } }, "localname": "RestructuringPlanAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringPlanDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identification of the individual restructuring plans.", "label": "Restructuring Plan [Domain]" } } }, "localname": "RestructuringPlanDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringReserve": { "auth_ref": [ "r339", "r346" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.", "label": "Accrued restructuring", "periodEndLabel": "Accrued Restructuring, Ending Balance", "periodStartLabel": "Accrued Restructuring, Beginning Balance", "terseLabel": "Accrued Restructuring" } } }, "localname": "RestructuringReserve", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveCurrent": { "auth_ref": [ "r26", "r339", "r350" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 28.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.", "label": "Restructuring Reserve, Current", "periodEndLabel": "Accrued Restructuring, Ending Balance", "periodStartLabel": "Accrued Restructuring, Beginning Balance", "terseLabel": "Accrued restructuring" } } }, "localname": "RestructuringReserveCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Restructuring Reserve [Roll Forward]" } } }, "localname": "RestructuringReserveRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringReserveTranslationAdjustment": { "auth_ref": [ "r339", "r350" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.", "label": "Currency Translation Adjustments", "negatedLabel": "Currency translation adjustments" } } }, "localname": "RestructuringReserveTranslationAdjustment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Depreciation, depletion, amortization, and accretion related to oil and gas producing activities.", "label": "Results of Operations, Depreciation, Depletion, Amortization and Accretion", "terseLabel": "Depreciation and amortization" } } }, "localname": "ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r36", "r442", "r613", "r844", "r898", "r926", "r931" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 43.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained earnings", "terseLabel": "Adjustment to prior period earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r2", "r155", "r156", "r157", "r162", "r173", "r176", "r277", "r609", "r610", "r611", "r657", "r658", "r763", "r922", "r924" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanNameAxis": { "auth_ref": [ "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r506", "r507", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r529", "r530", "r531", "r532", "r535", "r538", "r544", "r545", "r546", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r582" ], "lang": { "en-us": { "role": { "documentation": "Information by name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.", "label": "Retirement Plan Name [Axis]" } } }, "localname": "RetirementPlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanNameDomain": { "auth_ref": [ "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r506", "r507", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r529", "r530", "r531", "r532", "r535", "r538", "r544", "r545", "r546", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r582" ], "lang": { "en-us": { "role": { "documentation": "Name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.", "label": "Retirement Plan Name [Domain]" } } }, "localname": "RetirementPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanSponsorLocationAxis": { "auth_ref": [ "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r506", "r507", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r529", "r530", "r531", "r532", "r535", "r538", "r545", "r546", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r564", "r568", "r581" ], "lang": { "en-us": { "role": { "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Retirement Plan Sponsor Location [Axis]" } } }, "localname": "RetirementPlanSponsorLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanSponsorLocationDomain": { "auth_ref": [ "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r506", "r507", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r529", "r530", "r531", "r532", "r535", "r538", "r545", "r546", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r564", "r568", "r581" ], "lang": { "en-us": { "role": { "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Retirement Plan Sponsor Location [Domain]" } } }, "localname": "RetirementPlanSponsorLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanTypeAxis": { "auth_ref": [ "r478", "r479", "r480", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r506", "r507", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r529", "r531", "r532", "r535", "r538", "r544", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r563", "r564", "r565", "r566", "r567", "r568", "r578", "r579", "r580", "r581" ], "lang": { "en-us": { "role": { "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Axis]" } } }, "localname": "RetirementPlanTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanTypeDomain": { "auth_ref": [ "r478", "r479", "r480", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r506", "r507", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r529", "r531", "r532", "r535", "r538", "r544", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r563", "r564", "r565", "r566", "r567", "r568", "r578", "r579", "r580", "r581" ], "lang": { "en-us": { "role": { "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Domain]" } } }, "localname": "RetirementPlanTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Sales and Revenue Recognition [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r221", "r222", "r241", "r247", "r248", "r254", "r255", "r259", "r465", "r466", "r858" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue From Contract With Customer Excluding Assessed Tax", "terseLabel": "Net sales" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDisaggregatedRevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "auth_ref": [ "r221", "r222", "r241", "r247", "r248", "r254", "r255", "r259", "r465", "r466", "r858" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.", "label": "Revenue From Contract With Customer Including Assessed Tax", "terseLabel": "Income from third party license fees" } } }, "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherExpenseIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r144", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r476" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue recognition [Policy Text Block]", "terseLabel": "Revenue From Contract With Customer [Policy Text Block]" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r467", "r476" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Net Sales and Revenue Recognition [TextBlock]" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognition" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r144", "r145" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue Recognition [Policy Text Block]" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "The Revolver [Member]" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r829", "r834" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "Leased assets obtained in exchange for new operating lease liabilities" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r213", "r259" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Sales Revenue Net [Member]", "terseLabel": "Sales Revenue Net [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock": { "auth_ref": [ "r545", "r546", "r559" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of benefit obligation and plan assets of defined benefit plan with accumulated benefit obligation in excess of plan assets.", "label": "Schedule of Information for pension plans with an accumulated benefit obligation in excess of plan assets [Table Text Block]" } } }, "localname": "ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r85", "r801", "r802" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": { "auth_ref": [ "r505" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.", "label": "Schedule of compan's pension plan target asset allocation and pension plan investments measured at fair value on a recurring basis [Table Text Block]" } } }, "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAmountsInAccumulatedOtherComprehensiveIncomeLossToBeRecognizedOverNextFiscalYearTableTextBlock": { "auth_ref": [ "r542" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts related to pension plans and/or other employee benefit plans in accumulated other comprehensive income (loss) expected to be recognized as components of net periodic benefit cost over the next fiscal year, including the net gain (loss), net prior service cost or credit, and net transition asset or obligation.", "label": "Schedule of Amounts in Accumulated Other Comprehensive Income (Loss) to be Recognized over Next Fiscal Year [Table Text Block]" } } }, "localname": "ScheduleOfAmountsInAccumulatedOtherComprehensiveIncomeLossToBeRecognizedOverNextFiscalYearTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock": { "auth_ref": [ "r504" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts that are recognized in the balance sheet (or statement of financial position) for pension plans and/or other employee benefit plans, showing separately the assets and current and noncurrent liabilities (if applicable) recognized.", "label": "Scheudule of funded status of Company'ds plans' reconciled with amounts reported in the Consolidated Balance Sheets [Table Text Block]" } } }, "localname": "ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r526" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.", "label": "Schedule of other changes recognized in other comprehensive income - pension plans [Table Text Block]" } } }, "localname": "ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": { "auth_ref": [ "r528" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.", "label": "Schedule of Weighted-average assumptions used to determine benefit obligations [Table Text Block]" } } }, "localname": "ScheduleOfAssumptionsUsedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock": { "auth_ref": [ "r545", "r559" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of benefit obligation and plan assets for defined benefit pension plan with projected benefit obligation in excess of plan assets.", "label": "Schedule of Benefit Obligations in Excess of Fair Value of Plan Assets [Table Text Block]" } } }, "localname": "ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r681", "r682" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsTables", "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsAntidilutiveSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": { "auth_ref": [ "r681", "r682" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.", "label": "Schedule of fair value of consideration transferred in the Combination [Table Text Block]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of cash and cash equivalents.", "label": "Schedule Of Cash And Cash Equivalents [Table Text Block]" } } }, "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestrictedCashTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "auth_ref": [ "r740" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for cash flow hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.", "label": "Scheudule of fair values of the Company''s derivative instruments, Level 2 measurements [Table Text Block]" } } }, "localname": "ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": { "auth_ref": [ "r601" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.", "label": "Schedule of share-based compensation expense in its Consolidated Statements of Income [Table Text Block]" } } }, "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r653" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schecule of taxes on income before equity in net income of associated companies [Table Text Block]" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/TaxesOnIncomeAndUncertainPositionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "Schedule of Debt [Table Text Block]" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r646" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of total deferred tax assets and liabilities [Table Text Block]" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/TaxesOnIncomeAndUncertainPositionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "auth_ref": [ "r543", "r544", "r547", "r548", "r559" ], "lang": { "en-us": { "role": { "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Defined Benefit Plans Disclosures [Table]" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r200" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesTableTextBlock": { "auth_ref": [ "r534" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the effect of a one-percentage-point increase and the effect of a one-percentage-point decrease in the assumed health care cost trend rates on the aggregate of the service and interest cost components of net periodic postretirement health care benefit costs and the accumulated postretirement benefit obligation for health care benefits.", "label": "Schedule of Effect of One-Percentage-Point Change in Assumed Health Care Cost Trend Rates [Table Text Block]" } } }, "localname": "ScheduleOfEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock": { "auth_ref": [ "r510" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the effect of fair value measurements using significant unobservable inputs (Level 3) on changes in plan assets of pension plans and/or other employee benefit plans for the period.", "label": "Schedule of changes in the fair value of the plans' Level 3 investments [Table Text Block]" } } }, "localname": "ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r630" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/TaxesOnIncomeAndUncertainPositionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r585", "r601", "r615" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationOnGrantDateDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "auth_ref": [ "r585", "r601", "r615" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.", "label": "Schedule of The compensation expense recorded on each award during the year [Table Text Block]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": { "auth_ref": [ "r516" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.", "label": "Schedule of Expected Benefit Payments [Table Text Block]" } } }, "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r312", "r316", "r859" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIndefiniteLivedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r312", "r316" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": { "auth_ref": [ "r815" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.", "label": "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]" } } }, "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r309", "r310" ], "lang": { "en-us": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r309", "r310" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfHealthCareCostTrendRatesTableTextBlock": { "auth_ref": [ "r533" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the assumed health care cost trend rates for the next year used to measure the expected cost of benefits covered by the plans, including the ultimate trend rate(s) and when that rate is expected to be achieved.", "label": "Schedule of Assumed health care cost trend rates [Table Text Block]" } } }, "localname": "ScheduleOfHealthCareCostTrendRatesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "auth_ref": [ "r150" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.", "label": "Schedule of components of earnings before income taxes [Table Text Block]" } } }, "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/TaxesOnIncomeAndUncertainPositionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [ "r371" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.", "label": "Schedule of Maturities of Long-term Debt [Table Text Block]" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.", "label": "Schedule of components of net periodic benefit costs - pension plans [Table Text Block]" } } }, "localname": "ScheduleOfNetBenefitCostsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.", "label": "Schedule of other expense, net [Table Text Block]" } } }, "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherExpenseIncomeNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDisaggregatedRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfProductInformationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of product information that are included in the discussion of the nature of an entity's operations.", "label": "Schedule of Product Information [Table Text Block]" } } }, "localname": "ScheduleOfProductInformationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r688" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of estimated fair values of net assets acquired [Table Text Block]" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r338", "r339", "r340", "r341", "r349", "r350", "r351" ], "lang": { "en-us": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule of Restructuring and Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": { "auth_ref": [ "r343", "r344", "r347" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.", "label": "Restructuring and Related Costs [Table Text Block]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r230", "r233", "r245", "r309" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r230", "r233", "r245", "r309" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of information about the performance of the Company's reportable segments, sales and total assets [Table Text Block]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "auth_ref": [ "r590" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.", "label": "Schedule of activity of nonvested restricted stock units granted under the Company's LTIP plan [Table Text Block]" } } }, "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": { "auth_ref": [ "r604" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.", "label": "Schedule of summary of the Company's outstanding stock options [Table Text Block]" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r590", "r592", "r594" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Schedule of Stock option activity under all plans [Table Text Block]" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r595" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Black-Scholes option pricing model and the assumptions [Table Text Block]" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.", "label": "Schedule of activity of nonvested restricted stock awards granted under the Company's LTIP plan [Table Text Block]" } } }, "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": { "auth_ref": [ "r437" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.", "label": "Schedule of Stockholders Equity [Table Text Block]" } } }, "localname": "ScheduleOfStockholdersEquityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": { "auth_ref": [ "r641", "r654" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in unrecognized tax benefits.", "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]" } } }, "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/TaxesOnIncomeAndUncertainPositionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r217", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r241", "r242", "r243", "r244", "r246", "r247", "r248", "r249", "r250", "r252", "r259", "r341", "r351", "r914" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segment Domain" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDisaggregatedRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r217", "r219", "r220", "r230", "r234", "r246", "r250", "r251", "r252", "r253", "r254", "r258", "r259", "r260" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegments" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingMeasurementDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Segment Disclosures [Abstract]" } } }, "localname": "SegmentReportingMeasurementDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r235", "r236", "r237", "r238", "r239", "r240", "r255" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segments [Policy Text Block]" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r110" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome": { "order": 4.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": { "auth_ref": [ "r682" ], "lang": { "en-us": { "role": { "documentation": "Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period.", "label": "Other Acquisitions [Member]" } } }, "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r135" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation [Abstract]" } } }, "localname": "ShareBasedCompensationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": { "auth_ref": [ "r587" ], "lang": { "en-us": { "role": { "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period 1", "terseLabel": "Option Award Vesting Period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r587" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "terseLabel": "Equity Award Vesting Period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate": { "auth_ref": [ "r604" ], "lang": { "en-us": { "role": { "documentation": "Discount rate from fair value on purchase date that participants pay for shares.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Discount From Market Price Purchase Date", "terseLabel": "ESPP: Discount from Market Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r591" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period", "terseLabel": "Nonvested Stock Awards Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement By Share-Based Payment Award Fair Value Assumptions And Methodology [Abstract]", "terseLabel": "Black-Scholes option pricing model", "verboseLabel": "Mote Carlo option pricing model" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationBlackScholesOptionPricingModelDetails", "http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationOnGrantDateDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r598" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate", "terseLabel": "Dividend Yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationBlackScholesOptionPricingModelDetails", "http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationOnGrantDateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r597" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate", "terseLabel": "Expected Volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationBlackScholesOptionPricingModelDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r599" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate", "terseLabel": "Risk-free Interest Rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationBlackScholesOptionPricingModelDetails", "http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationOnGrantDateDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "auth_ref": [ "r593" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.", "label": "Share Based Compensation Arrangement By Share Based PaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "terseLabel": "Exercised Options, Intrinsic Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross", "terseLabel": "Number of options granted", "verboseLabel": "Number of PSUs granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationBlackScholesOptionPricingModelDetails", "http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationOnGrantDateDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r584", "r589" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationOnGrantDateDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance": { "auth_ref": [ "r588" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of shares (or other type of equity) that have been approved for issuance in the equity-based payment transaction.", "label": "Share Based Goods And Nonemployee Services Transaction Shares Approved For Issuance", "terseLabel": "Director Stock Ownership Plan Maximum Number of Shares Authorized Under Plan" } } }, "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareRepurchaseProgramAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by share repurchase program.", "label": "Share Repurchase program [Axis]" } } }, "localname": "ShareRepurchaseProgramAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareRepurchaseProgramDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the share repurchase program.", "label": "Share Repurchase Program [Domain]" } } }, "localname": "ShareRepurchaseProgramDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r596", "r614" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1", "terseLabel": "Expected Term (Years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationBlackScholesOptionPricingModelDetails", "http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationOnGrantDateDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase price of common stock expressed as a percentage of its fair value.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent", "terseLabel": "ESPP: Purchase Price Percentage" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r437" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares Issued" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermBorrowings": { "auth_ref": [ "r24", "r844", "r870", "r894" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.", "label": "Short Term Borrowings", "negatedLabel": "Less: short-term and current portion of long-term debts", "terseLabel": "Short-term Debt (including capital leases)" } } }, "localname": "ShortTermBorrowings", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short-term Debt, Type [Axis]" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeDomain": { "auth_ref": [ "r49" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.", "label": "Short-term Debt, Type [Domain]" } } }, "localname": "ShortTermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShortTermLeaseCost": { "auth_ref": [ "r825", "r834" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.", "label": "Short Term Lease Cost" } } }, "localname": "ShortTermLeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StateAndLocalJurisdictionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.", "label": "State and Local Jurisdiction [Member]" } } }, "localname": "StateAndLocalJurisdictionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r8", "r217", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r241", "r242", "r243", "r244", "r246", "r247", "r248", "r249", "r250", "r252", "r259", "r309", "r335", "r341", "r351", "r914" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Statement, Business Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDisaggregatedRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r2", "r62", "r94", "r95", "r96", "r155", "r156", "r157", "r162", "r173", "r176", "r209", "r277", "r437", "r442", "r609", "r610", "r611", "r657", "r658", "r763", "r796", "r797", "r798", "r799", "r800", "r802", "r922", "r923", "r924", "r966" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Statement, Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails", "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfChangesInEquity", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Changes in Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r155", "r156", "r157", "r209", "r858" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockCompensationPlanMember": { "auth_ref": [ "r201" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.", "label": "Annual Incentive Plan [Member]" } } }, "localname": "StockCompensationPlanMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, before forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Share based compensation plans", "verboseLabel": "Share issuance and equity-based compensation plans" } } }, "localname": "StockGrantedDuringPeriodValueSharebasedCompensationGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan": { "auth_ref": [ "r32", "r33", "r437", "r442", "r616" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of capital stock issued (purchased by employees) in connection with an employee stock ownership plan.", "label": "Stock Issued During Period Shares Employee Stock Ownership Plan", "terseLabel": "Shares issued for ESPP" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Stock Issued During Period Shares Other", "terseLabel": "Shares issued for Options exercise and Other activity" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r32", "r33", "r437", "r442" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Stock Issued During Period Shares Share Based Compensation", "terseLabel": "Shares issued for equity based comp plans" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan": { "auth_ref": [ "r32", "r33", "r437", "r442", "r616" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate value of stock issued during the period as a result of employee stock ownership plan (ESOP).", "label": "Shares issued for employee stock purchase plan" } } }, "localname": "StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r32", "r33", "r437", "r442" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock offering, net of related expenses" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r62", "r437", "r442" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Shares issued upon exercise of stock options and other" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stock repurchase plan authorized.", "label": "Stock Repurchase Program Authorized Amount" } } }, "localname": "StockRepurchaseProgramAuthorizedAmount1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount remaining of a stock repurchase plan authorized.", "label": "Stock Repurchase Program Remaining Authorize" } } }, "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": { "auth_ref": [ "r32", "r33", "r437", "r442" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased and retired during the period.", "label": "Stock Repurchased And Retired During Period Shares" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": { "auth_ref": [ "r32", "r33", "r437", "r442" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).", "label": "Repurchases of common stock", "negatedLabel": "Repurchases of common stock" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r33", "r38", "r39", "r149", "r264", "r272", "r778", "r844" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 45.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Total Quaker shareholders equity", "totalLabel": "Total Quaker shareholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r2", "r3", "r95", "r149", "r155", "r156", "r157", "r162", "r173", "r272", "r277", "r442", "r609", "r610", "r611", "r657", "r658", "r710", "r711", "r727", "r763", "r778", "r796", "r797", "r802", "r923", "r924", "r966" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 47.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Total equity", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "totalLabel": "Total equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r147", "r424", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r442", "r448" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Accumulated Other Comprehensive Income [Text Block]" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncome" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubleaseIncome": { "auth_ref": [ "r827", "r834" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of sublease income excluding finance and operating lease expense.", "label": "Sublease Income" } } }, "localname": "SubleaseIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsequentEventDescription": { "auth_ref": [ "r845" ], "lang": { "en-us": { "role": { "documentation": "Describes the event or transaction that occurred between the balance sheet date and the date the financial statements are issued or available to be issued.", "label": "Subsequent Event Description" } } }, "localname": "SubsequentEventDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r803", "r846" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r803", "r846" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r803", "r846" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsDate": { "auth_ref": [ "r845" ], "lang": { "en-us": { "role": { "documentation": "Date the event occurred after the balance sheet date but before financial statements are issues or available to be issued, in YYYY-MM-DD format.", "label": "Subsequent Events Date" } } }, "localname": "SubsequentEventsDate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "dateItemType" }, "us-gaap_SummaryOfValuationAllowanceTextBlock": { "auth_ref": [ "r645" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.", "label": "Schedule of changes in the Company's deferred tax asset valuation allowance [Table Text Block]" } } }, "localname": "SummaryOfValuationAllowanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/TaxesOnIncomeAndUncertainPositionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalEmployeeRetirementPlanDefinedBenefitMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide limited group of employees with supplemental retirement benefits, in addition to other pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Supplemental Employee Retirement Plans, Defined Benefit [Member]", "terseLabel": "Supplemental Retirement Benefits Plan [Member]" } } }, "localname": "SupplementalEmployeeRetirementPlanDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions": { "auth_ref": [ "r620", "r622" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) to previously recorded tax expense. Includes, but is not limited to, significant settlements of income tax disputes, and unusual tax positions or infrequent actions taken by the entity, including tax assessment reversal, and IRS tax settlement.", "label": "Tax Adjustments, Settlements, and Unusual Provisions" } } }, "localname": "TaxAdjustmentsSettlementsAndUnusualProvisions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxCreditCarryforwardDescription": { "auth_ref": [ "r649" ], "lang": { "en-us": { "role": { "documentation": "A description of the origin, nature, and characteristics of the tax credit carryforward.", "label": "TaxCreditCarryforwardDescription" } } }, "localname": "TaxCreditCarryforwardDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability": { "auth_ref": [ "r673" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tax liability from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act.", "label": "Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Liability" } } }, "localname": "TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TimingOfTransferOfGoodOrServiceAxis": { "auth_ref": [ "r466", "r471" ], "lang": { "en-us": { "role": { "documentation": "Information by timing of transfer of good or service to customer.", "label": "Timing Of Transfer Of Good Or Service [Axis]" } } }, "localname": "TimingOfTransferOfGoodOrServiceAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDisaggregatedRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TimingOfTransferOfGoodOrServiceDomain": { "auth_ref": [ "r466", "r471" ], "lang": { "en-us": { "role": { "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.", "label": "Timing Of Transfer Of Good Or Service Domain" } } }, "localname": "TimingOfTransferOfGoodOrServiceDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDisaggregatedRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TrademarksMember": { "auth_ref": [ "r690" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.", "label": "Trademarks [Member]", "verboseLabel": "Licensed Trademark [Member]" } } }, "localname": "TrademarksMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransferredAtPointInTimeMember": { "auth_ref": [ "r471" ], "lang": { "en-us": { "role": { "documentation": "Contract with customer in which good or service is transferred at point in time.", "label": "Transferred At Point In Time [Member]", "terseLabel": "Product sales at a point in time [Member]" } } }, "localname": "TransferredAtPointInTimeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDisaggregatedRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransferredOverTimeMember": { "auth_ref": [ "r471" ], "lang": { "en-us": { "role": { "documentation": "Contract with customer in which good or service is transferred over time.", "label": "Transferred Over Time [Member]", "terseLabel": "Services transferred over time [Member]" } } }, "localname": "TransferredOverTimeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDisaggregatedRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r161", "r162", "r163", "r165", "r178", "r265", "r266", "r274", "r275", "r276", "r277", "r280", "r281", "r373", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r613", "r655", "r656", "r657", "r658", "r754", "r755", "r756", "r757", "r758", "r759", "r760", "r762", "r763", "r764", "r765", "r779", "r780", "r781", "r782", "r783", "r784", "r788", "r789", "r836", "r860", "r861", "r862", "r920", "r921", "r922", "r923", "r924", "r925", "r926", "r927", "r928", "r929", "r930", "r931", "r962", "r963", "r964", "r965", "r966" ], "lang": { "en-us": { "role": { "documentation": "Amendment to accounting standards.", "label": "Type Of Adoption [Domain]" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic": { "auth_ref": [ "r194", "r197", "r198" ], "calculation": { "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsBasicDetails": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.", "label": "UndistributedEarningsAllocatedToParticipatingSecurities", "negatedLabel": "Less: income allocated to participating securities" } } }, "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsBasicDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted": { "auth_ref": [ "r192", "r194", "r197", "r198" ], "calculation": { "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsDilutedDetails": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.", "label": "Undistributed Earnings Allocated To Participating Securities Diluted", "negatedLabel": "Less: income allocated to participating securities" } } }, "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsDilutedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UndistributedEarningsOfForeignSubsidiaries": { "auth_ref": [ "r621", "r672", "r890", "r933" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.", "label": "Undistributed Earnings of Foreign Subsidiaries" } } }, "localname": "UndistributedEarningsOfForeignSubsidiaries", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss": { "auth_ref": [ "r740" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) related to the increase or decrease in fair value of interest rate derivatives designated as cash flow hedging instruments, which was recorded in accumulated other comprehensive income to the extent that the cash flow hedge was determined to be effective.", "label": "Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net" } } }, "localname": "UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r623", "r637" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "periodEndLabel": "Unrecognized Tax Benefits, Ending Balance", "periodStartLabel": "Unrecognized Tax Benefits, Beginning Balance" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": { "auth_ref": [ "r638" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.", "label": "Unrecognized Tax Benefits, Decreases Resulting from Settlements with Taxing Authorities", "terseLabel": "Decrease in Unrecognized Tax Benefits Due to Settlements" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued": { "auth_ref": [ "r632" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of statutory penalties accrued for a tax position claimed or expected to be claimed by the entity, in its tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties Accrued", "terseLabel": "Accrued Penalties" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense": { "auth_ref": [ "r632" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties Expense" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued": { "auth_ref": [ "r632" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense accrued for an underpayment of income taxes.", "label": "Unrecognized Tax Benefits, Interest on Income Taxes Accrued", "terseLabel": "Accrued Interest" } } }, "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense": { "auth_ref": [ "r632" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense for an underpayment of income taxes.", "label": "Unrecognized Tax Benefits, Interest on Income Taxes Expense" } } }, "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": { "auth_ref": [ "r637" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.", "label": "Unrecognized Tax Benefits Period Increase" } } }, "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": { "auth_ref": [ "r639" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.", "label": "Unrecognized Tax Benefits, Reductions Resulting from Lapse of Applicable Statute of Limitations", "negatedTerseLabel": "Decrease in Unrecognized Tax Benefits Due to Lapse of Statute of Limitations" } } }, "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": { "auth_ref": [ "r640" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.", "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate" } } }, "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableLeaseCost": { "auth_ref": [ "r826", "r834" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.", "label": "Variable Lease Cost" } } }, "localname": "VariableLeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r183", "r200" ], "calculation": { "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsDilutedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "WeightedAverageNumberOfDilutedSharesOutstanding", "totalLabel": "Diluted weighted average common shares outstanding" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsDilutedDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r181", "r200" ], "calculation": { "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsDilutedDetails": { "order": 4.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "WeightedAverageNumberOfSharesOutstandingBasic", "terseLabel": "Basic weighted average common shares outstanding" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsBasicDetails", "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsDilutedDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 6 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(22))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(23))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r12": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3337-108585" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "21B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=SL94080549-108585" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r154": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r180": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "http://asc.fasb.org/topic&trid=2122394" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "60", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2740-109256" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "65", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2793-109256" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "66", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2814-109256" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258" }, "r206": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e725-108305" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e765-108305" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592" }, "r216": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "b", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)(1)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)(2)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL82887624-210437" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "30", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124256539&loc=SL120269210-210444" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "30", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124256539&loc=SL120254536-210444" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "8A", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124266218&loc=SL120267834-210445" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL120267845-210446" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919260-210447" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919272-210447" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "3C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL120267966-210447" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "3D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL120267969-210447" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 6.M.Q4)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122651532&loc=SL122037091-237805" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124268681&loc=SL120267897-210452" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "13A", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=125515542&loc=SL120267917-210453" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=125515542&loc=SL120269220-210453" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL120267853-210455" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "3C", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL120267859-210455" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "3D", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL120267862-210455" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r323": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2420-110228" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2443-110228" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2473-110228" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(a))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(e))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r353": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "420", "URI": "http://asc.fasb.org/topic&trid=2175745" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r356": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r368": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S65", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r422": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656" }, "r448": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(i)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048" }, "r476": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r477": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "610", "URI": "http://asc.fasb.org/topic&trid=49130413" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(10)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(8)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(9)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(8)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(l)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(m)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(o)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(p)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(q)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(s)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(e)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(e)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r583": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "http://asc.fasb.org/topic&trid=2235017" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "40", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109244457&loc=d3e16649-113920" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "740", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121829988&loc=d3e23524-113945" }, "r618": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r619": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "720", "URI": "http://asc.fasb.org/topic&trid=2122503" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123452999&loc=d3e28511-109314" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123452999&loc=d3e28200-109314" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123452999&loc=d3e28446-109314" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32059-109318" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31928-109318" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31958-109318" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(1),(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(4),(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "217", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=124434304&loc=d3e36027-109320" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r673": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(3)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=SL65897772-128472" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6411-128476" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(4)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "15", "SubTopic": "50", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6911878&loc=d3e8732-128492" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "50", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123385561&loc=d3e9135-128495" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "50", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9212-128498" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "30", "SubTopic": "50", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9215-128498" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "55", "SubTopic": "50", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6829253&loc=SL6831962-166255" }, "r709": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613674-111683" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569655-111683" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4616395-111683" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226006-175313" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r729": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r730": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r733": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959" }, "r734": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r735": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r736": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r737": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r738": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r739": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a-c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r740": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r741": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r742": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r743": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r744": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r745": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r746": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r747": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959" }, "r748": { "Name": "Accounting Standards Codification", "Paragraph": "4F", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624186-113959" }, "r749": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r750": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961" }, "r751": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Subparagraph": "(a)(1),(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986" }, "r752": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986" }, "r753": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008" }, "r754": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r755": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r756": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r757": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r758": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r759": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r760": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r761": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r762": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r763": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r764": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r765": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r766": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "http://asc.fasb.org/topic&trid=2229140" }, "r767": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r768": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r769": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r770": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r771": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r772": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r773": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r774": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258" }, "r775": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r776": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r777": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r778": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r779": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r780": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497" }, "r781": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r782": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r783": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r784": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r785": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r786": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r787": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r788": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497" }, "r789": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r790": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885" }, "r791": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892" }, "r792": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894" }, "r793": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895" }, "r794": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r795": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900" }, "r796": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r797": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r798": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r799": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i),(j),(k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r800": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r801": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r802": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r803": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r804": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6897108&loc=SL6897125-166521" }, "r805": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r806": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r807": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r808": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r809": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i-k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r810": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r811": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123389372&loc=d3e36991-112694" }, "r812": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(Note 1)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697" }, "r813": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(Note 3)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697" }, "r814": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717" }, "r815": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717" }, "r816": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123341672&loc=SL77916155-209984" }, "r817": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r818": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r819": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r820": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r821": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980" }, "r822": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980" }, "r823": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980" }, "r824": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r825": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r826": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r827": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r828": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r829": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580" }, "r830": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r831": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r832": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r833": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980" }, "r834": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r835": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/subtopic&trid=77888251" }, "r836": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846" }, "r837": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "848", "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846" }, "r838": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r839": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580" }, "r840": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r841": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764" }, "r842": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r843": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r844": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r845": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r846": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r847": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r848": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r849": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580" }, "r850": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r851": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r852": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r853": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r854": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r855": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r856": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r857": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r858": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r859": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580" }, "r860": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r861": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r862": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r863": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(1)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r864": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(2)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r865": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(3)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r866": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r867": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r868": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r869": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "17A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL34724391-108580" }, "r870": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r871": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r872": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r873": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r874": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r875": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.13,16)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r876": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r877": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r878": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r879": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r880": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r881": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(24))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r882": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(25))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r883": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r884": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r885": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r886": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r887": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r888": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817" }, "r889": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r890": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Subparagraph": "(b)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6479915&loc=d3e66715-112838" }, "r891": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788" }, "r892": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15)(b)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r893": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r894": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r895": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r896": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r897": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r898": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r899": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r900": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r901": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r902": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r903": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(f))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r904": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r905": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.16)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r906": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r907": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r908": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r909": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(20))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r910": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(21))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r911": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r912": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r913": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r914": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r915": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r916": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r917": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r918": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r919": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r920": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r921": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r922": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r923": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r924": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r925": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r926": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r927": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r928": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r929": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580" }, "r930": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r931": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r932": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "40", "Subparagraph": "(SAB Topic 5.W)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=27015833&loc=d3e570705-122907" }, "r933": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6487024&loc=d3e29054-158556" }, "r934": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r935": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r936": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580" }, "r937": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=120413209&loc=SL6242269-115581" }, "r938": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594" }, "r939": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r940": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r941": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r942": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r943": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r944": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r945": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r946": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r947": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r948": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r949": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r950": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r951": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r952": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r953": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r954": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r955": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r956": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r957": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r958": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r959": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r960": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r961": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r962": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848" }, "r963": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "848" }, "r964": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "848" }, "r965": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848" }, "r966": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r967": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "848" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" } }, "version": "2.1" } ZIP 95 0000081362-22-000007-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000081362-22-000007-xbrl.zip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
    5J0H2G;I7]A-;!QD<^2 M-,Q?%7PE[$8 Q>X>?D9;IG[Q1'Y=+:GZ/-X4NP*'61!Q+:@F-+?_P66YB-U1 M*7E!>,T CF6K0IJ"H 1$K54 .E9PN-YK+FG1G5=A.B9&L)@##>1*$HJSY-!0@ ML^%OP< ]E]O$K3+V_U&D81:$/O!%B8:2U@#.>;:%H@;XC%0#:>.P @XKIFO' MH6$OUMZ)78>B6=N%ZVB4(<2U.!KDWPFR>G?M4@[LFB]&N7BB6[YN ^-@5\.3 MSEWB];R_]TGLI6&BNA)N/@\#MVNAF&4>WR,N0.?N%)@9%>TWNT&MS<"7[_\: M9POBAY.0!/)P"Z\- $ 7;F%(F$,L"2SW,;V6Y#KJ.[F..B,7F7A%E.NSZZ@1 MNXZ7LG=BEE=L_%)==;1#8.46/*.MAO=@6,16!P*\G7F$I]XW<-,+*Z ;C.%SX= MQ2B$U=0@HUT6C=$81?K!UN"J\J6O=V12Q,$X^*O(9GX:+ALO^ M1FL*#L^%,2IJT*/V+E*T?DA37&UV&TRWUQOLX[FG146'IP_<$^GMMA5%0I#^^TE<7@C<5F]\L8 N;T7N9]/+?6J"B)S_5&P&U4",-% M;'-7AEY,)L3/;R;T97=T:3B;@4=)L*%@/@]#ZHU9QKYF1H;-1C$Q7)QR:5DU MNL23=ZWD/I[[9%2$KK3X[0*T4;0,%2&'=K7,/IZK951$SUXB6T"W43P-%V%= M&F KUR'="JWNC=B\,>(ZB?V"KB8Q[YZ0!CT!Z-X85>Q[:YJCME+C#1>A7=I/ M'*?.+4G#)* C3XF7D7-2_5<"5*LO -X;ZXE]!4X;W%8*TN&BMQ-Y3]$H7GRR4)V(TZA,$T1N;[5 82FN#'T?Y/*MT-U>3C+YD'86\ MI.^*JMW?>4$>DM7QG41@NVGV CEXO3'F#KF5S/01U[0<;G3L",7A=[A?/?;I MQF^9<+6A)T77K$Y7 +LW1N"1VD%Y==@UI[="<%W=K'?IA2D8K^0+_1(4:36^ MRJ5\7SS]1?S\(6$]8_AZ/6VF,L>]^N4?(4FIZF=J!UVU^GHRO-XG%V M-U&''I^W4:-(=G/)YV8>TE6IW6@:B"GK[M?@'(M5Z@]H=8)0$5V.,VT M&A7FJ(J(V@9.0UYGWG9[+Y,G:%:+%&MX)V'&>R(*1J)0)3Z *#XO+L&5IWCLR#;./[N1=%SF:R@;>#N- <2+!!A&9SV9QD411"Z/5L-G<>7:;UY54XH&TO.@>O M8[(@ 1W@Q9RD4SJX+U[ZC4#QE\ZFN*TA@6 'Z\XZXI["=RQN%,4C>KT8F/.. MR:AP&;Z =B$3O2S]30_@MD>1,[89Z5YI62]56M %P,1G M'DK5HIDAP ;-"F5V=:+L#Q+ ;G/LY^%S.96OO32EV])GXOK,V#E)P^=R)%=Q MEJ<%"/ NS+XI).6(FCZ.#D9NC\[78SM+XCSU_/R!OE-IM1 U!5B6S2RMY#(% M%?#GC@)0%.%_>Q3='R9%]SNCJ$HNF((.&G-T'Q]'C:\W;JN8@WF5Y5#B\/Z[ MMU"_9GNG$86RA\:<59 YGY-"?"C8>.I%D$-R/R,D+TWLD8 ME]+4XC<$2):-/JT/N43T?#)*(:(EI $-F@OPW^0SDFZ8VF=5^3;A>B=M!T-$ M$UB72I+MCE,!B()BZR5][=!0=9 )VU*0'U 4 \@VALG2YNDK^[-V^KHT/\]) M%D[5[VRS]V+XQ-K="TB/DZJH7,'M8$LT0S@O.BR^NCQ89-%)@^PZ:>LZ5#$U MN9)"\:$;Z/QRZ7TW;R^-L)[*MJ4[/0ME0THH#BW8W#SNN;U9IA[<:FPWD_4O M5Y6LJQJ3UTE^,YED)!]/J5V0Y6=)!*7:4R]2ED&[UX"XT,2G5!2K\CDQ(A(4 MGQZKTP2'+WZE%ZJ1,FNLTH\R.$Y[ (@F/T]%%2K$%F,=_L+N]A:<>G!_>FD( M'^)-M[0R,E9CB*L@]-3SE:#"50%0% >M;!)UWZ7S?N,[6&7N-6#I3DL A29G M2T7\2OL$#DH4!XBL\M.<'_^6FD74;O>F=+/U0-+YY\2+3Y,T3;Y3TT54:%[< M$ :)QI.O(DZV,U\))(H3+E;IAL,@ P7<3&H;6QG3=C. TQN#:5_18&)"9)VU M<):^M^G3.(N\+%M?IQL'F[Z6H2;W.;V1P5ZRC>V*!B:3^\1W+B@ 1>92,*Y+ MEQ$;LXE3>([G*\BT#YJ82I]C'Q94AHB6D 0VZ M]+66&47K&S*WSC2?:(H/R>9\BE%M4XH M;*=760A'N0J2EE<%6K=W>"K1^.X& B)W7/Q? MBQMZ*1Y69=;C-*X?E.@X?$.FS77+ASZUTU$ZUZG>FO!&X (%HA6!VVH#0- DFZF(7!Z!8^$;/AM=KIJE.[\: MH7J88_-Y ( F#*PB:DEH@X$-OXUG/)9Q[-+?^#5."=3#)D$]M)MX,T8/U]5< M1LEW,#Y(=IN2W'L9^WXQ+^!L2E"J$>IMIF0&GU4 "SJ%CB3RL?AF$"K"C#@% M'O GC'UQH5C\.YYZ. X<,49Y1_QE3B$)+BFO-E5Y=D45GU3ZNYA,"*0DDMLD M!7)?$_4T4K.O!7&B";IK,:!AL+"]K'[$CQV. U-L=2;3&!;8J[A2W%5,WJAN M' ?5^;:+%S\J@DKO*_W&),L>Z'(>F#0&B<'IV M.V%/,-CO.QN<]='I?)5JKY%9*^T+@*.Q][5T)3?\=03 .G?6U8F+<_*4E]$* M]T: M<)&84X:IZW;[QE,!G!;3 [73FH([0+1%$BF@"4DW,2(Q.\PR\\!M1O!33K>3 MR]OE/A,O(S=/43BM O4*F/B- 1JBG8A(_&)>2B$BV5P;IJ7;FH'5!>*780QY M56=)EF JB;O595NL$H/; MCD0VC9:4%%<>&F:KH[K M>&T.2RWW=Z<%!6&Y8I?""2V1>%6MEDTTO3X[94BI+C>0L##DRX4!#ODK9"VR MF@ ,9$6F^<(6+Y,<:"B7,WN U0LN*P769[X/F3O3[ MXBDKKZ'/+Y[!0:!F3G-:/8Z.G3H8&<-2FMW<=A20[>L!M.QJL=P%01D)0!0[ M L-4/'%ZRXH%*I[8OE5%[\2P6/"-N'BRA\4RLK*2N,S<>3,PI7TJLPT 0;-= MD(E;F85;V&PP,$OS#671G]XJBO[J\0H& MV=FJ)?B LB2W2P[VX-W204_:QQ\,+C)*@_Q"=3DOYM)A;CT' W6^B+"%QV8% M:_0VK%E[L]#@OER-%]Z+&B\VGP/).@\VL(7'X05C]"@V,(831XZ<%I0PE&-P M9+FH1//$D2-Q$0D^FI^)(T=.RTH82T4XLES(P4SBR)&X=H, &HI%T9BVCC]@ MRE9JY<$^_M!9';+&B2.EN-5IMP5M6,0[<>I$,$J\$]MN!#UWED#>^LP[L>5& M<+U6./W6FH@8'W_ $V 525G .1XJ''PSHJ31X%)*CD>H4TI*B0L,$!FR(7%O M8"DEQR,\*QY/WGSFR8#A2"DQ0[Q&WGQF*DE]X;$T563[01@$GHQ+GHQVR<)% M@N*HM2%VN$RLN"//2?0>7];144(C; N9"\X=OE*Y\YQ4LD.?8")H:%XSMGED0N5[2S)%TDJ9<3. IR3_PB M5;^64]@6E@P\*YI(]OQ5304@CD^K44*.!I#+>SQR'E=7DC-[#6R$%L7WU5@T MRVG28EV[0\-/S6P#0-!=_\83-W\=%&%#\4$VJ+#C/:?IB6\'I99MR6X%8#J+ M+:AD;0LDKD&^+7 H'&X&Z7?B]N" 6?J=='=H0"E36R#R!OP[P7-BP/2JX32J M3W*Z6])S%#&: PTH0:QJ 4Q+CXP%,0SMMO#=DN D2NXCRS7X#>U]],NN_\& M(@H3V)H6C_=PW ]_EL1YZOGJZ[NH*<#"5"A'004J%.4"1;):6M.E2VMYJS;Z M=V^A=>OB=B. @L9WK2!S/B>%^)"PTG%R MXD2XE9/ 0U&+V+CFCIW6?&6-2VE/RF\(D#"=II"(7H^.6Q!1[.2,$_+$JR;,?($C:5K:4UQR,2#6"R(D^X&$2 MV&5DA:6$J]A/X:*19C#,"\)4;Y)5:,G (TFD5&L&#T*B_$BB2@:9J]+*__6>RVO MD;Z9E /,LF)U'YX$D* E@$*38R$6/)^=8&V-C(F&(F>:^G[\VD/GYV MFX:Q'RZ\:#Q/TCS\=VEA_ _QTIN8C./@X7LB2/9NUB& 0F-@B06_R\;6L!%Z MY@V0U-SY*BWA&J3G4D,],*C8]Z&W (S"6V^A'+7)S2]@"P!T:.^&YT592U1_[#L CJ,J:T%OUE^$*"S31596KNM 10/3!P MQ)>BR_'5=!Q6A.@ Q]F;4R\+L_M%2KS@)O[32T/(%].B);<'"O*P!X;.@>(Y M'!G.FJ;#BOT*X+.">9 MGX8+8-#-9%,#I6JT$(J[ M@]L)T.-:X:4 )<,WA8<:)#IZ6.R_//JRHX-T6> MY5X<4!-6R9J2-0=X/3"F#L5UD-5 UNP<5H#HT*TMM3FLKW&1D6 GN4S1[%?N M"4#WP-8ZE-A:NGAK^@XKF'2(P_:J)'TS^8,$4VKYTL$I&UV[32FLHQY86X>* MUA878,W(8461CO"869L>F/,BI2M#E>2HA8W7"4#M@8EUI&%B2:#6?!U6*.G( MI8%U1Q:KY#&H\EA7^!G' ?V(A;D7K8N&2A#J= 6P>V!@'0D-K : :P8/*UYU M9"X1[PH8X$5G29PE41C0=0 RPLN:4\GF+R^>PCSP[B#L+(B0-N@-X/3 H#KB MIN UQUPGW \K5G5D+@&/*<=Q\%>1*3-2M0L8> ]LI"-NPITFT)I[PPI,'9G+ MM..+\2&IMTT7+PL29T3&0=VN*)#C'IA#1]PLNX: :TX.*PIU;"[);GD:<1S' M!?W@>-GL/'P. Q('V1V5:!KZP(]3+R/!37R6/)/8B[EG-1KW!Y!Z8 8=<]/K MVJ"N*3JLD%.S&ZJER75;LJ4_S@OXFSN4E&,2-*33+):_- M$%,2^E& 6/-R6,$?IZ5<67*_3F*_$OVG-,GDP*0] ,@>V#OB J_J.&N:#BOF M8[+JJWY*$J.8Q1T!G8?QU$19)GYG +T'EA"[FFPKR#6/AQ7Y<5I_EJ6'Y6?. M!(MY70'L'AA1XBJU#0#7%6V&%1XZ<6UCK8?UQ=N+6Z>.)OS-#'TCO= )0\=M;I3HT/_<\J#5?!Q54.OF S>2JY0]I8S)8 MTO8 $+]A52JA&4LW4=8$'51(Z>2#N2PZ>$FX>LE\^4EZ)1ZOY+>X$0P.O\53 M"I =OY1"JQDUJ/C1R0=SJ6]7<5! ,H(7!>291,D"WI72?\8%>4IB7D:[2E,8 M*'[;I!0FFUV* &N.#2H0=/+!I4E2%O+?3+V6P-AYG@(8X3= 2B'S/YL\5#7A M!A7A.1EALSNJA.OR^@F% @H*/0#('E@<(VV+@XVSINF@(CPG([=E$^JS?ZNX M1.V7D!?XX#<%6#TP,D:2L@A2@#4C!Q6K.1EAB]5LG?93]G=K] 2@>V"WC+0C M-6*\=;'W005J3D;FC)G_I/]/GR')Q"_%FM8+P5,=^O+%84.]3F#P/3!P1EP# M1QMJSD.9D.:G#U>ZH3*:6+HC:_<#U>CTP=D;<GT.Y91X M4!ZB+F2FD9FNW1\(H =6SYXXM-(0=4WHK5#+/]^O\=,A?*M_O?W;+;&0EYS$ M 5GYB;<$\_W[]]_^+KQO=%PS,O_-3^;O2[F<%AD%F&7W9%J66: #GR3I'$*5 M-Y,[LDC2'(9=__F\,,35+\PV6TI_>,A1NEU^^^Q-)IJFWF(6^%PEO MB16V>:0O<)F.=)W$7]6NAMUX$@;M?'>K(E;^Y-A%8^.^+#=\,KA14 (PGI.4 MCD!,H]T'8:C.-P4JPMQE$1>,C=M8W9#(Y??_XLO%6&E-6C\(0W;^Q581*G]) MV@%CXS94-V0RZ(946Y&RT+NEUN(D].6+TMMG8<#.78@J(N6L2QP\*&XG74(2 MLHGY+( PYXOY%"5/7G2_('[H1?EKO>DDXD^80DLZS'TT_A:6 -E>%C54**X: MO\^II0*PWEH*XQ=I/7!A6P#I,K&AS=2P?6%X2-^6T-"N1 MC],*P*#PH4FDS:>=&!@.B[0:6145I2.]BLM0Z3(8JY0 H-(%A>PT ?_>GY&@ MB,C-1##:T]?E'Q\@/"Q#K=\C",&N!>)%D9([3T57 B.W,?0EY7\M.0\H@OP? M?D(7YQ>Z+)<&T>_OELOT^N]1DI'@]W=Y6I"?#/I@,AV[X_VWY:3J&6V9^L43 M^76UE95,AL8*4-WC;@#'L=IC(7'7EIAI5YCEQ.RNJ,PUUV38;6R6^\MFIR$? MBR$%RVG?7;%<'"M2D &FL'<'._6/+G?J=]4!^$M* /H]S5//S_\5YK.S(LN3 M.4DO7ORH**]XA= RW1@^>"\2U UZ!"$X3RMKH#4^S9L+ >S;QTJG!GZ6X3@.$\2M) [J(] Q>EC8,.F/EI+FWTT@O3/[VH(/_$TI,8U& MY=A4OB4:B\)D$*U/B4Y($W\-U1((7>F[1-8BE;W;: M@=!.,R"-Y;QP6R^NPWEASF"[3N*D-D+$&P'.TS"(Z MI)C3G HHTW=.%BD,Z MY+!+$XOAVE'-"5JW !!],[ .A 86'^22G&XKR75(3I<1M,W/7*6(Y:7>$FS< M=I#3VC=;[$ 8))-!K6,$;DO'=VV++RIVA/=4+$O([/50" Y1;9>F.NJ\\IG1FB C M-'7/A )6I=86+$3D:J4AEVXRPU5;1K:KH+6MVC)B%T%3 X9B:V?\\]GS\_@C MO.?Q6:+F&!42?#A.O9EFWD#/SH_PGIUGJ4!@@BC@1.$2-F#NCIS6[ZL'=)=$ MT662?O=2WG$@00L @<9QS!,QGVU\1"B^N\94Y'+54SR7LSY5,K)=&EZ?4;OB ME'-J"6101'):JF.5)0-'F5,2G)<'16])&B:J:%A- 9;S? ZYV.6$$X!#L91L:^#ZE8D),5_%6HI08J]0% G1NV(L*GT3GZC2%4[$J'<$D)TGGLA5(F>J,E04 MY0B,T16#$5)]K:YB/R5TJ3@GU7]5UU%F8X"&SC39%;W" BJ"QSI]C25M^5-* MI\QVRG(&AR-]OY@790V:S7.25"SGF^?-W_9F.,=9FZJ7Y= ^LX9V^OK%^RM) MSR(O4_'E:/1$M7SBZ+4W)TKY/YJ] ?C.+J%0R!#2UQM_,VD:EQ00G7[TX6*1)4/AY3OQ9G$3)]+7B@_042+,. M 10:3V0SA>RRNK4X4+@LG9/=Y99\K3ZE=?OMXS!\-'&?9J+G+]8((Q*Y6 8_UNH].L%Q@Z-@M'JYJ+*. ++=#8GTR)B&9OC\UD8\ MB(-EG=+$I>?$61P,[<$U18TU^B)P!,':!'45]KV?>2DY]3*X0F0.Q>[*;]2U ME\(QEF?B.DZ[ULO%?!$EKX3 MD:(W>PV^DW[UG7X"QY"E\$!?HS"5MYZ%@=O]D+68K.85Q)_7+*F@,%]:J=9E M^B5'773IB:?E3H$NF.MG;KU7^%V)8 TC#FXC+U;VBMEX)8C1LDM5*[.!I6/! M!L^>1/H^._8/G=;B&W=U_;3)UMML",#2A=(N:4YY"3/&@ M2(\:T%0REVBU>4_R\BS+[GW)TNPJC5Y@^&A2JBSJAYUWI2\H''>O#F?JF"M) M71[9@N'%=/U[*F!X\#KI9!&V@R$.?$NVS\Z%414-CALQAS,AS%VX_3F)IP\D MG5_%/GUU^$S@99_S<"&=$I*6=)AX$F$LZH$]*=2$@^.2S:%,BSVWY9AA([T) M1_I=46@)'!OX)-J3U'B6"@=%9OM@)M&^TV-.MR0MKU^+EY%NM51Y3BL ,W ' M\[[X#)18,*Q:#"UW$VR4GR6)E@HMZ3IQC*/8_@"R=!P5^E=7L^!S8%$F+O(Z MNYY%^TZK$I3#>Q(L@LLU\.GM&E@7Y;I-J:IO)K3U/(G+K0'5I5\I1/JMM/)B M$*ES7[*ZZB5I #9%U"Z:V?U$09TWQMLLG(=96;8.;I#]XJ7?2%ZJI=;1N9=+ MOSH67PUB=>Y'5E=_BYR9]D)J%\GL?KHT,AOXPVRR$GWQ7L)Y,;\N0/DWDVK+ MNUR$O"FA_ZHW#3*H=M\.XG)NF*BKE>WAZDY.[0S\[F>"N6C%^F50NPZ*T5TG M,=G>^&9EW4?/AV%4LAPO%FGR3(++)+W*L@*LOXN7!8%H+[@DE< 9?!^(Q'ET M1%UU K9;DDR[0'OW_'9JAYO2@_(NJ.5[J, LWW5ACOUBR]NP1-K%R#MG_5XC MNYD=@PY3N@0D:97V^3TF:38+%V=>-KN#LVBQ.! M;0R#[8E%NL>T2+5@]LN) MN;]G+@NH%E$MD'$<%UYT*=S<UQ$W5DZ-IE(73/%7,F%7LZK3?= M#[1M-DLB7DENK3Y@Z#TQ;_:XYHTNVG:A_.ZY93"E:BFI#"25U)):1%Z\6$G+ MIPNW K5D7<# >V)*[/'SI?3 +HEUTA=BN;0.EN$>$K#'";97+"W3K]8)A6K[ MEG9C5!3NZ[7@UC[\#SUAH\F;B9N?F!-%**D1]4PR** $OK'L(3,8"@>V)QL&]2=B&M>BKU)1[F] YF3H[Q4E_I%R_W M9V$\W?I[]3&]F91_E$R3UOV#@'IB/XFO=S8EB9K>?8E?[;M,>VLN=&N\!I'T MQ(C;%^; M19!S>2^Q)^:W=(K.BWC;\@&[)2EUS>=+V6W]?=*=O,JR"<_4=.\ M;X#:$V.0?:NO22G4).U+$*G9%;\Z1[KJ"4ZW:Q<1-;C#9T+_&829GQ)XQDM? M-YMDX@75_(NH$-Q?'*RN+"%]S8JDYG)?0D-.;QF6:."<)_/J?KMVVP=)YR": MGIB%XAN+C8BA9G5?(E5.KRUNG%]7_L\=J4YGUW9\E>\]DI#=RCM!D#VQ"\77 M(]N43CTU^A*8:W9CV*.L>\Q;H*V)E=?HG,?<>3N:7Y"+NC'(W^]BK,\+9%R]=ZI]H%WEV%5>?%5O?>)P.J##WV),1Z8RPS\ MDWZYPGB:E:F3N9?2Q29*OI-T(?5-2%K",'MBBAUPF?7E3 K2'%O/H8 MW(79M\N4D*LX)Z"A.XMG%57?#P+NB<5TT*[(MR%)U=.G+\&R Y9T5HY "[AZ$[Y*WA.]A'K=C @^IY8T(=N M]#'XRO6HJEW=;>",(L2Y]=%I1JM.C41_=5WFRJT;^]]W5!]UW?YFZ'&H(ONT4Y#N*.^ %0VF5TI,V]K'AOCS>O(,''E"$5%-_, M5JIU'G(063.]J5-O^Q+$-A=2[XLO,+0H$12S8T D,W=,:?,(.,,BD%ZWH]2> MVA5#OR]DGWU?B*Z(?DX4DTKYV.RB4.9$6?F>2W56#N@F$T:K'X#@W+W?@8[8 M$Z>)J'[>M&M6.>;2 .LC[W&0V->\4P*%Q!UK4'GMJM9;; MS^NMS&K*W-FME25TZUD-C/&Z^-ZLCM+5UV;C+]Z/Z>K ZT)O#Z287S M\Y9LLPN=RXQEPS>9?ASZ7=H?V7=IJPF&=0E 5XE4IT46QB3+QGY5X@*L8)$OFIZ\;/SU059Y&_+(9;;H$,:"QNQ3TI9( MH8T>A?O<(L]=QF@98[M-DTM8_J[BC06DH"4^NYL!1^'6MDAL M')=HKW-"K@*Z.P@G(0G&64;R:MPI_2D./H?>4QA1""0KS]*1H/RNZJ_M1M[V MN'> )[2JH&659=^D8%#XJ:U-G(-F 4X'.Q^M;#NU[@"^X]Q0!>V8V>=LX!U$ M#JJT)6WM:3=!AX/-NJ0F.3B8T,JS_!.)N:A2R9;#I+ M4B\ZFY%YZ%=E![Q83BQ^(Q@00AH$I EFN*SN#EP M%%N0[?'!D.':E"C)BI2HNFB5^@#0.*+4UZ36T/K(JW[P0M@+@$43B]91CXJS M5@4YBD6[4VX[/3V\TDUUM5&V$4"*RP4*]J0IF<$7]YE-P[-&!/9,3_;9H\O_=A2YJ^5AB7/Y3P2F#+7SQ^O>>,>_T # O-SEU= MC+M39 <2BBUW9]1RZ8:Y3%(23M6/KNT\#P#0N%;4!X26GY:#YT: M>];C,H>633HC'NU#L3VGB'*@_'1J8B&)RQQ:-L[,L%AL@34'CF(ST*'_[?#8 MI>]Z=Y#LC?_XB:K2\WFW)3;M#N"CV=/J*(S/_(8B0+&>(V"#R_W)[GB7Y7QA MD-I8-]I28"=H=B8-M:+#^%WH/^E="M)I5?[=\=9753;B]V9C@(9FT])0+SH$ M9V!'NF_IG.$N7=&[XZWOF*0;V2*-;TJSJCK+J0V=WQ7 1I-*U5!G.NR72@+% MJ5<$<\&EJV]WO.NT"#KR3Y1/D -Q7I"'Y)[D>17WS63W"S;M%L2!QG'84)$I-])08SJS0B8(5HDW!$SH>"(< M.2U#(M/:+1UYNN$1.4M)$.H+0:53$$6/S? C<<&25C)!4444P4S!99ZSQVL( M-L#ML5E^)"Y.HBF%)?^/D?'?6ECMR&DE$^92I7HTH?'L;_ .$!1BLYRO6LW/ M1$.Y('7J(B:32Q->=-9')>FU3$V@J^C7V*LV%B2H+=%Q&F9A/#TO4OJ_U2I[ M2B9)2AZ\%Y4*S"[+QY2RH5JJD!DX^8I M"J?EGUH:;MQ^J4#PU/PQJ>+F!IU,5C^_SIKJ<'J!BFAUWM3[./BKR')8EB\I M-\"V[A<@(G8H-5?:[I0T)2NDD6W$<\C<39SEV_S-MX7EVR*J MG@4LABN%"2:,>B

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